data_1ah9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ah9 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 . . . . . 0 CA--C 1.571 1.772 0 CA-C-O 121.302 0.572 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -96.66 141.13 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 124.187 0.995 . . . . 0.0 110.104 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.378 14.7 pt-20 -92.29 126.21 37.27 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 124.858 2.266 . . . . 0.0 109.536 165.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.283 20.4 ttt -168.46 82.96 0.16 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 109.968 -3.287 . . . . 0.0 104.765 -152.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.666 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -98.47 -153.03 0.42 Allowed 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 -159.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -167.36 -174.37 36.39 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 120.487 2.955 . . . . 0.0 120.487 -170.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.7 m -100.54 124.97 46.81 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.465 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 67.3 t -60.66 117.54 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.763 0 CA-C-N 121.096 1.771 . . . . 0.0 107.294 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.302 73.3 mt -100.95 -26.43 13.74 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.169 -1.582 . . . . 0.0 112.773 171.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -136.42 145.86 45.74 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 123.09 1.424 . . . . 0.0 109.487 162.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' MET . 5.8 p -96.61 110.27 22.72 Favored 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 100.827 -3.768 . . . . 0.0 100.827 168.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.429 2.5 mt -79.65 -124.89 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.91 0 CA-C-O 113.986 -2.911 . . . . 0.0 115.655 -159.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.36 -70.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.185 1 CA-C-N 130.561 4.807 . . . . 0.0 116.243 -176.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -78.67 -70.31 0.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.251 -0.906 . . . . 0.0 110.731 175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 m -159.33 75.89 0.67 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 15' ' ' THR . 67.9 mtt -118.58 -175.42 2.88 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.512 0.725 . . . . 0.0 111.426 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -144.29 109.88 5.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 119.454 -2.029 . . . . 0.0 106.398 -166.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -85.32 93.86 8.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 170.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 t -100.94 135.21 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -163.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -85.91 116.18 23.99 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.298 4.7 mt -70.52 174.95 5.2 Favored 'General case' 0 CA--C 1.577 1.99 0 CA-C-O 124.112 1.91 . . . . 0.0 112.569 -172.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -24.17 63.21 Favored 'General case' 0 CA--C 1.586 2.355 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.908 165.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.6 -8.25 56.3 Favored 'General case' 0 CA--C 1.586 2.365 0 C-N-CA 126.186 1.794 . . . . 0.0 115.398 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.72 9.31 75.08 Favored Glycine 0 CA--C 1.554 2.521 0 N-CA-C 119.496 2.558 . . . . 0.0 119.496 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -114.36 147.45 39.14 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 118.665 1.232 . . . . 0.0 112.452 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.4 t -82.27 126.88 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.861 -1.149 . . . . 0.0 111.216 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.3 147.68 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.598 1.19 . . . . 0.0 112.791 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.9 m -89.59 123.64 33.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.72 -1.238 . . . . 0.0 109.08 172.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.31 155.17 47.9 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 159.71 19.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 172.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -73.0 176.33 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.631 0 O-C-N 119.973 -1.704 . . . . 0.0 110.758 166.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 92.5 p -79.9 25.24 0.37 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 121.086 3.735 . . . . 0.0 121.086 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.85 -52.44 1.63 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.295 64.4 pttt -59.83 -58.17 9.73 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 118.061 2.615 . . . . 0.0 118.061 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -21.5 62.97 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -38.44 -39.02 0.42 Allowed 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . 0.258 14.4 mptt -98.02 -4.55 35.87 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 121.639 3.94 . . . . 0.0 121.639 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -93.46 53.25 1.86 Allowed 'General case' 0 CA--C 1.587 2.404 0 N-CA-C 102.316 -3.216 . . . . 0.0 102.316 153.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.416 1.8 t80 -45.74 98.11 0.01 OUTLIER 'General case' 0 C--N 1.379 1.86 0 N-CA-C 118.679 2.844 . . . . 0.0 118.679 -152.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mt -82.07 74.53 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 109.175 -3.648 . . . . 0.0 107.562 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 137.96 58.03 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 -170.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.274 1.4 pt -141.78 154.96 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 CA-C-N 111.466 -2.606 . . . . 0.0 111.87 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 tp -131.39 -174.44 3.4 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.128 0.966 . . . . 0.0 111.033 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -72.87 84.88 1.24 Allowed 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 123.317 1.532 . . . . 0.0 113.074 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 130.34 25.23 0.88 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 117.631 1.812 . . . . 0.0 117.631 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.55 165.62 12.44 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 123.2 1.476 . . . . 0.0 114.131 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -84.73 82.65 8.33 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 125.583 2.611 . . . . 0.0 113.674 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 m -79.03 152.82 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 CA-C-N 110.595 -3.002 . . . . 0.0 113.284 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.475 ' HA ' ' CB ' ' A' ' 9' ' ' GLN . 63.8 m -94.76 161.15 14.29 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 160.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.666 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -157.35 86.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 O-C-N 118.128 -2.858 . . . . 0.0 105.658 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -78.19 138.6 38.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.102 -0.999 . . . . 0.0 109.743 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -136.0 -179.32 5.59 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.665 1.221 . . . . 0.0 111.699 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 p -100.36 161.06 25.28 Favored Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -53.9 -43.48 57.7 Favored 'Trans proline' 0 CA--C 1.572 2.388 0 C-N-CA 123.231 2.621 . . . . 0.0 118.22 163.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -82.87 -49.39 9.71 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.72 83.25 2.23 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 122.25 1.024 . . . . 0.0 112.049 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -17.1 61.17 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.2 p -68.97 -7.97 40.26 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -122.73 -177.74 3.73 Favored 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 119.963 1.256 . . . . 0.0 114.056 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.33 177.0 48.29 Favored Glycine 0 CA--C 1.548 2.127 0 N-CA-C 117.686 1.834 . . . . 0.0 117.686 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -162.69 115.86 1.67 Allowed 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 172.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -38.99 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 118.929 -2.357 . . . . 0.0 116.912 165.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.279 2.1 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.538 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 CA--C 1.575 1.925 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -89.16 138.44 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.427 -1.421 . . . . 0.0 111.741 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.332 10.5 pt-20 -93.74 123.29 36.99 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 125.257 2.456 . . . . 0.0 109.219 168.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.26 20.5 ttt -170.34 85.08 0.11 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 109.173 -3.649 . . . . 0.0 104.626 -151.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.67 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -105.16 -149.24 0.41 Allowed 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -162.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.29 -142.44 5.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.8 m -122.86 135.26 54.46 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 54.0 t -58.99 124.6 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.607 3.168 0 O-C-N 121.364 -0.835 . . . . 0.0 109.528 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.5 mt -90.66 -27.6 18.92 Favored 'General case' 0 N--CA 1.514 2.737 0 O-C-N 119.314 -2.116 . . . . 0.0 112.031 163.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -148.47 143.51 26.77 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 120.83 -1.169 . . . . 0.0 111.736 166.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.1 p -103.94 103.76 13.64 Favored 'General case' 0 N--CA 1.518 2.958 0 N-CA-C 102.087 -3.301 . . . . 0.0 102.087 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.393 0.2 OUTLIER -77.08 178.6 1.97 Allowed Pre-proline 0 CA--C 1.593 2.626 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -168.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -54.41 -36.15 86.81 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 N-CA-C 121.25 3.519 . . . . 0.0 121.25 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -79.74 -100.78 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.4 m -152.97 72.77 0.97 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 76.0 mtp -126.04 162.7 24.68 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -132.77 114.48 14.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.141 -1.6 . . . . 0.0 107.087 -163.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.2 ttm105 -85.67 89.41 7.73 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.3 t -96.3 137.29 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -162.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.7 111.82 22.4 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.302 4.9 mt -72.3 174.24 7.56 Favored 'General case' 0 CA--C 1.577 2.002 0 CA-C-O 124.135 1.921 . . . . 0.0 112.779 -173.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.96 -22.59 61.43 Favored 'General case' 0 CA--C 1.585 2.298 0 CA-C-N 113.804 -1.544 . . . . 0.0 114.128 166.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -74.58 -9.09 58.23 Favored 'General case' 0 CA--C 1.587 2.366 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.68 23.79 55.09 Favored Glycine 0 CA--C 1.555 2.54 0 N-CA-C 118.632 2.213 . . . . 0.0 118.632 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -125.94 145.71 50.16 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.309 1.044 . . . . 0.0 111.224 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.0 t -86.04 117.5 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.728 -1.232 . . . . 0.0 110.123 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.7 148.9 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.1 m -92.54 125.5 37.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.405 -1.434 . . . . 0.0 110.062 173.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.32 159.84 40.79 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 177.11 4.75 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 165.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 pt -88.99 -178.27 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.36 0 O-C-N 119.211 -2.181 . . . . 0.0 110.632 165.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.4 p -82.49 122.32 27.9 Favored 'General case' 0 CA--C 1.56 1.33 0 O-C-N 119.714 -1.866 . . . . 0.0 109.205 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.49 -20.34 0.59 Allowed Glycine 0 N--CA 1.503 3.161 0 N-CA-C 122.312 3.685 . . . . 0.0 122.312 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -71.24 -55.75 7.46 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 125.641 1.577 . . . . 0.0 114.405 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 ptm -69.39 -20.54 63.81 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -37.93 -35.66 0.16 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -94.47 33.58 1.4 Allowed 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -150.93 -69.93 0.18 Allowed 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.408 ' HH ' ' CD1' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -82.64 101.04 10.55 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 163.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.83 -73.55 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.439 -0.788 . . . . 0.0 109.381 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -132.1 -179.27 5.31 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-O 124.512 2.101 . . . . 0.0 114.316 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.408 ' CD1' ' HH ' ' A' ' 43' ' ' TYR 0.258 1.1 pt -143.39 175.67 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 C-N-CA 126.932 2.093 . . . . 0.0 110.858 -173.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.4 158.5 16.3 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.256 1.027 . . . . 0.0 111.115 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 m -71.58 86.84 0.9 Allowed 'General case' 0 CA--C 1.572 1.807 0 CA-C-O 123.577 1.655 . . . . 0.0 110.423 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.447 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 130.36 24.2 0.95 Allowed Glycine 0 N--CA 1.492 2.423 0 CA-C-N 113.02 -1.9 . . . . 0.0 117.049 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -94.57 162.3 13.86 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-O 122.976 1.37 . . . . 0.0 114.166 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -85.59 81.35 8.7 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 125.575 2.607 . . . . 0.0 113.796 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -77.79 158.15 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 110.324 -3.126 . . . . 0.0 113.839 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.513 ' HA ' ' CB ' ' A' ' 9' ' ' GLN 0.299 35.3 m -95.44 162.78 13.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 160.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.67 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -158.44 89.55 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 118.473 -2.642 . . . . 0.0 104.897 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.55 134.87 36.5 Favored 'General case' 0 CA--C 1.563 1.47 0 O-C-N 121.17 -0.956 . . . . 0.0 110.014 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.45 ' HB3' ' H ' ' A' ' 57' ' ' THR . 3.4 mp -101.06 -171.76 2.05 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 125.972 2.796 . . . . 0.0 111.878 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.45 ' H ' ' HB3' ' A' ' 56' ' ' LEU . 1.2 p -122.5 162.04 40.32 Favored Pre-proline 0 CA--C 1.577 1.987 0 CA-C-N 109.657 -3.429 . . . . 0.0 112.657 173.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -52.85 -41.27 71.6 Favored 'Trans proline' 0 CA--C 1.569 2.249 0 C-N-CA 123.656 2.904 . . . . 0.0 119.166 164.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -95.21 -52.81 4.03 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -91.39 77.03 5.87 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 122.528 1.156 . . . . 0.0 112.779 -172.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.5 mt -70.89 -22.86 62.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 117.643 2.46 . . . . 0.0 117.643 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.5 t -75.89 6.95 4.41 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -139.8 166.48 24.5 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 120.564 1.529 . . . . 0.0 113.475 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.14 -164.08 29.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 115.633 1.013 . . . . 0.0 115.633 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.95 122.31 2.57 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.493 HG13 ' H ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -35.64 91.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 166.326 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.268 2.8 m . . . . . 0 CA--C 1.567 1.616 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.412 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 m120 . . . . . 0 CA--C 1.573 1.83 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.08 142.24 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.615 1.166 . . . . 0.0 109.661 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.409 16.3 pt-20 -95.03 122.27 37.51 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 125.036 2.351 . . . . 0.0 109.82 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.275 18.6 ttt -168.34 81.2 0.16 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 109.777 -3.374 . . . . 0.0 105.683 -149.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.695 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -96.04 -149.86 0.32 Allowed 'General case' 0 CA--C 1.563 1.456 0 N-CA-C 118.713 2.857 . . . . 0.0 118.713 -157.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.88 -178.34 39.27 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 121.951 3.54 . . . . 0.0 121.951 -168.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.6 m -99.73 124.88 45.43 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 61.4 t -60.2 122.14 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.989 0 CA-C-N 120.487 1.494 . . . . 0.0 107.253 175.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.299 62.6 mt -99.51 -22.06 15.65 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 119.823 -1.798 . . . . 0.0 112.844 168.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -145.01 143.84 30.7 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 122.372 1.082 . . . . 0.0 110.833 161.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 20' ' ' MET . 24.7 p -106.17 106.58 17.16 Favored 'General case' 0 N--CA 1.515 2.798 0 N-CA-C 101.395 -3.557 . . . . 0.0 101.395 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.374 0.3 OUTLIER -76.48 174.37 5.81 Favored Pre-proline 0 CA--C 1.591 2.544 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -167.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -47.11 -42.22 26.42 Favored 'Trans proline' 0 CA--C 1.565 2.064 0 N-CA-C 121.493 3.613 . . . . 0.0 121.493 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -80.49 -93.21 0.05 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.9 m -159.5 75.38 0.64 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 15' ' ' THR . 69.6 mtm -126.78 167.87 15.19 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.795 0.838 . . . . 0.0 112.512 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -132.22 114.89 15.0 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 118.703 -2.498 . . . . 0.0 108.815 -163.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -87.05 95.89 10.1 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 170.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 t -105.13 139.97 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -162.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.87 111.57 18.88 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 167.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.257 0.1 OUTLIER -79.84 166.21 21.93 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 121.879 2.127 . . . . 0.0 113.082 -179.971 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.308 18.1 pt-20 -67.41 -6.35 18.78 Favored 'General case' 0 CA--C 1.579 2.065 0 CA-C-N 112.677 -2.056 . . . . 0.0 114.959 169.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.491 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 45.8 t-20 -86.41 -15.47 40.23 Favored 'General case' 0 CA--C 1.588 2.408 0 O-C-N 121.129 -0.982 . . . . 0.0 112.721 162.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.51 -25.73 24.89 Favored Glycine 0 CA--C 1.549 2.178 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -75.17 140.2 43.18 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 124.292 1.037 . . . . 0.0 112.334 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.4 t -81.53 112.69 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 122.688 1.232 . . . . 0.0 108.947 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.91 147.63 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 114.129 -1.396 . . . . 0.0 113.465 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 m -87.3 127.19 35.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.805 -1.184 . . . . 0.0 108.54 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.16 152.3 49.78 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.1 151.29 42.2 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 170.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.57 162.68 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.437 0 O-C-N 120.738 -1.226 . . . . 0.0 111.287 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.7 p -76.52 98.4 4.63 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 119.246 -2.159 . . . . 0.0 109.937 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -16.52 -50.19 0.01 OUTLIER Glycine 0 N--CA 1.505 3.234 1 N-CA-C 123.761 4.264 . . . . 0.0 123.761 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -47.69 -49.51 27.57 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 119.065 2.987 . . . . 0.0 119.065 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ptm -70.89 -18.08 62.69 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -39.6 -35.54 0.32 Allowed 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 169.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -92.79 34.06 1.11 Allowed 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -150.23 -71.63 0.18 Allowed 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 102.958 -2.978 . . . . 0.0 102.958 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -81.09 93.49 6.43 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.802 1.241 . . . . 0.0 107.771 164.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mt -74.01 -70.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.217 -0.927 . . . . 0.0 111.491 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -134.78 171.94 13.67 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 125.284 2.469 . . . . 0.0 115.009 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.265 1.0 OUTLIER -148.73 170.36 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 CA-C-N 110.85 -2.886 . . . . 0.0 109.777 -175.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.6 tp -109.43 163.41 13.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.891 -1.13 . . . . 0.0 112.986 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.8 m -71.48 85.15 0.84 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 123.813 1.768 . . . . 0.0 111.095 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.407 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 131.77 23.15 0.89 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 112.8 -2.0 . . . . 0.0 117.053 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -94.5 160.89 14.44 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 123.043 1.401 . . . . 0.0 113.145 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -88.78 83.63 6.69 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 124.999 2.333 . . . . 0.0 112.475 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -71.76 163.35 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 CA-C-N 110.802 -2.908 . . . . 0.0 114.34 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.487 ' HA ' ' CB ' ' A' ' 9' ' ' GLN 0.306 75.3 m -95.13 160.2 14.67 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 159.224 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.695 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -158.44 84.55 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 O-C-N 118.37 -2.706 . . . . 0.0 105.769 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -76.77 134.8 39.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.019 -1.051 . . . . 0.0 109.838 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -137.61 -172.14 3.16 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.821 0.82 . . . . 0.0 111.299 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -104.79 155.74 37.04 Favored Pre-proline 0 CA--C 1.573 1.833 0 O-C-N 120.993 -1.067 . . . . 0.0 113.259 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -54.34 -42.03 71.2 Favored 'Trans proline' 0 CA--C 1.572 2.392 0 C-N-CA 123.738 2.959 . . . . 0.0 118.387 164.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -79.42 -47.38 15.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -108.22 89.24 2.93 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 122.195 0.998 . . . . 0.0 110.308 -174.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.82 -14.9 57.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 118.996 2.962 . . . . 0.0 118.996 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.9 t -73.46 -1.28 17.74 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -129.56 -177.5 4.29 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 120.276 1.398 . . . . 0.0 113.277 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.0 -173.86 45.22 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -161.63 113.65 1.77 Allowed 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 119.595 3.183 . . . . 0.0 119.595 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -36.45 94.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 118.762 -2.461 . . . . 0.0 117.556 166.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.57 1.737 0 CA-C-N 114.062 -1.426 . . . . 0.0 112.847 176.727 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 . . . . . 0 CA--C 1.568 1.667 0 CA-C-O 120.813 0.34 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -91.33 142.05 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.847 -1.158 . . . . 0.0 111.227 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.337 13.2 pt-20 -100.28 123.17 44.18 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 123.705 1.717 . . . . 0.0 110.177 169.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.261 13.9 ttt -155.15 -12.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 119.315 3.08 . . . . 0.0 119.315 -151.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.586 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.503 0.0 OUTLIER -69.68 -173.02 0.55 Allowed 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 121.765 3.987 . . . . 0.0 121.765 -169.915 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.56 -108.64 1.78 Allowed Glycine 0 N--CA 1.48 1.567 0 N-CA-C 122.442 3.737 . . . . 0.0 122.442 -164.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.7 m -121.43 136.92 54.91 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.517 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 79.1 t -62.76 117.05 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.91 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.7 mt -79.34 -37.36 37.71 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 122.107 2.231 . . . . 0.0 111.236 165.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -143.31 144.96 32.31 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 122.062 0.934 . . . . 0.0 112.346 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 20' ' ' MET . 32.2 p -104.2 109.3 21.06 Favored 'General case' 0 N--CA 1.513 2.725 0 N-CA-C 101.763 -3.421 . . . . 0.0 101.763 171.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.376 0.5 OUTLIER -77.32 -177.51 0.81 Allowed Pre-proline 0 CA--C 1.592 2.559 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -167.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -54.38 -36.59 87.8 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 N-CA-C 120.893 3.382 . . . . 0.0 120.893 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -85.72 -93.83 0.08 Allowed 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.624 ' HG1' ' NE ' ' A' ' 45' ' ' ARG . 23.0 m -156.23 74.89 0.86 Allowed 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 174.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 15' ' ' THR . 57.9 mtt -130.23 162.25 29.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.976 -1.077 . . . . 0.0 112.76 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -128.75 113.3 15.16 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 118.723 -2.485 . . . . 0.0 106.979 -162.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.594 ' NE ' ' HG1' ' A' ' 32' ' ' THR . 1.2 mpt_? -85.76 96.11 9.62 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 167.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.95 140.13 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -164.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.06 114.92 26.67 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.426 HD21 ' H ' ' A' ' 26' ' ' GLU 0.256 0.5 OUTLIER -58.4 178.07 0.11 Allowed 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -177.751 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.426 ' H ' HD21 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -66.49 -24.57 66.42 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 167.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -92.63 6.96 45.44 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 170.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.9 -1.74 87.86 Favored Glycine 0 CA--C 1.554 2.519 0 N-CA-C 119.911 2.725 . . . . 0.0 119.911 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -83.9 143.19 30.04 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.641 1.72 . . . . 0.0 113.262 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.5 t -89.05 130.84 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.663 0 CA-C-O 122.578 1.18 . . . . 0.0 111.52 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.86 153.92 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.54 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.594 ' HG1' ' NE ' ' A' ' 22' ' ' ARG . 53.0 m -99.51 122.0 41.97 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.495 -1.378 . . . . 0.0 109.853 174.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.39 149.36 32.6 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 119.733 3.235 . . . . 0.0 119.733 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -99.95 158.26 15.94 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.509 -1.37 . . . . 0.0 111.206 170.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.17 178.21 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.752 0 O-C-N 120.444 -1.41 . . . . 0.0 111.981 164.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.2 p -80.08 15.72 1.42 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 120.07 3.359 . . . . 0.0 120.07 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.67 -25.66 0.06 OUTLIER Glycine 0 N--CA 1.506 3.33 0 N-CA-C 121.842 3.497 . . . . 0.0 121.842 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -79.99 -45.95 17.51 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -46.25 89.42 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 118.537 2.792 . . . . 0.0 118.537 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.6 ptm85 -36.28 -45.99 0.5 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.806 3.262 . . . . 0.0 119.806 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -92.0 0.6 57.47 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-N 110.048 -3.251 . . . . 0.0 118.929 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -96.57 -71.58 0.67 Allowed 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 167.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.27 125.81 37.09 Favored 'General case' 0 CA--C 1.57 1.744 0 C-N-CA 124.154 0.982 . . . . 0.0 109.122 170.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.57 108.99 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.722 0 CA-C-O 124.429 2.061 . . . . 0.0 107.747 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.624 ' NE ' ' HG1' ' A' ' 19' ' ' THR . 4.7 ppt_? -44.66 174.62 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.878 1 N-CA-C 124.267 4.914 . . . . 0.0 124.267 -165.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -75.57 159.79 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 109.845 -3.343 . . . . 0.0 116.604 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -122.44 174.77 6.82 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.184 0.993 . . . . 0.0 112.285 -171.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -68.47 100.61 1.11 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 123.494 1.616 . . . . 0.0 112.576 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.517 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 113.36 20.47 6.22 Favored Glycine 0 N--CA 1.489 2.224 0 CA-C-N 112.837 -1.983 . . . . 0.0 117.883 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.55 158.58 15.92 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-O 122.917 1.341 . . . . 0.0 112.764 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -87.75 94.54 9.78 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 125.764 2.697 . . . . 0.0 113.106 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.56 148.12 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 CA-C-N 109.594 -3.457 . . . . 0.0 110.986 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.2 m -140.94 107.19 5.23 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 100.33 -3.952 . . . . 0.0 100.33 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.586 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.252 51.0 t -117.17 128.45 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 111.177 -2.738 . . . . 0.0 106.042 -159.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -80.65 134.32 35.86 Favored 'General case' 0 CA--C 1.558 1.266 0 O-C-N 121.345 -0.847 . . . . 0.0 112.182 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.56 -176.38 3.37 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.488 1.137 . . . . 0.0 110.707 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 p -108.56 164.12 15.44 Favored Pre-proline 0 CA--C 1.571 1.772 0 O-C-N 120.987 -1.071 . . . . 0.0 113.883 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -51.09 -40.77 59.26 Favored 'Trans proline' 0 CA--C 1.572 2.393 0 N-CA-C 118.976 2.645 . . . . 0.0 118.976 163.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -94.98 -53.39 3.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.508 ' HD2' ' NZ ' ' A' ' 63' ' ' LYS . 49.1 t0 -89.63 79.87 6.73 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.576 1.179 . . . . 0.0 111.924 -172.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.65 -21.23 57.88 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.2 t -77.64 11.75 1.95 Allowed 'General case' 0 CA--C 1.58 2.127 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 173.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.508 ' NZ ' ' HD2' ' A' ' 60' ' ' ASP . 15.3 mtmm -137.56 177.38 7.91 Favored 'General case' 0 CA--C 1.57 1.742 0 CA-C-N 120.249 1.386 . . . . 0.0 114.612 -175.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.2 -176.25 45.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.22 114.85 3.69 Favored 'General case' 0 CA--C 1.592 2.58 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 168.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.548 ' H ' HG12 ' A' ' 54' ' ' VAL . 1.3 mp -45.13 108.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 O-C-N 119.076 -2.265 . . . . 0.0 114.893 171.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.574 1.87 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.799 173.74 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 . . . . . 0 CA--C 1.579 2.066 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mt -88.99 138.73 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.294 -1.504 . . . . 0.0 112.298 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.328 8.6 pt-20 -88.56 121.63 31.15 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 125.052 2.358 . . . . 0.0 109.235 170.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 18.0 ttt -172.01 84.79 0.07 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 109.289 -3.596 . . . . 0.0 104.852 -148.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.774 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -110.92 -149.03 0.44 Allowed 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -156.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 -150.72 9.44 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 117.967 1.947 . . . . 0.0 117.967 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.9 m -115.89 133.79 55.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.464 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 46.9 t -60.06 118.31 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.003 0 O-C-N 121.384 -0.822 . . . . 0.0 109.102 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -84.24 -31.44 25.01 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.599 -1.938 . . . . 0.0 111.874 165.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -147.04 143.88 28.7 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 122.726 1.251 . . . . 0.0 111.807 167.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 20' ' ' MET . 24.3 p -104.16 105.68 15.93 Favored 'General case' 0 N--CA 1.516 2.862 0 N-CA-C 100.793 -3.781 . . . . 0.0 100.793 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.371 0.3 OUTLIER -75.26 173.39 7.06 Favored Pre-proline 0 CA--C 1.591 2.526 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -167.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -47.58 -35.26 22.14 Favored 'Trans proline' 0 CA--C 1.567 2.128 0 N-CA-C 122.103 3.847 . . . . 0.0 122.103 -174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -85.3 -96.34 0.07 Allowed 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 m -157.68 73.38 0.7 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 15' ' ' THR . 95.9 mtp -125.38 167.27 15.19 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.385 1.074 . . . . 0.0 112.529 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -130.04 114.06 15.32 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 118.883 -2.386 . . . . 0.0 108.363 -164.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.2 ttm105 -85.34 97.95 10.26 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.75 143.03 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -162.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -88.13 106.73 18.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 171.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.285 3.8 mt -72.31 176.37 5.34 Favored 'General case' 0 CA--C 1.58 2.107 0 CA-C-O 123.995 1.855 . . . . 0.0 113.208 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.77 -25.12 62.75 Favored 'General case' 0 CA--C 1.585 2.304 0 CA-C-N 114.088 -1.415 . . . . 0.0 114.101 166.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -72.02 -5.83 37.84 Favored 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.72 -4.47 79.0 Favored Glycine 0 CA--C 1.557 2.706 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -88.33 147.71 24.64 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.77 1.228 . . . . 0.0 112.903 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.44 106.84 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.95 151.32 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.1 m -92.53 124.83 36.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.525 -1.359 . . . . 0.0 109.005 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.53 159.59 41.34 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -113.25 -164.28 0.91 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 169.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.437 HD13 ' H ' ' A' ' 40' ' ' ARG . 0.6 OUTLIER -108.34 -177.94 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.384 0 O-C-N 120.254 -1.529 . . . . 0.0 108.369 166.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 84.8 p -76.79 20.08 0.26 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.98 -55.18 0.79 Allowed Glycine 0 N--CA 1.499 2.871 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -57.11 -52.54 64.9 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.259 0.7 OUTLIER -70.11 -19.48 63.24 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 117.611 2.449 . . . . 0.0 117.611 177.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.437 ' H ' HD13 ' A' ' 35' ' ' ILE . 79.7 mtt-85 -39.43 -35.59 0.29 Allowed 'General case' 0 CA--C 1.578 2.056 0 N-CA-C 117.338 2.347 . . . . 0.0 117.338 170.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.8 38.62 1.21 Allowed 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 171.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -152.93 -74.82 0.13 Allowed 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.423 ' HH ' HG12 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -86.44 99.75 11.87 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 164.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mt -76.39 -64.59 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 O-C-N 121.666 -0.646 . . . . 0.0 111.773 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -128.47 167.42 17.08 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 119.94 3.311 . . . . 0.0 119.94 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.423 HG12 ' HH ' ' A' ' 43' ' ' TYR 0.268 1.5 pt -142.65 170.83 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 109.57 -3.468 . . . . 0.0 110.666 176.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.3 tp -111.22 163.27 14.1 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.147 0.975 . . . . 0.0 111.406 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.1 m -69.97 88.41 0.57 Allowed 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 123.451 1.596 . . . . 0.0 111.206 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.464 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 129.49 22.17 1.22 Allowed Glycine 0 N--CA 1.493 2.473 0 CA-C-N 113.184 -1.825 . . . . 0.0 117.304 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -93.42 160.33 14.86 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 122.891 1.329 . . . . 0.0 113.478 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -88.35 84.54 6.83 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 125.438 2.542 . . . . 0.0 112.765 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -71.13 166.63 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-N 110.156 -3.202 . . . . 0.0 115.218 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.515 ' HA ' ' CB ' ' A' ' 9' ' ' GLN 0.321 14.3 m -125.95 75.71 1.53 Allowed 'General case' 0 N--CA 1.508 2.445 0 CA-C-O 123.798 1.761 . . . . 0.0 113.54 171.283 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.774 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -75.04 101.3 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.315 1.446 . . . . 0.0 109.528 -172.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -80.65 146.01 31.36 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.277 1.037 . . . . 0.0 109.911 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.39 -173.46 2.57 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 124.623 2.154 . . . . 0.0 116.405 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 p -131.32 153.84 81.76 Favored Pre-proline 0 CA--C 1.578 2.045 0 CA-C-N 111.027 -2.806 . . . . 0.0 111.421 165.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.2 -42.85 61.93 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 123.734 2.956 . . . . 0.0 118.352 165.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -87.27 -54.4 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -96.86 74.25 2.65 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -171.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.8 mp -66.11 -20.99 66.33 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.3 m -73.36 1.55 9.38 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -135.36 169.89 16.78 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 123.333 1.54 . . . . 0.0 111.963 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.55 -164.83 31.69 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 115.87 1.108 . . . . 0.0 115.87 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.24 110.83 1.21 Allowed 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 119.234 3.049 . . . . 0.0 119.234 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.43 ' H ' ' HA ' ' A' ' 54' ' ' VAL 0.264 0.7 OUTLIER -25.1 89.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 163.924 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 CA--C 1.568 1.647 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.459 173.523 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 . . . . . 0 CA--C 1.572 1.821 0 CA-C-O 121.567 0.698 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.5 140.11 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.58 1.152 . . . . 0.0 110.444 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.375 11.4 pt-20 -92.21 123.48 35.58 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 124.644 2.164 . . . . 0.0 109.81 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.259 25.2 ttt -172.62 86.93 0.07 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 110.143 -3.208 . . . . 0.0 105.228 -147.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.792 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -116.24 -147.07 0.41 Allowed 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -156.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.88 -144.59 9.02 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 121.23 3.252 . . . . 0.0 121.23 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.2 m -102.74 129.54 49.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.235 -0.568 . . . . 0.0 109.611 -176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 56.0 t -61.64 123.46 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.773 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 173.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.296 63.3 mt -101.68 -17.53 16.26 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 119.816 -1.803 . . . . 0.0 112.99 167.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -148.18 143.35 27.0 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.512 1.149 . . . . 0.0 110.598 161.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 20' ' ' MET . 22.8 p -106.18 106.09 16.43 Favored 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 100.545 -3.872 . . . . 0.0 100.545 171.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.364 0.3 OUTLIER -75.23 173.58 6.74 Favored Pre-proline 0 CA--C 1.592 2.56 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -167.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -48.65 -34.48 27.19 Favored 'Trans proline' 0 CA--C 1.567 2.148 0 N-CA-C 121.729 3.704 . . . . 0.0 121.729 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -84.69 -95.46 0.07 Allowed 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -158.97 73.53 0.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 15' ' ' THR . 58.8 mtt -126.92 167.3 16.04 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.703 0.801 . . . . 0.0 112.264 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.401 ' CE1' ' CD1' ' A' ' 46' ' ' ILE . 57.7 m-85 -128.82 114.59 16.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 118.544 -2.598 . . . . 0.0 108.205 -163.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -87.28 91.35 8.69 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.3 142.02 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -162.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -82.98 124.37 30.33 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 165.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.269 3.0 mt -74.47 -173.89 1.88 Allowed 'General case' 0 CA--C 1.579 2.066 0 CA-C-O 123.76 1.743 . . . . 0.0 112.016 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -26.03 63.65 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 171.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -90.77 8.72 33.23 Favored 'General case' 0 CA--C 1.582 2.209 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 169.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.55 6.55 89.26 Favored Glycine 0 CA--C 1.552 2.393 0 N-CA-C 119.61 2.604 . . . . 0.0 119.61 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -89.48 142.69 27.44 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 119.908 1.854 . . . . 0.0 112.001 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 t -84.57 124.35 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 122.087 0.946 . . . . 0.0 110.805 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.41 145.69 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.745 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 m -91.24 122.1 33.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.533 -1.354 . . . . 0.0 108.547 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.91 153.68 44.56 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -114.51 148.34 38.05 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.511 1.148 . . . . 0.0 109.129 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -66.94 179.24 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.598 2.798 0 O-C-N 121.025 -1.047 . . . . 0.0 112.521 166.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.7 p -102.82 157.3 17.06 Favored 'General case' 0 CA--C 1.558 1.287 0 O-C-N 119.513 -1.992 . . . . 0.0 115.048 -176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.31 -3.98 27.73 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 119.297 2.479 . . . . 0.0 119.297 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.282 21.9 pttm -95.31 -54.26 3.47 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.691 1.738 . . . . 0.0 115.691 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -31.47 66.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 118.197 2.665 . . . . 0.0 118.197 175.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -35.58 -42.25 0.23 Allowed 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 120.344 3.461 . . . . 0.0 120.344 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.83 34.79 0.72 Allowed 'General case' 0 CA--C 1.581 2.149 0 CA-C-N 111.306 -2.679 . . . . 0.0 116.567 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -155.53 -74.9 0.11 Allowed 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 102.226 -3.25 . . . . 0.0 102.226 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.436 ' HH ' HG12 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -83.4 97.44 8.95 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.485 1.514 . . . . 0.0 107.943 165.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mt -74.26 -63.44 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.255 -0.903 . . . . 0.0 111.768 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -129.24 170.45 13.57 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.436 HG12 ' HH ' ' A' ' 43' ' ' TYR . 2.8 pt -146.73 171.56 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 109.507 -3.497 . . . . 0.0 111.363 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.5 tp -116.39 167.03 11.4 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.179 0.99 . . . . 0.0 110.973 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.1 m -70.74 86.17 0.67 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 123.539 1.638 . . . . 0.0 111.905 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 133.83 19.43 0.92 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 117.726 1.85 . . . . 0.0 117.726 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -94.79 165.71 12.34 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.985 1.314 . . . . 0.0 113.312 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -88.29 121.87 31.18 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 124.178 1.942 . . . . 0.0 111.945 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.69 163.98 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.881 0 CA-C-N 111.183 -2.735 . . . . 0.0 113.109 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.522 ' HA ' ' CB ' ' A' ' 9' ' ' GLN 0.361 22.7 m -121.85 75.3 1.2 Allowed 'General case' 0 N--CA 1.514 2.743 0 CA-C-O 124.543 2.116 . . . . 0.0 114.754 172.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.792 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -75.84 100.56 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 126.82 2.048 . . . . 0.0 110.56 -174.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -83.25 144.34 29.81 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 120.842 -1.161 . . . . 0.0 109.081 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.4 -175.01 4.61 Favored 'General case' 0 CA--C 1.564 1.495 0 O-C-N 120.863 -1.148 . . . . 0.0 112.042 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -94.28 159.95 32.95 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -52.14 -41.45 65.0 Favored 'Trans proline' 0 CA--C 1.57 2.297 0 C-N-CA 123.443 2.762 . . . . 0.0 118.868 164.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -91.18 -54.55 3.89 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -93.64 78.9 4.28 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 122.507 1.146 . . . . 0.0 113.234 -171.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.16 -8.82 57.46 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 119.711 3.226 . . . . 0.0 119.711 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -75.96 -0.82 22.87 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -129.86 179.99 5.54 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.89 1.677 . . . . 0.0 113.053 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.18 -177.58 46.2 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 117.522 1.769 . . . . 0.0 117.522 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.34 111.27 1.64 Allowed 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 53' ' ' THR 0.351 1.3 mp -38.57 89.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 119.152 -2.217 . . . . 0.0 116.547 164.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.56 1.365 0 CA-C-N 114.246 -1.343 . . . . 0.0 114.273 -176.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.981 0.42 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.97 155.49 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.705 -1.247 . . . . 0.0 110.246 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.331 12.4 pt-20 -113.78 119.32 36.93 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 124.128 1.918 . . . . 0.0 111.565 170.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.276 25.8 ttt -164.43 68.98 0.17 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 110.807 -2.906 . . . . 0.0 112.48 -152.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.642 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.597 0.3 OUTLIER -133.69 -167.86 2.01 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 177.075 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.45 -112.39 0.89 Allowed Glycine 0 N--CA 1.483 1.798 0 N-CA-C 122.226 3.65 . . . . 0.0 122.226 -167.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.2 m -103.97 136.32 43.84 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.654 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 45.9 t -71.49 100.01 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.615 3.451 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -64.5 -44.58 90.47 Favored 'General case' 0 N--CA 1.521 3.084 2 CA-C-N 127.163 4.529 . . . . 0.0 112.81 174.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -129.76 150.35 51.1 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 122.921 1.343 . . . . 0.0 110.464 171.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 20' ' ' MET . 6.9 p -104.34 97.9 7.77 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 101.391 -3.559 . . . . 0.0 101.391 171.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.281 5.2 mt -78.76 155.98 77.85 Favored Pre-proline 0 CA--C 1.595 2.68 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.259 -163.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.347 6.1 Cg_endo -14.15 -62.62 0.01 OUTLIER 'Trans proline' 0 CA--C 1.567 2.145 2 N-CA-C 125.343 5.093 . . . . 0.0 125.343 -169.676 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -75.81 -85.87 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.152 1.342 . . . . 0.0 109.108 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.6 m -155.94 75.11 0.89 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 15' ' ' THR . 81.3 mtp -120.24 179.37 4.31 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.756 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -145.29 106.52 4.19 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 -165.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.3 ttt85 -84.2 93.94 8.29 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 170.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.6 t -98.57 136.0 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -162.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -96.03 108.42 20.82 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.577 HD22 ' H ' ' A' ' 26' ' ' GLU 0.345 0.3 OUTLIER -48.8 178.39 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 N-CA-C 121.473 3.879 . . . . 0.0 121.473 -177.15 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.577 ' H ' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -75.43 -23.13 56.93 Favored 'General case' 0 CA--C 1.579 2.074 0 CA-C-N 112.462 -2.154 . . . . 0.0 113.704 166.437 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.264 0.1 OUTLIER -93.45 4.89 53.23 Favored 'General case' 0 CA--C 1.595 2.707 0 C-N-CA 124.703 1.201 . . . . 0.0 112.481 168.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.79 15.36 79.47 Favored Glycine 0 CA--C 1.547 2.056 0 N-CA-C 119.634 2.613 . . . . 0.0 119.634 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -101.08 136.12 41.44 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.007 1.904 . . . . 0.0 111.62 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.67 128.12 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 119.926 -1.734 . . . . 0.0 112.398 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -122.47 169.76 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.281 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -112.04 121.88 46.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.909 -1.12 . . . . 0.0 109.793 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.81 158.74 43.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 118.377 2.732 . . . . 0.0 118.377 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -106.74 166.21 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.806 1.289 . . . . 0.0 109.499 167.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -78.55 -176.37 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.58 0 O-C-N 119.854 -1.779 . . . . 0.0 111.414 168.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.8 p -102.42 97.05 7.34 Favored 'General case' 0 CA--C 1.552 1.04 0 O-C-N 120.173 -1.58 . . . . 0.0 107.347 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -39.41 -30.43 0.16 Allowed Glycine 0 N--CA 1.499 2.868 0 N-CA-C 122.914 3.926 . . . . 0.0 122.914 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -66.13 -50.45 63.97 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -52.78 5.18 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 124.759 1.224 . . . . 0.0 113.596 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . 0.314 37.7 mmt180 -70.37 -47.84 59.1 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -171.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -94.13 46.21 1.16 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 123.855 1.788 . . . . 0.0 114.891 169.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -103.69 -53.38 2.79 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 167.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.264 39.4 p90 -72.33 -138.82 0.01 OUTLIER 'General case' 0 CA--C 1.592 2.594 0 CA-C-O 122.149 0.976 . . . . 0.0 108.96 154.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -118.62 -82.03 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 O-C-N 119.986 -1.696 . . . . 0.0 111.509 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -141.87 166.71 23.97 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 123.895 1.807 . . . . 0.0 114.802 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.284 2.4 pp -105.58 151.01 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.32 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.3 tp -86.64 162.49 17.92 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -165.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -65.43 99.33 0.41 Allowed 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 123.893 1.806 . . . . 0.0 112.069 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.654 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 113.66 -4.34 24.57 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 120.428 2.931 . . . . 0.0 120.428 -175.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -60.55 155.45 18.58 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -83.17 87.97 6.91 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 126.08 2.848 . . . . 0.0 113.235 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.19 146.06 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 108.987 -3.733 . . . . 0.0 110.314 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.3 m -137.02 115.91 12.28 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 100.421 -3.918 . . . . 0.0 100.421 171.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.642 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.26 92.3 t -121.46 127.05 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 112.779 -2.01 . . . . 0.0 107.429 -158.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -80.46 125.64 30.2 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.449 0.642 . . . . 0.0 111.955 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.263 0.3 OUTLIER -111.85 -110.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.209 -171.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.15 166.32 15.4 Favored Pre-proline 0 CA--C 1.582 2.183 0 C-N-CA 123.793 0.837 . . . . 0.0 112.924 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -60.09 -46.33 19.49 Favored 'Trans proline' 0 CA--C 1.568 2.22 0 C-N-CA 123.412 2.741 . . . . 0.0 117.759 166.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -100.5 -55.55 2.57 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -93.62 70.19 4.17 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.1 mp -68.63 2.24 2.61 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -69.31 -11.17 60.58 Favored 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -142.96 159.14 42.81 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 125.824 1.65 . . . . 0.0 113.223 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.47 -158.97 19.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 117.016 1.566 . . . . 0.0 117.016 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.26 124.29 7.43 Favored 'General case' 0 CA--C 1.59 2.498 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.557 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -41.29 99.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 174.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 CA--C 1.579 2.095 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 170.708 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 CA--C 1.577 2.004 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.84 156.97 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.457 -1.402 . . . . 0.0 111.878 -171.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.35 9.8 pt-20 -106.29 120.78 42.76 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 124.537 2.113 . . . . 0.0 110.684 165.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 21.0 ttt -169.61 78.74 0.11 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 110.601 -3.0 . . . . 0.0 109.08 -155.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.587 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.612 0.0 OUTLIER -139.24 -168.42 2.44 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 173.274 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.64 -108.51 1.0 Allowed Glycine 0 N--CA 1.478 1.497 0 N-CA-C 121.198 3.239 . . . . 0.0 121.198 -165.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 98.9 m -121.88 135.31 54.88 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.477 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 73.7 t -61.49 117.57 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.612 3.327 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.7 mt -81.14 -45.23 16.72 Favored 'General case' 0 N--CA 1.511 2.577 0 CA-C-N 123.091 2.678 . . . . 0.0 110.809 167.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -129.53 143.03 50.66 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 122.752 1.263 . . . . 0.0 111.535 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 20' ' ' MET . 20.4 p -103.01 107.56 18.4 Favored 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 101.03 -3.693 . . . . 0.0 101.03 171.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.391 0.2 OUTLIER -75.45 -175.35 0.46 Allowed Pre-proline 0 CA--C 1.594 2.646 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -167.086 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -52.35 -51.1 11.9 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 124.091 3.194 . . . . 0.0 119.493 -173.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.39 -86.75 0.05 OUTLIER 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -163.02 75.1 0.39 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 172.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 15' ' ' THR . 69.1 mtm -123.28 175.9 6.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.464 -0.772 . . . . 0.0 111.551 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -140.68 113.67 8.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 118.908 -2.37 . . . . 0.0 107.29 -163.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -86.59 96.34 10.06 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 169.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.2 136.54 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -162.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -94.07 113.14 25.05 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 171.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.256 0.5 OUTLIER -56.5 178.77 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 -175.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.77 -25.63 66.57 Favored 'General case' 0 CA--C 1.573 1.844 0 CA-C-N 113.564 -1.653 . . . . 0.0 114.976 167.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -93.26 8.01 42.05 Favored 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 168.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.89 8.78 85.37 Favored Glycine 0 CA--C 1.556 2.639 0 N-CA-C 120.333 2.893 . . . . 0.0 120.333 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -93.67 138.97 31.35 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 119.275 1.537 . . . . 0.0 112.789 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.9 t -85.56 130.34 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.209 -1.557 . . . . 0.0 112.805 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.3 m -126.72 167.42 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 114.359 -1.291 . . . . 0.0 113.571 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 m -109.29 123.26 48.98 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.966 -1.084 . . . . 0.0 110.152 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.26 151.95 39.17 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 119.171 3.026 . . . . 0.0 119.171 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.33 170.16 8.62 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.036 -1.04 . . . . 0.0 109.594 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 pt -76.76 -177.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.552 0 O-C-N 119.531 -1.981 . . . . 0.0 110.97 164.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.2 p -100.73 144.52 29.6 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 119.646 -1.909 . . . . 0.0 110.761 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.93 -23.2 6.89 Favored Glycine 0 N--CA 1.508 3.463 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -63.78 -55.78 20.52 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.246 1.818 . . . . 0.0 114.768 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.6 ptp -73.77 -36.14 65.05 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 116.148 -1.882 . . . . 0.0 115.791 172.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -37.33 -41.03 0.39 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.549 2.425 . . . . 0.0 117.549 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -93.19 -1.44 56.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -94.34 -68.68 0.79 Allowed 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.61 130.8 55.29 Favored 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 125.501 1.52 . . . . 0.0 107.717 170.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.6 mt -73.54 -65.37 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.044 0 O-C-N 120.004 -1.685 . . . . 0.0 111.166 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -105.33 164.52 11.79 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 120.954 3.687 . . . . 0.0 120.954 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.275 0.5 OUTLIER -133.97 168.6 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-N 109.545 -3.479 . . . . 0.0 109.457 173.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.59 163.81 12.17 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.445 1.117 . . . . 0.0 113.206 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 m -72.67 89.64 1.34 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 123.351 1.548 . . . . 0.0 110.955 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.477 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 121.64 24.17 2.41 Favored Glycine 0 N--CA 1.489 2.213 0 CA-C-N 113.382 -1.736 . . . . 0.0 116.749 -174.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -92.28 156.64 17.14 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-O 122.634 1.207 . . . . 0.0 112.224 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -86.69 91.67 8.68 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 125.76 2.695 . . . . 0.0 113.685 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -93.17 151.3 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.038 0 CA-C-N 109.59 -3.459 . . . . 0.0 111.503 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -143.55 112.18 6.47 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 100.34 -3.948 . . . . 0.0 100.34 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.587 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.278 94.1 t -120.54 125.5 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 112.108 -2.314 . . . . 0.0 107.066 -156.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -78.0 120.61 23.1 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.671 0.748 . . . . 0.0 111.102 -174.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.278 0.2 OUTLIER -105.2 -122.87 0.22 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.858 -175.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.4 169.05 11.22 Favored Pre-proline 0 CA--C 1.584 2.257 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.98 -49.31 0.69 Allowed 'Trans proline' 0 CA--C 1.551 1.346 0 C-N-CA 124.766 3.644 . . . . 0.0 118.517 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -96.24 -34.14 11.74 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.048 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.515 ' HD2' ' NZ ' ' A' ' 63' ' ' LYS . 9.4 t70 -103.56 81.33 1.9 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.971 -173.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.13 -19.47 34.14 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 118.815 2.894 . . . . 0.0 118.815 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.0 m -65.69 -6.37 11.23 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.515 ' NZ ' ' HD2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -143.48 160.19 41.05 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 125.746 1.618 . . . . 0.0 113.654 -177.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.81 -159.32 17.84 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -157.07 117.96 3.63 Favored 'General case' 0 CA--C 1.586 2.332 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.51 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -38.79 97.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 174.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 CA--C 1.568 1.672 0 C-N-CA 124.388 1.075 . . . . 0.0 112.455 171.209 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 . . . . . 0 CA--C 1.572 1.79 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.14 139.75 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.561 1.144 . . . . 0.0 109.663 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.308 6.6 pt-20 -97.56 116.51 29.92 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 124.89 2.281 . . . . 0.0 109.115 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 21.7 ttt -168.22 76.32 0.13 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 109.392 -3.549 . . . . 0.0 110.208 -148.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.561 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.613 0.0 OUTLIER -140.1 -166.92 2.2 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 174.691 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.16 -112.02 1.1 Allowed Glycine 0 N--CA 1.479 1.546 0 N-CA-C 120.633 3.013 . . . . 0.0 120.633 -165.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.8 m -118.26 137.53 52.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.488 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 58.8 t -64.57 105.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.608 3.176 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 mp -77.0 -45.0 28.83 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 117.966 -2.959 . . . . 0.0 113.175 170.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -122.56 148.84 44.73 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.354 1.074 . . . . 0.0 111.029 167.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 20' ' ' MET . 13.3 p -103.3 98.35 8.28 Favored 'General case' 0 N--CA 1.516 2.86 0 N-CA-C 101.667 -3.457 . . . . 0.0 101.667 170.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.27 5.3 mt -79.38 151.7 75.23 Favored Pre-proline 0 CA--C 1.591 2.535 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.482 -163.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.415 3.8 Cg_exo 8.61 -80.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.268 2 C-N-CA 126.686 4.924 . . . . 0.0 124.283 -170.696 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -76.04 -75.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 120.435 1.47 . . . . 0.0 110.869 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -158.34 75.96 0.75 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.258 61.9 mtt -118.37 -174.11 2.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 0.0 111.011 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -148.3 108.83 4.16 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 118.919 -2.363 . . . . 0.0 105.152 -165.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -86.57 92.76 8.99 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 103.725 -2.695 . . . . 0.0 103.725 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.8 t -99.37 135.53 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -163.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.94 113.93 26.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 170.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.29 0.5 OUTLIER -58.46 -179.92 0.07 Allowed 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -176.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.79 -24.29 64.39 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-N 113.46 -1.7 . . . . 0.0 115.01 168.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -90.21 5.09 48.53 Favored 'General case' 0 CA--C 1.585 2.308 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.37 5.24 82.69 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 120.165 2.826 . . . . 0.0 120.165 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -94.93 142.46 27.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.616 1.708 . . . . 0.0 113.346 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.86 129.76 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-O 122.153 0.977 . . . . 0.0 112.384 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 m -139.83 152.6 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-O 122.208 1.004 . . . . 0.0 113.185 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -89.87 128.52 36.2 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.156 -1.59 . . . . 0.0 111.594 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.59 150.48 36.45 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -103.32 155.43 18.47 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.081 0.943 . . . . 0.0 110.595 170.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -66.15 175.32 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.601 2.942 0 CA-C-O 122.913 1.339 . . . . 0.0 112.053 165.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.2 p -103.38 140.43 37.46 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 119.826 -1.796 . . . . 0.0 109.655 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.13 -16.27 6.17 Favored Glycine 0 N--CA 1.505 3.273 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -72.1 -49.64 34.62 Favored 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 126.656 1.982 . . . . 0.0 114.74 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.7 ptp -73.04 -24.16 60.68 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -38.74 -33.25 0.1 Allowed 'General case' 0 CA--C 1.587 2.381 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -91.85 -4.78 54.4 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -89.16 -72.97 0.52 Allowed 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 168.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -101.35 135.13 43.35 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 124.41 1.084 . . . . 0.0 108.759 166.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mt -71.5 -53.38 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.76 -1.212 . . . . 0.0 110.803 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -135.6 175.26 9.75 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-O 124.516 2.103 . . . . 0.0 112.792 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.11 156.15 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 113.138 -1.846 . . . . 0.0 108.758 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.8 mp -95.77 166.51 11.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -73.69 87.14 1.68 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 123.48 1.609 . . . . 0.0 111.18 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.488 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 124.6 18.86 2.63 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-N 113.308 -1.769 . . . . 0.0 117.233 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -91.26 167.0 12.63 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 122.781 1.276 . . . . 0.0 111.234 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -90.08 129.67 36.35 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 124.951 2.31 . . . . 0.0 114.306 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.5 m -134.14 152.53 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.827 0 CA-C-N 110.511 -3.041 . . . . 0.0 110.693 -173.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.9 m -142.99 111.6 6.32 Favored 'General case' 0 N--CA 1.501 2.103 1 N-CA-C 100.19 -4.004 . . . . 0.0 100.19 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.561 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.276 71.7 t -125.35 123.85 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 112.261 -2.245 . . . . 0.0 107.182 -156.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -79.32 141.58 36.86 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.45 -175.81 4.93 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 122.125 0.964 . . . . 0.0 110.864 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -90.41 158.48 43.22 Favored Pre-proline 0 CA--C 1.573 1.835 0 O-C-N 120.611 -1.306 . . . . 0.0 112.999 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -54.86 -42.65 66.79 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 123.068 2.512 . . . . 0.0 118.422 164.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -90.39 -45.73 8.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -102.74 81.44 2.01 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 122.35 1.072 . . . . 0.0 113.031 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.67 43.06 0.81 Allowed 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 64.2 m -95.32 -28.6 14.89 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -132.29 -178.23 4.82 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-O 122.749 1.261 . . . . 0.0 114.049 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.49 177.25 40.2 Favored Glycine 0 CA--C 1.554 2.514 0 N-CA-C 117.145 1.618 . . . . 0.0 117.145 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.3 113.21 3.15 Favored 'General case' 0 CA--C 1.596 2.732 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 168.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.541 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -45.5 104.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 CA-C-N 122.495 2.407 . . . . 0.0 113.968 173.227 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.564 1.511 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.941 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 CA--C 1.577 1.991 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 mt -92.3 143.95 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.773 -1.204 . . . . 0.0 110.84 -171.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.293 8.8 pt-20 -99.22 122.57 42.59 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 124.664 2.173 . . . . 0.0 109.512 170.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.293 6.5 ttt -152.95 -4.49 0.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 109.898 -3.319 . . . . 0.0 119.283 -151.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.686 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.537 0.5 OUTLIER -75.8 -164.03 0.32 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 121.657 3.947 . . . . 0.0 121.657 -166.607 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.42 -112.54 1.08 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 122.514 3.766 . . . . 0.0 122.514 -163.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.8 m -108.78 135.97 49.12 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.642 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 78.3 t -71.81 107.38 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.981 0 CA-C-N 120.379 1.445 . . . . 0.0 107.327 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.13 -42.56 72.45 Favored 'General case' 0 N--CA 1.516 2.843 0 CA-C-N 124.814 3.461 . . . . 0.0 112.056 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -132.6 147.83 52.35 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.151 0.977 . . . . 0.0 110.988 170.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 20' ' ' MET . 11.0 p -102.66 102.99 13.23 Favored 'General case' 0 N--CA 1.514 2.728 0 N-CA-C 101.94 -3.356 . . . . 0.0 101.94 170.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.347 5.4 mt -80.82 -179.03 1.3 Allowed Pre-proline 0 CA--C 1.598 2.797 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -164.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.273 21.1 Cg_endo -47.51 -45.55 22.79 Favored 'Trans proline' 0 CA--C 1.568 2.185 1 N-CA-C 123.786 4.495 . . . . 0.0 123.786 -167.963 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.58 -89.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.38 1.445 . . . . 0.0 108.31 172.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.4 m -153.03 76.22 1.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 171.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 15' ' ' THR . 42.4 mtt -120.61 176.25 5.6 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.521 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -146.05 108.71 4.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -164.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 tpt85 -83.51 94.63 8.08 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.9 t -100.72 139.09 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -162.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -92.36 115.24 27.92 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.436 HD21 ' H ' ' A' ' 26' ' ' GLU 0.27 0.6 OUTLIER -64.7 178.92 0.7 Allowed 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -177.421 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' H ' HD21 ' A' ' 25' ' ' LEU . 16.8 pt-20 -67.66 -27.37 66.8 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 168.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -91.79 8.86 35.19 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 171.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.06 16.62 78.46 Favored Glycine 0 CA--C 1.555 2.549 0 N-CA-C 119.929 2.731 . . . . 0.0 119.929 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -98.58 131.46 44.78 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.188 1.494 . . . . 0.0 111.823 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -83.89 127.61 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 123.17 1.462 . . . . 0.0 111.435 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 HE21 ' A' ' 9' ' ' GLN . 18.7 m -123.38 159.77 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.882 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 m -106.73 123.24 47.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.54 -1.35 . . . . 0.0 109.432 172.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.57 157.85 44.28 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 118.881 2.919 . . . . 0.0 118.881 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -104.47 167.58 9.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 163.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.12 177.19 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.526 0 O-C-N 119.98 -1.7 . . . . 0.0 110.295 162.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.3 p -77.97 87.83 4.14 Favored 'General case' 0 CA--C 1.573 1.829 0 O-C-N 119.062 -2.274 . . . . 0.0 108.591 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -17.93 -47.61 0.01 OUTLIER Glycine 0 N--CA 1.505 3.26 1 N-CA-C 124.297 4.479 . . . . 0.0 124.297 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -45.36 -46.16 12.93 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 118.776 2.88 . . . . 0.0 118.776 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.27 0.0 OUTLIER -69.46 -23.87 63.71 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 177.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -37.97 -41.18 0.53 Allowed 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 122.9 2.591 . . . . 0.0 117.159 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -96.76 3.93 52.06 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 119.804 3.261 . . . . 0.0 119.804 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -110.37 -63.12 1.42 Allowed 'General case' 0 CA--C 1.571 1.764 0 C-N-CA 125.605 1.562 . . . . 0.0 107.062 172.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.88 104.08 10.22 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 169.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -67.91 112.64 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-O 124.426 2.06 . . . . 0.0 107.906 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -41.84 161.34 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.851 1 N-CA-C 123.557 4.651 . . . . 0.0 123.557 -167.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.255 1.1 pt -89.61 160.82 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.78 0 CA-C-N 109.26 -3.609 . . . . 0.0 115.409 -175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 tp -115.14 175.54 5.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.378 -170.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -67.7 91.84 0.32 Allowed 'General case' 0 CA--C 1.575 1.917 0 CA-C-O 124.389 2.042 . . . . 0.0 114.296 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.642 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 124.04 -2.15 9.13 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -65.32 156.89 30.67 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -81.91 90.75 6.47 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 125.699 2.666 . . . . 0.0 113.962 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 m -93.07 154.67 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 CA-C-N 109.435 -3.529 . . . . 0.0 110.766 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.3 m -147.9 103.25 3.48 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 100.609 -3.848 . . . . 0.0 100.609 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.686 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 23.7 t -109.06 131.63 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 111.076 -2.784 . . . . 0.0 107.305 -162.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -83.77 130.16 34.94 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.908 -1.12 . . . . 0.0 111.991 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.275 0.5 OUTLIER -108.28 -155.81 0.56 Allowed 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 122.047 0.927 . . . . 0.0 110.962 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.4 p -138.12 161.39 59.77 Favored Pre-proline 0 CA--C 1.572 1.789 0 O-C-N 121.021 -1.049 . . . . 0.0 112.064 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.99 -42.16 59.99 Favored 'Trans proline' 0 CA--C 1.573 2.441 0 C-N-CA 123.315 2.677 . . . . 0.0 118.459 163.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -87.49 -50.42 6.55 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -102.37 80.68 1.97 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.314 1.054 . . . . 0.0 112.337 -172.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -28.51 64.89 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.9 t -76.75 13.62 0.98 Allowed 'General case' 0 CA--C 1.587 2.374 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -139.14 172.75 12.38 Favored 'General case' 0 CA--C 1.57 1.732 0 O-C-N 119.643 -1.911 . . . . 0.0 114.353 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.57 -165.84 38.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.52 122.67 5.46 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.52 ' H ' HD13 ' A' ' 66' ' ' ILE . 2.2 mp -46.62 104.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.933 0 CA-C-N 121.734 2.061 . . . . 0.0 114.475 170.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 CA--C 1.564 1.519 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.164 -179.9 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 . . . . . 0 CA--C 1.572 1.801 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -95.37 141.33 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.098 0.959 . . . . 0.0 110.222 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.303 9.1 pt-20 -96.4 122.09 38.91 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 125.068 2.366 . . . . 0.0 108.62 169.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 22.0 ttt -172.61 89.06 0.09 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 109.471 -3.513 . . . . 0.0 105.035 -149.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.802 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -117.19 -151.15 0.47 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -157.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.56 -137.65 3.52 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 117.348 1.699 . . . . 0.0 117.348 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.8 m -124.71 133.72 53.09 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 59.7 t -59.22 116.53 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.602 2.959 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.561 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.1 mt -83.9 -42.07 16.73 Favored 'General case' 0 N--CA 1.509 2.504 0 CA-C-N 122.299 2.318 . . . . 0.0 110.941 166.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.97 143.97 48.49 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.829 1.299 . . . . 0.0 111.576 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 20' ' ' MET . 41.4 p -97.8 105.1 17.19 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 170.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.324 5.2 mt -78.86 179.77 1.65 Allowed Pre-proline 0 CA--C 1.596 2.718 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -164.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.266 27.8 Cg_endo -47.89 -45.91 23.24 Favored 'Trans proline' 0 CA--C 1.568 2.191 1 N-CA-C 122.552 4.02 . . . . 0.0 122.552 -169.591 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -82.84 -92.33 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.1 1.318 . . . . 0.0 107.735 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -151.61 73.28 1.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 171.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 15' ' ' THR . 88.7 mtp -119.78 176.52 5.36 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.641 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -140.68 112.04 7.32 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -83.28 94.26 7.88 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 169.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 t -100.96 136.91 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -163.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -88.48 113.06 23.68 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.268 4.3 mt -73.39 -179.54 3.48 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 124.1 1.905 . . . . 0.0 112.554 -172.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.37 -22.18 61.18 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -90.11 6.37 42.77 Favored 'General case' 0 CA--C 1.585 2.292 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.95 15.79 76.52 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 119.828 2.691 . . . . 0.0 119.828 -176.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -102.91 139.9 37.88 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 119.248 1.524 . . . . 0.0 111.837 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -87.42 113.39 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.762 -1.211 . . . . 0.0 109.93 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.7 m -109.93 153.93 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -96.23 118.42 32.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.813 -1.179 . . . . 0.0 109.588 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.11 158.59 44.11 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.72 2.118 . . . . 0.0 116.72 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -105.68 -176.51 3.1 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.416 HD12 ' H ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -90.45 175.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.367 0 O-C-N 119.899 -1.751 . . . . 0.0 109.215 161.647 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.6 p -75.12 20.07 0.14 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 120.612 3.56 . . . . 0.0 120.612 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.79 -45.79 1.1 Allowed Glycine 0 N--CA 1.499 2.844 0 N-CA-C 118.644 2.218 . . . . 0.0 118.644 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -63.62 -54.07 41.68 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -22.8 64.79 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.416 ' H ' HD12 ' A' ' 35' ' ' ILE . 10.9 mtp-105 -39.81 -35.81 0.38 Allowed 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 172.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -90.63 4.78 50.42 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 118.965 2.95 . . . . 0.0 118.965 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -97.15 -74.07 0.58 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 167.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -110.87 138.47 47.23 Favored 'General case' 0 CA--C 1.579 2.061 0 C-N-CA 125.334 1.453 . . . . 0.0 107.217 166.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.4 mt -73.66 -68.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 119.976 -1.702 . . . . 0.0 111.275 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -113.54 168.14 10.01 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 119.755 3.243 . . . . 0.0 119.755 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.357 1.8 pp -119.12 169.66 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 110.017 -3.265 . . . . 0.0 108.873 171.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.6 tp -100.98 163.2 12.4 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -168.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 m -69.73 92.94 0.69 Allowed 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 123.783 1.754 . . . . 0.0 111.49 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.499 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 117.01 22.92 4.07 Favored Glycine 0 N--CA 1.488 2.148 0 CA-C-N 112.678 -2.055 . . . . 0.0 117.439 -175.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -93.11 156.68 16.71 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.881 1.324 . . . . 0.0 113.33 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -88.66 83.32 6.74 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 125.231 2.444 . . . . 0.0 112.967 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 m -73.64 165.24 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 CA-C-N 110.436 -3.075 . . . . 0.0 114.972 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.542 ' H ' HG22 ' A' ' 66' ' ' ILE 0.274 5.1 m -120.52 77.23 1.25 Allowed 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 124.079 1.895 . . . . 0.0 112.434 173.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.802 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -75.47 94.05 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 O-C-N 120.219 -1.551 . . . . 0.0 110.328 -171.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -81.97 136.41 35.28 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.059 -1.026 . . . . 0.0 109.049 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.251 2.4 pt? -136.62 -165.01 1.66 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.844 -1.16 . . . . 0.0 112.351 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 p -110.29 159.5 31.82 Favored Pre-proline 0 CA--C 1.573 1.856 0 O-C-N 120.731 -1.231 . . . . 0.0 113.342 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.18 -38.91 81.76 Favored 'Trans proline' 0 CA--C 1.569 2.258 0 C-N-CA 123.39 2.727 . . . . 0.0 119.094 163.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -87.06 -52.23 5.55 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.499 ' HD2' ' NZ ' ' A' ' 63' ' ' LYS . 13.2 t70 -96.86 78.87 2.88 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 122.323 1.058 . . . . 0.0 113.286 -172.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.36 -11.2 60.19 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 120.316 3.45 . . . . 0.0 120.316 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.0 m -73.69 -2.96 25.41 Favored 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 173.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.499 ' NZ ' ' HD2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -129.58 178.85 6.18 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -176.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.31 -172.4 42.67 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 116.942 1.537 . . . . 0.0 116.942 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.3 105.9 1.0 Allowed 'General case' 0 CA--C 1.583 2.234 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.542 HG22 ' H ' ' A' ' 53' ' ' THR 0.26 0.0 OUTLIER -28.08 87.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.063 0 N-CA-C 119.276 3.065 . . . . 0.0 119.276 167.261 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 CA--C 1.569 1.701 0 C-N-CA 124.483 1.113 . . . . 0.0 112.88 177.557 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 CA--C 1.577 2.0 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mt -109.35 141.55 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.885 -1.134 . . . . 0.0 110.356 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.339 12.7 pt-20 -100.78 118.7 37.38 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 124.014 1.864 . . . . 0.0 110.664 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.285 21.2 ttt -159.26 38.5 0.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.603 -2.544 . . . . 0.0 117.312 -148.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.65 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.531 0.0 OUTLIER -123.11 -175.91 3.29 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 120.01 3.337 . . . . 0.0 120.01 -173.201 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.9 -110.97 1.09 Allowed Glycine 0 N--CA 1.481 1.7 1 N-CA-C 123.653 4.221 . . . . 0.0 123.653 -163.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.1 m -102.89 131.01 50.11 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.474 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 83.8 t -63.46 107.19 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.601 2.913 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.318 98.4 mt -86.33 -36.02 19.51 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 118.813 -2.429 . . . . 0.0 111.98 173.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -128.21 147.05 50.56 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 123.149 1.452 . . . . 0.0 110.563 164.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.3 p -108.89 105.08 14.48 Favored 'General case' 0 N--CA 1.511 2.615 1 N-CA-C 99.889 -4.115 . . . . 0.0 99.889 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.356 0.4 OUTLIER -74.06 -178.78 0.82 Allowed Pre-proline 0 CA--C 1.592 2.584 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -165.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -55.24 -40.91 83.21 Favored 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 123.886 3.057 . . . . 0.0 120.036 -174.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -83.13 -92.95 0.07 Allowed 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.4 m -157.58 73.87 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.7 mtt -124.14 166.63 15.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.964 0.887 . . . . 0.0 112.658 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.453 ' CE2' ' HB ' ' A' ' 35' ' ' ILE . 57.5 m-85 -127.84 110.88 13.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -165.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.503 ' NE ' ' HG1' ' A' ' 32' ' ' THR . 2.3 tpt180 -84.22 92.02 7.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 171.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.72 134.03 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -164.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -83.26 115.11 21.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.503 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.264 0.1 OUTLIER -69.54 177.05 3.1 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 178.881 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.6 -14.24 40.66 Favored 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 167.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.503 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 23.7 t30 -92.12 -3.82 55.15 Favored 'General case' 0 CA--C 1.586 2.362 0 O-C-N 121.352 -0.843 . . . . 0.0 112.845 167.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.46 -5.38 81.28 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 119.182 2.433 . . . . 0.0 119.182 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -86.93 142.17 28.19 Favored 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 124.071 0.948 . . . . 0.0 110.388 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.8 131.4 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 CA-C-O 122.476 1.131 . . . . 0.0 112.831 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 m -130.97 150.25 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.503 ' HG1' ' NE ' ' A' ' 22' ' ' ARG . 17.5 m -92.62 124.88 36.96 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.263 -1.523 . . . . 0.0 110.801 175.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.77 170.16 16.4 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -120.23 136.04 54.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.736 -1.227 . . . . 0.0 112.518 174.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.453 ' HB ' ' CE2' ' A' ' 21' ' ' PHE 0.349 0.0 OUTLIER -79.56 146.92 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.068 0 O-C-N 120.541 -1.349 . . . . 0.0 109.304 176.211 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.97 92.25 1.63 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 119.434 -2.041 . . . . 0.0 113.88 -170.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -42.69 -30.34 0.91 Allowed Glycine 0 N--CA 1.491 2.327 1 N-CA-C 123.944 4.338 . . . . 0.0 123.944 -173.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -54.32 -49.46 69.64 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.94 -45.2 11.03 Favored 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 125.903 1.681 . . . . 0.0 114.717 170.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.485 ' NE ' ' HH ' ' A' ' 43' ' ' TYR 0.28 3.9 mmp_? -82.42 -40.58 21.03 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.203 1.801 . . . . 0.0 115.185 -166.035 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -92.91 40.03 1.05 Allowed 'General case' 0 CA--C 1.586 2.358 0 CA-C-O 122.52 1.152 . . . . 0.0 113.284 164.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -96.55 -43.93 7.38 Favored 'General case' 0 CA--C 1.576 1.945 0 C-N-CA 124.949 1.299 . . . . 0.0 108.45 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.485 ' HH ' ' NE ' ' A' ' 40' ' ' ARG 0.278 35.2 p90 -68.54 -113.34 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 126.04 1.736 . . . . 0.0 109.81 162.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.45 -91.26 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.71 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -147.85 172.41 14.19 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 124.035 1.874 . . . . 0.0 109.957 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.252 1.1 pp -89.79 152.67 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.984 170.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -86.93 160.32 18.73 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 -166.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 m -73.57 83.81 1.54 Allowed 'General case' 0 CA--C 1.571 1.751 0 CA-C-O 123.854 1.787 . . . . 0.0 111.001 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.474 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 129.47 22.2 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 CA-C-N 112.982 -1.917 . . . . 0.0 116.813 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -91.61 160.14 15.54 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 123.331 1.538 . . . . 0.0 112.332 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -87.71 94.35 9.71 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 125.719 2.676 . . . . 0.0 113.518 -175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 m -99.8 145.78 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-N 109.757 -3.383 . . . . 0.0 110.122 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.7 m -137.07 112.02 8.93 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.65 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.251 24.2 t -116.32 130.64 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.531 -159.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -88.4 136.46 32.97 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.006 0.907 . . . . 0.0 112.397 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.25 -169.98 2.24 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.64 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.512 ' OG1' ' HD2' ' A' ' 58' ' ' PRO . 0.5 OUTLIER -153.83 166.0 16.66 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 120.321 -1.487 . . . . 0.0 111.395 175.101 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.512 ' HD2' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -35.1 -48.87 0.77 Allowed 'Trans proline' 0 CA--C 1.561 1.828 1 N-CA-C 122.778 4.107 . . . . 0.0 122.778 173.348 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.5 -29.76 52.67 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.825 1.298 . . . . 0.0 113.992 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -96.65 69.91 2.54 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 114.106 -1.406 . . . . 0.0 113.474 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.5 mt -87.09 -41.3 13.92 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -76.88 5.56 7.67 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -143.09 173.77 11.27 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 120.991 1.723 . . . . 0.0 114.953 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.95 -165.53 34.0 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -155.86 122.64 5.28 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.539 -1.565 . . . . 0.0 113.554 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.551 ' H ' HD13 ' A' ' 66' ' ' ILE . 1.8 mp -45.81 113.15 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 172.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.572 1.796 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.21 173.267 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 CA--C 1.573 1.839 0 CA-C-O 121.338 0.59 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -97.48 143.96 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.287 1.035 . . . . 0.0 111.29 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.325 11.1 pt-20 -92.86 120.45 33.22 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 125.525 2.583 . . . . 0.0 108.305 168.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.282 16.1 ttt -167.16 81.29 0.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 108.873 -3.785 . . . . 0.0 105.308 -150.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.671 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -97.33 -152.55 0.39 Allowed 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -158.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.38 -173.42 33.01 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 120.411 2.924 . . . . 0.0 120.411 -172.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.8 m -98.49 127.96 44.64 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 57.4 t -60.55 117.09 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.912 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 175.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.285 68.2 mt -101.34 -16.88 16.77 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 119.786 -1.822 . . . . 0.0 113.467 170.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -146.8 141.52 26.77 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.956 1.36 . . . . 0.0 109.621 160.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 20' ' ' MET . 18.3 p -94.56 100.62 12.56 Favored 'General case' 0 N--CA 1.516 2.825 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 169.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.282 6.0 mt -79.78 154.26 75.7 Favored Pre-proline 0 CA--C 1.594 2.644 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.873 -166.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.399 2.3 Cg_endo 2.11 -78.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.57 2.324 2 C-N-CA 126.777 4.985 . . . . 0.0 124.997 -171.618 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.29 -77.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 120.64 1.564 . . . . 0.0 110.877 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -156.38 76.03 0.88 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 15' ' ' THR . 64.1 mtt -119.69 -177.3 3.36 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.517 0.727 . . . . 0.0 111.708 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -146.74 108.32 4.31 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 119.669 -1.894 . . . . 0.0 106.735 -166.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -86.9 94.52 9.61 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.86 135.73 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -163.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.55 111.75 21.55 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.286 0.1 OUTLIER -78.6 171.46 15.09 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 124.116 1.912 . . . . 0.0 115.782 -176.704 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.34 -13.96 44.81 Favored 'General case' 0 CA--C 1.578 2.056 0 CA-C-N 112.454 -2.157 . . . . 0.0 114.652 167.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.497 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 46.0 t30 -83.64 -11.21 57.56 Favored 'General case' 0 CA--C 1.587 2.371 0 CA-C-N 119.334 0.97 . . . . 0.0 113.337 164.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.84 -22.18 40.76 Favored Glycine 0 CA--C 1.549 2.216 0 N-CA-C 118.351 2.1 . . . . 0.0 118.351 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -79.71 143.38 34.61 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.122 0.969 . . . . 0.0 112.168 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.7 t -83.75 121.33 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 122.447 1.118 . . . . 0.0 109.507 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.54 144.36 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.801 -175.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.7 m -86.79 126.33 34.54 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.489 -1.382 . . . . 0.0 110.574 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.93 159.37 42.29 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -119.5 164.86 15.17 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 168.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.47 171.8 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.594 2.65 0 O-C-N 120.562 -1.336 . . . . 0.0 110.906 168.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.1 p -76.19 14.11 0.79 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 120.353 3.464 . . . . 0.0 120.353 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.83 -47.86 0.78 Allowed Glycine 0 N--CA 1.5 2.953 0 N-CA-C 117.819 1.888 . . . . 0.0 117.819 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -63.21 -51.13 67.54 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 126.54 1.936 . . . . 0.0 115.289 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ptm -70.16 -17.94 63.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 118.607 2.817 . . . . 0.0 118.607 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -39.14 -34.05 0.16 Allowed 'General case' 0 CA--C 1.583 2.244 0 CA-C-N 121.772 2.078 . . . . 0.0 116.443 167.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm -93.56 40.52 1.07 Allowed 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 173.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -157.56 -68.81 0.1 Allowed 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -93.38 101.18 13.4 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 165.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.27 20.9 mt -72.66 -77.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.768 -1.207 . . . . 0.0 111.444 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -136.61 171.09 15.0 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-O 125.988 2.804 . . . . 0.0 114.013 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 pt -147.08 167.18 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 109.959 -3.291 . . . . 0.0 109.581 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.279 1.3 pt? -122.73 -174.71 2.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 111.262 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.255 94.2 m -75.25 87.12 2.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 123.376 1.56 . . . . 0.0 113.399 -175.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.419 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 133.77 22.7 0.74 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.62 170.33 9.28 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 125.389 1.475 . . . . 0.0 114.77 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -81.6 118.55 22.87 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 125.342 2.496 . . . . 0.0 112.402 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.08 149.1 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 109.761 -3.381 . . . . 0.0 111.265 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.5 ' H ' HG13 ' A' ' 66' ' ' ILE 0.311 89.3 m -94.42 162.39 13.84 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 162.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.671 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -158.07 87.03 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 O-C-N 118.452 -2.655 . . . . 0.0 105.104 -179.234 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -76.86 140.62 40.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.09 -1.006 . . . . 0.0 110.059 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.96 -167.53 2.8 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 121.7 0.762 . . . . 0.0 112.582 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -99.52 160.46 27.39 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -56.8 -42.53 63.74 Favored 'Trans proline' 0 CA--C 1.57 2.312 0 N-CA-C 118.756 2.56 . . . . 0.0 118.756 164.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -92.24 -45.02 8.44 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -174.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -102.0 81.9 2.17 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.068 0.937 . . . . 0.0 112.685 -173.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.05 41.04 0.73 Allowed 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.7 m -101.47 -20.98 14.89 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -137.52 178.77 6.85 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 124.761 1.225 . . . . 0.0 113.593 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.0 -171.08 43.11 Favored Glycine 0 CA--C 1.551 2.314 0 O-C-N 121.468 -0.77 . . . . 0.0 114.687 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.96 121.53 2.81 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.5 HG13 ' H ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -40.0 92.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 119.346 -2.096 . . . . 0.0 116.216 166.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.272 0.2 OUTLIER . . . . . 0 CA--C 1.568 1.652 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.931 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 . . . . . 0 CA--C 1.576 1.953 0 CA-C-O 120.732 0.301 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.02 140.31 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.492 -1.38 . . . . 0.0 110.249 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.382 11.3 pt-20 -99.23 120.48 39.61 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 124.466 2.079 . . . . 0.0 110.778 169.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 20.2 ttt -170.69 76.94 0.07 Allowed 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 110.565 -3.016 . . . . 0.0 110.764 -149.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.547 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.608 0.0 OUTLIER -143.13 -166.13 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 119.231 3.049 . . . . 0.0 119.231 175.548 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 -111.16 1.19 Allowed Glycine 0 CA--C 1.542 1.764 0 N-CA-C 121.871 3.508 . . . . 0.0 121.871 -164.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -122.35 139.43 53.84 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.504 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 60.6 t -67.25 101.21 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.605 3.058 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.96 -44.2 61.41 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 117.947 -2.971 . . . . 0.0 113.39 171.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.25 148.89 47.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.305 1.05 . . . . 0.0 110.857 167.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 20' ' ' MET . 6.9 p -102.16 101.62 11.96 Favored 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 168.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.274 5.5 mt -79.86 150.55 72.43 Favored Pre-proline 0 CA--C 1.59 2.484 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.031 -164.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.413 3.0 Cg_exo 8.62 -77.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.351 2 C-N-CA 126.624 4.883 . . . . 0.0 124.378 -170.126 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -79.31 -81.67 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.017 1.281 . . . . 0.0 110.461 174.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.408 ' HG1' ' CZ ' ' A' ' 45' ' ' ARG . 18.4 m -149.23 74.79 1.26 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.443 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.274 61.3 mtt -118.79 -175.83 2.98 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.221 -0.925 . . . . 0.0 111.521 177.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.42 ' CD2' HD12 ' A' ' 66' ' ' ILE . 58.1 m-85 -147.35 107.87 4.11 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 -166.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -86.35 96.21 9.92 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.81 133.04 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -162.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.38 110.19 21.49 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.301 0.5 OUTLIER -56.25 179.22 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 -175.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.44 -25.47 66.76 Favored 'General case' 0 CA--C 1.58 2.11 0 CA-C-N 113.55 -1.659 . . . . 0.0 114.375 165.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.25 1.5 m-20 -78.87 -12.46 60.03 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 169.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.41 5.98 74.75 Favored Glycine 0 CA--C 1.562 2.984 0 N-CA-C 117.432 1.733 . . . . 0.0 117.432 -169.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -90.94 132.36 36.0 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.391 1.596 . . . . 0.0 112.701 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.14 125.38 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.73 -1.231 . . . . 0.0 111.698 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.42 154.5 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 122.287 1.041 . . . . 0.0 113.126 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 m -88.36 127.19 35.49 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.178 -1.576 . . . . 0.0 111.095 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.2 168.88 18.69 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -138.87 141.21 38.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.675 0.79 . . . . 0.0 111.802 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . 0.3 0.0 OUTLIER -73.13 137.84 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 O-C-N 120.202 -1.561 . . . . 0.0 110.372 173.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.33 128.34 35.2 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 120.786 -1.196 . . . . 0.0 112.566 -171.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.39 -27.67 4.22 Favored Glycine 0 N--CA 1.508 3.491 0 N-CA-C 119.276 2.471 . . . . 0.0 119.276 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -58.22 -51.36 70.09 Favored 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 125.898 1.679 . . . . 0.0 114.243 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.4 ptm -78.53 -32.68 48.11 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -39.35 -38.0 0.5 Allowed 'General case' 0 CA--C 1.578 2.042 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -93.42 29.99 1.83 Allowed 'General case' 0 CA--C 1.583 2.223 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -144.01 -66.34 0.35 Allowed 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -75.86 96.84 3.79 Favored 'General case' 0 CA--C 1.571 1.764 0 C-N-CA 125.652 1.581 . . . . 0.0 109.571 167.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.62 111.44 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-O 124.026 1.869 . . . . 0.0 106.552 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.408 ' CZ ' ' HG1' ' A' ' 19' ' ' THR . 6.5 ptm180 -40.51 168.97 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.095 1 N-CA-C 124.101 4.852 . . . . 0.0 124.101 -166.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -106.67 165.24 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 109.32 -3.582 . . . . 0.0 116.749 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.1 tp -121.44 179.14 4.53 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 122.319 1.057 . . . . 0.0 112.204 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -69.47 97.07 0.96 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 123.415 1.578 . . . . 0.0 113.28 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.504 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 115.74 20.82 5.23 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 117.884 1.914 . . . . 0.0 117.884 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -91.78 160.72 15.19 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 123.119 1.437 . . . . 0.0 111.899 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -88.05 116.78 26.48 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 124.932 2.301 . . . . 0.0 112.561 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.52 152.22 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.92 0 CA-C-N 110.437 -3.074 . . . . 0.0 111.822 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.5 m -142.86 113.92 7.69 Favored 'General case' 0 N--CA 1.502 2.13 1 N-CA-C 100.052 -4.055 . . . . 0.0 100.052 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.547 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 74.5 t -128.41 124.89 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 112.459 -2.155 . . . . 0.0 107.1 -155.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -78.58 135.33 37.25 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -133.88 -178.02 4.83 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.051 1.34 . . . . 0.0 108.518 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -94.72 164.12 20.57 Favored Pre-proline 0 CA--C 1.575 1.933 0 O-C-N 119.964 -1.71 . . . . 0.0 114.209 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -61.16 -38.2 68.73 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 C-N-CA 123.982 3.122 . . . . 0.0 116.709 166.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -89.91 -54.63 3.96 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.056 -1.883 . . . . 0.0 115.589 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -102.86 80.37 1.88 Allowed 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 122.423 1.106 . . . . 0.0 113.033 -171.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.5 mp -78.66 1.62 22.22 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 120.363 3.468 . . . . 0.0 120.363 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.3 t -70.37 -9.49 56.4 Favored 'General case' 0 CA--C 1.579 2.06 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -130.98 -177.12 4.24 Favored 'General case' 0 CA--C 1.576 1.95 0 CA-C-N 120.182 1.356 . . . . 0.0 113.069 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.5 174.55 40.54 Favored Glycine 0 CA--C 1.555 2.579 0 N-CA-C 117.919 1.928 . . . . 0.0 117.919 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -154.28 111.82 3.45 Favored 'General case' 0 CA--C 1.597 2.763 0 O-C-N 120.639 -1.507 . . . . 0.0 112.845 169.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.535 ' H ' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -47.52 103.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 O-C-N 118.554 -2.591 . . . . 0.0 115.204 172.435 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 CA--C 1.568 1.65 0 N-CA-C 120.01 3.337 . . . . 0.0 120.01 -175.539 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 . . . . . 0 CA--C 1.573 1.863 0 CA-C-O 121.349 0.595 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mt -87.04 141.63 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.436 -1.415 . . . . 0.0 111.521 -170.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.333 12.9 pt-20 -97.45 122.98 41.13 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 123.676 1.703 . . . . 0.0 110.092 169.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.29 13.1 ttt -155.49 10.02 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 -150.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.594 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.532 0.2 OUTLIER -98.55 -161.64 0.89 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 120.79 3.626 . . . . 0.0 120.79 -166.679 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.42 -106.06 0.52 Allowed Glycine 0 N--CA 1.487 2.067 1 N-CA-C 123.86 4.304 . . . . 0.0 123.86 -163.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m -106.52 131.32 53.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.528 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 65.6 t -66.54 105.43 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.608 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 172.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.308 82.6 mt -85.91 -29.18 23.83 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.555 -1.966 . . . . 0.0 112.254 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.14 149.32 44.34 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.194 -0.941 . . . . 0.0 110.64 164.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' MET . 4.2 p -96.01 116.67 29.3 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 101.536 -3.505 . . . . 0.0 101.536 167.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.436 ' HB3' ' CD ' ' A' ' 17' ' ' PRO 0.394 6.5 mt -76.83 -108.22 0.0 OUTLIER Pre-proline 0 CA--C 1.598 2.818 0 CA-C-O 113.683 -3.056 . . . . 0.0 112.311 -158.295 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.436 ' CD ' ' HB3' ' A' ' 16' ' ' LEU . 92.9 Cg_endo -82.3 -69.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.574 2.494 1 CA-C-N 130.138 4.657 . . . . 0.0 115.038 177.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -83.45 -71.96 0.48 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 120.369 1.44 . . . . 0.0 111.945 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -151.24 71.56 1.01 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.374 74.4 mtp -114.23 -166.27 1.09 Allowed 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.073 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -156.66 109.46 2.57 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 124.864 3.483 . . . . 0.0 109.859 -163.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -88.85 96.97 10.91 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.77 136.35 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -163.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -92.09 112.58 24.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 170.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.251 0.1 OUTLIER -69.13 176.32 3.3 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 179.425 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -15.11 53.5 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 167.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.479 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 39.8 t30 -89.98 -6.46 55.62 Favored 'General case' 0 CA--C 1.585 2.292 0 CA-C-N 118.895 0.771 . . . . 0.0 112.628 168.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.71 -13.7 61.95 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 118.598 2.199 . . . . 0.0 118.598 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -78.25 135.3 37.54 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.278 1.031 . . . . 0.0 110.945 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.3 t -85.69 129.57 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 CA-C-O 123.017 1.389 . . . . 0.0 111.629 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.24 156.3 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 114.113 -1.403 . . . . 0.0 112.804 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -98.29 124.57 42.98 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.581 -1.325 . . . . 0.0 110.152 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.02 161.16 39.48 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 118.316 2.709 . . . . 0.0 118.316 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.57 -179.87 4.04 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 164.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.73 169.66 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.557 0 O-C-N 119.588 -1.945 . . . . 0.0 107.82 157.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.3 p -73.24 17.05 0.14 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 117.671 -3.143 . . . . 0.0 119.362 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.15 -51.2 0.76 Allowed Glycine 0 N--CA 1.499 2.886 0 N-CA-C 118.01 1.964 . . . . 0.0 118.01 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.53 -46.26 89.19 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 126.39 1.876 . . . . 0.0 115.451 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.402 ' SD ' ' O ' ' A' ' 67' ' ' VAL . 1.0 OUTLIER -73.41 -17.02 61.31 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 175.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -38.67 -38.45 0.41 Allowed 'General case' 0 CA--C 1.582 2.178 0 CA-C-N 122.838 2.563 . . . . 0.0 116.895 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -94.17 33.96 1.31 Allowed 'General case' 0 CA--C 1.585 2.314 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -148.12 -64.52 0.25 Allowed 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -78.66 93.47 4.89 Favored 'General case' 0 CA--C 1.571 1.766 0 C-N-CA 125.346 1.458 . . . . 0.0 108.623 166.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.5 mt -69.54 107.02 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.535 0 CA-C-O 124.554 2.121 . . . . 0.0 105.939 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.16 174.97 0.01 OUTLIER 'General case' 0 CA--C 1.577 1.986 1 N-CA-C 121.891 4.034 . . . . 0.0 121.891 -161.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 pt -119.36 167.73 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 111.082 -2.781 . . . . 0.0 115.194 -164.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.2 tp -125.93 -177.58 3.99 Favored 'General case' 0 CA--C 1.573 1.847 0 CA-C-O 122.038 0.923 . . . . 0.0 112.662 -171.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 m -68.34 95.55 0.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.475 1.607 . . . . 0.0 113.712 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.528 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 119.08 19.39 4.35 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 118.281 2.073 . . . . 0.0 118.281 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.33 163.31 13.65 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 122.953 1.359 . . . . 0.0 112.919 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -86.54 117.55 25.39 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 124.772 2.225 . . . . 0.0 112.949 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -121.85 157.6 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.692 0 CA-C-N 110.654 -2.975 . . . . 0.0 111.484 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.4 m -150.4 106.83 3.49 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 100.506 -3.887 . . . . 0.0 100.506 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.594 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 27.3 t -112.21 130.73 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 111.413 -2.63 . . . . 0.0 107.945 -161.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -83.67 136.98 34.0 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 121.163 -0.961 . . . . 0.0 111.876 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.285 2.2 pt? -123.97 -168.59 1.81 Allowed 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 121.252 0.549 . . . . 0.0 110.705 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.0 p -118.48 160.57 39.33 Favored Pre-proline 0 CA--C 1.572 1.807 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.73 -41.15 63.46 Favored 'Trans proline' 0 CA--C 1.569 2.235 0 C-N-CA 123.626 2.884 . . . . 0.0 118.773 164.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -88.85 -54.45 4.13 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -99.66 79.49 2.26 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 122.421 1.105 . . . . 0.0 112.716 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mp -70.19 -22.49 62.94 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -72.31 4.4 3.74 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -124.22 -174.55 3.03 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.462 1.483 . . . . 0.0 114.538 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.02 168.05 39.7 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 120.068 2.787 . . . . 0.0 120.068 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -153.39 110.2 3.42 Favored 'General case' 0 CA--C 1.594 2.669 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 167.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.479 ' H ' HG12 ' A' ' 54' ' ' VAL . 3.2 mp -44.05 104.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 O-C-N 117.437 -3.289 . . . . 0.0 115.86 168.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.402 ' O ' ' SD ' ' A' ' 39' ' ' MET . 14.2 m . . . . . 0 CA--C 1.578 2.033 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.927 171.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 CA--C 1.577 1.994 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.55 151.84 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.372 1.069 . . . . 0.0 109.631 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.279 8.1 pt-20 -108.51 124.74 50.92 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 123.831 1.777 . . . . 0.0 109.833 168.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.3 10.2 ttt -153.17 3.66 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 -151.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.656 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.533 0.0 OUTLIER -86.04 -166.31 1.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 121.287 3.81 . . . . 0.0 121.287 -166.905 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.19 -112.4 0.99 Allowed Glycine 0 N--CA 1.48 1.613 0 N-CA-C 121.45 3.34 . . . . 0.0 121.45 -164.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -102.29 130.23 48.93 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 99.6 t -63.9 111.51 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.881 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 171.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.324 58.6 mt -92.85 -34.04 13.99 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 122.585 2.448 . . . . 0.0 112.21 172.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.03 148.38 50.54 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-O 122.776 1.274 . . . . 0.0 109.922 163.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 20' ' ' MET . 11.9 p -105.52 106.23 16.63 Favored 'General case' 0 N--CA 1.513 2.675 0 N-CA-C 100.75 -3.796 . . . . 0.0 100.75 171.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.441 4.4 mt -82.8 -138.4 0.0 OUTLIER Pre-proline 0 CA--C 1.604 3.056 0 CA-C-O 115.033 -2.413 . . . . 0.0 113.779 -160.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.66 -73.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 1 CA-C-N 129.599 4.464 . . . . 0.0 117.766 -172.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -63.66 -67.35 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.979 -1.076 . . . . 0.0 111.965 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -169.7 79.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' ' 15' ' ' THR . 60.5 mtt -119.93 177.37 5.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.607 0.763 . . . . 0.0 112.589 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.4 ' CE1' ' CD1' ' A' ' 46' ' ' ILE . 57.2 m-85 -145.6 109.68 4.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -165.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -85.3 94.92 9.05 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 168.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.23 133.16 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -164.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -93.31 113.19 25.31 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.617 HD22 ' H ' ' A' ' 26' ' ' GLU 0.358 0.2 OUTLIER -53.93 -179.13 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 120.662 3.579 . . . . 0.0 120.662 -176.238 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.617 ' H ' HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -70.34 -28.72 65.37 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 112.212 -2.267 . . . . 0.0 114.347 167.312 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -90.91 4.54 51.61 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 168.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.18 8.22 78.79 Favored Glycine 0 CA--C 1.549 2.199 0 N-CA-C 119.432 2.533 . . . . 0.0 119.432 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -91.54 140.29 29.88 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.197 2.498 . . . . 0.0 113.081 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.61 123.85 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 O-C-N 120.799 -1.188 . . . . 0.0 112.029 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 m -131.33 152.14 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.0 m -91.46 130.25 37.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.548 -1.345 . . . . 0.0 110.712 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.14 155.49 43.33 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -104.32 177.49 4.83 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 123.349 1.547 . . . . 0.0 108.573 165.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.42 161.17 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.52 0 O-C-N 120.313 -1.492 . . . . 0.0 108.771 166.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 90.8 p -78.18 24.87 0.24 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 119.864 3.283 . . . . 0.0 119.864 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.52 -45.7 1.03 Allowed Glycine 0 N--CA 1.501 3.032 0 N-CA-C 116.645 1.418 . . . . 0.0 116.645 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -58.9 -48.56 81.0 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 127.061 2.144 . . . . 0.0 116.568 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.451 ' SD ' HG21 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.85 -21.88 61.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 118.487 2.773 . . . . 0.0 118.487 177.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -41.97 -34.02 0.64 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 171.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -84.55 -11.17 56.57 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 118.795 2.887 . . . . 0.0 118.795 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -89.75 -72.63 0.55 Allowed 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -101.96 132.03 48.02 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.55 1.14 . . . . 0.0 109.38 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.7 mt -70.64 -51.06 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 O-C-N 120.285 -1.509 . . . . 0.0 110.235 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -130.52 174.63 9.71 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 124.634 2.159 . . . . 0.0 113.053 171.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.4 ' CD1' ' CE1' ' A' ' 21' ' ' PHE 0.286 0.7 OUTLIER -135.05 161.11 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-N 112.685 -2.052 . . . . 0.0 108.773 175.363 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.48 159.74 18.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.717 -1.24 . . . . 0.0 113.923 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.1 m -75.08 79.12 2.24 Favored 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 123.884 1.802 . . . . 0.0 110.59 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.447 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 136.6 22.3 0.55 Allowed Glycine 0 N--CA 1.491 2.349 0 CA-C-N 113.182 -1.827 . . . . 0.0 116.802 -176.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -92.16 159.49 15.63 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 122.869 1.319 . . . . 0.0 112.81 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -90.57 85.5 6.13 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 125.598 2.618 . . . . 0.0 114.032 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.97 158.09 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.021 0 CA-C-N 109.818 -3.356 . . . . 0.0 111.771 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -146.89 112.7 5.71 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 101.387 -3.561 . . . . 0.0 101.387 174.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.656 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 40.3 t -117.77 131.19 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 111.988 -2.369 . . . . 0.0 107.354 -160.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -83.91 128.59 34.65 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.027 0.917 . . . . 0.0 111.593 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.76 -129.96 0.23 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -146.43 167.38 14.04 Favored Pre-proline 0 CA--C 1.569 1.709 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.16 -43.23 19.57 Favored 'Trans proline' 0 CA--C 1.576 2.624 0 C-N-CA 123.09 2.527 . . . . 0.0 115.518 164.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -80.4 -48.24 13.2 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 111.864 -2.426 . . . . 0.0 116.449 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -115.22 88.66 2.92 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 122.507 1.146 . . . . 0.0 112.425 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -83.32 12.61 5.15 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 118.909 2.929 . . . . 0.0 118.909 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.2 p -75.47 -30.5 59.94 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -140.27 167.82 21.24 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 124.305 1.042 . . . . 0.0 113.103 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.44 -166.61 32.03 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 117.272 1.669 . . . . 0.0 117.272 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -154.94 122.51 5.69 Favored 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.536 ' H ' HD13 ' A' ' 66' ' ' ILE . 1.5 mp -45.11 106.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 CA-C-N 121.753 2.07 . . . . 0.0 114.657 170.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.572 1.806 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.517 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 N--CA 1.501 2.097 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -95.39 148.81 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.112 -0.992 . . . . 0.0 111.001 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.314 6.6 pt-20 -98.09 120.26 38.18 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 125.573 2.606 . . . . 0.0 108.31 166.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 18.5 ttt -168.91 87.1 0.17 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 108.795 -3.82 . . . . 0.0 105.053 -150.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.789 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -110.35 -148.99 0.44 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 111.078 -2.783 . . . . 0.0 115.652 -156.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.79 -141.89 4.91 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 116.94 1.536 . . . . 0.0 116.94 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.2 m -122.17 134.34 54.73 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.481 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 42.4 t -59.07 114.74 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.871 0 O-C-N 121.689 -0.632 . . . . 0.0 110.187 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.1 mt -82.24 -32.8 29.53 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 119.641 -1.912 . . . . 0.0 111.956 166.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -146.56 141.74 27.29 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.024 1.392 . . . . 0.0 111.025 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 20' ' ' MET . 25.1 p -92.88 110.18 21.63 Favored 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 102.464 -3.161 . . . . 0.0 102.464 169.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.434 3.8 mt -81.83 -133.35 0.0 OUTLIER Pre-proline 0 CA--C 1.602 2.958 0 CA-C-O 114.609 -2.615 . . . . 0.0 114.191 -160.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -73.43 -69.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.379 2.163 1 CA-C-N 129.994 4.605 . . . . 0.0 117.086 -174.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -73.01 -76.06 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.126 -0.984 . . . . 0.0 110.318 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -157.73 77.06 0.82 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 15' ' ' THR . 67.2 mtt -121.23 179.13 4.51 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.83 0.852 . . . . 0.0 112.242 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -145.21 109.74 4.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.66 -1.9 . . . . 0.0 106.812 -166.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -84.57 101.92 12.48 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 167.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.77 141.11 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -163.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -93.36 108.04 19.77 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 171.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.501 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.261 0.1 OUTLIER -77.11 169.27 18.63 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 124.058 1.885 . . . . 0.0 115.047 -176.234 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.271 20.8 pt-20 -68.03 -8.9 41.54 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 112.555 -2.111 . . . . 0.0 114.703 169.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.501 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 15.3 t30 -91.14 -6.45 53.56 Favored 'General case' 0 CA--C 1.588 2.432 0 CA-C-N 119.124 0.874 . . . . 0.0 112.647 164.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.47 -20.9 45.78 Favored Glycine 0 CA--C 1.549 2.182 0 N-CA-C 118.961 2.345 . . . . 0.0 118.961 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -78.09 137.76 38.39 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.735 0.814 . . . . 0.0 111.486 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.45 112.99 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 122.879 1.323 . . . . 0.0 109.304 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 m -102.64 148.91 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 113.932 -1.486 . . . . 0.0 113.661 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.5 m -93.22 120.93 34.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.007 -1.058 . . . . 0.0 108.28 171.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.36 161.41 36.37 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -113.04 -160.6 0.72 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.1 173.79 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.07 0 O-C-N 120.584 -1.323 . . . . 0.0 108.524 166.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.1 p -78.54 100.69 7.03 Favored 'General case' 0 CA--C 1.561 1.382 0 O-C-N 119.254 -2.154 . . . . 0.0 108.39 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -31.69 -30.8 0.01 OUTLIER Glycine 0 N--CA 1.506 3.329 1 N-CA-C 123.852 4.301 . . . . 0.0 123.852 -175.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -62.46 -46.67 87.45 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 174.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 ptm -73.25 -17.82 61.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -39.75 -30.51 0.08 Allowed 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 118.348 2.721 . . . . 0.0 118.348 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -90.55 -5.93 55.34 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -103.9 -66.91 0.92 Allowed 'General case' 0 CA--C 1.578 2.026 0 C-N-CA 126.155 1.782 . . . . 0.0 106.617 169.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -81.6 98.24 8.25 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 125.509 1.524 . . . . 0.0 107.838 168.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.9 mt -73.3 -71.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.411 -0.805 . . . . 0.0 110.908 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.404 ' HB3' ' H ' ' A' ' 46' ' ' ILE . 23.7 mtp180 -140.03 171.69 13.82 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 125.853 2.74 . . . . 0.0 115.491 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.404 ' H ' ' HB3' ' A' ' 45' ' ' ARG . 1.3 pt -142.86 167.86 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 110.56 -3.018 . . . . 0.0 108.483 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.444 ' CD1' ' H ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -110.54 177.35 4.71 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.838 1.304 . . . . 0.0 112.822 -173.286 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.444 ' H ' ' CD1' ' A' ' 47' ' ' LEU . 48.8 m -76.0 83.65 2.88 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 123.36 1.552 . . . . 0.0 110.998 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.481 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 134.04 23.31 0.69 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 117.524 1.77 . . . . 0.0 117.524 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.76 160.53 14.72 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 122.858 1.313 . . . . 0.0 113.877 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -87.99 82.46 7.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 125.754 2.693 . . . . 0.0 113.368 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -71.93 163.83 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-N 110.088 -3.233 . . . . 0.0 115.504 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.521 ' HA ' ' CB ' ' A' ' 9' ' ' GLN 0.355 19.5 m -125.63 78.94 1.78 Allowed 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 124.261 1.981 . . . . 0.0 113.417 170.309 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.789 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.2 OUTLIER -75.99 101.3 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 125.813 1.645 . . . . 0.0 109.806 -173.409 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -82.75 140.97 32.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.709 -0.619 . . . . 0.0 109.354 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.21 -116.64 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 110.584 -171.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.42 166.32 17.15 Favored Pre-proline 0 CA--C 1.575 1.907 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -176.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -61.38 -47.36 12.07 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 C-N-CA 123.088 2.526 . . . . 0.0 117.425 166.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -97.46 -43.63 7.18 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -175.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -95.49 77.3 3.35 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.17 49.47 1.66 Allowed 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 94.5 p -106.92 -27.86 10.43 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 125.668 1.587 . . . . 0.0 114.744 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -126.24 -173.49 2.87 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 124.06 0.944 . . . . 0.0 112.736 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.59 179.73 45.38 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.73 108.27 1.17 Allowed 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 118.895 2.924 . . . . 0.0 118.895 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.434 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -26.71 91.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.118 0 N-CA-C 118.889 2.922 . . . . 0.0 118.889 162.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 CA--C 1.58 2.117 0 N-CA-C 117.271 2.322 . . . . 0.0 117.271 176.408 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 . . . . . 0 CA--C 1.572 1.812 0 CA-C-O 120.891 0.377 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.14 141.97 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.107 -0.996 . . . . 0.0 111.411 -174.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.328 12.5 pt-20 -99.14 124.35 44.1 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.636 1.684 . . . . 0.0 110.224 168.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.284 11.4 ttt -154.71 -8.06 0.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 120.539 3.533 . . . . 0.0 120.539 -151.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.562 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.574 0.0 OUTLIER -78.9 -165.35 0.72 Allowed 'General case' 0 N--CA 1.491 1.583 1 N-CA-C 122.053 4.094 . . . . 0.0 122.053 -165.11 . . . . . . . . 5 4 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.39 -112.61 1.53 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 122.42 3.728 . . . . 0.0 122.42 -166.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.3 m -110.78 141.11 44.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.532 -0.981 . . . . 0.0 108.363 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.535 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 90.4 t -69.51 101.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.602 2.948 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 174.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.12 -38.38 52.25 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 117.923 -2.985 . . . . 0.0 112.828 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -128.93 145.71 51.15 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.761 1.267 . . . . 0.0 110.762 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 20' ' ' MET . 2.4 p -95.77 106.0 18.07 Favored 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 101.775 -3.417 . . . . 0.0 101.775 167.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.288 5.7 mt -78.47 166.47 42.64 Favored Pre-proline 0 CA--C 1.593 2.626 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.482 -167.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.385 6.0 Cg_endo -20.54 -57.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.57 2.302 2 N-CA-C 125.459 5.138 . . . . 0.0 125.459 -164.798 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -82.71 -78.34 0.21 Allowed 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 120.651 1.569 . . . . 0.0 109.782 172.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -158.13 72.81 0.64 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.255 67.3 mtm -115.98 -169.61 1.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.681 0.792 . . . . 0.0 110.588 178.14 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -148.49 108.15 3.99 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 119.114 -2.241 . . . . 0.0 106.952 -166.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -84.48 97.59 9.62 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.78 133.7 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -164.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -95.96 111.49 23.47 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.58 HD22 ' H ' ' A' ' 26' ' ' GLU 0.365 0.2 OUTLIER -52.26 -178.54 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 120.608 3.558 . . . . 0.0 120.608 -176.11 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.58 ' H ' HD22 ' A' ' 25' ' ' LEU . 11.0 pt-20 -69.62 -31.45 69.57 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 112.729 -2.032 . . . . 0.0 113.949 167.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -88.68 6.74 37.05 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.19 13.41 79.06 Favored Glycine 0 CA--C 1.549 2.165 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -95.1 130.01 41.96 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 120.821 2.31 . . . . 0.0 112.561 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.0 t -82.76 124.9 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.438 -1.414 . . . . 0.0 112.333 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.16 149.76 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 114.705 -1.134 . . . . 0.0 113.499 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 m -87.45 127.08 35.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.487 -1.383 . . . . 0.0 110.396 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.4 139.98 28.75 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.71 155.73 17.47 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 168.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.408 HD13 ' H ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -64.31 170.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.536 0 O-C-N 120.456 -1.402 . . . . 0.0 112.166 168.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -75.68 92.9 3.01 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 119.226 -2.171 . . . . 0.0 107.902 169.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.81 -38.23 0.01 OUTLIER Glycine 0 N--CA 1.505 3.266 1 N-CA-C 123.314 4.086 . . . . 0.0 123.314 -174.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -54.32 -45.54 72.65 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -73.18 -21.87 60.59 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 173.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.408 ' H ' HD13 ' A' ' 35' ' ' ILE . 88.6 mtt-85 -37.06 -39.68 0.25 Allowed 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 123.718 2.963 . . . . 0.0 117.524 174.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -91.07 47.41 1.4 Allowed 'General case' 0 CA--C 1.582 2.183 0 CA-C-O 124.231 1.967 . . . . 0.0 114.402 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -168.12 -60.36 0.02 OUTLIER 'General case' 0 CA--C 1.581 2.17 0 C-N-CA 128.151 2.581 . . . . 0.0 105.193 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -83.43 68.45 9.73 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 127.144 2.178 . . . . 0.0 114.017 175.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 mt -88.33 71.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.389 84.8 mmt-85 -100.98 -76.02 0.57 Allowed 'General case' 0 N--CA 1.489 1.488 1 N-CA-C 124.465 4.987 . . . . 0.0 124.465 -164.003 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pt -99.77 162.47 3.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 112.116 -2.311 . . . . 0.0 116.678 -157.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -129.45 -174.55 3.32 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.528 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.8 m -70.52 84.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.768 1.27 . . . . 0.0 112.585 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.535 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 132.68 19.22 1.06 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 118.218 2.047 . . . . 0.0 118.218 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.03 157.73 16.62 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-O 123.014 1.388 . . . . 0.0 111.803 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -90.61 94.11 9.56 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 125.217 2.437 . . . . 0.0 113.429 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -97.01 142.46 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.827 0 CA-C-N 109.733 -3.394 . . . . 0.0 111.836 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 m -126.48 119.15 26.47 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 100.62 -3.844 . . . . 0.0 100.62 171.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.645 HG12 ' H ' ' A' ' 66' ' ' ILE 0.252 93.6 t -127.86 125.42 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 112.9 -1.955 . . . . 0.0 106.345 -157.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -79.09 137.97 37.74 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -172.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.275 2.3 pt? -129.03 -171.19 2.42 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 121.625 0.726 . . . . 0.0 111.14 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 p -106.13 164.87 14.05 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -43.04 -51.66 5.38 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 N-CA-C 122.212 3.889 . . . . 0.0 122.212 161.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -110.75 -41.4 4.29 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.61 69.14 6.69 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.859 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.42 -9.09 58.33 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.3 t -69.71 -6.57 32.64 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -124.05 -176.62 3.53 Favored 'General case' 0 CA--C 1.575 1.928 0 CA-C-O 123.211 1.482 . . . . 0.0 113.259 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.89 174.47 43.46 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -153.7 106.74 2.92 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 171.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.645 ' H ' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -41.3 110.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 117.973 2.582 . . . . 0.0 117.973 173.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.572 1.82 0 C-N-CA 124.708 1.203 . . . . 0.0 110.444 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 m120 . . . . . 0 CA--C 1.582 2.203 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mt -97.21 144.82 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.112 -1.617 . . . . 0.0 111.095 -170.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.279 7.2 pt-20 -99.84 119.56 38.38 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 124.219 1.961 . . . . 0.0 109.219 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.295 10.8 ttt -154.26 -4.77 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 110.399 -3.091 . . . . 0.0 119.322 -152.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.558 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.603 0.2 OUTLIER -75.89 -157.85 0.08 Allowed 'General case' 0 CA--C 1.566 1.584 1 N-CA-C 125.778 5.473 . . . . 0.0 125.778 -162.18 . . . . . . . . 5 4 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 9' ' ' GLN . . . -114.43 -150.75 10.2 Favored Glycine 0 CA--C 1.535 1.292 1 N-CA-C 126.29 5.276 . . . . 0.0 126.29 -157.525 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -101.79 136.53 41.47 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.45 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 63.1 t -64.56 111.66 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.588 0 O-C-N 121.074 -1.017 . . . . 0.0 109.332 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.9 -36.56 64.77 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-N 122.738 2.517 . . . . 0.0 111.943 168.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -146.07 147.3 31.46 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 122.32 1.057 . . . . 0.0 111.789 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 20' ' ' MET . 0.3 OUTLIER -93.93 116.23 28.66 Favored 'General case' 0 N--CA 1.511 2.593 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 169.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.454 1.2 mm? -79.79 -127.71 0.0 OUTLIER Pre-proline 0 CA--C 1.597 2.779 0 CA-C-O 114.369 -2.729 . . . . 0.0 114.81 -164.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.55 -67.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.566 2.113 1 CA-C-N 130.159 4.664 . . . . 0.0 116.966 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -81.24 -72.94 0.4 Allowed 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.387 -0.82 . . . . 0.0 110.603 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m -157.43 74.31 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.26 89.4 mtp -113.98 -169.57 1.54 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 117.326 -1.321 . . . . 0.0 111.901 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.402 ' HB3' HG23 ' A' ' 23' ' ' VAL . 57.9 m-85 -154.92 112.01 3.33 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 123.366 2.803 . . . . 0.0 111.337 -166.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -93.89 97.61 10.5 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 167.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 21' ' ' PHE . 2.5 t -101.52 141.2 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -163.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -98.35 107.86 20.42 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.0 171.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.49 HD21 ' H ' ' A' ' 26' ' ' GLU 0.264 0.6 OUTLIER -50.47 176.56 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 118.718 2.859 . . . . 0.0 118.718 -177.089 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.49 ' H ' HD21 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -66.28 -22.68 66.31 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 168.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -95.47 6.11 49.84 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.47 -1.58 85.96 Favored Glycine 0 CA--C 1.554 2.52 0 N-CA-C 119.955 2.742 . . . . 0.0 119.955 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -82.63 140.44 33.18 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.834 1.817 . . . . 0.0 113.04 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.3 130.18 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 CA-C-O 122.846 1.307 . . . . 0.0 111.374 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.27 153.03 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.376 -1.284 . . . . 0.0 113.168 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.8 m -98.16 126.1 43.48 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.439 -1.413 . . . . 0.0 110.256 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.42 163.39 34.77 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.6 176.14 5.14 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.825 -1.534 . . . . 0.0 107.63 164.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.14 171.0 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.59 2.49 0 O-C-N 119.731 -1.856 . . . . 0.0 108.84 161.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 p -74.91 27.48 0.09 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 118.26 -2.775 . . . . 0.0 117.988 177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.06 -49.78 0.18 Allowed Glycine 0 N--CA 1.502 3.048 0 N-CA-C 119.937 2.735 . . . . 0.0 119.937 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -65.62 -52.34 52.73 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.044 2.138 . . . . 0.0 115.499 -177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -18.1 65.1 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -38.43 -39.21 0.43 Allowed 'General case' 0 CA--C 1.575 1.922 0 CA-C-N 122.419 2.372 . . . . 0.0 116.492 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -92.28 32.4 1.19 Allowed 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -149.73 -54.98 0.17 Allowed 'General case' 0 CA--C 1.577 1.991 0 C-N-CA 127.25 2.22 . . . . 0.0 107.141 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -76.46 63.47 2.02 Favored 'General case' 0 CA--C 1.58 2.107 0 C-N-CA 125.605 1.562 . . . . 0.0 112.947 171.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mt -84.98 72.18 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 CA-C-O 124.752 2.215 . . . . 0.0 108.788 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -112.19 -43.19 3.58 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 120.811 3.634 . . . . 0.0 120.811 -169.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.403 0.0 OUTLIER -120.23 160.82 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 1 N-CA-C 122.992 4.442 . . . . 0.0 122.992 -138.901 . . . . . . . . 4 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.9 tp -159.15 178.67 9.76 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 110.203 -3.18 . . . . 0.0 112.387 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.1 m -68.55 116.02 8.61 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.615 1.198 . . . . 0.0 111.709 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.45 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 95.27 14.37 48.42 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 119.371 2.508 . . . . 0.0 119.371 -175.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.46 172.97 8.04 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 124.96 1.304 . . . . 0.0 111.757 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -97.59 136.62 37.72 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 124.516 2.103 . . . . 0.0 115.87 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.06 153.95 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.954 0 CA-C-N 111.51 -2.587 . . . . 0.0 110.901 -171.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.8 m -143.71 102.89 3.99 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 101.978 -3.341 . . . . 0.0 101.978 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.558 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 19.7 t -105.87 132.14 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 111.107 -2.77 . . . . 0.0 108.056 -164.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -82.86 127.54 33.59 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.665 -1.272 . . . . 0.0 111.771 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.321 2.2 pt? -102.0 -165.53 1.2 Allowed 'General case' 0 CA--C 1.566 1.574 0 CA-C-O 121.26 0.552 . . . . 0.0 111.385 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 p -131.74 161.49 62.08 Favored Pre-proline 0 CA--C 1.572 1.813 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -51.54 -43.74 48.37 Favored 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 123.999 3.133 . . . . 0.0 118.843 164.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -95.57 -57.2 2.45 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.562 ' HD2' ' NZ ' ' A' ' 63' ' ' LYS . 21.6 t0 -95.16 74.08 3.4 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.343 1.068 . . . . 0.0 113.342 -172.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.51 -20.0 65.94 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 118.377 2.732 . . . . 0.0 118.377 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 t -74.98 4.53 6.44 Favored 'General case' 0 CA--C 1.583 2.241 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 171.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.562 ' NZ ' ' HD2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -137.68 170.71 15.6 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 121.093 1.769 . . . . 0.0 115.516 -176.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.53 -169.19 42.13 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.98 124.9 7.89 Favored 'General case' 0 CA--C 1.59 2.49 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 173.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.497 ' H ' HD13 ' A' ' 66' ' ' ILE . 2.8 mp -43.71 104.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 171.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.1 m . . . . . 0 CA--C 1.579 2.069 0 CA-C-N 113.891 -1.504 . . . . 0.0 114.054 174.479 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.561 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -123.72 -87.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.882 0.764 . . . . 0.0 109.385 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -87.18 56.38 3.96 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.34 155.28 27.29 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 123.397 1.57 . . . . 0.0 114.079 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -76.91 128.91 35.41 Favored 'General case' 0 CA--C 1.571 1.772 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.82 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -96.66 141.13 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 124.187 0.995 . . . . 0.0 110.104 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.378 14.7 pt-20 -92.29 126.21 37.27 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 124.858 2.266 . . . . 0.0 109.536 165.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.283 20.4 ttt -168.46 82.96 0.16 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 109.968 -3.287 . . . . 0.0 104.765 -152.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.666 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -98.47 -153.03 0.42 Allowed 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 -159.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -167.36 -174.37 36.39 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 120.487 2.955 . . . . 0.0 120.487 -170.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.7 m -100.54 124.97 46.81 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.465 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 67.3 t -60.66 117.54 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.763 0 CA-C-N 121.096 1.771 . . . . 0.0 107.294 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.302 73.3 mt -100.95 -26.43 13.74 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.169 -1.582 . . . . 0.0 112.773 171.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -136.42 145.86 45.74 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 123.09 1.424 . . . . 0.0 109.487 162.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' MET . 5.8 p -96.61 110.27 22.72 Favored 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 100.827 -3.768 . . . . 0.0 100.827 168.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.429 2.5 mt -79.65 -124.89 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.91 0 CA-C-O 113.986 -2.911 . . . . 0.0 115.655 -159.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.36 -70.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.185 1 CA-C-N 130.561 4.807 . . . . 0.0 116.243 -176.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -78.67 -70.31 0.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.251 -0.906 . . . . 0.0 110.731 175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 m -159.33 75.89 0.67 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 15' ' ' THR . 67.9 mtt -118.58 -175.42 2.88 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.512 0.725 . . . . 0.0 111.426 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -144.29 109.88 5.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 119.454 -2.029 . . . . 0.0 106.398 -166.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -85.32 93.86 8.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 170.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 t -100.94 135.21 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -163.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -85.91 116.18 23.99 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.298 4.7 mt -70.52 174.95 5.2 Favored 'General case' 0 CA--C 1.577 1.99 0 CA-C-O 124.112 1.91 . . . . 0.0 112.569 -172.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -24.17 63.21 Favored 'General case' 0 CA--C 1.586 2.355 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.908 165.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.6 -8.25 56.3 Favored 'General case' 0 CA--C 1.586 2.365 0 C-N-CA 126.186 1.794 . . . . 0.0 115.398 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.72 9.31 75.08 Favored Glycine 0 CA--C 1.554 2.521 0 N-CA-C 119.496 2.558 . . . . 0.0 119.496 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -114.36 147.45 39.14 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 118.665 1.232 . . . . 0.0 112.452 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.4 t -82.27 126.88 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.861 -1.149 . . . . 0.0 111.216 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.3 147.68 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.598 1.19 . . . . 0.0 112.791 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.9 m -89.59 123.64 33.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.72 -1.238 . . . . 0.0 109.08 172.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.31 155.17 47.9 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 159.71 19.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 172.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -73.0 176.33 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.631 0 O-C-N 119.973 -1.704 . . . . 0.0 110.758 166.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 92.5 p -79.9 25.24 0.37 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 121.086 3.735 . . . . 0.0 121.086 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.85 -52.44 1.63 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.295 64.4 pttt -59.83 -58.17 9.73 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 118.061 2.615 . . . . 0.0 118.061 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -21.5 62.97 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -38.44 -39.02 0.42 Allowed 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . 0.258 14.4 mptt -98.02 -4.55 35.87 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 121.639 3.94 . . . . 0.0 121.639 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -93.46 53.25 1.86 Allowed 'General case' 0 CA--C 1.587 2.404 0 N-CA-C 102.316 -3.216 . . . . 0.0 102.316 153.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.416 1.8 t80 -45.74 98.11 0.01 OUTLIER 'General case' 0 C--N 1.379 1.86 0 N-CA-C 118.679 2.844 . . . . 0.0 118.679 -152.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mt -82.07 74.53 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 109.175 -3.648 . . . . 0.0 107.562 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 137.96 58.03 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 -170.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.274 1.4 pt -141.78 154.96 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 CA-C-N 111.466 -2.606 . . . . 0.0 111.87 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 tp -131.39 -174.44 3.4 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.128 0.966 . . . . 0.0 111.033 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -72.87 84.88 1.24 Allowed 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 123.317 1.532 . . . . 0.0 113.074 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 130.34 25.23 0.88 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 117.631 1.812 . . . . 0.0 117.631 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.55 165.62 12.44 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 123.2 1.476 . . . . 0.0 114.131 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -84.73 82.65 8.33 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 125.583 2.611 . . . . 0.0 113.674 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 m -79.03 152.82 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 CA-C-N 110.595 -3.002 . . . . 0.0 113.284 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.475 ' HA ' ' CB ' ' A' ' 9' ' ' GLN . 63.8 m -94.76 161.15 14.29 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 160.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.666 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -157.35 86.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 O-C-N 118.128 -2.858 . . . . 0.0 105.658 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -78.19 138.6 38.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.102 -0.999 . . . . 0.0 109.743 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -136.0 -179.32 5.59 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.665 1.221 . . . . 0.0 111.699 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 p -100.36 161.06 25.28 Favored Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -53.9 -43.48 57.7 Favored 'Trans proline' 0 CA--C 1.572 2.388 0 C-N-CA 123.231 2.621 . . . . 0.0 118.22 163.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -82.87 -49.39 9.71 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.72 83.25 2.23 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 122.25 1.024 . . . . 0.0 112.049 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -17.1 61.17 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.2 p -68.97 -7.97 40.26 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -122.73 -177.74 3.73 Favored 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 119.963 1.256 . . . . 0.0 114.056 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.33 177.0 48.29 Favored Glycine 0 CA--C 1.548 2.127 0 N-CA-C 117.686 1.834 . . . . 0.0 117.686 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -162.69 115.86 1.67 Allowed 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 172.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -38.99 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 118.929 -2.357 . . . . 0.0 116.912 165.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.279 2.1 m -77.19 -87.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.538 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -116.96 145.91 43.34 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -60.64 99.86 0.09 Allowed 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.0 m -110.82 -29.76 7.83 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -175.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 . . . . . 0 CA--C 1.56 1.331 0 CA-C-O 124.799 2.238 . . . . 0.0 112.472 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.56 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -79.25 84.31 5.21 Favored 'General case' 0 CA--C 1.574 1.883 0 O-C-N 120.919 -1.113 . . . . 0.0 113.309 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.46 47.97 2.21 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -133.32 113.48 12.65 Favored 'General case' 0 CA--C 1.568 1.656 0 C-N-CA 124.357 1.063 . . . . 0.0 112.914 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -83.98 107.75 16.54 Favored 'General case' 0 CA--C 1.575 1.925 0 O-C-N 120.985 -1.072 . . . . 0.0 108.818 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -89.16 138.44 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.427 -1.421 . . . . 0.0 111.741 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.332 10.5 pt-20 -93.74 123.29 36.99 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 125.257 2.456 . . . . 0.0 109.219 168.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.26 20.5 ttt -170.34 85.08 0.11 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 109.173 -3.649 . . . . 0.0 104.626 -151.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.67 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -105.16 -149.24 0.41 Allowed 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -162.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.29 -142.44 5.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.8 m -122.86 135.26 54.46 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 54.0 t -58.99 124.6 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.607 3.168 0 O-C-N 121.364 -0.835 . . . . 0.0 109.528 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.5 mt -90.66 -27.6 18.92 Favored 'General case' 0 N--CA 1.514 2.737 0 O-C-N 119.314 -2.116 . . . . 0.0 112.031 163.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -148.47 143.51 26.77 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 120.83 -1.169 . . . . 0.0 111.736 166.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.1 p -103.94 103.76 13.64 Favored 'General case' 0 N--CA 1.518 2.958 0 N-CA-C 102.087 -3.301 . . . . 0.0 102.087 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.393 0.2 OUTLIER -77.08 178.6 1.97 Allowed Pre-proline 0 CA--C 1.593 2.626 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -168.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -54.41 -36.15 86.81 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 N-CA-C 121.25 3.519 . . . . 0.0 121.25 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -79.74 -100.78 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.4 m -152.97 72.77 0.97 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 76.0 mtp -126.04 162.7 24.68 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -132.77 114.48 14.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.141 -1.6 . . . . 0.0 107.087 -163.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.2 ttm105 -85.67 89.41 7.73 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.3 t -96.3 137.29 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -162.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.7 111.82 22.4 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.302 4.9 mt -72.3 174.24 7.56 Favored 'General case' 0 CA--C 1.577 2.002 0 CA-C-O 124.135 1.921 . . . . 0.0 112.779 -173.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.96 -22.59 61.43 Favored 'General case' 0 CA--C 1.585 2.298 0 CA-C-N 113.804 -1.544 . . . . 0.0 114.128 166.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -74.58 -9.09 58.23 Favored 'General case' 0 CA--C 1.587 2.366 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.68 23.79 55.09 Favored Glycine 0 CA--C 1.555 2.54 0 N-CA-C 118.632 2.213 . . . . 0.0 118.632 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -125.94 145.71 50.16 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.309 1.044 . . . . 0.0 111.224 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.0 t -86.04 117.5 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.728 -1.232 . . . . 0.0 110.123 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.7 148.9 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.1 m -92.54 125.5 37.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.405 -1.434 . . . . 0.0 110.062 173.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.32 159.84 40.79 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 177.11 4.75 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 165.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 pt -88.99 -178.27 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.36 0 O-C-N 119.211 -2.181 . . . . 0.0 110.632 165.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.4 p -82.49 122.32 27.9 Favored 'General case' 0 CA--C 1.56 1.33 0 O-C-N 119.714 -1.866 . . . . 0.0 109.205 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.49 -20.34 0.59 Allowed Glycine 0 N--CA 1.503 3.161 0 N-CA-C 122.312 3.685 . . . . 0.0 122.312 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -71.24 -55.75 7.46 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 125.641 1.577 . . . . 0.0 114.405 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 ptm -69.39 -20.54 63.81 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -37.93 -35.66 0.16 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -94.47 33.58 1.4 Allowed 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -150.93 -69.93 0.18 Allowed 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.408 ' HH ' ' CD1' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -82.64 101.04 10.55 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 163.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.83 -73.55 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.439 -0.788 . . . . 0.0 109.381 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -132.1 -179.27 5.31 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-O 124.512 2.101 . . . . 0.0 114.316 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.408 ' CD1' ' HH ' ' A' ' 43' ' ' TYR 0.258 1.1 pt -143.39 175.67 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 C-N-CA 126.932 2.093 . . . . 0.0 110.858 -173.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.4 158.5 16.3 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.256 1.027 . . . . 0.0 111.115 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 m -71.58 86.84 0.9 Allowed 'General case' 0 CA--C 1.572 1.807 0 CA-C-O 123.577 1.655 . . . . 0.0 110.423 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.447 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 130.36 24.2 0.95 Allowed Glycine 0 N--CA 1.492 2.423 0 CA-C-N 113.02 -1.9 . . . . 0.0 117.049 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -94.57 162.3 13.86 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-O 122.976 1.37 . . . . 0.0 114.166 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -85.59 81.35 8.7 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 125.575 2.607 . . . . 0.0 113.796 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -77.79 158.15 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 110.324 -3.126 . . . . 0.0 113.839 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.513 ' HA ' ' CB ' ' A' ' 9' ' ' GLN 0.299 35.3 m -95.44 162.78 13.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 160.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.67 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -158.44 89.55 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 118.473 -2.642 . . . . 0.0 104.897 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.55 134.87 36.5 Favored 'General case' 0 CA--C 1.563 1.47 0 O-C-N 121.17 -0.956 . . . . 0.0 110.014 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.45 ' HB3' ' H ' ' A' ' 57' ' ' THR . 3.4 mp -101.06 -171.76 2.05 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 125.972 2.796 . . . . 0.0 111.878 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.45 ' H ' ' HB3' ' A' ' 56' ' ' LEU . 1.2 p -122.5 162.04 40.32 Favored Pre-proline 0 CA--C 1.577 1.987 0 CA-C-N 109.657 -3.429 . . . . 0.0 112.657 173.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -52.85 -41.27 71.6 Favored 'Trans proline' 0 CA--C 1.569 2.249 0 C-N-CA 123.656 2.904 . . . . 0.0 119.166 164.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -95.21 -52.81 4.03 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -91.39 77.03 5.87 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 122.528 1.156 . . . . 0.0 112.779 -172.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.5 mt -70.89 -22.86 62.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 117.643 2.46 . . . . 0.0 117.643 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.5 t -75.89 6.95 4.41 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -139.8 166.48 24.5 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 120.564 1.529 . . . . 0.0 113.475 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.14 -164.08 29.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 115.633 1.013 . . . . 0.0 115.633 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.95 122.31 2.57 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.493 HG13 ' H ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -35.64 91.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 166.326 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.268 2.8 m -77.94 -71.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.412 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.288 47.4 t80 61.69 -84.25 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 173.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -153.52 148.79 26.99 Favored 'General case' 0 CA--C 1.57 1.726 0 C-N-CA 124.262 1.025 . . . . 0.0 110.885 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 99.6 p -64.23 -48.25 76.54 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 124.935 2.302 . . . . 0.0 108.82 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.553 0 CA-C-O 121.656 0.741 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -83.21 79.15 9.48 Favored 'General case' 0 CA--C 1.572 1.81 0 O-C-N 120.953 -1.092 . . . . 0.0 112.84 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -104.33 66.11 0.8 Allowed 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 122.321 1.057 . . . . 0.0 112.172 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.19 125.1 24.47 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -64.58 124.3 21.51 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.08 142.24 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.615 1.166 . . . . 0.0 109.661 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.409 16.3 pt-20 -95.03 122.27 37.51 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 125.036 2.351 . . . . 0.0 109.82 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.275 18.6 ttt -168.34 81.2 0.16 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 109.777 -3.374 . . . . 0.0 105.683 -149.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.695 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -96.04 -149.86 0.32 Allowed 'General case' 0 CA--C 1.563 1.456 0 N-CA-C 118.713 2.857 . . . . 0.0 118.713 -157.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.88 -178.34 39.27 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 121.951 3.54 . . . . 0.0 121.951 -168.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.6 m -99.73 124.88 45.43 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 61.4 t -60.2 122.14 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.989 0 CA-C-N 120.487 1.494 . . . . 0.0 107.253 175.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.299 62.6 mt -99.51 -22.06 15.65 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 119.823 -1.798 . . . . 0.0 112.844 168.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -145.01 143.84 30.7 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 122.372 1.082 . . . . 0.0 110.833 161.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 20' ' ' MET . 24.7 p -106.17 106.58 17.16 Favored 'General case' 0 N--CA 1.515 2.798 0 N-CA-C 101.395 -3.557 . . . . 0.0 101.395 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.374 0.3 OUTLIER -76.48 174.37 5.81 Favored Pre-proline 0 CA--C 1.591 2.544 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -167.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -47.11 -42.22 26.42 Favored 'Trans proline' 0 CA--C 1.565 2.064 0 N-CA-C 121.493 3.613 . . . . 0.0 121.493 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -80.49 -93.21 0.05 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.9 m -159.5 75.38 0.64 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 15' ' ' THR . 69.6 mtm -126.78 167.87 15.19 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.795 0.838 . . . . 0.0 112.512 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -132.22 114.89 15.0 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 118.703 -2.498 . . . . 0.0 108.815 -163.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -87.05 95.89 10.1 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 170.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 t -105.13 139.97 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -162.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.87 111.57 18.88 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 167.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.257 0.1 OUTLIER -79.84 166.21 21.93 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 121.879 2.127 . . . . 0.0 113.082 -179.971 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.308 18.1 pt-20 -67.41 -6.35 18.78 Favored 'General case' 0 CA--C 1.579 2.065 0 CA-C-N 112.677 -2.056 . . . . 0.0 114.959 169.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.491 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 45.8 t-20 -86.41 -15.47 40.23 Favored 'General case' 0 CA--C 1.588 2.408 0 O-C-N 121.129 -0.982 . . . . 0.0 112.721 162.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.51 -25.73 24.89 Favored Glycine 0 CA--C 1.549 2.178 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -75.17 140.2 43.18 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 124.292 1.037 . . . . 0.0 112.334 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.4 t -81.53 112.69 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 122.688 1.232 . . . . 0.0 108.947 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.91 147.63 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 114.129 -1.396 . . . . 0.0 113.465 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 m -87.3 127.19 35.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.805 -1.184 . . . . 0.0 108.54 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.16 152.3 49.78 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.1 151.29 42.2 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 170.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.57 162.68 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.437 0 O-C-N 120.738 -1.226 . . . . 0.0 111.287 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.7 p -76.52 98.4 4.63 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 119.246 -2.159 . . . . 0.0 109.937 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -16.52 -50.19 0.01 OUTLIER Glycine 0 N--CA 1.505 3.234 1 N-CA-C 123.761 4.264 . . . . 0.0 123.761 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -47.69 -49.51 27.57 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 119.065 2.987 . . . . 0.0 119.065 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ptm -70.89 -18.08 62.69 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -39.6 -35.54 0.32 Allowed 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 169.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -92.79 34.06 1.11 Allowed 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -150.23 -71.63 0.18 Allowed 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 102.958 -2.978 . . . . 0.0 102.958 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -81.09 93.49 6.43 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.802 1.241 . . . . 0.0 107.771 164.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mt -74.01 -70.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.217 -0.927 . . . . 0.0 111.491 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -134.78 171.94 13.67 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 125.284 2.469 . . . . 0.0 115.009 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.265 1.0 OUTLIER -148.73 170.36 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 CA-C-N 110.85 -2.886 . . . . 0.0 109.777 -175.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.6 tp -109.43 163.41 13.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.891 -1.13 . . . . 0.0 112.986 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.8 m -71.48 85.15 0.84 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 123.813 1.768 . . . . 0.0 111.095 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.407 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 131.77 23.15 0.89 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 112.8 -2.0 . . . . 0.0 117.053 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -94.5 160.89 14.44 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 123.043 1.401 . . . . 0.0 113.145 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -88.78 83.63 6.69 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 124.999 2.333 . . . . 0.0 112.475 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -71.76 163.35 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 CA-C-N 110.802 -2.908 . . . . 0.0 114.34 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.487 ' HA ' ' CB ' ' A' ' 9' ' ' GLN 0.306 75.3 m -95.13 160.2 14.67 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 159.224 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.695 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -158.44 84.55 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 O-C-N 118.37 -2.706 . . . . 0.0 105.769 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -76.77 134.8 39.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.019 -1.051 . . . . 0.0 109.838 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -137.61 -172.14 3.16 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.821 0.82 . . . . 0.0 111.299 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -104.79 155.74 37.04 Favored Pre-proline 0 CA--C 1.573 1.833 0 O-C-N 120.993 -1.067 . . . . 0.0 113.259 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -54.34 -42.03 71.2 Favored 'Trans proline' 0 CA--C 1.572 2.392 0 C-N-CA 123.738 2.959 . . . . 0.0 118.387 164.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -79.42 -47.38 15.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -108.22 89.24 2.93 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 122.195 0.998 . . . . 0.0 110.308 -174.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.82 -14.9 57.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 118.996 2.962 . . . . 0.0 118.996 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.9 t -73.46 -1.28 17.74 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -129.56 -177.5 4.29 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 120.276 1.398 . . . . 0.0 113.277 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.0 -173.86 45.22 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -161.63 113.65 1.77 Allowed 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 119.595 3.183 . . . . 0.0 119.595 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -36.45 94.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 118.762 -2.461 . . . . 0.0 117.556 166.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.33 -64.48 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.737 0 CA-C-N 114.062 -1.426 . . . . 0.0 112.847 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.251 32.6 m-85 63.9 -54.84 0.23 Allowed 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -177.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mmt-85 -75.45 60.59 1.18 Allowed 'General case' 0 CA--C 1.582 2.207 0 C-N-CA 124.746 1.218 . . . . 0.0 113.196 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.9 p -168.96 -34.45 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 124.037 1.875 . . . . 0.0 115.846 -178.197 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 1.698 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.538 ' NZ ' ' HD2' ' A' ' 4' ' ' ASP . 11.9 tmtt? -81.81 80.62 8.07 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 120.804 1.638 . . . . 0.0 111.396 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -125.0 53.68 1.48 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.538 ' HD2' ' NZ ' ' A' ' 2' ' ' LYS . 9.2 p-10 -86.35 108.96 18.68 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 120.459 -1.401 . . . . 0.0 111.979 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -86.29 119.34 26.46 Favored 'General case' 0 CA--C 1.568 1.667 0 O-C-N 121.748 -0.595 . . . . 0.0 111.322 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -91.33 142.05 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.847 -1.158 . . . . 0.0 111.227 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.337 13.2 pt-20 -100.28 123.17 44.18 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 123.705 1.717 . . . . 0.0 110.177 169.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.261 13.9 ttt -155.15 -12.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 119.315 3.08 . . . . 0.0 119.315 -151.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.586 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.503 0.0 OUTLIER -69.68 -173.02 0.55 Allowed 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 121.765 3.987 . . . . 0.0 121.765 -169.915 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.56 -108.64 1.78 Allowed Glycine 0 N--CA 1.48 1.567 0 N-CA-C 122.442 3.737 . . . . 0.0 122.442 -164.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.7 m -121.43 136.92 54.91 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.517 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 79.1 t -62.76 117.05 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.91 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.7 mt -79.34 -37.36 37.71 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 122.107 2.231 . . . . 0.0 111.236 165.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -143.31 144.96 32.31 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 122.062 0.934 . . . . 0.0 112.346 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 20' ' ' MET . 32.2 p -104.2 109.3 21.06 Favored 'General case' 0 N--CA 1.513 2.725 0 N-CA-C 101.763 -3.421 . . . . 0.0 101.763 171.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.376 0.5 OUTLIER -77.32 -177.51 0.81 Allowed Pre-proline 0 CA--C 1.592 2.559 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -167.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -54.38 -36.59 87.8 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 N-CA-C 120.893 3.382 . . . . 0.0 120.893 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -85.72 -93.83 0.08 Allowed 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.624 ' HG1' ' NE ' ' A' ' 45' ' ' ARG . 23.0 m -156.23 74.89 0.86 Allowed 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 174.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 15' ' ' THR . 57.9 mtt -130.23 162.25 29.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.976 -1.077 . . . . 0.0 112.76 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -128.75 113.3 15.16 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 118.723 -2.485 . . . . 0.0 106.979 -162.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.594 ' NE ' ' HG1' ' A' ' 32' ' ' THR . 1.2 mpt_? -85.76 96.11 9.62 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 167.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.95 140.13 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -164.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.06 114.92 26.67 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.426 HD21 ' H ' ' A' ' 26' ' ' GLU 0.256 0.5 OUTLIER -58.4 178.07 0.11 Allowed 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -177.751 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.426 ' H ' HD21 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -66.49 -24.57 66.42 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 167.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -92.63 6.96 45.44 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 170.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.9 -1.74 87.86 Favored Glycine 0 CA--C 1.554 2.519 0 N-CA-C 119.911 2.725 . . . . 0.0 119.911 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -83.9 143.19 30.04 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.641 1.72 . . . . 0.0 113.262 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.5 t -89.05 130.84 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.663 0 CA-C-O 122.578 1.18 . . . . 0.0 111.52 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.86 153.92 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.54 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.594 ' HG1' ' NE ' ' A' ' 22' ' ' ARG . 53.0 m -99.51 122.0 41.97 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.495 -1.378 . . . . 0.0 109.853 174.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.39 149.36 32.6 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 119.733 3.235 . . . . 0.0 119.733 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -99.95 158.26 15.94 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.509 -1.37 . . . . 0.0 111.206 170.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.17 178.21 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.752 0 O-C-N 120.444 -1.41 . . . . 0.0 111.981 164.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.2 p -80.08 15.72 1.42 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 120.07 3.359 . . . . 0.0 120.07 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.67 -25.66 0.06 OUTLIER Glycine 0 N--CA 1.506 3.33 0 N-CA-C 121.842 3.497 . . . . 0.0 121.842 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -79.99 -45.95 17.51 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -46.25 89.42 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 118.537 2.792 . . . . 0.0 118.537 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.6 ptm85 -36.28 -45.99 0.5 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.806 3.262 . . . . 0.0 119.806 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -92.0 0.6 57.47 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-N 110.048 -3.251 . . . . 0.0 118.929 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -96.57 -71.58 0.67 Allowed 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 167.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.27 125.81 37.09 Favored 'General case' 0 CA--C 1.57 1.744 0 C-N-CA 124.154 0.982 . . . . 0.0 109.122 170.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.57 108.99 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.722 0 CA-C-O 124.429 2.061 . . . . 0.0 107.747 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.624 ' NE ' ' HG1' ' A' ' 19' ' ' THR . 4.7 ppt_? -44.66 174.62 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.878 1 N-CA-C 124.267 4.914 . . . . 0.0 124.267 -165.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -75.57 159.79 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 109.845 -3.343 . . . . 0.0 116.604 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -122.44 174.77 6.82 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.184 0.993 . . . . 0.0 112.285 -171.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -68.47 100.61 1.11 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 123.494 1.616 . . . . 0.0 112.576 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.517 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 113.36 20.47 6.22 Favored Glycine 0 N--CA 1.489 2.224 0 CA-C-N 112.837 -1.983 . . . . 0.0 117.883 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.55 158.58 15.92 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-O 122.917 1.341 . . . . 0.0 112.764 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -87.75 94.54 9.78 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 125.764 2.697 . . . . 0.0 113.106 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.56 148.12 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 CA-C-N 109.594 -3.457 . . . . 0.0 110.986 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.2 m -140.94 107.19 5.23 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 100.33 -3.952 . . . . 0.0 100.33 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.586 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.252 51.0 t -117.17 128.45 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 111.177 -2.738 . . . . 0.0 106.042 -159.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -80.65 134.32 35.86 Favored 'General case' 0 CA--C 1.558 1.266 0 O-C-N 121.345 -0.847 . . . . 0.0 112.182 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.56 -176.38 3.37 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.488 1.137 . . . . 0.0 110.707 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 p -108.56 164.12 15.44 Favored Pre-proline 0 CA--C 1.571 1.772 0 O-C-N 120.987 -1.071 . . . . 0.0 113.883 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -51.09 -40.77 59.26 Favored 'Trans proline' 0 CA--C 1.572 2.393 0 N-CA-C 118.976 2.645 . . . . 0.0 118.976 163.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -94.98 -53.39 3.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.508 ' HD2' ' NZ ' ' A' ' 63' ' ' LYS . 49.1 t0 -89.63 79.87 6.73 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.576 1.179 . . . . 0.0 111.924 -172.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.65 -21.23 57.88 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.2 t -77.64 11.75 1.95 Allowed 'General case' 0 CA--C 1.58 2.127 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 173.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.508 ' NZ ' ' HD2' ' A' ' 60' ' ' ASP . 15.3 mtmm -137.56 177.38 7.91 Favored 'General case' 0 CA--C 1.57 1.742 0 CA-C-N 120.249 1.386 . . . . 0.0 114.612 -175.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.2 -176.25 45.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.22 114.85 3.69 Favored 'General case' 0 CA--C 1.592 2.58 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 168.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.548 ' H ' HG12 ' A' ' 54' ' ' VAL . 1.3 mp -45.13 108.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 O-C-N 119.076 -2.265 . . . . 0.0 114.893 171.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -90.6 -40.81 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.87 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.799 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.6 t80 67.85 148.7 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 171.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.33 52.77 2.11 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.0 t -160.15 -84.7 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 . . . . . 0 CA--C 1.566 1.583 0 CA-C-O 125.018 2.342 . . . . 0.0 107.9 171.487 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.532 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -69.76 -27.33 64.84 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.37 56.11 3.43 Favored 'General case' 0 CA--C 1.579 2.082 0 CA-C-N 120.256 1.389 . . . . 0.0 114.323 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -104.26 114.95 29.53 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -85.46 105.89 16.41 Favored 'General case' 0 CA--C 1.579 2.066 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mt -88.99 138.73 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.294 -1.504 . . . . 0.0 112.298 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.655 ' HE2' ' NE ' ' A' ' 69' ' ' ARG 0.328 8.6 pt-20 -88.56 121.63 31.15 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 125.052 2.358 . . . . 0.0 109.235 170.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 18.0 ttt -172.01 84.79 0.07 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 109.289 -3.596 . . . . 0.0 104.852 -148.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.774 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -110.92 -149.03 0.44 Allowed 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -156.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 -150.72 9.44 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 117.967 1.947 . . . . 0.0 117.967 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.9 m -115.89 133.79 55.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.464 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 46.9 t -60.06 118.31 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.003 0 O-C-N 121.384 -0.822 . . . . 0.0 109.102 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -84.24 -31.44 25.01 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.599 -1.938 . . . . 0.0 111.874 165.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -147.04 143.88 28.7 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 122.726 1.251 . . . . 0.0 111.807 167.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 20' ' ' MET . 24.3 p -104.16 105.68 15.93 Favored 'General case' 0 N--CA 1.516 2.862 0 N-CA-C 100.793 -3.781 . . . . 0.0 100.793 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.371 0.3 OUTLIER -75.26 173.39 7.06 Favored Pre-proline 0 CA--C 1.591 2.526 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -167.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -47.58 -35.26 22.14 Favored 'Trans proline' 0 CA--C 1.567 2.128 0 N-CA-C 122.103 3.847 . . . . 0.0 122.103 -174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -85.3 -96.34 0.07 Allowed 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 m -157.68 73.38 0.7 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 15' ' ' THR . 95.9 mtp -125.38 167.27 15.19 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.385 1.074 . . . . 0.0 112.529 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -130.04 114.06 15.32 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 118.883 -2.386 . . . . 0.0 108.363 -164.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.2 ttm105 -85.34 97.95 10.26 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.75 143.03 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -162.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -88.13 106.73 18.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 171.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.285 3.8 mt -72.31 176.37 5.34 Favored 'General case' 0 CA--C 1.58 2.107 0 CA-C-O 123.995 1.855 . . . . 0.0 113.208 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.77 -25.12 62.75 Favored 'General case' 0 CA--C 1.585 2.304 0 CA-C-N 114.088 -1.415 . . . . 0.0 114.101 166.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -72.02 -5.83 37.84 Favored 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.72 -4.47 79.0 Favored Glycine 0 CA--C 1.557 2.706 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -88.33 147.71 24.64 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.77 1.228 . . . . 0.0 112.903 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.44 106.84 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.95 151.32 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.1 m -92.53 124.83 36.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.525 -1.359 . . . . 0.0 109.005 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.53 159.59 41.34 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -113.25 -164.28 0.91 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 169.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.437 HD13 ' H ' ' A' ' 40' ' ' ARG . 0.6 OUTLIER -108.34 -177.94 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.384 0 O-C-N 120.254 -1.529 . . . . 0.0 108.369 166.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 84.8 p -76.79 20.08 0.26 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.98 -55.18 0.79 Allowed Glycine 0 N--CA 1.499 2.871 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -57.11 -52.54 64.9 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.259 0.7 OUTLIER -70.11 -19.48 63.24 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 117.611 2.449 . . . . 0.0 117.611 177.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.437 ' H ' HD13 ' A' ' 35' ' ' ILE . 79.7 mtt-85 -39.43 -35.59 0.29 Allowed 'General case' 0 CA--C 1.578 2.056 0 N-CA-C 117.338 2.347 . . . . 0.0 117.338 170.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.8 38.62 1.21 Allowed 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 171.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -152.93 -74.82 0.13 Allowed 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.423 ' HH ' HG12 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -86.44 99.75 11.87 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 164.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mt -76.39 -64.59 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 O-C-N 121.666 -0.646 . . . . 0.0 111.773 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -128.47 167.42 17.08 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 119.94 3.311 . . . . 0.0 119.94 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.423 HG12 ' HH ' ' A' ' 43' ' ' TYR 0.268 1.5 pt -142.65 170.83 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 109.57 -3.468 . . . . 0.0 110.666 176.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.3 tp -111.22 163.27 14.1 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.147 0.975 . . . . 0.0 111.406 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.1 m -69.97 88.41 0.57 Allowed 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 123.451 1.596 . . . . 0.0 111.206 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.464 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 129.49 22.17 1.22 Allowed Glycine 0 N--CA 1.493 2.473 0 CA-C-N 113.184 -1.825 . . . . 0.0 117.304 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -93.42 160.33 14.86 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 122.891 1.329 . . . . 0.0 113.478 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -88.35 84.54 6.83 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 125.438 2.542 . . . . 0.0 112.765 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -71.13 166.63 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-N 110.156 -3.202 . . . . 0.0 115.218 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.515 ' HA ' ' CB ' ' A' ' 9' ' ' GLN 0.321 14.3 m -125.95 75.71 1.53 Allowed 'General case' 0 N--CA 1.508 2.445 0 CA-C-O 123.798 1.761 . . . . 0.0 113.54 171.283 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.774 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -75.04 101.3 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.315 1.446 . . . . 0.0 109.528 -172.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -80.65 146.01 31.36 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.277 1.037 . . . . 0.0 109.911 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.39 -173.46 2.57 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 124.623 2.154 . . . . 0.0 116.405 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 p -131.32 153.84 81.76 Favored Pre-proline 0 CA--C 1.578 2.045 0 CA-C-N 111.027 -2.806 . . . . 0.0 111.421 165.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.2 -42.85 61.93 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 123.734 2.956 . . . . 0.0 118.352 165.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -87.27 -54.4 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -96.86 74.25 2.65 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -171.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.8 mp -66.11 -20.99 66.33 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.3 m -73.36 1.55 9.38 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -135.36 169.89 16.78 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 123.333 1.54 . . . . 0.0 111.963 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.55 -164.83 31.69 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 115.87 1.108 . . . . 0.0 115.87 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.24 110.83 1.21 Allowed 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 119.234 3.049 . . . . 0.0 119.234 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.43 ' H ' ' HA ' ' A' ' 54' ' ' VAL 0.264 0.7 OUTLIER -25.1 89.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 163.924 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -82.0 -56.9 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.459 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.1 t80 58.34 91.95 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.655 ' NE ' ' HE2' ' A' ' 7' ' ' GLU . 96.6 mtt-85 -80.61 64.56 5.44 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 t -156.83 -76.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.094 0.958 . . . . 0.0 110.211 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 124.894 2.283 . . . . 0.0 108.866 178.821 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.536 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.0 90.36 6.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.981 -1.075 . . . . 0.0 112.03 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.3 57.95 4.73 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 122.399 1.095 . . . . 0.0 113.763 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -148.25 153.72 39.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 123.302 1.525 . . . . 0.0 111.18 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -77.46 129.47 35.78 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.143 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.5 140.11 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.58 1.152 . . . . 0.0 110.444 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.375 11.4 pt-20 -92.21 123.48 35.58 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 124.644 2.164 . . . . 0.0 109.81 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.259 25.2 ttt -172.62 86.93 0.07 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 110.143 -3.208 . . . . 0.0 105.228 -147.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.792 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -116.24 -147.07 0.41 Allowed 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -156.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.88 -144.59 9.02 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 121.23 3.252 . . . . 0.0 121.23 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.2 m -102.74 129.54 49.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.235 -0.568 . . . . 0.0 109.611 -176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 56.0 t -61.64 123.46 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.773 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 173.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.296 63.3 mt -101.68 -17.53 16.26 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 119.816 -1.803 . . . . 0.0 112.99 167.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -148.18 143.35 27.0 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.512 1.149 . . . . 0.0 110.598 161.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 20' ' ' MET . 22.8 p -106.18 106.09 16.43 Favored 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 100.545 -3.872 . . . . 0.0 100.545 171.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.364 0.3 OUTLIER -75.23 173.58 6.74 Favored Pre-proline 0 CA--C 1.592 2.56 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -167.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -48.65 -34.48 27.19 Favored 'Trans proline' 0 CA--C 1.567 2.148 0 N-CA-C 121.729 3.704 . . . . 0.0 121.729 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -84.69 -95.46 0.07 Allowed 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -158.97 73.53 0.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 15' ' ' THR . 58.8 mtt -126.92 167.3 16.04 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.703 0.801 . . . . 0.0 112.264 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.401 ' CE1' ' CD1' ' A' ' 46' ' ' ILE . 57.7 m-85 -128.82 114.59 16.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 118.544 -2.598 . . . . 0.0 108.205 -163.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -87.28 91.35 8.69 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.3 142.02 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -162.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -82.98 124.37 30.33 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 165.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.269 3.0 mt -74.47 -173.89 1.88 Allowed 'General case' 0 CA--C 1.579 2.066 0 CA-C-O 123.76 1.743 . . . . 0.0 112.016 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -26.03 63.65 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 171.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -90.77 8.72 33.23 Favored 'General case' 0 CA--C 1.582 2.209 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 169.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.55 6.55 89.26 Favored Glycine 0 CA--C 1.552 2.393 0 N-CA-C 119.61 2.604 . . . . 0.0 119.61 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -89.48 142.69 27.44 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 119.908 1.854 . . . . 0.0 112.001 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 t -84.57 124.35 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 122.087 0.946 . . . . 0.0 110.805 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.41 145.69 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.745 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 m -91.24 122.1 33.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.533 -1.354 . . . . 0.0 108.547 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.91 153.68 44.56 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -114.51 148.34 38.05 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.511 1.148 . . . . 0.0 109.129 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -66.94 179.24 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.598 2.798 0 O-C-N 121.025 -1.047 . . . . 0.0 112.521 166.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.7 p -102.82 157.3 17.06 Favored 'General case' 0 CA--C 1.558 1.287 0 O-C-N 119.513 -1.992 . . . . 0.0 115.048 -176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.31 -3.98 27.73 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 119.297 2.479 . . . . 0.0 119.297 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.282 21.9 pttm -95.31 -54.26 3.47 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.691 1.738 . . . . 0.0 115.691 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -31.47 66.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 118.197 2.665 . . . . 0.0 118.197 175.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -35.58 -42.25 0.23 Allowed 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 120.344 3.461 . . . . 0.0 120.344 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.83 34.79 0.72 Allowed 'General case' 0 CA--C 1.581 2.149 0 CA-C-N 111.306 -2.679 . . . . 0.0 116.567 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -155.53 -74.9 0.11 Allowed 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 102.226 -3.25 . . . . 0.0 102.226 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.436 ' HH ' HG12 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -83.4 97.44 8.95 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.485 1.514 . . . . 0.0 107.943 165.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mt -74.26 -63.44 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.255 -0.903 . . . . 0.0 111.768 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -129.24 170.45 13.57 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.436 HG12 ' HH ' ' A' ' 43' ' ' TYR . 2.8 pt -146.73 171.56 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 109.507 -3.497 . . . . 0.0 111.363 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.5 tp -116.39 167.03 11.4 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.179 0.99 . . . . 0.0 110.973 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.1 m -70.74 86.17 0.67 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 123.539 1.638 . . . . 0.0 111.905 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 133.83 19.43 0.92 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 117.726 1.85 . . . . 0.0 117.726 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -94.79 165.71 12.34 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.985 1.314 . . . . 0.0 113.312 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -88.29 121.87 31.18 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 124.178 1.942 . . . . 0.0 111.945 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.69 163.98 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.881 0 CA-C-N 111.183 -2.735 . . . . 0.0 113.109 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.522 ' HA ' ' CB ' ' A' ' 9' ' ' GLN 0.361 22.7 m -121.85 75.3 1.2 Allowed 'General case' 0 N--CA 1.514 2.743 0 CA-C-O 124.543 2.116 . . . . 0.0 114.754 172.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.792 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -75.84 100.56 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 126.82 2.048 . . . . 0.0 110.56 -174.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -83.25 144.34 29.81 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 120.842 -1.161 . . . . 0.0 109.081 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.4 -175.01 4.61 Favored 'General case' 0 CA--C 1.564 1.495 0 O-C-N 120.863 -1.148 . . . . 0.0 112.042 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -94.28 159.95 32.95 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -52.14 -41.45 65.0 Favored 'Trans proline' 0 CA--C 1.57 2.297 0 C-N-CA 123.443 2.762 . . . . 0.0 118.868 164.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -91.18 -54.55 3.89 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -93.64 78.9 4.28 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 122.507 1.146 . . . . 0.0 113.234 -171.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.16 -8.82 57.46 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 119.711 3.226 . . . . 0.0 119.711 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -75.96 -0.82 22.87 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -129.86 179.99 5.54 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.89 1.677 . . . . 0.0 113.053 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.18 -177.58 46.2 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 117.522 1.769 . . . . 0.0 117.522 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.34 111.27 1.64 Allowed 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 53' ' ' THR 0.351 1.3 mp -38.57 89.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 119.152 -2.217 . . . . 0.0 116.547 164.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -75.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 CA-C-N 114.246 -1.343 . . . . 0.0 114.273 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -145.8 77.68 1.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.903 1.683 . . . . 0.0 114.568 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.471 ' NE ' ' HG1' ' A' ' 53' ' ' THR . 44.3 ttm-85 -95.97 66.58 2.6 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 171.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.9 t -146.33 -98.74 0.09 Allowed 'General case' 0 CA--C 1.569 1.692 0 O-C-N 120.863 -1.148 . . . . 0.0 112.426 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 125.02 2.343 . . . . 0.0 112.32 -177.059 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.547 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.277 59.5 mtpt 68.46 -76.3 0.06 Allowed 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.89 78.33 6.06 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.339 1.066 . . . . 0.0 110.714 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.71 160.05 26.41 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.871 1.32 . . . . 0.0 114.225 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -94.64 136.41 34.98 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.563 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.97 155.49 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.705 -1.247 . . . . 0.0 110.246 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.331 12.4 pt-20 -113.78 119.32 36.93 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 124.128 1.918 . . . . 0.0 111.565 170.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.276 25.8 ttt -164.43 68.98 0.17 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 110.807 -2.906 . . . . 0.0 112.48 -152.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.642 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.597 0.3 OUTLIER -133.69 -167.86 2.01 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 177.075 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.45 -112.39 0.89 Allowed Glycine 0 N--CA 1.483 1.798 0 N-CA-C 122.226 3.65 . . . . 0.0 122.226 -167.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.2 m -103.97 136.32 43.84 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.654 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 45.9 t -71.49 100.01 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.615 3.451 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -64.5 -44.58 90.47 Favored 'General case' 0 N--CA 1.521 3.084 2 CA-C-N 127.163 4.529 . . . . 0.0 112.81 174.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -129.76 150.35 51.1 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 122.921 1.343 . . . . 0.0 110.464 171.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 20' ' ' MET . 6.9 p -104.34 97.9 7.77 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 101.391 -3.559 . . . . 0.0 101.391 171.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.281 5.2 mt -78.76 155.98 77.85 Favored Pre-proline 0 CA--C 1.595 2.68 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.259 -163.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.347 6.1 Cg_endo -14.15 -62.62 0.01 OUTLIER 'Trans proline' 0 CA--C 1.567 2.145 2 N-CA-C 125.343 5.093 . . . . 0.0 125.343 -169.676 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -75.81 -85.87 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.152 1.342 . . . . 0.0 109.108 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.6 m -155.94 75.11 0.89 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 15' ' ' THR . 81.3 mtp -120.24 179.37 4.31 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.756 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -145.29 106.52 4.19 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 -165.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.3 ttt85 -84.2 93.94 8.29 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 170.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.6 t -98.57 136.0 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -162.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -96.03 108.42 20.82 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.577 HD22 ' H ' ' A' ' 26' ' ' GLU 0.345 0.3 OUTLIER -48.8 178.39 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 N-CA-C 121.473 3.879 . . . . 0.0 121.473 -177.15 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.577 ' H ' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -75.43 -23.13 56.93 Favored 'General case' 0 CA--C 1.579 2.074 0 CA-C-N 112.462 -2.154 . . . . 0.0 113.704 166.437 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.264 0.1 OUTLIER -93.45 4.89 53.23 Favored 'General case' 0 CA--C 1.595 2.707 0 C-N-CA 124.703 1.201 . . . . 0.0 112.481 168.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.79 15.36 79.47 Favored Glycine 0 CA--C 1.547 2.056 0 N-CA-C 119.634 2.613 . . . . 0.0 119.634 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -101.08 136.12 41.44 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.007 1.904 . . . . 0.0 111.62 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.67 128.12 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 119.926 -1.734 . . . . 0.0 112.398 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -122.47 169.76 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.281 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -112.04 121.88 46.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.909 -1.12 . . . . 0.0 109.793 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.81 158.74 43.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 118.377 2.732 . . . . 0.0 118.377 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -106.74 166.21 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.806 1.289 . . . . 0.0 109.499 167.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -78.55 -176.37 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.58 0 O-C-N 119.854 -1.779 . . . . 0.0 111.414 168.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.8 p -102.42 97.05 7.34 Favored 'General case' 0 CA--C 1.552 1.04 0 O-C-N 120.173 -1.58 . . . . 0.0 107.347 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -39.41 -30.43 0.16 Allowed Glycine 0 N--CA 1.499 2.868 0 N-CA-C 122.914 3.926 . . . . 0.0 122.914 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -66.13 -50.45 63.97 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -52.78 5.18 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 124.759 1.224 . . . . 0.0 113.596 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . 0.314 37.7 mmt180 -70.37 -47.84 59.1 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -171.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -94.13 46.21 1.16 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 123.855 1.788 . . . . 0.0 114.891 169.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -103.69 -53.38 2.79 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 167.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.264 39.4 p90 -72.33 -138.82 0.01 OUTLIER 'General case' 0 CA--C 1.592 2.594 0 CA-C-O 122.149 0.976 . . . . 0.0 108.96 154.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -118.62 -82.03 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 O-C-N 119.986 -1.696 . . . . 0.0 111.509 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -141.87 166.71 23.97 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 123.895 1.807 . . . . 0.0 114.802 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.284 2.4 pp -105.58 151.01 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.32 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.3 tp -86.64 162.49 17.92 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -165.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -65.43 99.33 0.41 Allowed 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 123.893 1.806 . . . . 0.0 112.069 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.654 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 113.66 -4.34 24.57 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 120.428 2.931 . . . . 0.0 120.428 -175.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -60.55 155.45 18.58 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -83.17 87.97 6.91 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 126.08 2.848 . . . . 0.0 113.235 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.19 146.06 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 108.987 -3.733 . . . . 0.0 110.314 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.3 m -137.02 115.91 12.28 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 100.421 -3.918 . . . . 0.0 100.421 171.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.642 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.26 92.3 t -121.46 127.05 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 112.779 -2.01 . . . . 0.0 107.429 -158.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -80.46 125.64 30.2 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.449 0.642 . . . . 0.0 111.955 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.263 0.3 OUTLIER -111.85 -110.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.209 -171.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.15 166.32 15.4 Favored Pre-proline 0 CA--C 1.582 2.183 0 C-N-CA 123.793 0.837 . . . . 0.0 112.924 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -60.09 -46.33 19.49 Favored 'Trans proline' 0 CA--C 1.568 2.22 0 C-N-CA 123.412 2.741 . . . . 0.0 117.759 166.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -100.5 -55.55 2.57 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -93.62 70.19 4.17 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.1 mp -68.63 2.24 2.61 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -69.31 -11.17 60.58 Favored 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -142.96 159.14 42.81 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 125.824 1.65 . . . . 0.0 113.223 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.47 -158.97 19.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 117.016 1.566 . . . . 0.0 117.016 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.26 124.29 7.43 Favored 'General case' 0 CA--C 1.59 2.498 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.557 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -41.29 99.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 174.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -96.37 -30.87 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.095 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -124.47 146.2 49.08 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -89.47 111.09 21.88 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.926 0.89 . . . . 0.0 110.025 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 m -97.3 -0.16 47.01 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 . . . . . 0 CA--C 1.563 1.443 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 179.486 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 1.465 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -126.99 79.79 1.9 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.983 1.265 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.281 24.9 tt0 -130.46 -130.1 0.2 Allowed 'General case' 0 CA--C 1.57 1.726 0 CA-C-O 122.526 1.155 . . . . 0.0 108.887 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -109.06 149.68 28.93 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.17 1.388 . . . . 0.0 111.128 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -64.86 119.25 10.32 Favored 'General case' 0 CA--C 1.577 2.004 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.459 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.84 156.97 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.457 -1.402 . . . . 0.0 111.878 -171.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.35 9.8 pt-20 -106.29 120.78 42.76 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 124.537 2.113 . . . . 0.0 110.684 165.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 21.0 ttt -169.61 78.74 0.11 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 110.601 -3.0 . . . . 0.0 109.08 -155.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.587 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.612 0.0 OUTLIER -139.24 -168.42 2.44 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 173.274 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.64 -108.51 1.0 Allowed Glycine 0 N--CA 1.478 1.497 0 N-CA-C 121.198 3.239 . . . . 0.0 121.198 -165.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 98.9 m -121.88 135.31 54.88 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.477 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 73.7 t -61.49 117.57 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.612 3.327 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.7 mt -81.14 -45.23 16.72 Favored 'General case' 0 N--CA 1.511 2.577 0 CA-C-N 123.091 2.678 . . . . 0.0 110.809 167.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -129.53 143.03 50.66 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 122.752 1.263 . . . . 0.0 111.535 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 20' ' ' MET . 20.4 p -103.01 107.56 18.4 Favored 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 101.03 -3.693 . . . . 0.0 101.03 171.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.391 0.2 OUTLIER -75.45 -175.35 0.46 Allowed Pre-proline 0 CA--C 1.594 2.646 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -167.086 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -52.35 -51.1 11.9 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 124.091 3.194 . . . . 0.0 119.493 -173.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.39 -86.75 0.05 OUTLIER 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -163.02 75.1 0.39 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 172.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 15' ' ' THR . 69.1 mtm -123.28 175.9 6.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.464 -0.772 . . . . 0.0 111.551 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -140.68 113.67 8.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 118.908 -2.37 . . . . 0.0 107.29 -163.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -86.59 96.34 10.06 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 169.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.2 136.54 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -162.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -94.07 113.14 25.05 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 171.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.256 0.5 OUTLIER -56.5 178.77 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 -175.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.77 -25.63 66.57 Favored 'General case' 0 CA--C 1.573 1.844 0 CA-C-N 113.564 -1.653 . . . . 0.0 114.976 167.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -93.26 8.01 42.05 Favored 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 168.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.89 8.78 85.37 Favored Glycine 0 CA--C 1.556 2.639 0 N-CA-C 120.333 2.893 . . . . 0.0 120.333 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -93.67 138.97 31.35 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 119.275 1.537 . . . . 0.0 112.789 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.9 t -85.56 130.34 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.209 -1.557 . . . . 0.0 112.805 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.3 m -126.72 167.42 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 114.359 -1.291 . . . . 0.0 113.571 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 m -109.29 123.26 48.98 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.966 -1.084 . . . . 0.0 110.152 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.26 151.95 39.17 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 119.171 3.026 . . . . 0.0 119.171 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.33 170.16 8.62 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.036 -1.04 . . . . 0.0 109.594 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 pt -76.76 -177.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.552 0 O-C-N 119.531 -1.981 . . . . 0.0 110.97 164.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.2 p -100.73 144.52 29.6 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 119.646 -1.909 . . . . 0.0 110.761 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.93 -23.2 6.89 Favored Glycine 0 N--CA 1.508 3.463 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -63.78 -55.78 20.52 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.246 1.818 . . . . 0.0 114.768 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.6 ptp -73.77 -36.14 65.05 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 116.148 -1.882 . . . . 0.0 115.791 172.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -37.33 -41.03 0.39 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.549 2.425 . . . . 0.0 117.549 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -93.19 -1.44 56.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -94.34 -68.68 0.79 Allowed 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.61 130.8 55.29 Favored 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 125.501 1.52 . . . . 0.0 107.717 170.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.6 mt -73.54 -65.37 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.044 0 O-C-N 120.004 -1.685 . . . . 0.0 111.166 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -105.33 164.52 11.79 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 120.954 3.687 . . . . 0.0 120.954 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.275 0.5 OUTLIER -133.97 168.6 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-N 109.545 -3.479 . . . . 0.0 109.457 173.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.59 163.81 12.17 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.445 1.117 . . . . 0.0 113.206 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 m -72.67 89.64 1.34 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 123.351 1.548 . . . . 0.0 110.955 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.477 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 121.64 24.17 2.41 Favored Glycine 0 N--CA 1.489 2.213 0 CA-C-N 113.382 -1.736 . . . . 0.0 116.749 -174.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -92.28 156.64 17.14 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-O 122.634 1.207 . . . . 0.0 112.224 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -86.69 91.67 8.68 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 125.76 2.695 . . . . 0.0 113.685 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -93.17 151.3 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.038 0 CA-C-N 109.59 -3.459 . . . . 0.0 111.503 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -143.55 112.18 6.47 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 100.34 -3.948 . . . . 0.0 100.34 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.587 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.278 94.1 t -120.54 125.5 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 112.108 -2.314 . . . . 0.0 107.066 -156.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -78.0 120.61 23.1 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.671 0.748 . . . . 0.0 111.102 -174.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.278 0.2 OUTLIER -105.2 -122.87 0.22 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.858 -175.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.4 169.05 11.22 Favored Pre-proline 0 CA--C 1.584 2.257 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.98 -49.31 0.69 Allowed 'Trans proline' 0 CA--C 1.551 1.346 0 C-N-CA 124.766 3.644 . . . . 0.0 118.517 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -96.24 -34.14 11.74 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.048 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.515 ' HD2' ' NZ ' ' A' ' 63' ' ' LYS . 9.4 t70 -103.56 81.33 1.9 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.971 -173.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.13 -19.47 34.14 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 118.815 2.894 . . . . 0.0 118.815 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.0 m -65.69 -6.37 11.23 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.515 ' NZ ' ' HD2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -143.48 160.19 41.05 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 125.746 1.618 . . . . 0.0 113.654 -177.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.81 -159.32 17.84 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -157.07 117.96 3.63 Favored 'General case' 0 CA--C 1.586 2.332 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.51 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -38.79 97.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 174.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -95.99 -48.07 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 C-N-CA 124.388 1.075 . . . . 0.0 112.455 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.281 15.8 t80 71.95 -72.03 0.12 Allowed 'General case' 0 CA--C 1.572 1.816 0 C-N-CA 125.527 1.531 . . . . 0.0 112.782 -175.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -108.44 55.94 0.63 Allowed 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.9 p -80.67 -35.26 34.01 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? . . . . . 0 CA--C 1.558 1.283 0 CA-C-O 124.679 2.18 . . . . 0.0 110.758 -179.84 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.539 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -63.26 -55.29 26.04 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.46 73.24 4.45 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 121.475 -0.766 . . . . 0.0 110.042 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -71.61 151.63 43.59 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-O 123.679 1.704 . . . . 0.0 114.152 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -77.56 126.98 31.75 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 113.604 -1.635 . . . . 0.0 113.44 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.14 139.75 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.561 1.144 . . . . 0.0 109.663 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.308 6.6 pt-20 -97.56 116.51 29.92 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 124.89 2.281 . . . . 0.0 109.115 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 21.7 ttt -168.22 76.32 0.13 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 109.392 -3.549 . . . . 0.0 110.208 -148.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.561 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.613 0.0 OUTLIER -140.1 -166.92 2.2 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 174.691 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.16 -112.02 1.1 Allowed Glycine 0 N--CA 1.479 1.546 0 N-CA-C 120.633 3.013 . . . . 0.0 120.633 -165.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.8 m -118.26 137.53 52.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.488 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 58.8 t -64.57 105.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.608 3.176 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 mp -77.0 -45.0 28.83 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 117.966 -2.959 . . . . 0.0 113.175 170.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -122.56 148.84 44.73 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.354 1.074 . . . . 0.0 111.029 167.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 20' ' ' MET . 13.3 p -103.3 98.35 8.28 Favored 'General case' 0 N--CA 1.516 2.86 0 N-CA-C 101.667 -3.457 . . . . 0.0 101.667 170.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.27 5.3 mt -79.38 151.7 75.23 Favored Pre-proline 0 CA--C 1.591 2.535 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.482 -163.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.415 3.8 Cg_exo 8.61 -80.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.268 2 C-N-CA 126.686 4.924 . . . . 0.0 124.283 -170.696 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -76.04 -75.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 120.435 1.47 . . . . 0.0 110.869 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -158.34 75.96 0.75 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.258 61.9 mtt -118.37 -174.11 2.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 0.0 111.011 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -148.3 108.83 4.16 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 118.919 -2.363 . . . . 0.0 105.152 -165.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -86.57 92.76 8.99 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 103.725 -2.695 . . . . 0.0 103.725 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.8 t -99.37 135.53 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -163.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.94 113.93 26.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 170.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.29 0.5 OUTLIER -58.46 -179.92 0.07 Allowed 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -176.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.79 -24.29 64.39 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-N 113.46 -1.7 . . . . 0.0 115.01 168.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -90.21 5.09 48.53 Favored 'General case' 0 CA--C 1.585 2.308 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.37 5.24 82.69 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 120.165 2.826 . . . . 0.0 120.165 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -94.93 142.46 27.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.616 1.708 . . . . 0.0 113.346 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.86 129.76 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-O 122.153 0.977 . . . . 0.0 112.384 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 m -139.83 152.6 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-O 122.208 1.004 . . . . 0.0 113.185 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -89.87 128.52 36.2 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.156 -1.59 . . . . 0.0 111.594 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.59 150.48 36.45 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -103.32 155.43 18.47 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.081 0.943 . . . . 0.0 110.595 170.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -66.15 175.32 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.601 2.942 0 CA-C-O 122.913 1.339 . . . . 0.0 112.053 165.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.2 p -103.38 140.43 37.46 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 119.826 -1.796 . . . . 0.0 109.655 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.13 -16.27 6.17 Favored Glycine 0 N--CA 1.505 3.273 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -72.1 -49.64 34.62 Favored 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 126.656 1.982 . . . . 0.0 114.74 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.7 ptp -73.04 -24.16 60.68 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -38.74 -33.25 0.1 Allowed 'General case' 0 CA--C 1.587 2.381 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -91.85 -4.78 54.4 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -89.16 -72.97 0.52 Allowed 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 168.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -101.35 135.13 43.35 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 124.41 1.084 . . . . 0.0 108.759 166.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mt -71.5 -53.38 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.76 -1.212 . . . . 0.0 110.803 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -135.6 175.26 9.75 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-O 124.516 2.103 . . . . 0.0 112.792 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.11 156.15 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 113.138 -1.846 . . . . 0.0 108.758 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.8 mp -95.77 166.51 11.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -73.69 87.14 1.68 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 123.48 1.609 . . . . 0.0 111.18 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.488 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 124.6 18.86 2.63 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-N 113.308 -1.769 . . . . 0.0 117.233 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -91.26 167.0 12.63 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 122.781 1.276 . . . . 0.0 111.234 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -90.08 129.67 36.35 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 124.951 2.31 . . . . 0.0 114.306 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.5 m -134.14 152.53 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.827 0 CA-C-N 110.511 -3.041 . . . . 0.0 110.693 -173.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.9 m -142.99 111.6 6.32 Favored 'General case' 0 N--CA 1.501 2.103 1 N-CA-C 100.19 -4.004 . . . . 0.0 100.19 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.561 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.276 71.7 t -125.35 123.85 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 112.261 -2.245 . . . . 0.0 107.182 -156.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.688 ' HE2' ' NE ' ' A' ' 71' ' ' ARG . 11.8 tt0 -79.32 141.58 36.86 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -170.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.45 -175.81 4.93 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 122.125 0.964 . . . . 0.0 110.864 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -90.41 158.48 43.22 Favored Pre-proline 0 CA--C 1.573 1.835 0 O-C-N 120.611 -1.306 . . . . 0.0 112.999 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -54.86 -42.65 66.79 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 123.068 2.512 . . . . 0.0 118.422 164.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -90.39 -45.73 8.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -102.74 81.44 2.01 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 122.35 1.072 . . . . 0.0 113.031 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.67 43.06 0.81 Allowed 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 64.2 m -95.32 -28.6 14.89 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -132.29 -178.23 4.82 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-O 122.749 1.261 . . . . 0.0 114.049 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.49 177.25 40.2 Favored Glycine 0 CA--C 1.554 2.514 0 N-CA-C 117.145 1.618 . . . . 0.0 117.145 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.3 113.21 3.15 Favored 'General case' 0 CA--C 1.596 2.732 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 168.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.541 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -45.5 104.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 CA-C-N 122.495 2.407 . . . . 0.0 113.968 173.227 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m -94.67 145.25 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -109.46 28.61 8.36 Favored 'General case' 0 CA--C 1.586 2.36 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -147.44 164.21 34.07 Favored 'General case' 0 CA--C 1.574 1.894 0 C-N-CA 125.488 1.515 . . . . 0.0 110.502 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.5 p -94.39 71.59 3.77 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.058 -1.651 . . . . 0.0 112.569 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.688 ' NE ' ' HE2' ' A' ' 55' ' ' GLU . 60.0 ttp180 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 123.326 1.536 . . . . 0.0 113.616 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.583 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.287 60.8 mttp 74.78 -55.36 0.65 Allowed 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.08 33.76 0.29 Allowed 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.622 ' HD2' ' NE ' ' A' ' 71' ' ' ARG 0.256 4.8 p-10 -109.0 -151.13 0.47 Allowed 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 125.795 1.638 . . . . 0.0 111.802 -179.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -76.0 97.2 3.95 Favored 'General case' 0 CA--C 1.577 1.991 0 O-C-N 120.484 -1.385 . . . . 0.0 108.472 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 mt -92.3 143.95 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.773 -1.204 . . . . 0.0 110.84 -171.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.293 8.8 pt-20 -99.22 122.57 42.59 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 124.664 2.173 . . . . 0.0 109.512 170.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.293 6.5 ttt -152.95 -4.49 0.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 109.898 -3.319 . . . . 0.0 119.283 -151.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.686 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.537 0.5 OUTLIER -75.8 -164.03 0.32 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 121.657 3.947 . . . . 0.0 121.657 -166.607 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.42 -112.54 1.08 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 122.514 3.766 . . . . 0.0 122.514 -163.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.8 m -108.78 135.97 49.12 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.642 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 78.3 t -71.81 107.38 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.981 0 CA-C-N 120.379 1.445 . . . . 0.0 107.327 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.13 -42.56 72.45 Favored 'General case' 0 N--CA 1.516 2.843 0 CA-C-N 124.814 3.461 . . . . 0.0 112.056 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -132.6 147.83 52.35 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.151 0.977 . . . . 0.0 110.988 170.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 20' ' ' MET . 11.0 p -102.66 102.99 13.23 Favored 'General case' 0 N--CA 1.514 2.728 0 N-CA-C 101.94 -3.356 . . . . 0.0 101.94 170.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.347 5.4 mt -80.82 -179.03 1.3 Allowed Pre-proline 0 CA--C 1.598 2.797 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -164.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.273 21.1 Cg_endo -47.51 -45.55 22.79 Favored 'Trans proline' 0 CA--C 1.568 2.185 1 N-CA-C 123.786 4.495 . . . . 0.0 123.786 -167.963 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.58 -89.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.38 1.445 . . . . 0.0 108.31 172.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.4 m -153.03 76.22 1.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 171.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 15' ' ' THR . 42.4 mtt -120.61 176.25 5.6 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.521 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -146.05 108.71 4.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -164.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 tpt85 -83.51 94.63 8.08 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.9 t -100.72 139.09 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -162.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -92.36 115.24 27.92 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.436 HD21 ' H ' ' A' ' 26' ' ' GLU 0.27 0.6 OUTLIER -64.7 178.92 0.7 Allowed 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -177.421 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' H ' HD21 ' A' ' 25' ' ' LEU . 16.8 pt-20 -67.66 -27.37 66.8 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 168.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -91.79 8.86 35.19 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 171.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.06 16.62 78.46 Favored Glycine 0 CA--C 1.555 2.549 0 N-CA-C 119.929 2.731 . . . . 0.0 119.929 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -98.58 131.46 44.78 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.188 1.494 . . . . 0.0 111.823 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -83.89 127.61 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 123.17 1.462 . . . . 0.0 111.435 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 HE21 ' A' ' 9' ' ' GLN . 18.7 m -123.38 159.77 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.882 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 m -106.73 123.24 47.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.54 -1.35 . . . . 0.0 109.432 172.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.57 157.85 44.28 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 118.881 2.919 . . . . 0.0 118.881 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -104.47 167.58 9.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 163.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.12 177.19 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.526 0 O-C-N 119.98 -1.7 . . . . 0.0 110.295 162.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.3 p -77.97 87.83 4.14 Favored 'General case' 0 CA--C 1.573 1.829 0 O-C-N 119.062 -2.274 . . . . 0.0 108.591 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -17.93 -47.61 0.01 OUTLIER Glycine 0 N--CA 1.505 3.26 1 N-CA-C 124.297 4.479 . . . . 0.0 124.297 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -45.36 -46.16 12.93 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 118.776 2.88 . . . . 0.0 118.776 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.27 0.0 OUTLIER -69.46 -23.87 63.71 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 177.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -37.97 -41.18 0.53 Allowed 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 122.9 2.591 . . . . 0.0 117.159 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -96.76 3.93 52.06 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 119.804 3.261 . . . . 0.0 119.804 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -110.37 -63.12 1.42 Allowed 'General case' 0 CA--C 1.571 1.764 0 C-N-CA 125.605 1.562 . . . . 0.0 107.062 172.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.88 104.08 10.22 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 169.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -67.91 112.64 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-O 124.426 2.06 . . . . 0.0 107.906 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -41.84 161.34 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.851 1 N-CA-C 123.557 4.651 . . . . 0.0 123.557 -167.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.255 1.1 pt -89.61 160.82 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.78 0 CA-C-N 109.26 -3.609 . . . . 0.0 115.409 -175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 tp -115.14 175.54 5.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.378 -170.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -67.7 91.84 0.32 Allowed 'General case' 0 CA--C 1.575 1.917 0 CA-C-O 124.389 2.042 . . . . 0.0 114.296 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.642 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 124.04 -2.15 9.13 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -65.32 156.89 30.67 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -81.91 90.75 6.47 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 125.699 2.666 . . . . 0.0 113.962 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 m -93.07 154.67 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 CA-C-N 109.435 -3.529 . . . . 0.0 110.766 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.3 m -147.9 103.25 3.48 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 100.609 -3.848 . . . . 0.0 100.609 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.686 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 23.7 t -109.06 131.63 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 111.076 -2.784 . . . . 0.0 107.305 -162.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -83.77 130.16 34.94 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.908 -1.12 . . . . 0.0 111.991 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.275 0.5 OUTLIER -108.28 -155.81 0.56 Allowed 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 122.047 0.927 . . . . 0.0 110.962 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.4 p -138.12 161.39 59.77 Favored Pre-proline 0 CA--C 1.572 1.789 0 O-C-N 121.021 -1.049 . . . . 0.0 112.064 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.99 -42.16 59.99 Favored 'Trans proline' 0 CA--C 1.573 2.441 0 C-N-CA 123.315 2.677 . . . . 0.0 118.459 163.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -87.49 -50.42 6.55 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -102.37 80.68 1.97 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.314 1.054 . . . . 0.0 112.337 -172.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -28.51 64.89 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.9 t -76.75 13.62 0.98 Allowed 'General case' 0 CA--C 1.587 2.374 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -139.14 172.75 12.38 Favored 'General case' 0 CA--C 1.57 1.732 0 O-C-N 119.643 -1.911 . . . . 0.0 114.353 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.57 -165.84 38.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.52 122.67 5.46 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.52 ' H ' HD13 ' A' ' 66' ' ' ILE . 2.2 mp -46.62 104.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.933 0 CA-C-N 121.734 2.061 . . . . 0.0 114.475 170.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 m -96.43 142.28 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.164 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -88.1 70.16 9.3 Favored 'General case' 0 CA--C 1.578 2.049 0 O-C-N 121.045 -1.035 . . . . 0.0 110.67 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.47 ' NE ' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -160.02 173.58 15.64 Favored 'General case' 0 CA--C 1.575 1.942 0 C-N-CA 124.358 1.063 . . . . 0.0 111.779 -176.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.47 ' H ' ' NE ' ' A' ' 69' ' ' ARG . 83.2 p -123.3 76.13 1.37 Allowed 'General case' 0 CA--C 1.571 1.771 0 O-C-N 120.782 -1.198 . . . . 0.0 113.257 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.622 ' NE ' ' HD2' ' A' ' 4' ' ' ASP . 52.6 ttt85 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 125.062 2.363 . . . . 0.0 110.897 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.572 0 CA-C-O 121.874 0.845 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -84.42 91.31 7.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.999 -1.063 . . . . 0.0 111.926 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -89.69 62.03 5.67 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-O 122.727 1.251 . . . . 0.0 113.741 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.77 143.74 43.9 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -67.93 122.98 19.34 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -95.37 141.33 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.098 0.959 . . . . 0.0 110.222 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.626 ' HE2' ' NE ' ' A' ' 69' ' ' ARG 0.303 9.1 pt-20 -96.4 122.09 38.91 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 125.068 2.366 . . . . 0.0 108.62 169.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 22.0 ttt -172.61 89.06 0.09 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 109.471 -3.513 . . . . 0.0 105.035 -149.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.802 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -117.19 -151.15 0.47 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -157.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.56 -137.65 3.52 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 117.348 1.699 . . . . 0.0 117.348 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.8 m -124.71 133.72 53.09 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 59.7 t -59.22 116.53 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.602 2.959 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.561 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.1 mt -83.9 -42.07 16.73 Favored 'General case' 0 N--CA 1.509 2.504 0 CA-C-N 122.299 2.318 . . . . 0.0 110.941 166.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.97 143.97 48.49 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.829 1.299 . . . . 0.0 111.576 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 20' ' ' MET . 41.4 p -97.8 105.1 17.19 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 170.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.324 5.2 mt -78.86 179.77 1.65 Allowed Pre-proline 0 CA--C 1.596 2.718 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -164.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.266 27.8 Cg_endo -47.89 -45.91 23.24 Favored 'Trans proline' 0 CA--C 1.568 2.191 1 N-CA-C 122.552 4.02 . . . . 0.0 122.552 -169.591 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -82.84 -92.33 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.1 1.318 . . . . 0.0 107.735 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -151.61 73.28 1.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 171.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 15' ' ' THR . 88.7 mtp -119.78 176.52 5.36 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.641 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -140.68 112.04 7.32 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -83.28 94.26 7.88 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 169.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 t -100.96 136.91 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -163.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -88.48 113.06 23.68 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.268 4.3 mt -73.39 -179.54 3.48 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 124.1 1.905 . . . . 0.0 112.554 -172.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.37 -22.18 61.18 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -90.11 6.37 42.77 Favored 'General case' 0 CA--C 1.585 2.292 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.95 15.79 76.52 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 119.828 2.691 . . . . 0.0 119.828 -176.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -102.91 139.9 37.88 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 119.248 1.524 . . . . 0.0 111.837 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -87.42 113.39 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.762 -1.211 . . . . 0.0 109.93 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.7 m -109.93 153.93 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -96.23 118.42 32.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.813 -1.179 . . . . 0.0 109.588 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.11 158.59 44.11 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.72 2.118 . . . . 0.0 116.72 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -105.68 -176.51 3.1 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.416 HD12 ' H ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -90.45 175.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.367 0 O-C-N 119.899 -1.751 . . . . 0.0 109.215 161.647 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.6 p -75.12 20.07 0.14 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 120.612 3.56 . . . . 0.0 120.612 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.79 -45.79 1.1 Allowed Glycine 0 N--CA 1.499 2.844 0 N-CA-C 118.644 2.218 . . . . 0.0 118.644 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -63.62 -54.07 41.68 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -22.8 64.79 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.416 ' H ' HD12 ' A' ' 35' ' ' ILE . 10.9 mtp-105 -39.81 -35.81 0.38 Allowed 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 172.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -90.63 4.78 50.42 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 118.965 2.95 . . . . 0.0 118.965 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -97.15 -74.07 0.58 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 167.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -110.87 138.47 47.23 Favored 'General case' 0 CA--C 1.579 2.061 0 C-N-CA 125.334 1.453 . . . . 0.0 107.217 166.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.4 mt -73.66 -68.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 119.976 -1.702 . . . . 0.0 111.275 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -113.54 168.14 10.01 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 119.755 3.243 . . . . 0.0 119.755 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.357 1.8 pp -119.12 169.66 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 110.017 -3.265 . . . . 0.0 108.873 171.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.6 tp -100.98 163.2 12.4 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -168.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 m -69.73 92.94 0.69 Allowed 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 123.783 1.754 . . . . 0.0 111.49 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.499 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 117.01 22.92 4.07 Favored Glycine 0 N--CA 1.488 2.148 0 CA-C-N 112.678 -2.055 . . . . 0.0 117.439 -175.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -93.11 156.68 16.71 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.881 1.324 . . . . 0.0 113.33 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -88.66 83.32 6.74 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 125.231 2.444 . . . . 0.0 112.967 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 m -73.64 165.24 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 CA-C-N 110.436 -3.075 . . . . 0.0 114.972 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.616 ' HG1' ' NE ' ' A' ' 71' ' ' ARG 0.274 5.1 m -120.52 77.23 1.25 Allowed 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 124.079 1.895 . . . . 0.0 112.434 173.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.802 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -75.47 94.05 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 O-C-N 120.219 -1.551 . . . . 0.0 110.328 -171.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -81.97 136.41 35.28 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.059 -1.026 . . . . 0.0 109.049 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.251 2.4 pt? -136.62 -165.01 1.66 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.844 -1.16 . . . . 0.0 112.351 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 p -110.29 159.5 31.82 Favored Pre-proline 0 CA--C 1.573 1.856 0 O-C-N 120.731 -1.231 . . . . 0.0 113.342 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.18 -38.91 81.76 Favored 'Trans proline' 0 CA--C 1.569 2.258 0 C-N-CA 123.39 2.727 . . . . 0.0 119.094 163.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -87.06 -52.23 5.55 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.499 ' HD2' ' NZ ' ' A' ' 63' ' ' LYS . 13.2 t70 -96.86 78.87 2.88 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 122.323 1.058 . . . . 0.0 113.286 -172.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.36 -11.2 60.19 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 120.316 3.45 . . . . 0.0 120.316 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.0 m -73.69 -2.96 25.41 Favored 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 173.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.499 ' NZ ' ' HD2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -129.58 178.85 6.18 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -176.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.31 -172.4 42.67 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 116.942 1.537 . . . . 0.0 116.942 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.3 105.9 1.0 Allowed 'General case' 0 CA--C 1.583 2.234 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.542 HG22 ' H ' ' A' ' 53' ' ' THR 0.26 0.0 OUTLIER -28.08 87.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.063 0 N-CA-C 119.276 3.065 . . . . 0.0 119.276 167.261 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -88.67 140.5 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 C-N-CA 124.483 1.113 . . . . 0.0 112.88 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -80.53 96.3 6.75 Favored 'General case' 0 CA--C 1.569 1.7 0 O-C-N 120.806 -1.184 . . . . 0.0 111.399 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.626 ' NE ' ' HE2' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -138.33 141.35 39.75 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.482 0.658 . . . . 0.0 112.415 -177.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.2 p -84.28 66.75 9.51 Favored 'General case' 0 CA--C 1.571 1.788 0 O-C-N 120.828 -1.17 . . . . 0.0 113.284 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.616 ' NE ' ' HG1' ' A' ' 53' ' ' THR . 44.3 ptt85 . . . . . 0 CA--C 1.56 1.365 0 CA-C-O 125.109 2.385 . . . . 0.0 114.279 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' N ' ' HE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.567 1.622 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -81.91 -29.57 32.29 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.43 ' HE2' ' N ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -79.44 59.26 2.86 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -91.38 20.84 4.9 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 118.997 2.962 . . . . 0.0 118.997 -175.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.85 128.36 35.37 Favored 'General case' 0 CA--C 1.577 2.0 0 C-N-CA 123.976 0.91 . . . . 0.0 113.235 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mt -109.35 141.55 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.885 -1.134 . . . . 0.0 110.356 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.339 12.7 pt-20 -100.78 118.7 37.38 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 124.014 1.864 . . . . 0.0 110.664 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.285 21.2 ttt -159.26 38.5 0.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.603 -2.544 . . . . 0.0 117.312 -148.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.65 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.531 0.0 OUTLIER -123.11 -175.91 3.29 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 120.01 3.337 . . . . 0.0 120.01 -173.201 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.9 -110.97 1.09 Allowed Glycine 0 N--CA 1.481 1.7 1 N-CA-C 123.653 4.221 . . . . 0.0 123.653 -163.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.1 m -102.89 131.01 50.11 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.474 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 83.8 t -63.46 107.19 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.601 2.913 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.318 98.4 mt -86.33 -36.02 19.51 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 118.813 -2.429 . . . . 0.0 111.98 173.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -128.21 147.05 50.56 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 123.149 1.452 . . . . 0.0 110.563 164.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.3 p -108.89 105.08 14.48 Favored 'General case' 0 N--CA 1.511 2.615 1 N-CA-C 99.889 -4.115 . . . . 0.0 99.889 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.356 0.4 OUTLIER -74.06 -178.78 0.82 Allowed Pre-proline 0 CA--C 1.592 2.584 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -165.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -55.24 -40.91 83.21 Favored 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 123.886 3.057 . . . . 0.0 120.036 -174.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -83.13 -92.95 0.07 Allowed 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.4 m -157.58 73.87 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.7 mtt -124.14 166.63 15.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.964 0.887 . . . . 0.0 112.658 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.453 ' CE2' ' HB ' ' A' ' 35' ' ' ILE . 57.5 m-85 -127.84 110.88 13.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -165.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.503 ' NE ' ' HG1' ' A' ' 32' ' ' THR . 2.3 tpt180 -84.22 92.02 7.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 171.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.72 134.03 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -164.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -83.26 115.11 21.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.503 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.264 0.1 OUTLIER -69.54 177.05 3.1 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 178.881 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.6 -14.24 40.66 Favored 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 167.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.503 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 23.7 t30 -92.12 -3.82 55.15 Favored 'General case' 0 CA--C 1.586 2.362 0 O-C-N 121.352 -0.843 . . . . 0.0 112.845 167.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.46 -5.38 81.28 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 119.182 2.433 . . . . 0.0 119.182 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -86.93 142.17 28.19 Favored 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 124.071 0.948 . . . . 0.0 110.388 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.8 131.4 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 CA-C-O 122.476 1.131 . . . . 0.0 112.831 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 m -130.97 150.25 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.503 ' HG1' ' NE ' ' A' ' 22' ' ' ARG . 17.5 m -92.62 124.88 36.96 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.263 -1.523 . . . . 0.0 110.801 175.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.77 170.16 16.4 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -120.23 136.04 54.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.736 -1.227 . . . . 0.0 112.518 174.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.453 ' HB ' ' CE2' ' A' ' 21' ' ' PHE 0.349 0.0 OUTLIER -79.56 146.92 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.068 0 O-C-N 120.541 -1.349 . . . . 0.0 109.304 176.211 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.97 92.25 1.63 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 119.434 -2.041 . . . . 0.0 113.88 -170.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -42.69 -30.34 0.91 Allowed Glycine 0 N--CA 1.491 2.327 1 N-CA-C 123.944 4.338 . . . . 0.0 123.944 -173.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -54.32 -49.46 69.64 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.94 -45.2 11.03 Favored 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 125.903 1.681 . . . . 0.0 114.717 170.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.485 ' NE ' ' HH ' ' A' ' 43' ' ' TYR 0.28 3.9 mmp_? -82.42 -40.58 21.03 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.203 1.801 . . . . 0.0 115.185 -166.035 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -92.91 40.03 1.05 Allowed 'General case' 0 CA--C 1.586 2.358 0 CA-C-O 122.52 1.152 . . . . 0.0 113.284 164.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -96.55 -43.93 7.38 Favored 'General case' 0 CA--C 1.576 1.945 0 C-N-CA 124.949 1.299 . . . . 0.0 108.45 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.485 ' HH ' ' NE ' ' A' ' 40' ' ' ARG 0.278 35.2 p90 -68.54 -113.34 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 126.04 1.736 . . . . 0.0 109.81 162.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.45 -91.26 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.71 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -147.85 172.41 14.19 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 124.035 1.874 . . . . 0.0 109.957 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.252 1.1 pp -89.79 152.67 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.984 170.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -86.93 160.32 18.73 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 -166.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 m -73.57 83.81 1.54 Allowed 'General case' 0 CA--C 1.571 1.751 0 CA-C-O 123.854 1.787 . . . . 0.0 111.001 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.474 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 129.47 22.2 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 CA-C-N 112.982 -1.917 . . . . 0.0 116.813 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -91.61 160.14 15.54 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 123.331 1.538 . . . . 0.0 112.332 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -87.71 94.35 9.71 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 125.719 2.676 . . . . 0.0 113.518 -175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 m -99.8 145.78 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-N 109.757 -3.383 . . . . 0.0 110.122 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.7 m -137.07 112.02 8.93 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.65 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.251 24.2 t -116.32 130.64 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.531 -159.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -88.4 136.46 32.97 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.006 0.907 . . . . 0.0 112.397 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.25 -169.98 2.24 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.64 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.512 ' OG1' ' HD2' ' A' ' 58' ' ' PRO . 0.5 OUTLIER -153.83 166.0 16.66 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 120.321 -1.487 . . . . 0.0 111.395 175.101 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.512 ' HD2' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -35.1 -48.87 0.77 Allowed 'Trans proline' 0 CA--C 1.561 1.828 1 N-CA-C 122.778 4.107 . . . . 0.0 122.778 173.348 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.5 -29.76 52.67 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.825 1.298 . . . . 0.0 113.992 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -96.65 69.91 2.54 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 114.106 -1.406 . . . . 0.0 113.474 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.5 mt -87.09 -41.3 13.92 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -76.88 5.56 7.67 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -143.09 173.77 11.27 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 120.991 1.723 . . . . 0.0 114.953 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.95 -165.53 34.0 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -155.86 122.64 5.28 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.539 -1.565 . . . . 0.0 113.554 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.551 ' H ' HD13 ' A' ' 66' ' ' ILE . 1.8 mp -45.81 113.15 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 172.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -94.06 -70.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.21 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -165.73 132.11 2.66 Favored 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.68 1.192 . . . . 0.0 110.183 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.0 ttt85 -87.19 71.5 10.07 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.456 -1.402 . . . . 0.0 112.111 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.4 m -163.26 74.75 0.36 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.436 1.094 . . . . 0.0 109.257 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 123.839 1.78 . . . . 0.0 112.169 -178.423 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.564 1.494 0 CA-C-O 121.628 0.728 . . . . 0.0 112.574 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -152.42 -74.94 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.453 -0.779 . . . . 0.0 110.375 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.32 8.3 tp10 -115.31 -117.06 0.32 Allowed 'General case' 0 CA--C 1.565 1.528 0 CA-C-O 122.766 1.27 . . . . 0.0 109.915 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -100.65 134.38 43.7 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 125.63 1.572 . . . . 0.0 114.881 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -72.65 116.1 12.72 Favored 'General case' 0 CA--C 1.573 1.839 0 O-C-N 121.071 -1.018 . . . . 0.0 111.53 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -97.48 143.96 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.287 1.035 . . . . 0.0 111.29 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.325 11.1 pt-20 -92.86 120.45 33.22 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 125.525 2.583 . . . . 0.0 108.305 168.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.282 16.1 ttt -167.16 81.29 0.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 108.873 -3.785 . . . . 0.0 105.308 -150.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.671 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -97.33 -152.55 0.39 Allowed 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -158.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.38 -173.42 33.01 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 120.411 2.924 . . . . 0.0 120.411 -172.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.8 m -98.49 127.96 44.64 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 57.4 t -60.55 117.09 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.912 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 175.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.285 68.2 mt -101.34 -16.88 16.77 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 119.786 -1.822 . . . . 0.0 113.467 170.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -146.8 141.52 26.77 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.956 1.36 . . . . 0.0 109.621 160.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 20' ' ' MET . 18.3 p -94.56 100.62 12.56 Favored 'General case' 0 N--CA 1.516 2.825 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 169.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.282 6.0 mt -79.78 154.26 75.7 Favored Pre-proline 0 CA--C 1.594 2.644 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.873 -166.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.399 2.3 Cg_endo 2.11 -78.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.57 2.324 2 C-N-CA 126.777 4.985 . . . . 0.0 124.997 -171.618 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.29 -77.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 120.64 1.564 . . . . 0.0 110.877 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -156.38 76.03 0.88 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 15' ' ' THR . 64.1 mtt -119.69 -177.3 3.36 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.517 0.727 . . . . 0.0 111.708 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -146.74 108.32 4.31 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 119.669 -1.894 . . . . 0.0 106.735 -166.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -86.9 94.52 9.61 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.86 135.73 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -163.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.55 111.75 21.55 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.286 0.1 OUTLIER -78.6 171.46 15.09 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 124.116 1.912 . . . . 0.0 115.782 -176.704 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.34 -13.96 44.81 Favored 'General case' 0 CA--C 1.578 2.056 0 CA-C-N 112.454 -2.157 . . . . 0.0 114.652 167.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.497 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 46.0 t30 -83.64 -11.21 57.56 Favored 'General case' 0 CA--C 1.587 2.371 0 CA-C-N 119.334 0.97 . . . . 0.0 113.337 164.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.84 -22.18 40.76 Favored Glycine 0 CA--C 1.549 2.216 0 N-CA-C 118.351 2.1 . . . . 0.0 118.351 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -79.71 143.38 34.61 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.122 0.969 . . . . 0.0 112.168 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.7 t -83.75 121.33 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 122.447 1.118 . . . . 0.0 109.507 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.54 144.36 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.801 -175.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.7 m -86.79 126.33 34.54 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.489 -1.382 . . . . 0.0 110.574 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.93 159.37 42.29 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -119.5 164.86 15.17 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 168.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.47 171.8 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.594 2.65 0 O-C-N 120.562 -1.336 . . . . 0.0 110.906 168.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.1 p -76.19 14.11 0.79 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 120.353 3.464 . . . . 0.0 120.353 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.83 -47.86 0.78 Allowed Glycine 0 N--CA 1.5 2.953 0 N-CA-C 117.819 1.888 . . . . 0.0 117.819 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -63.21 -51.13 67.54 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 126.54 1.936 . . . . 0.0 115.289 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ptm -70.16 -17.94 63.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 118.607 2.817 . . . . 0.0 118.607 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -39.14 -34.05 0.16 Allowed 'General case' 0 CA--C 1.583 2.244 0 CA-C-N 121.772 2.078 . . . . 0.0 116.443 167.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm -93.56 40.52 1.07 Allowed 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 173.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -157.56 -68.81 0.1 Allowed 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -93.38 101.18 13.4 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 165.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.27 20.9 mt -72.66 -77.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.768 -1.207 . . . . 0.0 111.444 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -136.61 171.09 15.0 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-O 125.988 2.804 . . . . 0.0 114.013 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 pt -147.08 167.18 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 109.959 -3.291 . . . . 0.0 109.581 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.279 1.3 pt? -122.73 -174.71 2.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 111.262 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.255 94.2 m -75.25 87.12 2.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 123.376 1.56 . . . . 0.0 113.399 -175.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.419 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 133.77 22.7 0.74 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.62 170.33 9.28 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 125.389 1.475 . . . . 0.0 114.77 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -81.6 118.55 22.87 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 125.342 2.496 . . . . 0.0 112.402 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.08 149.1 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 109.761 -3.381 . . . . 0.0 111.265 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.5 ' H ' HG13 ' A' ' 66' ' ' ILE 0.311 89.3 m -94.42 162.39 13.84 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 162.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.671 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -158.07 87.03 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 O-C-N 118.452 -2.655 . . . . 0.0 105.104 -179.234 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -76.86 140.62 40.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.09 -1.006 . . . . 0.0 110.059 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.96 -167.53 2.8 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 121.7 0.762 . . . . 0.0 112.582 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -99.52 160.46 27.39 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -56.8 -42.53 63.74 Favored 'Trans proline' 0 CA--C 1.57 2.312 0 N-CA-C 118.756 2.56 . . . . 0.0 118.756 164.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -92.24 -45.02 8.44 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -174.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -102.0 81.9 2.17 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.068 0.937 . . . . 0.0 112.685 -173.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.05 41.04 0.73 Allowed 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.7 m -101.47 -20.98 14.89 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -137.52 178.77 6.85 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 124.761 1.225 . . . . 0.0 113.593 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.0 -171.08 43.11 Favored Glycine 0 CA--C 1.551 2.314 0 O-C-N 121.468 -0.77 . . . . 0.0 114.687 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.96 121.53 2.81 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.5 HG13 ' H ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -40.0 92.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 119.346 -2.096 . . . . 0.0 116.216 166.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.272 0.2 OUTLIER -70.92 -67.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.652 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.931 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -140.41 84.43 1.95 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.404 1.456 . . . . 0.0 112.513 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -108.49 86.42 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.2 m -152.75 -80.47 0.1 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.597 -1.314 . . . . 0.0 112.012 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 . . . . . 0 CA--C 1.555 1.155 0 CA-C-O 124.842 2.258 . . . . 0.0 111.428 -176.307 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.328 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.292 56.2 mtpt 69.47 -74.7 0.08 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.297 0.3 OUTLIER -112.14 -113.67 0.33 Allowed 'General case' 0 CA--C 1.564 1.49 0 CA-C-O 122.522 1.153 . . . . 0.0 109.463 179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -100.5 113.87 27.01 Favored 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 125.206 1.402 . . . . 0.0 114.395 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -157.14 139.99 15.17 Favored 'General case' 0 CA--C 1.576 1.953 0 C-N-CA 124.079 0.952 . . . . 0.0 110.489 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.02 140.31 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.492 -1.38 . . . . 0.0 110.249 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.382 11.3 pt-20 -99.23 120.48 39.61 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 124.466 2.079 . . . . 0.0 110.778 169.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 20.2 ttt -170.69 76.94 0.07 Allowed 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 110.565 -3.016 . . . . 0.0 110.764 -149.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.547 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.608 0.0 OUTLIER -143.13 -166.13 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 119.231 3.049 . . . . 0.0 119.231 175.548 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 -111.16 1.19 Allowed Glycine 0 CA--C 1.542 1.764 0 N-CA-C 121.871 3.508 . . . . 0.0 121.871 -164.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -122.35 139.43 53.84 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.504 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 60.6 t -67.25 101.21 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.605 3.058 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.96 -44.2 61.41 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 117.947 -2.971 . . . . 0.0 113.39 171.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.25 148.89 47.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.305 1.05 . . . . 0.0 110.857 167.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 20' ' ' MET . 6.9 p -102.16 101.62 11.96 Favored 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 168.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.274 5.5 mt -79.86 150.55 72.43 Favored Pre-proline 0 CA--C 1.59 2.484 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.031 -164.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.413 3.0 Cg_exo 8.62 -77.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.351 2 C-N-CA 126.624 4.883 . . . . 0.0 124.378 -170.126 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -79.31 -81.67 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.017 1.281 . . . . 0.0 110.461 174.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.408 ' HG1' ' CZ ' ' A' ' 45' ' ' ARG . 18.4 m -149.23 74.79 1.26 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.443 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.274 61.3 mtt -118.79 -175.83 2.98 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.221 -0.925 . . . . 0.0 111.521 177.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.42 ' CD2' HD12 ' A' ' 66' ' ' ILE . 58.1 m-85 -147.35 107.87 4.11 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 -166.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -86.35 96.21 9.92 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.81 133.04 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -162.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.38 110.19 21.49 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.301 0.5 OUTLIER -56.25 179.22 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 -175.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.44 -25.47 66.76 Favored 'General case' 0 CA--C 1.58 2.11 0 CA-C-N 113.55 -1.659 . . . . 0.0 114.375 165.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.25 1.5 m-20 -78.87 -12.46 60.03 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 169.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.41 5.98 74.75 Favored Glycine 0 CA--C 1.562 2.984 0 N-CA-C 117.432 1.733 . . . . 0.0 117.432 -169.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -90.94 132.36 36.0 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.391 1.596 . . . . 0.0 112.701 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.14 125.38 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.73 -1.231 . . . . 0.0 111.698 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.42 154.5 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 122.287 1.041 . . . . 0.0 113.126 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 m -88.36 127.19 35.49 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.178 -1.576 . . . . 0.0 111.095 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.2 168.88 18.69 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -138.87 141.21 38.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.675 0.79 . . . . 0.0 111.802 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . 0.3 0.0 OUTLIER -73.13 137.84 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 O-C-N 120.202 -1.561 . . . . 0.0 110.372 173.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.33 128.34 35.2 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 120.786 -1.196 . . . . 0.0 112.566 -171.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.39 -27.67 4.22 Favored Glycine 0 N--CA 1.508 3.491 0 N-CA-C 119.276 2.471 . . . . 0.0 119.276 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -58.22 -51.36 70.09 Favored 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 125.898 1.679 . . . . 0.0 114.243 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.4 ptm -78.53 -32.68 48.11 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -39.35 -38.0 0.5 Allowed 'General case' 0 CA--C 1.578 2.042 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -93.42 29.99 1.83 Allowed 'General case' 0 CA--C 1.583 2.223 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -144.01 -66.34 0.35 Allowed 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -75.86 96.84 3.79 Favored 'General case' 0 CA--C 1.571 1.764 0 C-N-CA 125.652 1.581 . . . . 0.0 109.571 167.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.62 111.44 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-O 124.026 1.869 . . . . 0.0 106.552 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.408 ' CZ ' ' HG1' ' A' ' 19' ' ' THR . 6.5 ptm180 -40.51 168.97 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.095 1 N-CA-C 124.101 4.852 . . . . 0.0 124.101 -166.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -106.67 165.24 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 109.32 -3.582 . . . . 0.0 116.749 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.1 tp -121.44 179.14 4.53 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 122.319 1.057 . . . . 0.0 112.204 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -69.47 97.07 0.96 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 123.415 1.578 . . . . 0.0 113.28 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.504 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 115.74 20.82 5.23 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 117.884 1.914 . . . . 0.0 117.884 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -91.78 160.72 15.19 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 123.119 1.437 . . . . 0.0 111.899 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -88.05 116.78 26.48 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 124.932 2.301 . . . . 0.0 112.561 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.52 152.22 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.92 0 CA-C-N 110.437 -3.074 . . . . 0.0 111.822 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.5 m -142.86 113.92 7.69 Favored 'General case' 0 N--CA 1.502 2.13 1 N-CA-C 100.052 -4.055 . . . . 0.0 100.052 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.547 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 74.5 t -128.41 124.89 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 112.459 -2.155 . . . . 0.0 107.1 -155.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -78.58 135.33 37.25 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -133.88 -178.02 4.83 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.051 1.34 . . . . 0.0 108.518 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -94.72 164.12 20.57 Favored Pre-proline 0 CA--C 1.575 1.933 0 O-C-N 119.964 -1.71 . . . . 0.0 114.209 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -61.16 -38.2 68.73 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 C-N-CA 123.982 3.122 . . . . 0.0 116.709 166.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -89.91 -54.63 3.96 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.056 -1.883 . . . . 0.0 115.589 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -102.86 80.37 1.88 Allowed 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 122.423 1.106 . . . . 0.0 113.033 -171.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.5 mp -78.66 1.62 22.22 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 120.363 3.468 . . . . 0.0 120.363 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.3 t -70.37 -9.49 56.4 Favored 'General case' 0 CA--C 1.579 2.06 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -130.98 -177.12 4.24 Favored 'General case' 0 CA--C 1.576 1.95 0 CA-C-N 120.182 1.356 . . . . 0.0 113.069 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.5 174.55 40.54 Favored Glycine 0 CA--C 1.555 2.579 0 N-CA-C 117.919 1.928 . . . . 0.0 117.919 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -154.28 111.82 3.45 Favored 'General case' 0 CA--C 1.597 2.763 0 O-C-N 120.639 -1.507 . . . . 0.0 112.845 169.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.535 ' H ' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -47.52 103.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 O-C-N 118.554 -2.591 . . . . 0.0 115.204 172.435 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 m -96.45 -15.48 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 N-CA-C 120.01 3.337 . . . . 0.0 120.01 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -14.24 -68.65 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 121.071 3.73 . . . . 0.0 121.071 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -101.28 45.51 0.97 Allowed 'General case' 0 CA--C 1.579 2.09 0 CA-C-N 119.475 1.034 . . . . 0.0 113.538 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.3 p -148.8 -95.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.411 -1.43 . . . . 0.0 112.523 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 . . . . . 0 CA--C 1.56 1.36 0 CA-C-O 124.945 2.307 . . . . 0.0 111.214 -175.635 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.52 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -72.06 -39.13 69.25 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -79.47 31.0 0.23 Allowed 'General case' 0 CA--C 1.582 2.19 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -148.78 -160.6 1.2 Allowed 'General case' 0 CA--C 1.575 1.92 0 O-C-N 120.642 -1.286 . . . . 0.0 108.951 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -77.46 101.41 6.41 Favored 'General case' 0 CA--C 1.573 1.863 0 O-C-N 120.132 -1.605 . . . . 0.0 109.411 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mt -87.04 141.63 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.436 -1.415 . . . . 0.0 111.521 -170.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.333 12.9 pt-20 -97.45 122.98 41.13 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 123.676 1.703 . . . . 0.0 110.092 169.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.29 13.1 ttt -155.49 10.02 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 -150.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.594 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.532 0.2 OUTLIER -98.55 -161.64 0.89 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 120.79 3.626 . . . . 0.0 120.79 -166.679 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.42 -106.06 0.52 Allowed Glycine 0 N--CA 1.487 2.067 1 N-CA-C 123.86 4.304 . . . . 0.0 123.86 -163.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m -106.52 131.32 53.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.528 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 65.6 t -66.54 105.43 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.608 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 172.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.308 82.6 mt -85.91 -29.18 23.83 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.555 -1.966 . . . . 0.0 112.254 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.14 149.32 44.34 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.194 -0.941 . . . . 0.0 110.64 164.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' MET . 4.2 p -96.01 116.67 29.3 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 101.536 -3.505 . . . . 0.0 101.536 167.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.436 ' HB3' ' CD ' ' A' ' 17' ' ' PRO 0.394 6.5 mt -76.83 -108.22 0.0 OUTLIER Pre-proline 0 CA--C 1.598 2.818 0 CA-C-O 113.683 -3.056 . . . . 0.0 112.311 -158.295 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.436 ' CD ' ' HB3' ' A' ' 16' ' ' LEU . 92.9 Cg_endo -82.3 -69.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.574 2.494 1 CA-C-N 130.138 4.657 . . . . 0.0 115.038 177.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -83.45 -71.96 0.48 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 120.369 1.44 . . . . 0.0 111.945 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -151.24 71.56 1.01 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.374 74.4 mtp -114.23 -166.27 1.09 Allowed 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.073 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -156.66 109.46 2.57 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 124.864 3.483 . . . . 0.0 109.859 -163.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -88.85 96.97 10.91 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.77 136.35 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -163.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -92.09 112.58 24.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 170.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.251 0.1 OUTLIER -69.13 176.32 3.3 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 179.425 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -15.11 53.5 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 167.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.479 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 39.8 t30 -89.98 -6.46 55.62 Favored 'General case' 0 CA--C 1.585 2.292 0 CA-C-N 118.895 0.771 . . . . 0.0 112.628 168.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.71 -13.7 61.95 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 118.598 2.199 . . . . 0.0 118.598 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -78.25 135.3 37.54 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.278 1.031 . . . . 0.0 110.945 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.3 t -85.69 129.57 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 CA-C-O 123.017 1.389 . . . . 0.0 111.629 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.24 156.3 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 114.113 -1.403 . . . . 0.0 112.804 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -98.29 124.57 42.98 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.581 -1.325 . . . . 0.0 110.152 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.02 161.16 39.48 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 118.316 2.709 . . . . 0.0 118.316 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.57 -179.87 4.04 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 164.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.73 169.66 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.557 0 O-C-N 119.588 -1.945 . . . . 0.0 107.82 157.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.3 p -73.24 17.05 0.14 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 117.671 -3.143 . . . . 0.0 119.362 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.15 -51.2 0.76 Allowed Glycine 0 N--CA 1.499 2.886 0 N-CA-C 118.01 1.964 . . . . 0.0 118.01 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.53 -46.26 89.19 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 126.39 1.876 . . . . 0.0 115.451 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.402 ' SD ' ' O ' ' A' ' 67' ' ' VAL . 1.0 OUTLIER -73.41 -17.02 61.31 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 175.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -38.67 -38.45 0.41 Allowed 'General case' 0 CA--C 1.582 2.178 0 CA-C-N 122.838 2.563 . . . . 0.0 116.895 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -94.17 33.96 1.31 Allowed 'General case' 0 CA--C 1.585 2.314 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -148.12 -64.52 0.25 Allowed 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -78.66 93.47 4.89 Favored 'General case' 0 CA--C 1.571 1.766 0 C-N-CA 125.346 1.458 . . . . 0.0 108.623 166.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.5 mt -69.54 107.02 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.535 0 CA-C-O 124.554 2.121 . . . . 0.0 105.939 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.16 174.97 0.01 OUTLIER 'General case' 0 CA--C 1.577 1.986 1 N-CA-C 121.891 4.034 . . . . 0.0 121.891 -161.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 pt -119.36 167.73 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 111.082 -2.781 . . . . 0.0 115.194 -164.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.2 tp -125.93 -177.58 3.99 Favored 'General case' 0 CA--C 1.573 1.847 0 CA-C-O 122.038 0.923 . . . . 0.0 112.662 -171.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 m -68.34 95.55 0.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.475 1.607 . . . . 0.0 113.712 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.528 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 119.08 19.39 4.35 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 118.281 2.073 . . . . 0.0 118.281 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.33 163.31 13.65 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 122.953 1.359 . . . . 0.0 112.919 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -86.54 117.55 25.39 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 124.772 2.225 . . . . 0.0 112.949 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -121.85 157.6 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.692 0 CA-C-N 110.654 -2.975 . . . . 0.0 111.484 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.4 m -150.4 106.83 3.49 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 100.506 -3.887 . . . . 0.0 100.506 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.594 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 27.3 t -112.21 130.73 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 111.413 -2.63 . . . . 0.0 107.945 -161.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -83.67 136.98 34.0 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 121.163 -0.961 . . . . 0.0 111.876 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.285 2.2 pt? -123.97 -168.59 1.81 Allowed 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 121.252 0.549 . . . . 0.0 110.705 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.0 p -118.48 160.57 39.33 Favored Pre-proline 0 CA--C 1.572 1.807 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.73 -41.15 63.46 Favored 'Trans proline' 0 CA--C 1.569 2.235 0 C-N-CA 123.626 2.884 . . . . 0.0 118.773 164.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -88.85 -54.45 4.13 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -99.66 79.49 2.26 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 122.421 1.105 . . . . 0.0 112.716 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mp -70.19 -22.49 62.94 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -72.31 4.4 3.74 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -124.22 -174.55 3.03 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.462 1.483 . . . . 0.0 114.538 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.02 168.05 39.7 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 120.068 2.787 . . . . 0.0 120.068 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -153.39 110.2 3.42 Favored 'General case' 0 CA--C 1.594 2.669 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 167.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.479 ' H ' HG12 ' A' ' 54' ' ' VAL . 3.2 mp -44.05 104.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 O-C-N 117.437 -3.289 . . . . 0.0 115.86 168.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' O ' ' SD ' ' A' ' 39' ' ' MET . 14.2 m -95.83 -43.05 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.033 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.927 171.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.285 1.2 t80 55.05 -88.15 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 172.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -134.47 27.98 3.69 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.453 ' HG ' ' NE ' ' A' ' 71' ' ' ARG . 18.1 t -152.71 -77.82 0.12 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.644 -1.285 . . . . 0.0 112.693 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.453 ' NE ' ' HG ' ' A' ' 70' ' ' SER . 53.0 mtm180 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 124.308 2.004 . . . . 0.0 110.382 -174.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.559 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -72.89 -79.52 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.163 -0.96 . . . . 0.0 113.002 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pm0 -79.94 45.51 0.72 Allowed 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -119.06 47.79 1.6 Allowed 'General case' 0 CA--C 1.58 2.116 0 CA-C-O 123.971 1.843 . . . . 0.0 111.667 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -49.3 125.53 11.15 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -170.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.55 151.84 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.372 1.069 . . . . 0.0 109.631 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.279 8.1 pt-20 -108.51 124.74 50.92 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 123.831 1.777 . . . . 0.0 109.833 168.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.3 10.2 ttt -153.17 3.66 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 -151.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.656 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.533 0.0 OUTLIER -86.04 -166.31 1.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 121.287 3.81 . . . . 0.0 121.287 -166.905 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.19 -112.4 0.99 Allowed Glycine 0 N--CA 1.48 1.613 0 N-CA-C 121.45 3.34 . . . . 0.0 121.45 -164.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -102.29 130.23 48.93 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 99.6 t -63.9 111.51 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.881 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 171.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.324 58.6 mt -92.85 -34.04 13.99 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 122.585 2.448 . . . . 0.0 112.21 172.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.03 148.38 50.54 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-O 122.776 1.274 . . . . 0.0 109.922 163.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 20' ' ' MET . 11.9 p -105.52 106.23 16.63 Favored 'General case' 0 N--CA 1.513 2.675 0 N-CA-C 100.75 -3.796 . . . . 0.0 100.75 171.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.441 4.4 mt -82.8 -138.4 0.0 OUTLIER Pre-proline 0 CA--C 1.604 3.056 0 CA-C-O 115.033 -2.413 . . . . 0.0 113.779 -160.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.66 -73.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 1 CA-C-N 129.599 4.464 . . . . 0.0 117.766 -172.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -63.66 -67.35 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.979 -1.076 . . . . 0.0 111.965 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -169.7 79.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' ' 15' ' ' THR . 60.5 mtt -119.93 177.37 5.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.607 0.763 . . . . 0.0 112.589 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.4 ' CE1' ' CD1' ' A' ' 46' ' ' ILE . 57.2 m-85 -145.6 109.68 4.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -165.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -85.3 94.92 9.05 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 168.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.23 133.16 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -164.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -93.31 113.19 25.31 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.617 HD22 ' H ' ' A' ' 26' ' ' GLU 0.358 0.2 OUTLIER -53.93 -179.13 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 120.662 3.579 . . . . 0.0 120.662 -176.238 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.617 ' H ' HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -70.34 -28.72 65.37 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 112.212 -2.267 . . . . 0.0 114.347 167.312 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -90.91 4.54 51.61 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 168.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.18 8.22 78.79 Favored Glycine 0 CA--C 1.549 2.199 0 N-CA-C 119.432 2.533 . . . . 0.0 119.432 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -91.54 140.29 29.88 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.197 2.498 . . . . 0.0 113.081 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.61 123.85 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 O-C-N 120.799 -1.188 . . . . 0.0 112.029 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 m -131.33 152.14 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.0 m -91.46 130.25 37.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.548 -1.345 . . . . 0.0 110.712 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.14 155.49 43.33 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -104.32 177.49 4.83 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 123.349 1.547 . . . . 0.0 108.573 165.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.42 161.17 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.52 0 O-C-N 120.313 -1.492 . . . . 0.0 108.771 166.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 90.8 p -78.18 24.87 0.24 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 119.864 3.283 . . . . 0.0 119.864 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.52 -45.7 1.03 Allowed Glycine 0 N--CA 1.501 3.032 0 N-CA-C 116.645 1.418 . . . . 0.0 116.645 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -58.9 -48.56 81.0 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 127.061 2.144 . . . . 0.0 116.568 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.451 ' SD ' HG21 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.85 -21.88 61.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 118.487 2.773 . . . . 0.0 118.487 177.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -41.97 -34.02 0.64 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 171.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -84.55 -11.17 56.57 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 118.795 2.887 . . . . 0.0 118.795 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -89.75 -72.63 0.55 Allowed 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -101.96 132.03 48.02 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.55 1.14 . . . . 0.0 109.38 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.7 mt -70.64 -51.06 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 O-C-N 120.285 -1.509 . . . . 0.0 110.235 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -130.52 174.63 9.71 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 124.634 2.159 . . . . 0.0 113.053 171.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.4 ' CD1' ' CE1' ' A' ' 21' ' ' PHE 0.286 0.7 OUTLIER -135.05 161.11 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-N 112.685 -2.052 . . . . 0.0 108.773 175.363 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.48 159.74 18.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.717 -1.24 . . . . 0.0 113.923 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.1 m -75.08 79.12 2.24 Favored 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 123.884 1.802 . . . . 0.0 110.59 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.447 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 136.6 22.3 0.55 Allowed Glycine 0 N--CA 1.491 2.349 0 CA-C-N 113.182 -1.827 . . . . 0.0 116.802 -176.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -92.16 159.49 15.63 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 122.869 1.319 . . . . 0.0 112.81 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -90.57 85.5 6.13 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 125.598 2.618 . . . . 0.0 114.032 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.97 158.09 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.021 0 CA-C-N 109.818 -3.356 . . . . 0.0 111.771 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -146.89 112.7 5.71 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 101.387 -3.561 . . . . 0.0 101.387 174.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.656 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 40.3 t -117.77 131.19 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 111.988 -2.369 . . . . 0.0 107.354 -160.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -83.91 128.59 34.65 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.027 0.917 . . . . 0.0 111.593 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.76 -129.96 0.23 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -146.43 167.38 14.04 Favored Pre-proline 0 CA--C 1.569 1.709 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.16 -43.23 19.57 Favored 'Trans proline' 0 CA--C 1.576 2.624 0 C-N-CA 123.09 2.527 . . . . 0.0 115.518 164.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -80.4 -48.24 13.2 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 111.864 -2.426 . . . . 0.0 116.449 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -115.22 88.66 2.92 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 122.507 1.146 . . . . 0.0 112.425 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -83.32 12.61 5.15 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 118.909 2.929 . . . . 0.0 118.909 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.2 p -75.47 -30.5 59.94 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -140.27 167.82 21.24 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 124.305 1.042 . . . . 0.0 113.103 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.44 -166.61 32.03 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 117.272 1.669 . . . . 0.0 117.272 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -154.94 122.51 5.69 Favored 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.536 ' H ' HD13 ' A' ' 66' ' ' ILE . 1.5 mp -45.11 106.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 CA-C-N 121.753 2.07 . . . . 0.0 114.657 170.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.37 170.05 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.517 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -71.82 80.83 0.88 Allowed 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -94.03 119.06 32.38 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.243 1.017 . . . . 0.0 109.93 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.0 m -81.77 -59.85 2.45 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.619 -0.676 . . . . 0.0 112.744 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 . . . . . 0 CA--C 1.564 1.509 0 CA-C-O 123.686 1.708 . . . . 0.0 113.732 175.629 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 4' ' ' ASP . . . . . . . . 0 CA--C 1.565 1.529 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.295 61.4 mtpt 71.33 -73.81 0.09 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -86.29 70.91 10.56 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 122.565 1.174 . . . . 0.0 111.594 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.511 ' HD2' ' N ' ' A' ' 1' ' ' ALA . 62.4 m-20 -95.67 -161.22 0.85 Allowed 'General case' 0 CA--C 1.575 1.94 0 C-N-CA 124.029 0.931 . . . . 0.0 111.862 -178.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -61.14 114.77 3.31 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 119.454 -2.029 . . . . 0.0 112.162 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -95.39 148.81 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.112 -0.992 . . . . 0.0 111.001 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.314 6.6 pt-20 -98.09 120.26 38.18 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 125.573 2.606 . . . . 0.0 108.31 166.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 18.5 ttt -168.91 87.1 0.17 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 108.795 -3.82 . . . . 0.0 105.053 -150.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.789 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -110.35 -148.99 0.44 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 111.078 -2.783 . . . . 0.0 115.652 -156.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.79 -141.89 4.91 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 116.94 1.536 . . . . 0.0 116.94 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.2 m -122.17 134.34 54.73 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.481 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 42.4 t -59.07 114.74 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.871 0 O-C-N 121.689 -0.632 . . . . 0.0 110.187 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.1 mt -82.24 -32.8 29.53 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 119.641 -1.912 . . . . 0.0 111.956 166.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -146.56 141.74 27.29 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.024 1.392 . . . . 0.0 111.025 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 20' ' ' MET . 25.1 p -92.88 110.18 21.63 Favored 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 102.464 -3.161 . . . . 0.0 102.464 169.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.434 3.8 mt -81.83 -133.35 0.0 OUTLIER Pre-proline 0 CA--C 1.602 2.958 0 CA-C-O 114.609 -2.615 . . . . 0.0 114.191 -160.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -73.43 -69.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.379 2.163 1 CA-C-N 129.994 4.605 . . . . 0.0 117.086 -174.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -73.01 -76.06 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.126 -0.984 . . . . 0.0 110.318 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -157.73 77.06 0.82 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 15' ' ' THR . 67.2 mtt -121.23 179.13 4.51 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.83 0.852 . . . . 0.0 112.242 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -145.21 109.74 4.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.66 -1.9 . . . . 0.0 106.812 -166.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -84.57 101.92 12.48 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 167.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.77 141.11 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -163.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -93.36 108.04 19.77 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 171.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.501 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.261 0.1 OUTLIER -77.11 169.27 18.63 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 124.058 1.885 . . . . 0.0 115.047 -176.234 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.271 20.8 pt-20 -68.03 -8.9 41.54 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 112.555 -2.111 . . . . 0.0 114.703 169.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.501 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 15.3 t30 -91.14 -6.45 53.56 Favored 'General case' 0 CA--C 1.588 2.432 0 CA-C-N 119.124 0.874 . . . . 0.0 112.647 164.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.47 -20.9 45.78 Favored Glycine 0 CA--C 1.549 2.182 0 N-CA-C 118.961 2.345 . . . . 0.0 118.961 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -78.09 137.76 38.39 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.735 0.814 . . . . 0.0 111.486 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.45 112.99 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 122.879 1.323 . . . . 0.0 109.304 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 m -102.64 148.91 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 113.932 -1.486 . . . . 0.0 113.661 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.5 m -93.22 120.93 34.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.007 -1.058 . . . . 0.0 108.28 171.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.36 161.41 36.37 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -113.04 -160.6 0.72 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.1 173.79 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.07 0 O-C-N 120.584 -1.323 . . . . 0.0 108.524 166.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.1 p -78.54 100.69 7.03 Favored 'General case' 0 CA--C 1.561 1.382 0 O-C-N 119.254 -2.154 . . . . 0.0 108.39 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -31.69 -30.8 0.01 OUTLIER Glycine 0 N--CA 1.506 3.329 1 N-CA-C 123.852 4.301 . . . . 0.0 123.852 -175.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -62.46 -46.67 87.45 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 174.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 ptm -73.25 -17.82 61.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -39.75 -30.51 0.08 Allowed 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 118.348 2.721 . . . . 0.0 118.348 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -90.55 -5.93 55.34 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -103.9 -66.91 0.92 Allowed 'General case' 0 CA--C 1.578 2.026 0 C-N-CA 126.155 1.782 . . . . 0.0 106.617 169.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -81.6 98.24 8.25 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 125.509 1.524 . . . . 0.0 107.838 168.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.9 mt -73.3 -71.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.411 -0.805 . . . . 0.0 110.908 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.404 ' HB3' ' H ' ' A' ' 46' ' ' ILE . 23.7 mtp180 -140.03 171.69 13.82 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 125.853 2.74 . . . . 0.0 115.491 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.404 ' H ' ' HB3' ' A' ' 45' ' ' ARG . 1.3 pt -142.86 167.86 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 110.56 -3.018 . . . . 0.0 108.483 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.444 ' CD1' ' H ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -110.54 177.35 4.71 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.838 1.304 . . . . 0.0 112.822 -173.286 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.444 ' H ' ' CD1' ' A' ' 47' ' ' LEU . 48.8 m -76.0 83.65 2.88 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 123.36 1.552 . . . . 0.0 110.998 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 134.04 23.31 0.69 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 117.524 1.77 . . . . 0.0 117.524 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.76 160.53 14.72 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 122.858 1.313 . . . . 0.0 113.877 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -87.99 82.46 7.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 125.754 2.693 . . . . 0.0 113.368 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -71.93 163.83 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-N 110.088 -3.233 . . . . 0.0 115.504 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.521 ' HA ' ' CB ' ' A' ' 9' ' ' GLN 0.355 19.5 m -125.63 78.94 1.78 Allowed 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 124.261 1.981 . . . . 0.0 113.417 170.309 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.789 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.2 OUTLIER -75.99 101.3 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 125.813 1.645 . . . . 0.0 109.806 -173.409 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -82.75 140.97 32.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.709 -0.619 . . . . 0.0 109.354 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.21 -116.64 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 110.584 -171.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.42 166.32 17.15 Favored Pre-proline 0 CA--C 1.575 1.907 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -176.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -61.38 -47.36 12.07 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 C-N-CA 123.088 2.526 . . . . 0.0 117.425 166.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -97.46 -43.63 7.18 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -175.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -95.49 77.3 3.35 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.17 49.47 1.66 Allowed 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 94.5 p -106.92 -27.86 10.43 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 125.668 1.587 . . . . 0.0 114.744 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -126.24 -173.49 2.87 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 124.06 0.944 . . . . 0.0 112.736 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.59 179.73 45.38 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.73 108.27 1.17 Allowed 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 118.895 2.924 . . . . 0.0 118.895 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.434 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -26.71 91.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.118 0 N-CA-C 118.889 2.922 . . . . 0.0 118.889 162.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 m -92.14 -18.77 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 N-CA-C 117.271 2.322 . . . . 0.0 117.271 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -79.74 120.55 24.18 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -176.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.0 mtt85 -76.42 96.61 4.07 Favored 'General case' 0 CA--C 1.569 1.711 0 O-C-N 121.664 -0.648 . . . . 0.0 111.926 174.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.4 m -75.65 -28.33 58.72 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? . . . . . 0 CA--C 1.561 1.395 0 CA-C-O 125.238 2.447 . . . . 0.0 111.324 178.003 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.565 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.317 21.7 ptmt 47.8 54.47 9.88 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -88.21 69.87 9.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.221 -1.549 . . . . 0.0 110.933 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -107.91 164.94 11.83 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-O 122.708 1.242 . . . . 0.0 112.817 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -79.79 116.17 19.81 Favored 'General case' 0 CA--C 1.572 1.812 0 O-C-N 121.042 -1.036 . . . . 0.0 110.746 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.14 141.97 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.107 -0.996 . . . . 0.0 111.411 -174.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.328 12.5 pt-20 -99.14 124.35 44.1 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.636 1.684 . . . . 0.0 110.224 168.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.284 11.4 ttt -154.71 -8.06 0.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 120.539 3.533 . . . . 0.0 120.539 -151.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.562 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.574 0.0 OUTLIER -78.9 -165.35 0.72 Allowed 'General case' 0 N--CA 1.491 1.583 1 N-CA-C 122.053 4.094 . . . . 0.0 122.053 -165.11 . . . . . . . . 5 4 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.39 -112.61 1.53 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 122.42 3.728 . . . . 0.0 122.42 -166.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.3 m -110.78 141.11 44.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.532 -0.981 . . . . 0.0 108.363 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.535 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 90.4 t -69.51 101.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.602 2.948 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 174.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.12 -38.38 52.25 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 117.923 -2.985 . . . . 0.0 112.828 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -128.93 145.71 51.15 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.761 1.267 . . . . 0.0 110.762 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 20' ' ' MET . 2.4 p -95.77 106.0 18.07 Favored 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 101.775 -3.417 . . . . 0.0 101.775 167.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.288 5.7 mt -78.47 166.47 42.64 Favored Pre-proline 0 CA--C 1.593 2.626 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.482 -167.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.385 6.0 Cg_endo -20.54 -57.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.57 2.302 2 N-CA-C 125.459 5.138 . . . . 0.0 125.459 -164.798 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -82.71 -78.34 0.21 Allowed 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 120.651 1.569 . . . . 0.0 109.782 172.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -158.13 72.81 0.64 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.255 67.3 mtm -115.98 -169.61 1.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.681 0.792 . . . . 0.0 110.588 178.14 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -148.49 108.15 3.99 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 119.114 -2.241 . . . . 0.0 106.952 -166.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -84.48 97.59 9.62 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.78 133.7 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -164.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -95.96 111.49 23.47 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.58 HD22 ' H ' ' A' ' 26' ' ' GLU 0.365 0.2 OUTLIER -52.26 -178.54 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 120.608 3.558 . . . . 0.0 120.608 -176.11 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.58 ' H ' HD22 ' A' ' 25' ' ' LEU . 11.0 pt-20 -69.62 -31.45 69.57 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 112.729 -2.032 . . . . 0.0 113.949 167.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -88.68 6.74 37.05 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.19 13.41 79.06 Favored Glycine 0 CA--C 1.549 2.165 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -95.1 130.01 41.96 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 120.821 2.31 . . . . 0.0 112.561 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.0 t -82.76 124.9 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.438 -1.414 . . . . 0.0 112.333 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.16 149.76 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 114.705 -1.134 . . . . 0.0 113.499 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 m -87.45 127.08 35.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.487 -1.383 . . . . 0.0 110.396 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.4 139.98 28.75 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.71 155.73 17.47 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 168.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.408 HD13 ' H ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -64.31 170.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.536 0 O-C-N 120.456 -1.402 . . . . 0.0 112.166 168.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -75.68 92.9 3.01 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 119.226 -2.171 . . . . 0.0 107.902 169.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.81 -38.23 0.01 OUTLIER Glycine 0 N--CA 1.505 3.266 1 N-CA-C 123.314 4.086 . . . . 0.0 123.314 -174.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -54.32 -45.54 72.65 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -73.18 -21.87 60.59 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 173.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.408 ' H ' HD13 ' A' ' 35' ' ' ILE . 88.6 mtt-85 -37.06 -39.68 0.25 Allowed 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 123.718 2.963 . . . . 0.0 117.524 174.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -91.07 47.41 1.4 Allowed 'General case' 0 CA--C 1.582 2.183 0 CA-C-O 124.231 1.967 . . . . 0.0 114.402 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -168.12 -60.36 0.02 OUTLIER 'General case' 0 CA--C 1.581 2.17 0 C-N-CA 128.151 2.581 . . . . 0.0 105.193 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -83.43 68.45 9.73 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 127.144 2.178 . . . . 0.0 114.017 175.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 mt -88.33 71.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.389 84.8 mmt-85 -100.98 -76.02 0.57 Allowed 'General case' 0 N--CA 1.489 1.488 1 N-CA-C 124.465 4.987 . . . . 0.0 124.465 -164.003 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pt -99.77 162.47 3.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 112.116 -2.311 . . . . 0.0 116.678 -157.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -129.45 -174.55 3.32 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.528 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.8 m -70.52 84.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.768 1.27 . . . . 0.0 112.585 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.535 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 132.68 19.22 1.06 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 118.218 2.047 . . . . 0.0 118.218 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.03 157.73 16.62 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-O 123.014 1.388 . . . . 0.0 111.803 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -90.61 94.11 9.56 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 125.217 2.437 . . . . 0.0 113.429 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -97.01 142.46 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.827 0 CA-C-N 109.733 -3.394 . . . . 0.0 111.836 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.464 ' HG1' ' NE ' ' A' ' 71' ' ' ARG . 17.6 m -126.48 119.15 26.47 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 100.62 -3.844 . . . . 0.0 100.62 171.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.645 HG12 ' H ' ' A' ' 66' ' ' ILE 0.252 93.6 t -127.86 125.42 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 112.9 -1.955 . . . . 0.0 106.345 -157.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -79.09 137.97 37.74 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -172.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.275 2.3 pt? -129.03 -171.19 2.42 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 121.625 0.726 . . . . 0.0 111.14 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 p -106.13 164.87 14.05 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -43.04 -51.66 5.38 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 N-CA-C 122.212 3.889 . . . . 0.0 122.212 161.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -110.75 -41.4 4.29 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.61 69.14 6.69 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.859 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.42 -9.09 58.33 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.3 t -69.71 -6.57 32.64 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -124.05 -176.62 3.53 Favored 'General case' 0 CA--C 1.575 1.928 0 CA-C-O 123.211 1.482 . . . . 0.0 113.259 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.89 174.47 43.46 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -153.7 106.74 2.92 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 171.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.645 ' H ' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -41.3 110.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 117.973 2.582 . . . . 0.0 117.973 173.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.32 -55.83 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 C-N-CA 124.708 1.203 . . . . 0.0 110.444 172.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.254 0.6 OUTLIER 72.7 -50.62 0.7 Allowed 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 118.481 2.771 . . . . 0.0 118.481 174.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 66.54 3.31 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 121.139 1.791 . . . . 0.0 113.943 177.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 m -176.37 -65.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 127.082 2.153 . . . . 0.0 107.17 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.464 ' NE ' ' HG1' ' A' ' 53' ' ' THR . 14.9 ttt180 . . . . . 0 CA--C 1.565 1.534 0 CA-C-O 124.919 2.295 . . . . 0.0 107.492 174.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.571 1.775 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.283 66.0 mttm 68.06 -75.19 0.07 Allowed 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.23 59.96 5.95 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -127.93 172.65 10.7 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 122.779 1.276 . . . . 0.0 111.259 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -83.42 77.63 9.78 Favored 'General case' 0 CA--C 1.582 2.203 0 O-C-N 120.157 -1.59 . . . . 0.0 108.66 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mt -97.21 144.82 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.112 -1.617 . . . . 0.0 111.095 -170.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.279 7.2 pt-20 -99.84 119.56 38.38 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 124.219 1.961 . . . . 0.0 109.219 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.295 10.8 ttt -154.26 -4.77 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 110.399 -3.091 . . . . 0.0 119.322 -152.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.558 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.603 0.2 OUTLIER -75.89 -157.85 0.08 Allowed 'General case' 0 CA--C 1.566 1.584 1 N-CA-C 125.778 5.473 . . . . 0.0 125.778 -162.18 . . . . . . . . 5 4 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 9' ' ' GLN . . . -114.43 -150.75 10.2 Favored Glycine 0 CA--C 1.535 1.292 1 N-CA-C 126.29 5.276 . . . . 0.0 126.29 -157.525 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -101.79 136.53 41.47 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.45 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 63.1 t -64.56 111.66 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.588 0 O-C-N 121.074 -1.017 . . . . 0.0 109.332 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.9 -36.56 64.77 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-N 122.738 2.517 . . . . 0.0 111.943 168.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -146.07 147.3 31.46 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 122.32 1.057 . . . . 0.0 111.789 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 20' ' ' MET . 0.3 OUTLIER -93.93 116.23 28.66 Favored 'General case' 0 N--CA 1.511 2.593 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 169.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.454 1.2 mm? -79.79 -127.71 0.0 OUTLIER Pre-proline 0 CA--C 1.597 2.779 0 CA-C-O 114.369 -2.729 . . . . 0.0 114.81 -164.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.55 -67.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.566 2.113 1 CA-C-N 130.159 4.664 . . . . 0.0 116.966 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -81.24 -72.94 0.4 Allowed 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.387 -0.82 . . . . 0.0 110.603 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m -157.43 74.31 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.26 89.4 mtp -113.98 -169.57 1.54 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 117.326 -1.321 . . . . 0.0 111.901 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.402 ' HB3' HG23 ' A' ' 23' ' ' VAL . 57.9 m-85 -154.92 112.01 3.33 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 123.366 2.803 . . . . 0.0 111.337 -166.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -93.89 97.61 10.5 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 167.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 21' ' ' PHE . 2.5 t -101.52 141.2 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -163.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -98.35 107.86 20.42 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.0 171.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.49 HD21 ' H ' ' A' ' 26' ' ' GLU 0.264 0.6 OUTLIER -50.47 176.56 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 118.718 2.859 . . . . 0.0 118.718 -177.089 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.49 ' H ' HD21 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -66.28 -22.68 66.31 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 168.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -95.47 6.11 49.84 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.47 -1.58 85.96 Favored Glycine 0 CA--C 1.554 2.52 0 N-CA-C 119.955 2.742 . . . . 0.0 119.955 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -82.63 140.44 33.18 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.834 1.817 . . . . 0.0 113.04 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.3 130.18 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 CA-C-O 122.846 1.307 . . . . 0.0 111.374 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.27 153.03 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.376 -1.284 . . . . 0.0 113.168 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.8 m -98.16 126.1 43.48 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.439 -1.413 . . . . 0.0 110.256 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.42 163.39 34.77 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.6 176.14 5.14 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.825 -1.534 . . . . 0.0 107.63 164.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.14 171.0 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.59 2.49 0 O-C-N 119.731 -1.856 . . . . 0.0 108.84 161.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 p -74.91 27.48 0.09 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 118.26 -2.775 . . . . 0.0 117.988 177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.06 -49.78 0.18 Allowed Glycine 0 N--CA 1.502 3.048 0 N-CA-C 119.937 2.735 . . . . 0.0 119.937 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -65.62 -52.34 52.73 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.044 2.138 . . . . 0.0 115.499 -177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -18.1 65.1 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -38.43 -39.21 0.43 Allowed 'General case' 0 CA--C 1.575 1.922 0 CA-C-N 122.419 2.372 . . . . 0.0 116.492 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -92.28 32.4 1.19 Allowed 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -149.73 -54.98 0.17 Allowed 'General case' 0 CA--C 1.577 1.991 0 C-N-CA 127.25 2.22 . . . . 0.0 107.141 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -76.46 63.47 2.02 Favored 'General case' 0 CA--C 1.58 2.107 0 C-N-CA 125.605 1.562 . . . . 0.0 112.947 171.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mt -84.98 72.18 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 CA-C-O 124.752 2.215 . . . . 0.0 108.788 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -112.19 -43.19 3.58 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 120.811 3.634 . . . . 0.0 120.811 -169.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.403 0.0 OUTLIER -120.23 160.82 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 1 N-CA-C 122.992 4.442 . . . . 0.0 122.992 -138.901 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.9 tp -159.15 178.67 9.76 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 110.203 -3.18 . . . . 0.0 112.387 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.1 m -68.55 116.02 8.61 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.615 1.198 . . . . 0.0 111.709 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.45 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 95.27 14.37 48.42 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 119.371 2.508 . . . . 0.0 119.371 -175.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.46 172.97 8.04 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 124.96 1.304 . . . . 0.0 111.757 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -97.59 136.62 37.72 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 124.516 2.103 . . . . 0.0 115.87 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.06 153.95 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.954 0 CA-C-N 111.51 -2.587 . . . . 0.0 110.901 -171.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.8 m -143.71 102.89 3.99 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 101.978 -3.341 . . . . 0.0 101.978 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.558 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 19.7 t -105.87 132.14 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 111.107 -2.77 . . . . 0.0 108.056 -164.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -82.86 127.54 33.59 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.665 -1.272 . . . . 0.0 111.771 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.321 2.2 pt? -102.0 -165.53 1.2 Allowed 'General case' 0 CA--C 1.566 1.574 0 CA-C-O 121.26 0.552 . . . . 0.0 111.385 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 p -131.74 161.49 62.08 Favored Pre-proline 0 CA--C 1.572 1.813 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -51.54 -43.74 48.37 Favored 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 123.999 3.133 . . . . 0.0 118.843 164.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -95.57 -57.2 2.45 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.562 ' HD2' ' NZ ' ' A' ' 63' ' ' LYS . 21.6 t0 -95.16 74.08 3.4 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.343 1.068 . . . . 0.0 113.342 -172.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.51 -20.0 65.94 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 118.377 2.732 . . . . 0.0 118.377 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 t -74.98 4.53 6.44 Favored 'General case' 0 CA--C 1.583 2.241 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 171.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.562 ' NZ ' ' HD2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -137.68 170.71 15.6 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 121.093 1.769 . . . . 0.0 115.516 -176.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.53 -169.19 42.13 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.98 124.9 7.89 Favored 'General case' 0 CA--C 1.59 2.49 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 173.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.497 ' H ' HD13 ' A' ' 66' ' ' ILE . 2.8 mp -43.71 104.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 171.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.1 m -102.23 -63.34 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.069 0 CA-C-N 113.891 -1.504 . . . . 0.0 114.054 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.442 0.0 OUTLIER 10.05 -102.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.049 1 N-CA-C 121.991 4.071 . . . . 0.0 121.991 -172.87 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -147.51 127.32 13.49 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 120.883 1.674 . . . . 0.0 111.635 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.7 p -104.61 81.86 1.83 Allowed 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 122.353 1.073 . . . . 0.0 109.271 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.417 ' H ' ' HD3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.225 0 CA-C-O 125.053 2.358 . . . . 0.0 112.332 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 . . . . . 0 CA--C 1.571 1.772 0 CA-C-O 121.302 0.572 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -96.66 141.13 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 124.187 0.995 . . . . 0.0 110.104 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.378 14.7 pt-20 -92.29 126.21 37.27 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 124.858 2.266 . . . . 0.0 109.536 165.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.283 20.4 ttt -168.46 82.96 0.16 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 109.968 -3.287 . . . . 0.0 104.765 -152.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -98.47 -153.03 0.42 Allowed 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 -159.097 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -167.36 -174.37 36.39 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 120.487 2.955 . . . . 0.0 120.487 -170.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.7 m -100.54 124.97 46.81 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.503 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 67.3 t -60.66 117.54 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.763 0 CA-C-N 121.096 1.771 . . . . 0.0 107.294 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.302 73.3 mt -100.95 -26.43 13.74 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.169 -1.582 . . . . 0.0 112.773 171.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -136.42 145.86 45.74 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 123.09 1.424 . . . . 0.0 109.487 162.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 20' ' ' MET . 5.8 p -96.61 110.27 22.72 Favored 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 100.827 -3.768 . . . . 0.0 100.827 168.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.429 2.5 mt -79.65 -124.89 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.91 0 CA-C-O 113.986 -2.911 . . . . 0.0 115.655 -159.25 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 95.6 Cg_endo -73.36 -70.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.185 1 CA-C-N 130.561 4.807 . . . . 0.0 116.243 -176.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -78.67 -70.31 0.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.251 -0.906 . . . . 0.0 110.731 175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 m -159.33 75.89 0.67 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.415 ' O ' ' HA ' ' A' ' 15' ' ' THR . 67.9 mtt -118.58 -175.42 2.88 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.512 0.725 . . . . 0.0 111.426 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CE1' HD11 ' A' ' 46' ' ' ILE . 60.5 m-85 -144.29 109.88 5.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 119.454 -2.029 . . . . 0.0 106.398 -166.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -85.32 93.86 8.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 170.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.2 t -100.94 135.21 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -163.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -85.91 116.18 23.99 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.298 4.7 mt -70.52 174.95 5.2 Favored 'General case' 0 CA--C 1.577 1.99 0 CA-C-O 124.112 1.91 . . . . 0.0 112.569 -172.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -24.17 63.21 Favored 'General case' 0 CA--C 1.586 2.355 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.908 165.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.6 -8.25 56.3 Favored 'General case' 0 CA--C 1.586 2.365 0 C-N-CA 126.186 1.794 . . . . 0.0 115.398 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.72 9.31 75.08 Favored Glycine 0 CA--C 1.554 2.521 0 N-CA-C 119.496 2.558 . . . . 0.0 119.496 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -114.36 147.45 39.14 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 118.665 1.232 . . . . 0.0 112.452 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.4 t -82.27 126.88 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.861 -1.149 . . . . 0.0 111.216 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.3 147.68 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.598 1.19 . . . . 0.0 112.791 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.9 m -89.59 123.64 33.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.72 -1.238 . . . . 0.0 109.08 172.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.31 155.17 47.9 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 159.71 19.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 172.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.481 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -73.0 176.33 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.631 0 O-C-N 119.973 -1.704 . . . . 0.0 110.758 166.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 92.5 p -79.9 25.24 0.37 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 121.086 3.735 . . . . 0.0 121.086 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.85 -52.44 1.63 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.295 64.4 pttt -59.83 -58.17 9.73 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 118.061 2.615 . . . . 0.0 118.061 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -21.5 62.97 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -38.44 -39.02 0.42 Allowed 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . 0.258 14.4 mptt -98.02 -4.55 35.87 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 121.639 3.94 . . . . 0.0 121.639 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -93.46 53.25 1.86 Allowed 'General case' 0 CA--C 1.587 2.404 0 N-CA-C 102.316 -3.216 . . . . 0.0 102.316 153.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.416 1.8 t80 -45.74 98.11 0.01 OUTLIER 'General case' 0 C--N 1.379 1.86 0 N-CA-C 118.679 2.844 . . . . 0.0 118.679 -152.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mt -82.07 74.53 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 109.175 -3.648 . . . . 0.0 107.562 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 137.96 58.03 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 -170.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.559 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.274 1.4 pt -141.78 154.96 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 CA-C-N 111.466 -2.606 . . . . 0.0 111.87 -176.614 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 tp -131.39 -174.44 3.4 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.128 0.966 . . . . 0.0 111.033 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -72.87 84.88 1.24 Allowed 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 123.317 1.532 . . . . 0.0 113.074 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.503 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 130.34 25.23 0.88 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 117.631 1.812 . . . . 0.0 117.631 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.55 165.62 12.44 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 123.2 1.476 . . . . 0.0 114.131 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -84.73 82.65 8.33 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 125.583 2.611 . . . . 0.0 113.674 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 m -79.03 152.82 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 CA-C-N 110.595 -3.002 . . . . 0.0 113.284 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.489 ' HA ' ' HB3' ' A' ' 9' ' ' GLN . 63.8 m -94.76 161.15 14.29 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 160.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.459 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -157.35 86.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 O-C-N 118.128 -2.858 . . . . 0.0 105.658 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -78.19 138.6 38.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.102 -0.999 . . . . 0.0 109.743 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -136.0 -179.32 5.59 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.665 1.221 . . . . 0.0 111.699 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 p -100.36 161.06 25.28 Favored Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -53.9 -43.48 57.7 Favored 'Trans proline' 0 CA--C 1.572 2.388 0 C-N-CA 123.231 2.621 . . . . 0.0 118.22 163.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -82.87 -49.39 9.71 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.72 83.25 2.23 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 122.25 1.024 . . . . 0.0 112.049 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -17.1 61.17 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.2 p -68.97 -7.97 40.26 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -122.73 -177.74 3.73 Favored 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 119.963 1.256 . . . . 0.0 114.056 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.405 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . -177.33 177.0 48.29 Favored Glycine 0 CA--C 1.548 2.127 0 N-CA-C 117.686 1.834 . . . . 0.0 117.686 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -162.69 115.86 1.67 Allowed 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 172.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.618 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -38.99 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 118.929 -2.357 . . . . 0.0 116.912 165.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.279 2.1 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.538 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 CA--C 1.575 1.925 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -89.16 138.44 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.427 -1.421 . . . . 0.0 111.741 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.332 10.5 pt-20 -93.74 123.29 36.99 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 125.257 2.456 . . . . 0.0 109.219 168.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.26 20.5 ttt -170.34 85.08 0.11 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 109.173 -3.649 . . . . 0.0 104.626 -151.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -105.16 -149.24 0.41 Allowed 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -162.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 179.29 -142.44 5.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.8 m -122.86 135.26 54.46 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.513 HG11 HG23 ' A' ' 15' ' ' THR . 54.0 t -58.99 124.6 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.607 3.168 0 O-C-N 121.364 -0.835 . . . . 0.0 109.528 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.5 mt -90.66 -27.6 18.92 Favored 'General case' 0 N--CA 1.514 2.737 0 O-C-N 119.314 -2.116 . . . . 0.0 112.031 163.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.4 tp10 -148.47 143.51 26.77 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 120.83 -1.169 . . . . 0.0 111.736 166.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.513 HG23 HG11 ' A' ' 12' ' ' VAL . 33.1 p -103.94 103.76 13.64 Favored 'General case' 0 N--CA 1.518 2.958 0 N-CA-C 102.087 -3.301 . . . . 0.0 102.087 173.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.393 0.2 OUTLIER -77.08 178.6 1.97 Allowed Pre-proline 0 CA--C 1.593 2.626 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -168.443 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -54.41 -36.15 86.81 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 N-CA-C 121.25 3.519 . . . . 0.0 121.25 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -79.74 -100.78 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.4 m -152.97 72.77 0.97 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 76.0 mtp -126.04 162.7 24.68 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 46' ' ' ILE . 56.7 m-85 -132.77 114.48 14.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.141 -1.6 . . . . 0.0 107.087 -163.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.2 ttm105 -85.67 89.41 7.73 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.3 t -96.3 137.29 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -162.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.7 111.82 22.4 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.302 4.9 mt -72.3 174.24 7.56 Favored 'General case' 0 CA--C 1.577 2.002 0 CA-C-O 124.135 1.921 . . . . 0.0 112.779 -173.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.96 -22.59 61.43 Favored 'General case' 0 CA--C 1.585 2.298 0 CA-C-N 113.804 -1.544 . . . . 0.0 114.128 166.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -74.58 -9.09 58.23 Favored 'General case' 0 CA--C 1.587 2.366 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.68 23.79 55.09 Favored Glycine 0 CA--C 1.555 2.54 0 N-CA-C 118.632 2.213 . . . . 0.0 118.632 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -125.94 145.71 50.16 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.309 1.044 . . . . 0.0 111.224 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.0 t -86.04 117.5 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.728 -1.232 . . . . 0.0 110.123 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.7 148.9 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.1 m -92.54 125.5 37.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.405 -1.434 . . . . 0.0 110.062 173.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.32 159.84 40.79 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 177.11 4.75 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 165.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.514 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.2 pt -88.99 -178.27 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.36 0 O-C-N 119.211 -2.181 . . . . 0.0 110.632 165.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.4 p -82.49 122.32 27.9 Favored 'General case' 0 CA--C 1.56 1.33 0 O-C-N 119.714 -1.866 . . . . 0.0 109.205 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.49 -20.34 0.59 Allowed Glycine 0 N--CA 1.503 3.161 0 N-CA-C 122.312 3.685 . . . . 0.0 122.312 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -71.24 -55.75 7.46 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 125.641 1.577 . . . . 0.0 114.405 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 ptm -69.39 -20.54 63.81 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -37.93 -35.66 0.16 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -94.47 33.58 1.4 Allowed 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -150.93 -69.93 0.18 Allowed 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.64 101.04 10.55 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 163.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.83 -73.55 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.439 -0.788 . . . . 0.0 109.381 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -132.1 -179.27 5.31 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-O 124.512 2.101 . . . . 0.0 114.316 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.258 1.1 pt -143.39 175.67 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 C-N-CA 126.932 2.093 . . . . 0.0 110.858 -173.179 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.4 158.5 16.3 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.256 1.027 . . . . 0.0 111.115 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 m -71.58 86.84 0.9 Allowed 'General case' 0 CA--C 1.572 1.807 0 CA-C-O 123.577 1.655 . . . . 0.0 110.423 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 130.36 24.2 0.95 Allowed Glycine 0 N--CA 1.492 2.423 0 CA-C-N 113.02 -1.9 . . . . 0.0 117.049 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -94.57 162.3 13.86 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-O 122.976 1.37 . . . . 0.0 114.166 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -85.59 81.35 8.7 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 125.575 2.607 . . . . 0.0 113.796 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -77.79 158.15 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 110.324 -3.126 . . . . 0.0 113.839 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.299 35.3 m -95.44 162.78 13.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 160.508 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.454 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -158.44 89.55 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 118.473 -2.642 . . . . 0.0 104.897 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.55 134.87 36.5 Favored 'General case' 0 CA--C 1.563 1.47 0 O-C-N 121.17 -0.956 . . . . 0.0 110.014 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 mp -101.06 -171.76 2.05 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 125.972 2.796 . . . . 0.0 111.878 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 p -122.5 162.04 40.32 Favored Pre-proline 0 CA--C 1.577 1.987 0 CA-C-N 109.657 -3.429 . . . . 0.0 112.657 173.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -52.85 -41.27 71.6 Favored 'Trans proline' 0 CA--C 1.569 2.249 0 C-N-CA 123.656 2.904 . . . . 0.0 119.166 164.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -95.21 -52.81 4.03 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -91.39 77.03 5.87 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 122.528 1.156 . . . . 0.0 112.779 -172.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.5 mt -70.89 -22.86 62.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 117.643 2.46 . . . . 0.0 117.643 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.5 t -75.89 6.95 4.41 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -139.8 166.48 24.5 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 120.564 1.529 . . . . 0.0 113.475 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.14 -164.08 29.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 115.633 1.013 . . . . 0.0 115.633 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.95 122.31 2.57 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.607 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -35.64 91.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 166.326 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.268 2.8 m . . . . . 0 CA--C 1.567 1.616 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.412 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 m120 . . . . . 0 CA--C 1.573 1.83 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.08 142.24 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.615 1.166 . . . . 0.0 109.661 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.409 16.3 pt-20 -95.03 122.27 37.51 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 125.036 2.351 . . . . 0.0 109.82 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.275 18.6 ttt -168.34 81.2 0.16 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 109.777 -3.374 . . . . 0.0 105.683 -149.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -96.04 -149.86 0.32 Allowed 'General case' 0 CA--C 1.563 1.456 0 N-CA-C 118.713 2.857 . . . . 0.0 118.713 -157.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -166.88 -178.34 39.27 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 121.951 3.54 . . . . 0.0 121.951 -168.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.6 m -99.73 124.88 45.43 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 15' ' ' THR . 61.4 t -60.2 122.14 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.989 0 CA-C-N 120.487 1.494 . . . . 0.0 107.253 175.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.299 62.6 mt -99.51 -22.06 15.65 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 119.823 -1.798 . . . . 0.0 112.844 168.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.9 tp10 -145.01 143.84 30.7 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 122.372 1.082 . . . . 0.0 110.833 161.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.485 HG23 HG11 ' A' ' 12' ' ' VAL . 24.7 p -106.17 106.58 17.16 Favored 'General case' 0 N--CA 1.515 2.798 0 N-CA-C 101.395 -3.557 . . . . 0.0 101.395 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.374 0.3 OUTLIER -76.48 174.37 5.81 Favored Pre-proline 0 CA--C 1.591 2.544 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -167.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -47.11 -42.22 26.42 Favored 'Trans proline' 0 CA--C 1.565 2.064 0 N-CA-C 121.493 3.613 . . . . 0.0 121.493 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -80.49 -93.21 0.05 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.9 m -159.5 75.38 0.64 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 69.6 mtm -126.78 167.87 15.19 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.795 0.838 . . . . 0.0 112.512 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.545 ' CE1' HD11 ' A' ' 46' ' ' ILE . 59.8 m-85 -132.22 114.89 15.0 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 118.703 -2.498 . . . . 0.0 108.815 -163.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -87.05 95.89 10.1 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 170.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.4 t -105.13 139.97 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -162.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.87 111.57 18.88 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 167.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.257 0.1 OUTLIER -79.84 166.21 21.93 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 121.879 2.127 . . . . 0.0 113.082 -179.971 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.308 18.1 pt-20 -67.41 -6.35 18.78 Favored 'General case' 0 CA--C 1.579 2.065 0 CA-C-N 112.677 -2.056 . . . . 0.0 114.959 169.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.573 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 45.8 t-20 -86.41 -15.47 40.23 Favored 'General case' 0 CA--C 1.588 2.408 0 O-C-N 121.129 -0.982 . . . . 0.0 112.721 162.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.51 -25.73 24.89 Favored Glycine 0 CA--C 1.549 2.178 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -75.17 140.2 43.18 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 124.292 1.037 . . . . 0.0 112.334 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.4 t -81.53 112.69 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 122.688 1.232 . . . . 0.0 108.947 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.91 147.63 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 114.129 -1.396 . . . . 0.0 113.465 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 m -87.3 127.19 35.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.805 -1.184 . . . . 0.0 108.54 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.16 152.3 49.78 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.1 151.29 42.2 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 170.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.465 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.7 OUTLIER -69.57 162.68 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.437 0 O-C-N 120.738 -1.226 . . . . 0.0 111.287 173.264 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.7 p -76.52 98.4 4.63 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 119.246 -2.159 . . . . 0.0 109.937 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -16.52 -50.19 0.01 OUTLIER Glycine 0 N--CA 1.505 3.234 1 N-CA-C 123.761 4.264 . . . . 0.0 123.761 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -47.69 -49.51 27.57 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 119.065 2.987 . . . . 0.0 119.065 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ptm -70.89 -18.08 62.69 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -39.6 -35.54 0.32 Allowed 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 169.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -92.79 34.06 1.11 Allowed 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -150.23 -71.63 0.18 Allowed 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 102.958 -2.978 . . . . 0.0 102.958 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -81.09 93.49 6.43 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.802 1.241 . . . . 0.0 107.771 164.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mt -74.01 -70.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.217 -0.927 . . . . 0.0 111.491 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -134.78 171.94 13.67 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 125.284 2.469 . . . . 0.0 115.009 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.265 1.0 OUTLIER -148.73 170.36 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 CA-C-N 110.85 -2.886 . . . . 0.0 109.777 -175.899 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.6 tp -109.43 163.41 13.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.891 -1.13 . . . . 0.0 112.986 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.8 m -71.48 85.15 0.84 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 123.813 1.768 . . . . 0.0 111.095 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 131.77 23.15 0.89 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 112.8 -2.0 . . . . 0.0 117.053 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -94.5 160.89 14.44 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 123.043 1.401 . . . . 0.0 113.145 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -88.78 83.63 6.69 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 124.999 2.333 . . . . 0.0 112.475 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -71.76 163.35 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 CA-C-N 110.802 -2.908 . . . . 0.0 114.34 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.306 75.3 m -95.13 160.2 14.67 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 159.224 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -158.44 84.55 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 O-C-N 118.37 -2.706 . . . . 0.0 105.769 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -76.77 134.8 39.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.019 -1.051 . . . . 0.0 109.838 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -137.61 -172.14 3.16 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.821 0.82 . . . . 0.0 111.299 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -104.79 155.74 37.04 Favored Pre-proline 0 CA--C 1.573 1.833 0 O-C-N 120.993 -1.067 . . . . 0.0 113.259 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -54.34 -42.03 71.2 Favored 'Trans proline' 0 CA--C 1.572 2.392 0 C-N-CA 123.738 2.959 . . . . 0.0 118.387 164.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -79.42 -47.38 15.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -108.22 89.24 2.93 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 122.195 0.998 . . . . 0.0 110.308 -174.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.82 -14.9 57.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 118.996 2.962 . . . . 0.0 118.996 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.9 t -73.46 -1.28 17.74 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -129.56 -177.5 4.29 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 120.276 1.398 . . . . 0.0 113.277 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.0 -173.86 45.22 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -161.63 113.65 1.77 Allowed 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 119.595 3.183 . . . . 0.0 119.595 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.581 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -36.45 94.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 118.762 -2.461 . . . . 0.0 117.556 166.461 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.57 1.737 0 CA-C-N 114.062 -1.426 . . . . 0.0 112.847 176.727 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 . . . . . 0 CA--C 1.568 1.667 0 CA-C-O 120.813 0.34 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -91.33 142.05 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.847 -1.158 . . . . 0.0 111.227 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.337 13.2 pt-20 -100.28 123.17 44.18 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 123.705 1.717 . . . . 0.0 110.177 169.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.261 13.9 ttt -155.15 -12.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 119.315 3.08 . . . . 0.0 119.315 -151.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.725 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.503 0.0 OUTLIER -69.68 -173.02 0.55 Allowed 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 121.765 3.987 . . . . 0.0 121.765 -169.915 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.56 -108.64 1.78 Allowed Glycine 0 N--CA 1.48 1.567 0 N-CA-C 122.442 3.737 . . . . 0.0 122.442 -164.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.7 m -121.43 136.92 54.91 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.506 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 79.1 t -62.76 117.05 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.91 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.7 mt -79.34 -37.36 37.71 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 122.107 2.231 . . . . 0.0 111.236 165.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.5 tp10 -143.31 144.96 32.31 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 122.062 0.934 . . . . 0.0 112.346 169.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.526 HG22 ' HE1' ' A' ' 21' ' ' PHE . 32.2 p -104.2 109.3 21.06 Favored 'General case' 0 N--CA 1.513 2.725 0 N-CA-C 101.763 -3.421 . . . . 0.0 101.763 171.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.376 0.5 OUTLIER -77.32 -177.51 0.81 Allowed Pre-proline 0 CA--C 1.592 2.559 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -167.409 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -54.38 -36.59 87.8 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 N-CA-C 120.893 3.382 . . . . 0.0 120.893 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -85.72 -93.83 0.08 Allowed 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -156.23 74.89 0.86 Allowed 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.9 mtt -130.23 162.25 29.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.976 -1.077 . . . . 0.0 112.76 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.691 ' CE2' HG23 ' A' ' 35' ' ' ILE . 62.3 m-85 -128.75 113.3 15.16 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 118.723 -2.485 . . . . 0.0 106.979 -162.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -85.76 96.11 9.62 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 167.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 21' ' ' PHE . 2.1 t -99.95 140.13 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -164.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.06 114.92 26.67 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.256 0.5 OUTLIER -58.4 178.07 0.11 Allowed 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -177.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.49 -24.57 66.42 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 167.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -92.63 6.96 45.44 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 170.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.9 -1.74 87.86 Favored Glycine 0 CA--C 1.554 2.519 0 N-CA-C 119.911 2.725 . . . . 0.0 119.911 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -83.9 143.19 30.04 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.641 1.72 . . . . 0.0 113.262 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.5 t -89.05 130.84 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.663 0 CA-C-O 122.578 1.18 . . . . 0.0 111.52 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.86 153.92 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.54 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.0 m -99.51 122.0 41.97 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.495 -1.378 . . . . 0.0 109.853 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.39 149.36 32.6 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 119.733 3.235 . . . . 0.0 119.733 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -99.95 158.26 15.94 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.509 -1.37 . . . . 0.0 111.206 170.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.691 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -71.17 178.21 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.752 0 O-C-N 120.444 -1.41 . . . . 0.0 111.981 164.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.2 p -80.08 15.72 1.42 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 120.07 3.359 . . . . 0.0 120.07 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.67 -25.66 0.06 OUTLIER Glycine 0 N--CA 1.506 3.33 0 N-CA-C 121.842 3.497 . . . . 0.0 121.842 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -79.99 -45.95 17.51 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -46.25 89.42 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 118.537 2.792 . . . . 0.0 118.537 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HB3' HD11 ' A' ' 35' ' ' ILE . 7.6 ptm85 -36.28 -45.99 0.5 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.806 3.262 . . . . 0.0 119.806 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -92.0 0.6 57.47 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-N 110.048 -3.251 . . . . 0.0 118.929 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -96.57 -71.58 0.67 Allowed 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 167.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.27 125.81 37.09 Favored 'General case' 0 CA--C 1.57 1.744 0 C-N-CA 124.154 0.982 . . . . 0.0 109.122 170.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.57 108.99 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.722 0 CA-C-O 124.429 2.061 . . . . 0.0 107.747 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -44.66 174.62 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.878 1 N-CA-C 124.267 4.914 . . . . 0.0 124.267 -165.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' A' ' 21' ' ' PHE . 1.1 pt -75.57 159.79 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 109.845 -3.343 . . . . 0.0 116.604 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -122.44 174.77 6.82 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.184 0.993 . . . . 0.0 112.285 -171.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -68.47 100.61 1.11 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 123.494 1.616 . . . . 0.0 112.576 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.506 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 113.36 20.47 6.22 Favored Glycine 0 N--CA 1.489 2.224 0 CA-C-N 112.837 -1.983 . . . . 0.0 117.883 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.55 158.58 15.92 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-O 122.917 1.341 . . . . 0.0 112.764 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -87.75 94.54 9.78 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 125.764 2.697 . . . . 0.0 113.106 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.419 ' CG1' HD13 ' A' ' 46' ' ' ILE . 19.7 m -94.56 148.12 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 CA-C-N 109.594 -3.457 . . . . 0.0 110.986 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.2 m -140.94 107.19 5.23 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 100.33 -3.952 . . . . 0.0 100.33 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.725 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.252 51.0 t -117.17 128.45 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 111.177 -2.738 . . . . 0.0 106.042 -159.515 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -80.65 134.32 35.86 Favored 'General case' 0 CA--C 1.558 1.266 0 O-C-N 121.345 -0.847 . . . . 0.0 112.182 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.56 -176.38 3.37 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.488 1.137 . . . . 0.0 110.707 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 p -108.56 164.12 15.44 Favored Pre-proline 0 CA--C 1.571 1.772 0 O-C-N 120.987 -1.071 . . . . 0.0 113.883 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -51.09 -40.77 59.26 Favored 'Trans proline' 0 CA--C 1.572 2.393 0 N-CA-C 118.976 2.645 . . . . 0.0 118.976 163.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -94.98 -53.39 3.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -89.63 79.87 6.73 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.576 1.179 . . . . 0.0 111.924 -172.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.65 -21.23 57.88 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.2 t -77.64 11.75 1.95 Allowed 'General case' 0 CA--C 1.58 2.127 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 173.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 mtmm -137.56 177.38 7.91 Favored 'General case' 0 CA--C 1.57 1.742 0 CA-C-N 120.249 1.386 . . . . 0.0 114.612 -175.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.2 -176.25 45.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.22 114.85 3.69 Favored 'General case' 0 CA--C 1.592 2.58 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 168.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.64 ' H ' HD12 ' A' ' 66' ' ' ILE . 1.3 mp -45.13 108.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 O-C-N 119.076 -2.265 . . . . 0.0 114.893 171.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.574 1.87 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.799 173.74 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 . . . . . 0 CA--C 1.579 2.066 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mt -88.99 138.73 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.294 -1.504 . . . . 0.0 112.298 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.328 8.6 pt-20 -88.56 121.63 31.15 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 125.052 2.358 . . . . 0.0 109.235 170.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.407 ' HB3' HD23 ' A' ' 56' ' ' LEU . 18.0 ttt -172.01 84.79 0.07 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 109.289 -3.596 . . . . 0.0 104.852 -148.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.643 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -110.92 -149.03 0.44 Allowed 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -156.741 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 179.82 -150.72 9.44 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 117.967 1.947 . . . . 0.0 117.967 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.9 m -115.89 133.79 55.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.516 HG11 HG23 ' A' ' 15' ' ' THR . 46.9 t -60.06 118.31 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.003 0 O-C-N 121.384 -0.822 . . . . 0.0 109.102 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -84.24 -31.44 25.01 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.599 -1.938 . . . . 0.0 111.874 165.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -147.04 143.88 28.7 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 122.726 1.251 . . . . 0.0 111.807 167.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.516 HG23 HG11 ' A' ' 12' ' ' VAL . 24.3 p -104.16 105.68 15.93 Favored 'General case' 0 N--CA 1.516 2.862 0 N-CA-C 100.793 -3.781 . . . . 0.0 100.793 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.371 0.3 OUTLIER -75.26 173.39 7.06 Favored Pre-proline 0 CA--C 1.591 2.526 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -167.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -47.58 -35.26 22.14 Favored 'Trans proline' 0 CA--C 1.567 2.128 0 N-CA-C 122.103 3.847 . . . . 0.0 122.103 -174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -85.3 -96.34 0.07 Allowed 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 m -157.68 73.38 0.7 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 95.9 mtp -125.38 167.27 15.19 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.385 1.074 . . . . 0.0 112.529 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.534 ' CE1' HD11 ' A' ' 46' ' ' ILE . 55.3 m-85 -130.04 114.06 15.32 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 118.883 -2.386 . . . . 0.0 108.363 -164.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.2 ttm105 -85.34 97.95 10.26 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.5 t -106.75 143.03 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -162.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -88.13 106.73 18.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 171.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.285 3.8 mt -72.31 176.37 5.34 Favored 'General case' 0 CA--C 1.58 2.107 0 CA-C-O 123.995 1.855 . . . . 0.0 113.208 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.77 -25.12 62.75 Favored 'General case' 0 CA--C 1.585 2.304 0 CA-C-N 114.088 -1.415 . . . . 0.0 114.101 166.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -72.02 -5.83 37.84 Favored 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.72 -4.47 79.0 Favored Glycine 0 CA--C 1.557 2.706 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -88.33 147.71 24.64 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.77 1.228 . . . . 0.0 112.903 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.44 106.84 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.95 151.32 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.1 m -92.53 124.83 36.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.525 -1.359 . . . . 0.0 109.005 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.53 159.59 41.34 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -113.25 -164.28 0.91 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 169.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -108.34 -177.94 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.384 0 O-C-N 120.254 -1.529 . . . . 0.0 108.369 166.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 84.8 p -76.79 20.08 0.26 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.98 -55.18 0.79 Allowed Glycine 0 N--CA 1.499 2.871 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -57.11 -52.54 64.9 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.259 0.7 OUTLIER -70.11 -19.48 63.24 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 117.611 2.449 . . . . 0.0 117.611 177.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -39.43 -35.59 0.29 Allowed 'General case' 0 CA--C 1.578 2.056 0 N-CA-C 117.338 2.347 . . . . 0.0 117.338 170.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.8 38.62 1.21 Allowed 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 171.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -152.93 -74.82 0.13 Allowed 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.44 99.75 11.87 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 164.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mt -76.39 -64.59 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 O-C-N 121.666 -0.646 . . . . 0.0 111.773 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -128.47 167.42 17.08 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 119.94 3.311 . . . . 0.0 119.94 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.534 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.268 1.5 pt -142.65 170.83 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 109.57 -3.468 . . . . 0.0 110.666 176.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.3 tp -111.22 163.27 14.1 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.147 0.975 . . . . 0.0 111.406 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.1 m -69.97 88.41 0.57 Allowed 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 123.451 1.596 . . . . 0.0 111.206 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.499 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 129.49 22.17 1.22 Allowed Glycine 0 N--CA 1.493 2.473 0 CA-C-N 113.184 -1.825 . . . . 0.0 117.304 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -93.42 160.33 14.86 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 122.891 1.329 . . . . 0.0 113.478 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -88.35 84.54 6.83 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 125.438 2.542 . . . . 0.0 112.765 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -71.13 166.63 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-N 110.156 -3.202 . . . . 0.0 115.218 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.321 14.3 m -125.95 75.71 1.53 Allowed 'General case' 0 N--CA 1.508 2.445 0 CA-C-O 123.798 1.761 . . . . 0.0 113.54 171.283 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.643 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -75.04 101.3 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.315 1.446 . . . . 0.0 109.528 -172.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -80.65 146.01 31.36 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.277 1.037 . . . . 0.0 109.911 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 8' ' ' MET . 3.1 mm? -98.39 -173.46 2.57 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 124.623 2.154 . . . . 0.0 116.405 -171.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 p -131.32 153.84 81.76 Favored Pre-proline 0 CA--C 1.578 2.045 0 CA-C-N 111.027 -2.806 . . . . 0.0 111.421 165.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.2 -42.85 61.93 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 123.734 2.956 . . . . 0.0 118.352 165.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -87.27 -54.4 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -96.86 74.25 2.65 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -171.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.8 mp -66.11 -20.99 66.33 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.3 m -73.36 1.55 9.38 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -135.36 169.89 16.78 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 123.333 1.54 . . . . 0.0 111.963 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.55 -164.83 31.69 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 115.87 1.108 . . . . 0.0 115.87 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.24 110.83 1.21 Allowed 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 119.234 3.049 . . . . 0.0 119.234 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.513 ' CD1' ' H ' ' A' ' 66' ' ' ILE 0.264 0.7 OUTLIER -25.1 89.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 163.924 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 CA--C 1.568 1.647 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.459 173.523 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 . . . . . 0 CA--C 1.572 1.821 0 CA-C-O 121.567 0.698 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.5 140.11 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.58 1.152 . . . . 0.0 110.444 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.375 11.4 pt-20 -92.21 123.48 35.58 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 124.644 2.164 . . . . 0.0 109.81 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.259 25.2 ttt -172.62 86.93 0.07 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 110.143 -3.208 . . . . 0.0 105.228 -147.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.657 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -116.24 -147.07 0.41 Allowed 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -156.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.88 -144.59 9.02 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 121.23 3.252 . . . . 0.0 121.23 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.2 m -102.74 129.54 49.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.235 -0.568 . . . . 0.0 109.611 -176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.484 HG11 HG23 ' A' ' 15' ' ' THR . 56.0 t -61.64 123.46 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.773 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 173.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.296 63.3 mt -101.68 -17.53 16.26 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 119.816 -1.803 . . . . 0.0 112.99 167.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 6.1 tp10 -148.18 143.35 27.0 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.512 1.149 . . . . 0.0 110.598 161.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.484 HG23 HG11 ' A' ' 12' ' ' VAL . 22.8 p -106.18 106.09 16.43 Favored 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 100.545 -3.872 . . . . 0.0 100.545 171.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.364 0.3 OUTLIER -75.23 173.58 6.74 Favored Pre-proline 0 CA--C 1.592 2.56 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -167.125 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -48.65 -34.48 27.19 Favored 'Trans proline' 0 CA--C 1.567 2.148 0 N-CA-C 121.729 3.704 . . . . 0.0 121.729 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -84.69 -95.46 0.07 Allowed 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -158.97 73.53 0.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 58.8 mtt -126.92 167.3 16.04 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.703 0.801 . . . . 0.0 112.264 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.601 ' CE2' HG23 ' A' ' 35' ' ' ILE . 57.7 m-85 -128.82 114.59 16.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 118.544 -2.598 . . . . 0.0 108.205 -163.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -87.28 91.35 8.69 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.5 t -99.3 142.02 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -162.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -82.98 124.37 30.33 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 165.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.269 3.0 mt -74.47 -173.89 1.88 Allowed 'General case' 0 CA--C 1.579 2.066 0 CA-C-O 123.76 1.743 . . . . 0.0 112.016 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -26.03 63.65 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 171.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -90.77 8.72 33.23 Favored 'General case' 0 CA--C 1.582 2.209 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 169.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.55 6.55 89.26 Favored Glycine 0 CA--C 1.552 2.393 0 N-CA-C 119.61 2.604 . . . . 0.0 119.61 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -89.48 142.69 27.44 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 119.908 1.854 . . . . 0.0 112.001 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 t -84.57 124.35 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 122.087 0.946 . . . . 0.0 110.805 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.41 145.69 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.745 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 m -91.24 122.1 33.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.533 -1.354 . . . . 0.0 108.547 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.91 153.68 44.56 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -114.51 148.34 38.05 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.511 1.148 . . . . 0.0 109.129 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.601 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.1 pt -66.94 179.24 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.598 2.798 0 O-C-N 121.025 -1.047 . . . . 0.0 112.521 166.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.7 p -102.82 157.3 17.06 Favored 'General case' 0 CA--C 1.558 1.287 0 O-C-N 119.513 -1.992 . . . . 0.0 115.048 -176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.31 -3.98 27.73 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 119.297 2.479 . . . . 0.0 119.297 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.282 21.9 pttm -95.31 -54.26 3.47 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.691 1.738 . . . . 0.0 115.691 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -31.47 66.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 118.197 2.665 . . . . 0.0 118.197 175.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -35.58 -42.25 0.23 Allowed 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 120.344 3.461 . . . . 0.0 120.344 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.83 34.79 0.72 Allowed 'General case' 0 CA--C 1.581 2.149 0 CA-C-N 111.306 -2.679 . . . . 0.0 116.567 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -155.53 -74.9 0.11 Allowed 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 102.226 -3.25 . . . . 0.0 102.226 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.4 97.44 8.95 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.485 1.514 . . . . 0.0 107.943 165.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mt -74.26 -63.44 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.255 -0.903 . . . . 0.0 111.768 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -129.24 170.45 13.57 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.548 HD11 ' CE1' ' A' ' 21' ' ' PHE . 2.8 pt -146.73 171.56 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 109.507 -3.497 . . . . 0.0 111.363 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.5 tp -116.39 167.03 11.4 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.179 0.99 . . . . 0.0 110.973 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.1 m -70.74 86.17 0.67 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 123.539 1.638 . . . . 0.0 111.905 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.453 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 133.83 19.43 0.92 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 117.726 1.85 . . . . 0.0 117.726 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -94.79 165.71 12.34 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.985 1.314 . . . . 0.0 113.312 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -88.29 121.87 31.18 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 124.178 1.942 . . . . 0.0 111.945 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.69 163.98 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.881 0 CA-C-N 111.183 -2.735 . . . . 0.0 113.109 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 9' ' ' GLN 0.361 22.7 m -121.85 75.3 1.2 Allowed 'General case' 0 N--CA 1.514 2.743 0 CA-C-O 124.543 2.116 . . . . 0.0 114.754 172.047 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.657 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -75.84 100.56 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 126.82 2.048 . . . . 0.0 110.56 -174.706 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -83.25 144.34 29.81 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 120.842 -1.161 . . . . 0.0 109.081 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.4 -175.01 4.61 Favored 'General case' 0 CA--C 1.564 1.495 0 O-C-N 120.863 -1.148 . . . . 0.0 112.042 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -94.28 159.95 32.95 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -52.14 -41.45 65.0 Favored 'Trans proline' 0 CA--C 1.57 2.297 0 C-N-CA 123.443 2.762 . . . . 0.0 118.868 164.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -91.18 -54.55 3.89 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -93.64 78.9 4.28 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 122.507 1.146 . . . . 0.0 113.234 -171.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.16 -8.82 57.46 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 119.711 3.226 . . . . 0.0 119.711 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -75.96 -0.82 22.87 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -129.86 179.99 5.54 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.89 1.677 . . . . 0.0 113.053 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.18 -177.58 46.2 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 117.522 1.769 . . . . 0.0 117.522 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.34 111.27 1.64 Allowed 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.801 ' H ' HD12 ' A' ' 66' ' ' ILE 0.351 1.3 mp -38.57 89.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 119.152 -2.217 . . . . 0.0 116.547 164.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.56 1.365 0 CA-C-N 114.246 -1.343 . . . . 0.0 114.273 -176.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.981 0.42 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.97 155.49 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.705 -1.247 . . . . 0.0 110.246 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.331 12.4 pt-20 -113.78 119.32 36.93 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 124.128 1.918 . . . . 0.0 111.565 170.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.276 25.8 ttt -164.43 68.98 0.17 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 110.807 -2.906 . . . . 0.0 112.48 -152.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.665 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.597 0.3 OUTLIER -133.69 -167.86 2.01 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 177.075 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.45 -112.39 0.89 Allowed Glycine 0 N--CA 1.483 1.798 0 N-CA-C 122.226 3.65 . . . . 0.0 122.226 -167.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.2 m -103.97 136.32 43.84 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.682 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 45.9 t -71.49 100.01 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.615 3.451 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -64.5 -44.58 90.47 Favored 'General case' 0 N--CA 1.521 3.084 2 CA-C-N 127.163 4.529 . . . . 0.0 112.81 174.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -129.76 150.35 51.1 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 122.921 1.343 . . . . 0.0 110.464 171.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 p -104.34 97.9 7.77 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 101.391 -3.559 . . . . 0.0 101.391 171.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.281 5.2 mt -78.76 155.98 77.85 Favored Pre-proline 0 CA--C 1.595 2.68 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.259 -163.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.347 6.1 Cg_endo -14.15 -62.62 0.01 OUTLIER 'Trans proline' 0 CA--C 1.567 2.145 2 N-CA-C 125.343 5.093 . . . . 0.0 125.343 -169.676 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -75.81 -85.87 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.152 1.342 . . . . 0.0 109.108 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.6 m -155.94 75.11 0.89 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 81.3 mtp -120.24 179.37 4.31 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.756 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.476 ' HB3' HG22 ' A' ' 23' ' ' VAL . 58.3 m-85 -145.29 106.52 4.19 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 -165.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.3 ttt85 -84.2 93.94 8.29 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 170.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.6 t -98.57 136.0 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -162.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -96.03 108.42 20.82 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 26' ' ' GLU 0.345 0.3 OUTLIER -48.8 178.39 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 N-CA-C 121.473 3.879 . . . . 0.0 121.473 -177.15 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.554 ' H ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -75.43 -23.13 56.93 Favored 'General case' 0 CA--C 1.579 2.074 0 CA-C-N 112.462 -2.154 . . . . 0.0 113.704 166.437 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.264 0.1 OUTLIER -93.45 4.89 53.23 Favored 'General case' 0 CA--C 1.595 2.707 0 C-N-CA 124.703 1.201 . . . . 0.0 112.481 168.262 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.79 15.36 79.47 Favored Glycine 0 CA--C 1.547 2.056 0 N-CA-C 119.634 2.613 . . . . 0.0 119.634 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -101.08 136.12 41.44 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.007 1.904 . . . . 0.0 111.62 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.67 128.12 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 119.926 -1.734 . . . . 0.0 112.398 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -122.47 169.76 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.281 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -112.04 121.88 46.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.909 -1.12 . . . . 0.0 109.793 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.81 158.74 43.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 118.377 2.732 . . . . 0.0 118.377 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -106.74 166.21 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.806 1.289 . . . . 0.0 109.499 167.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.427 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.1 pt -78.55 -176.37 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.58 0 O-C-N 119.854 -1.779 . . . . 0.0 111.414 168.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.8 p -102.42 97.05 7.34 Favored 'General case' 0 CA--C 1.552 1.04 0 O-C-N 120.173 -1.58 . . . . 0.0 107.347 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -39.41 -30.43 0.16 Allowed Glycine 0 N--CA 1.499 2.868 0 N-CA-C 122.914 3.926 . . . . 0.0 122.914 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -66.13 -50.45 63.97 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -52.78 5.18 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 124.759 1.224 . . . . 0.0 113.596 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . 0.314 37.7 mmt180 -70.37 -47.84 59.1 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -171.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -94.13 46.21 1.16 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 123.855 1.788 . . . . 0.0 114.891 169.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -103.69 -53.38 2.79 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 167.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.264 39.4 p90 -72.33 -138.82 0.01 OUTLIER 'General case' 0 CA--C 1.592 2.594 0 CA-C-O 122.149 0.976 . . . . 0.0 108.96 154.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -118.62 -82.03 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 O-C-N 119.986 -1.696 . . . . 0.0 111.509 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -141.87 166.71 23.97 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 123.895 1.807 . . . . 0.0 114.802 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.284 2.4 pp -105.58 151.01 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.32 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.3 tp -86.64 162.49 17.92 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -165.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -65.43 99.33 0.41 Allowed 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 123.893 1.806 . . . . 0.0 112.069 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.682 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 113.66 -4.34 24.57 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 120.428 2.931 . . . . 0.0 120.428 -175.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -60.55 155.45 18.58 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -83.17 87.97 6.91 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 126.08 2.848 . . . . 0.0 113.235 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.19 146.06 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 108.987 -3.733 . . . . 0.0 110.314 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.3 m -137.02 115.91 12.28 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 100.421 -3.918 . . . . 0.0 100.421 171.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.665 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.26 92.3 t -121.46 127.05 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 112.779 -2.01 . . . . 0.0 107.429 -158.128 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -80.46 125.64 30.2 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.449 0.642 . . . . 0.0 111.955 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.263 0.3 OUTLIER -111.85 -110.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.209 -171.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.15 166.32 15.4 Favored Pre-proline 0 CA--C 1.582 2.183 0 C-N-CA 123.793 0.837 . . . . 0.0 112.924 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -60.09 -46.33 19.49 Favored 'Trans proline' 0 CA--C 1.568 2.22 0 C-N-CA 123.412 2.741 . . . . 0.0 117.759 166.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -100.5 -55.55 2.57 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -93.62 70.19 4.17 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.1 mp -68.63 2.24 2.61 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -69.31 -11.17 60.58 Favored 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -142.96 159.14 42.81 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 125.824 1.65 . . . . 0.0 113.223 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.47 -158.97 19.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 117.016 1.566 . . . . 0.0 117.016 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.26 124.29 7.43 Favored 'General case' 0 CA--C 1.59 2.498 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.486 ' CD1' ' H ' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -41.29 99.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 174.187 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 CA--C 1.579 2.095 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 170.708 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 CA--C 1.577 2.004 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.84 156.97 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.457 -1.402 . . . . 0.0 111.878 -171.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.35 9.8 pt-20 -106.29 120.78 42.76 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 124.537 2.113 . . . . 0.0 110.684 165.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 21.0 ttt -169.61 78.74 0.11 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 110.601 -3.0 . . . . 0.0 109.08 -155.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.669 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.612 0.0 OUTLIER -139.24 -168.42 2.44 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 173.274 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.64 -108.51 1.0 Allowed Glycine 0 N--CA 1.478 1.497 0 N-CA-C 121.198 3.239 . . . . 0.0 121.198 -165.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 98.9 m -121.88 135.31 54.88 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.497 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 73.7 t -61.49 117.57 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.612 3.327 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.7 mt -81.14 -45.23 16.72 Favored 'General case' 0 N--CA 1.511 2.577 0 CA-C-N 123.091 2.678 . . . . 0.0 110.809 167.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 6.1 tp10 -129.53 143.03 50.66 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 122.752 1.263 . . . . 0.0 111.535 170.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.458 HG23 HG11 ' A' ' 12' ' ' VAL . 20.4 p -103.01 107.56 18.4 Favored 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 101.03 -3.693 . . . . 0.0 101.03 171.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.391 0.2 OUTLIER -75.45 -175.35 0.46 Allowed Pre-proline 0 CA--C 1.594 2.646 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -167.086 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -52.35 -51.1 11.9 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 124.091 3.194 . . . . 0.0 119.493 -173.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.39 -86.75 0.05 OUTLIER 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -163.02 75.1 0.39 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 172.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 69.1 mtm -123.28 175.9 6.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.464 -0.772 . . . . 0.0 111.551 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.705 ' CE2' HG23 ' A' ' 35' ' ' ILE . 60.0 m-85 -140.68 113.67 8.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 118.908 -2.37 . . . . 0.0 107.29 -163.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -86.59 96.34 10.06 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 169.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -100.2 136.54 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -162.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -94.07 113.14 25.05 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 171.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.256 0.5 OUTLIER -56.5 178.77 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 -175.313 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.77 -25.63 66.57 Favored 'General case' 0 CA--C 1.573 1.844 0 CA-C-N 113.564 -1.653 . . . . 0.0 114.976 167.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -93.26 8.01 42.05 Favored 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 168.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.89 8.78 85.37 Favored Glycine 0 CA--C 1.556 2.639 0 N-CA-C 120.333 2.893 . . . . 0.0 120.333 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -93.67 138.97 31.35 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 119.275 1.537 . . . . 0.0 112.789 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.9 t -85.56 130.34 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.209 -1.557 . . . . 0.0 112.805 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.3 m -126.72 167.42 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 114.359 -1.291 . . . . 0.0 113.571 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 m -109.29 123.26 48.98 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.966 -1.084 . . . . 0.0 110.152 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.26 151.95 39.17 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 119.171 3.026 . . . . 0.0 119.171 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.33 170.16 8.62 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.036 -1.04 . . . . 0.0 109.594 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.705 HG23 ' CE2' ' A' ' 21' ' ' PHE . 6.4 pt -76.76 -177.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.552 0 O-C-N 119.531 -1.981 . . . . 0.0 110.97 164.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.2 p -100.73 144.52 29.6 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 119.646 -1.909 . . . . 0.0 110.761 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.93 -23.2 6.89 Favored Glycine 0 N--CA 1.508 3.463 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -63.78 -55.78 20.52 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.246 1.818 . . . . 0.0 114.768 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.6 ptp -73.77 -36.14 65.05 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 116.148 -1.882 . . . . 0.0 115.791 172.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HG2' HD11 ' A' ' 35' ' ' ILE . 51.4 mtt85 -37.33 -41.03 0.39 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.549 2.425 . . . . 0.0 117.549 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -93.19 -1.44 56.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -94.34 -68.68 0.79 Allowed 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.61 130.8 55.29 Favored 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 125.501 1.52 . . . . 0.0 107.717 170.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.6 mt -73.54 -65.37 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.044 0 O-C-N 120.004 -1.685 . . . . 0.0 111.166 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -105.33 164.52 11.79 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 120.954 3.687 . . . . 0.0 120.954 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.275 0.5 OUTLIER -133.97 168.6 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-N 109.545 -3.479 . . . . 0.0 109.457 173.701 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.59 163.81 12.17 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.445 1.117 . . . . 0.0 113.206 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 m -72.67 89.64 1.34 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 123.351 1.548 . . . . 0.0 110.955 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.497 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 121.64 24.17 2.41 Favored Glycine 0 N--CA 1.489 2.213 0 CA-C-N 113.382 -1.736 . . . . 0.0 116.749 -174.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -92.28 156.64 17.14 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-O 122.634 1.207 . . . . 0.0 112.224 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -86.69 91.67 8.68 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 125.76 2.695 . . . . 0.0 113.685 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -93.17 151.3 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.038 0 CA-C-N 109.59 -3.459 . . . . 0.0 111.503 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -143.55 112.18 6.47 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 100.34 -3.948 . . . . 0.0 100.34 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.669 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.278 94.1 t -120.54 125.5 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 112.108 -2.314 . . . . 0.0 107.066 -156.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -78.0 120.61 23.1 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.671 0.748 . . . . 0.0 111.102 -174.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.278 0.2 OUTLIER -105.2 -122.87 0.22 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.858 -175.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.4 169.05 11.22 Favored Pre-proline 0 CA--C 1.584 2.257 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.98 -49.31 0.69 Allowed 'Trans proline' 0 CA--C 1.551 1.346 0 C-N-CA 124.766 3.644 . . . . 0.0 118.517 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -96.24 -34.14 11.74 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.048 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -103.56 81.33 1.9 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.971 -173.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.13 -19.47 34.14 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 118.815 2.894 . . . . 0.0 118.815 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.0 m -65.69 -6.37 11.23 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 160.19 41.05 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 125.746 1.618 . . . . 0.0 113.654 -177.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.81 -159.32 17.84 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -157.07 117.96 3.63 Favored 'General case' 0 CA--C 1.586 2.332 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -38.79 97.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 174.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 CA--C 1.568 1.672 0 C-N-CA 124.388 1.075 . . . . 0.0 112.455 171.209 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 . . . . . 0 CA--C 1.572 1.79 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.14 139.75 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.561 1.144 . . . . 0.0 109.663 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.308 6.6 pt-20 -97.56 116.51 29.92 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 124.89 2.281 . . . . 0.0 109.115 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 21.7 ttt -168.22 76.32 0.13 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 109.392 -3.549 . . . . 0.0 110.208 -148.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.662 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.613 0.0 OUTLIER -140.1 -166.92 2.2 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 174.691 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.16 -112.02 1.1 Allowed Glycine 0 N--CA 1.479 1.546 0 N-CA-C 120.633 3.013 . . . . 0.0 120.633 -165.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.8 m -118.26 137.53 52.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.473 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 58.8 t -64.57 105.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.608 3.176 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 mp -77.0 -45.0 28.83 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 117.966 -2.959 . . . . 0.0 113.175 170.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -122.56 148.84 44.73 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.354 1.074 . . . . 0.0 111.029 167.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 p -103.3 98.35 8.28 Favored 'General case' 0 N--CA 1.516 2.86 0 N-CA-C 101.667 -3.457 . . . . 0.0 101.667 170.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.27 5.3 mt -79.38 151.7 75.23 Favored Pre-proline 0 CA--C 1.591 2.535 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.482 -163.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.415 3.8 Cg_exo 8.61 -80.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.268 2 C-N-CA 126.686 4.924 . . . . 0.0 124.283 -170.696 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -76.04 -75.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 120.435 1.47 . . . . 0.0 110.869 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -158.34 75.96 0.75 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.258 61.9 mtt -118.37 -174.11 2.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 0.0 111.011 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.712 ' CE2' HG23 ' A' ' 35' ' ' ILE . 61.8 m-85 -148.3 108.83 4.16 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 118.919 -2.363 . . . . 0.0 105.152 -165.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -86.57 92.76 8.99 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 103.725 -2.695 . . . . 0.0 103.725 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -99.37 135.53 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -163.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.94 113.93 26.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 170.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.29 0.5 OUTLIER -58.46 -179.92 0.07 Allowed 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -176.265 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.79 -24.29 64.39 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-N 113.46 -1.7 . . . . 0.0 115.01 168.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -90.21 5.09 48.53 Favored 'General case' 0 CA--C 1.585 2.308 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.37 5.24 82.69 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 120.165 2.826 . . . . 0.0 120.165 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -94.93 142.46 27.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.616 1.708 . . . . 0.0 113.346 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.86 129.76 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-O 122.153 0.977 . . . . 0.0 112.384 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 m -139.83 152.6 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-O 122.208 1.004 . . . . 0.0 113.185 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -89.87 128.52 36.2 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.156 -1.59 . . . . 0.0 111.594 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.59 150.48 36.45 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -103.32 155.43 18.47 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.081 0.943 . . . . 0.0 110.595 170.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.712 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.1 pt -66.15 175.32 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.601 2.942 0 CA-C-O 122.913 1.339 . . . . 0.0 112.053 165.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.2 p -103.38 140.43 37.46 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 119.826 -1.796 . . . . 0.0 109.655 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.13 -16.27 6.17 Favored Glycine 0 N--CA 1.505 3.273 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -72.1 -49.64 34.62 Favored 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 126.656 1.982 . . . . 0.0 114.74 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.7 ptp -73.04 -24.16 60.68 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -38.74 -33.25 0.1 Allowed 'General case' 0 CA--C 1.587 2.381 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -91.85 -4.78 54.4 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -89.16 -72.97 0.52 Allowed 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 168.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -101.35 135.13 43.35 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 124.41 1.084 . . . . 0.0 108.759 166.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mt -71.5 -53.38 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.76 -1.212 . . . . 0.0 110.803 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -135.6 175.26 9.75 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-O 124.516 2.103 . . . . 0.0 112.792 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.403 HD11 ' CE1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -137.11 156.15 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 113.138 -1.846 . . . . 0.0 108.758 177.19 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.8 mp -95.77 166.51 11.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -73.69 87.14 1.68 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 123.48 1.609 . . . . 0.0 111.18 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 124.6 18.86 2.63 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-N 113.308 -1.769 . . . . 0.0 117.233 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -91.26 167.0 12.63 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 122.781 1.276 . . . . 0.0 111.234 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -90.08 129.67 36.35 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 124.951 2.31 . . . . 0.0 114.306 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.5 m -134.14 152.53 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.827 0 CA-C-N 110.511 -3.041 . . . . 0.0 110.693 -173.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.9 m -142.99 111.6 6.32 Favored 'General case' 0 N--CA 1.501 2.103 1 N-CA-C 100.19 -4.004 . . . . 0.0 100.19 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.662 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.276 71.7 t -125.35 123.85 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 112.261 -2.245 . . . . 0.0 107.182 -156.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -79.32 141.58 36.86 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.45 -175.81 4.93 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 122.125 0.964 . . . . 0.0 110.864 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -90.41 158.48 43.22 Favored Pre-proline 0 CA--C 1.573 1.835 0 O-C-N 120.611 -1.306 . . . . 0.0 112.999 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -54.86 -42.65 66.79 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 123.068 2.512 . . . . 0.0 118.422 164.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -90.39 -45.73 8.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -102.74 81.44 2.01 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 122.35 1.072 . . . . 0.0 113.031 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.67 43.06 0.81 Allowed 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 64.2 m -95.32 -28.6 14.89 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -132.29 -178.23 4.82 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-O 122.749 1.261 . . . . 0.0 114.049 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.49 177.25 40.2 Favored Glycine 0 CA--C 1.554 2.514 0 N-CA-C 117.145 1.618 . . . . 0.0 117.145 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.3 113.21 3.15 Favored 'General case' 0 CA--C 1.596 2.732 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 168.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.48 ' CD1' ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -45.5 104.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 CA-C-N 122.495 2.407 . . . . 0.0 113.968 173.227 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.564 1.511 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.941 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 CA--C 1.577 1.991 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 mt -92.3 143.95 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.773 -1.204 . . . . 0.0 110.84 -171.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.293 8.8 pt-20 -99.22 122.57 42.59 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 124.664 2.173 . . . . 0.0 109.512 170.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.293 6.5 ttt -152.95 -4.49 0.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 109.898 -3.319 . . . . 0.0 119.283 -151.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.848 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.537 0.5 OUTLIER -75.8 -164.03 0.32 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 121.657 3.947 . . . . 0.0 121.657 -166.607 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.42 -112.54 1.08 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 122.514 3.766 . . . . 0.0 122.514 -163.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.8 m -108.78 135.97 49.12 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.712 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 78.3 t -71.81 107.38 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.981 0 CA-C-N 120.379 1.445 . . . . 0.0 107.327 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.13 -42.56 72.45 Favored 'General case' 0 N--CA 1.516 2.843 0 CA-C-N 124.814 3.461 . . . . 0.0 112.056 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -132.6 147.83 52.35 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.151 0.977 . . . . 0.0 110.988 170.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.409 HG23 HG11 ' A' ' 12' ' ' VAL . 11.0 p -102.66 102.99 13.23 Favored 'General case' 0 N--CA 1.514 2.728 0 N-CA-C 101.94 -3.356 . . . . 0.0 101.94 170.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.347 5.4 mt -80.82 -179.03 1.3 Allowed Pre-proline 0 CA--C 1.598 2.797 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -164.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.273 21.1 Cg_endo -47.51 -45.55 22.79 Favored 'Trans proline' 0 CA--C 1.568 2.185 1 N-CA-C 123.786 4.495 . . . . 0.0 123.786 -167.963 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.58 -89.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.38 1.445 . . . . 0.0 108.31 172.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.4 m -153.03 76.22 1.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 171.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.4 mtt -120.61 176.25 5.6 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.521 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CE2' HG23 ' A' ' 35' ' ' ILE . 55.6 m-85 -146.05 108.71 4.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -164.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 tpt85 -83.51 94.63 8.08 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.9 t -100.72 139.09 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -162.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -92.36 115.24 27.92 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.27 0.6 OUTLIER -64.7 178.92 0.7 Allowed 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -177.421 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -67.66 -27.37 66.8 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 168.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -91.79 8.86 35.19 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 171.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.06 16.62 78.46 Favored Glycine 0 CA--C 1.555 2.549 0 N-CA-C 119.929 2.731 . . . . 0.0 119.929 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -98.58 131.46 44.78 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.188 1.494 . . . . 0.0 111.823 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -83.89 127.61 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 123.17 1.462 . . . . 0.0 111.435 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.73 HG21 HE21 ' A' ' 9' ' ' GLN . 18.7 m -123.38 159.77 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.882 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 m -106.73 123.24 47.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.54 -1.35 . . . . 0.0 109.432 172.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.57 157.85 44.28 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 118.881 2.919 . . . . 0.0 118.881 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -104.47 167.58 9.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 163.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.58 HG23 ' CE2' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -77.12 177.19 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.526 0 O-C-N 119.98 -1.7 . . . . 0.0 110.295 162.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.3 p -77.97 87.83 4.14 Favored 'General case' 0 CA--C 1.573 1.829 0 O-C-N 119.062 -2.274 . . . . 0.0 108.591 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -17.93 -47.61 0.01 OUTLIER Glycine 0 N--CA 1.505 3.26 1 N-CA-C 124.297 4.479 . . . . 0.0 124.297 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -45.36 -46.16 12.93 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 118.776 2.88 . . . . 0.0 118.776 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.27 0.0 OUTLIER -69.46 -23.87 63.71 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 177.113 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.454 ' HG3' HD11 ' A' ' 35' ' ' ILE . 98.7 mtt180 -37.97 -41.18 0.53 Allowed 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 122.9 2.591 . . . . 0.0 117.159 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -96.76 3.93 52.06 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 119.804 3.261 . . . . 0.0 119.804 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -110.37 -63.12 1.42 Allowed 'General case' 0 CA--C 1.571 1.764 0 C-N-CA 125.605 1.562 . . . . 0.0 107.062 172.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.88 104.08 10.22 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 169.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -67.91 112.64 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-O 124.426 2.06 . . . . 0.0 107.906 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -41.84 161.34 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.851 1 N-CA-C 123.557 4.651 . . . . 0.0 123.557 -167.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.46 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.255 1.1 pt -89.61 160.82 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.78 0 CA-C-N 109.26 -3.609 . . . . 0.0 115.409 -175.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 tp -115.14 175.54 5.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.378 -170.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -67.7 91.84 0.32 Allowed 'General case' 0 CA--C 1.575 1.917 0 CA-C-O 124.389 2.042 . . . . 0.0 114.296 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.712 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 124.04 -2.15 9.13 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -65.32 156.89 30.67 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -81.91 90.75 6.47 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 125.699 2.666 . . . . 0.0 113.962 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 m -93.07 154.67 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 CA-C-N 109.435 -3.529 . . . . 0.0 110.766 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.3 m -147.9 103.25 3.48 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 100.609 -3.848 . . . . 0.0 100.609 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.848 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 23.7 t -109.06 131.63 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 111.076 -2.784 . . . . 0.0 107.305 -162.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -83.77 130.16 34.94 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.908 -1.12 . . . . 0.0 111.991 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.275 0.5 OUTLIER -108.28 -155.81 0.56 Allowed 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 122.047 0.927 . . . . 0.0 110.962 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.4 p -138.12 161.39 59.77 Favored Pre-proline 0 CA--C 1.572 1.789 0 O-C-N 121.021 -1.049 . . . . 0.0 112.064 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.99 -42.16 59.99 Favored 'Trans proline' 0 CA--C 1.573 2.441 0 C-N-CA 123.315 2.677 . . . . 0.0 118.459 163.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -87.49 -50.42 6.55 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -102.37 80.68 1.97 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.314 1.054 . . . . 0.0 112.337 -172.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -28.51 64.89 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.9 t -76.75 13.62 0.98 Allowed 'General case' 0 CA--C 1.587 2.374 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -139.14 172.75 12.38 Favored 'General case' 0 CA--C 1.57 1.732 0 O-C-N 119.643 -1.911 . . . . 0.0 114.353 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.57 -165.84 38.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.52 122.67 5.46 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.768 ' H ' HD12 ' A' ' 66' ' ' ILE . 2.2 mp -46.62 104.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.933 0 CA-C-N 121.734 2.061 . . . . 0.0 114.475 170.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 CA--C 1.564 1.519 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.164 -179.9 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 . . . . . 0 CA--C 1.572 1.801 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -95.37 141.33 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.098 0.959 . . . . 0.0 110.222 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.303 9.1 pt-20 -96.4 122.09 38.91 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 125.068 2.366 . . . . 0.0 108.62 169.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 22.0 ttt -172.61 89.06 0.09 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 109.471 -3.513 . . . . 0.0 105.035 -149.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.711 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -117.19 -151.15 0.47 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -157.282 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 177.56 -137.65 3.52 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 117.348 1.699 . . . . 0.0 117.348 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.8 m -124.71 133.72 53.09 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 59.7 t -59.22 116.53 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.602 2.959 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.561 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.1 mt -83.9 -42.07 16.73 Favored 'General case' 0 N--CA 1.509 2.504 0 CA-C-N 122.299 2.318 . . . . 0.0 110.941 166.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 6.1 tt0 -133.97 143.97 48.49 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.829 1.299 . . . . 0.0 111.576 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.4 p -97.8 105.1 17.19 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 170.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.324 5.2 mt -78.86 179.77 1.65 Allowed Pre-proline 0 CA--C 1.596 2.718 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -164.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.266 27.8 Cg_endo -47.89 -45.91 23.24 Favored 'Trans proline' 0 CA--C 1.568 2.191 1 N-CA-C 122.552 4.02 . . . . 0.0 122.552 -169.591 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -82.84 -92.33 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.1 1.318 . . . . 0.0 107.735 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -151.61 73.28 1.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 171.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.7 mtp -119.78 176.52 5.36 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.641 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.48 ' HB3' HG22 ' A' ' 23' ' ' VAL . 56.9 m-85 -140.68 112.04 7.32 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -166.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -83.28 94.26 7.88 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 169.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.1 t -100.96 136.91 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -163.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -88.48 113.06 23.68 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.268 4.3 mt -73.39 -179.54 3.48 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 124.1 1.905 . . . . 0.0 112.554 -172.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.37 -22.18 61.18 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -90.11 6.37 42.77 Favored 'General case' 0 CA--C 1.585 2.292 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.95 15.79 76.52 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 119.828 2.691 . . . . 0.0 119.828 -176.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -102.91 139.9 37.88 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 119.248 1.524 . . . . 0.0 111.837 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -87.42 113.39 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.762 -1.211 . . . . 0.0 109.93 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.7 m -109.93 153.93 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -96.23 118.42 32.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.813 -1.179 . . . . 0.0 109.588 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.11 158.59 44.11 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.72 2.118 . . . . 0.0 116.72 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -105.68 -176.51 3.1 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.492 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -90.45 175.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.367 0 O-C-N 119.899 -1.751 . . . . 0.0 109.215 161.647 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.6 p -75.12 20.07 0.14 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 120.612 3.56 . . . . 0.0 120.612 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.79 -45.79 1.1 Allowed Glycine 0 N--CA 1.499 2.844 0 N-CA-C 118.644 2.218 . . . . 0.0 118.644 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -63.62 -54.07 41.68 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -22.8 64.79 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.9 mtp-105 -39.81 -35.81 0.38 Allowed 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -90.63 4.78 50.42 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 118.965 2.95 . . . . 0.0 118.965 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -97.15 -74.07 0.58 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 167.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -110.87 138.47 47.23 Favored 'General case' 0 CA--C 1.579 2.061 0 C-N-CA 125.334 1.453 . . . . 0.0 107.217 166.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.4 mt -73.66 -68.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 119.976 -1.702 . . . . 0.0 111.275 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -113.54 168.14 10.01 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 119.755 3.243 . . . . 0.0 119.755 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.357 1.8 pp -119.12 169.66 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 110.017 -3.265 . . . . 0.0 108.873 171.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.6 tp -100.98 163.2 12.4 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -168.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 m -69.73 92.94 0.69 Allowed 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 123.783 1.754 . . . . 0.0 111.49 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.511 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 117.01 22.92 4.07 Favored Glycine 0 N--CA 1.488 2.148 0 CA-C-N 112.678 -2.055 . . . . 0.0 117.439 -175.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -93.11 156.68 16.71 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.881 1.324 . . . . 0.0 113.33 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -88.66 83.32 6.74 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 125.231 2.444 . . . . 0.0 112.967 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.512 ' HB ' HD12 ' A' ' 66' ' ' ILE . 6.9 m -73.64 165.24 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 CA-C-N 110.436 -3.075 . . . . 0.0 114.972 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.801 ' H ' HG23 ' A' ' 66' ' ' ILE 0.274 5.1 m -120.52 77.23 1.25 Allowed 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 124.079 1.895 . . . . 0.0 112.434 173.559 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.711 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -75.47 94.05 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 O-C-N 120.219 -1.551 . . . . 0.0 110.328 -171.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -81.97 136.41 35.28 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.059 -1.026 . . . . 0.0 109.049 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.251 2.4 pt? -136.62 -165.01 1.66 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.844 -1.16 . . . . 0.0 112.351 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 p -110.29 159.5 31.82 Favored Pre-proline 0 CA--C 1.573 1.856 0 O-C-N 120.731 -1.231 . . . . 0.0 113.342 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.18 -38.91 81.76 Favored 'Trans proline' 0 CA--C 1.569 2.258 0 C-N-CA 123.39 2.727 . . . . 0.0 119.094 163.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -87.06 -52.23 5.55 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -96.86 78.87 2.88 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 122.323 1.058 . . . . 0.0 113.286 -172.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.36 -11.2 60.19 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 120.316 3.45 . . . . 0.0 120.316 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.0 m -73.69 -2.96 25.41 Favored 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 173.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.58 178.85 6.18 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.451 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . -178.31 -172.4 42.67 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 116.942 1.537 . . . . 0.0 116.942 175.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.3 105.9 1.0 Allowed 'General case' 0 CA--C 1.583 2.234 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.819 HD13 ' H ' ' A' ' 66' ' ' ILE 0.26 0.0 OUTLIER -28.08 87.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.063 0 N-CA-C 119.276 3.065 . . . . 0.0 119.276 167.261 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 CA--C 1.569 1.701 0 C-N-CA 124.483 1.113 . . . . 0.0 112.88 177.557 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 CA--C 1.577 2.0 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mt -109.35 141.55 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.885 -1.134 . . . . 0.0 110.356 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.339 12.7 pt-20 -100.78 118.7 37.38 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 124.014 1.864 . . . . 0.0 110.664 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.285 21.2 ttt -159.26 38.5 0.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.603 -2.544 . . . . 0.0 117.312 -148.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.783 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.531 0.0 OUTLIER -123.11 -175.91 3.29 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 120.01 3.337 . . . . 0.0 120.01 -173.201 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.9 -110.97 1.09 Allowed Glycine 0 N--CA 1.481 1.7 1 N-CA-C 123.653 4.221 . . . . 0.0 123.653 -163.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.1 m -102.89 131.01 50.11 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.476 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 83.8 t -63.46 107.19 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.601 2.913 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.318 98.4 mt -86.33 -36.02 19.51 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 118.813 -2.429 . . . . 0.0 111.98 173.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -128.21 147.05 50.56 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 123.149 1.452 . . . . 0.0 110.563 164.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.3 p -108.89 105.08 14.48 Favored 'General case' 0 N--CA 1.511 2.615 1 N-CA-C 99.889 -4.115 . . . . 0.0 99.889 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.356 0.4 OUTLIER -74.06 -178.78 0.82 Allowed Pre-proline 0 CA--C 1.592 2.584 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -165.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -55.24 -40.91 83.21 Favored 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 123.886 3.057 . . . . 0.0 120.036 -174.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -83.13 -92.95 0.07 Allowed 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.4 m -157.58 73.87 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.7 mtt -124.14 166.63 15.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.964 0.887 . . . . 0.0 112.658 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 46' ' ' ILE . 57.5 m-85 -127.84 110.88 13.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -165.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -84.22 92.02 7.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 171.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.495 HG21 HG21 ' A' ' 54' ' ' VAL . 1.4 t -99.72 134.03 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -164.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -83.26 115.11 21.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.567 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.264 0.1 OUTLIER -69.54 177.05 3.1 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 178.881 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.6 -14.24 40.66 Favored 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 167.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.567 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 23.7 t30 -92.12 -3.82 55.15 Favored 'General case' 0 CA--C 1.586 2.362 0 O-C-N 121.352 -0.843 . . . . 0.0 112.845 167.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.46 -5.38 81.28 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 119.182 2.433 . . . . 0.0 119.182 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -86.93 142.17 28.19 Favored 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 124.071 0.948 . . . . 0.0 110.388 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.8 131.4 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 CA-C-O 122.476 1.131 . . . . 0.0 112.831 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 m -130.97 150.25 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.5 m -92.62 124.88 36.96 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.263 -1.523 . . . . 0.0 110.801 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.77 170.16 16.4 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -120.23 136.04 54.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.736 -1.227 . . . . 0.0 112.518 174.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.559 HD13 ' HG3' ' A' ' 40' ' ' ARG 0.349 0.0 OUTLIER -79.56 146.92 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.068 0 O-C-N 120.541 -1.349 . . . . 0.0 109.304 176.211 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.97 92.25 1.63 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 119.434 -2.041 . . . . 0.0 113.88 -170.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -42.69 -30.34 0.91 Allowed Glycine 0 N--CA 1.491 2.327 1 N-CA-C 123.944 4.338 . . . . 0.0 123.944 -173.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -54.32 -49.46 69.64 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.94 -45.2 11.03 Favored 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 125.903 1.681 . . . . 0.0 114.717 170.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.559 ' HG3' HD13 ' A' ' 35' ' ' ILE 0.28 3.9 mmp_? -82.42 -40.58 21.03 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.203 1.801 . . . . 0.0 115.185 -166.035 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -92.91 40.03 1.05 Allowed 'General case' 0 CA--C 1.586 2.358 0 CA-C-O 122.52 1.152 . . . . 0.0 113.284 164.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -96.55 -43.93 7.38 Favored 'General case' 0 CA--C 1.576 1.945 0 C-N-CA 124.949 1.299 . . . . 0.0 108.45 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.278 35.2 p90 -68.54 -113.34 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 126.04 1.736 . . . . 0.0 109.81 162.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.45 -91.26 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.71 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -147.85 172.41 14.19 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 124.035 1.874 . . . . 0.0 109.957 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.508 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.252 1.1 pp -89.79 152.67 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.984 170.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -86.93 160.32 18.73 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 -166.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 m -73.57 83.81 1.54 Allowed 'General case' 0 CA--C 1.571 1.751 0 CA-C-O 123.854 1.787 . . . . 0.0 111.001 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.476 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 129.47 22.2 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 CA-C-N 112.982 -1.917 . . . . 0.0 116.813 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -91.61 160.14 15.54 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 123.331 1.538 . . . . 0.0 112.332 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -87.71 94.35 9.71 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 125.719 2.676 . . . . 0.0 113.518 -175.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.41 HG23 HG11 ' A' ' 23' ' ' VAL . 21.7 m -99.8 145.78 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-N 109.757 -3.383 . . . . 0.0 110.122 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.7 m -137.07 112.02 8.93 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.783 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.251 24.2 t -116.32 130.64 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.531 -159.38 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -88.4 136.46 32.97 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.006 0.907 . . . . 0.0 112.397 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.25 -169.98 2.24 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.64 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 58' ' ' PRO . 0.5 OUTLIER -153.83 166.0 16.66 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 120.321 -1.487 . . . . 0.0 111.395 175.101 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -35.1 -48.87 0.77 Allowed 'Trans proline' 0 CA--C 1.561 1.828 1 N-CA-C 122.778 4.107 . . . . 0.0 122.778 173.348 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.5 -29.76 52.67 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.825 1.298 . . . . 0.0 113.992 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -96.65 69.91 2.54 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 114.106 -1.406 . . . . 0.0 113.474 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.5 mt -87.09 -41.3 13.92 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -76.88 5.56 7.67 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -143.09 173.77 11.27 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 120.991 1.723 . . . . 0.0 114.953 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.95 -165.53 34.0 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -155.86 122.64 5.28 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.539 -1.565 . . . . 0.0 113.554 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.725 HD12 ' H ' ' A' ' 66' ' ' ILE . 1.8 mp -45.81 113.15 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 172.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.572 1.796 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.21 173.267 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 CA--C 1.573 1.839 0 CA-C-O 121.338 0.59 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -97.48 143.96 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.287 1.035 . . . . 0.0 111.29 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.325 11.1 pt-20 -92.86 120.45 33.22 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 125.525 2.583 . . . . 0.0 108.305 168.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.282 16.1 ttt -167.16 81.29 0.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 108.873 -3.785 . . . . 0.0 105.308 -150.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.557 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -97.33 -152.55 0.39 Allowed 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -158.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -164.38 -173.42 33.01 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 120.411 2.924 . . . . 0.0 120.411 -172.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.8 m -98.49 127.96 44.64 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 57.4 t -60.55 117.09 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.912 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 175.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.285 68.2 mt -101.34 -16.88 16.77 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 119.786 -1.822 . . . . 0.0 113.467 170.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -146.8 141.52 26.77 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.956 1.36 . . . . 0.0 109.621 160.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.3 p -94.56 100.62 12.56 Favored 'General case' 0 N--CA 1.516 2.825 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 169.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.282 6.0 mt -79.78 154.26 75.7 Favored Pre-proline 0 CA--C 1.594 2.644 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.873 -166.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.399 2.3 Cg_endo 2.11 -78.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.57 2.324 2 C-N-CA 126.777 4.985 . . . . 0.0 124.997 -171.618 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.29 -77.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 120.64 1.564 . . . . 0.0 110.877 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -156.38 76.03 0.88 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtt -119.69 -177.3 3.36 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.517 0.727 . . . . 0.0 111.708 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.493 ' CE1' HD11 ' A' ' 46' ' ' ILE . 57.1 m-85 -146.74 108.32 4.31 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 119.669 -1.894 . . . . 0.0 106.735 -166.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -86.9 94.52 9.61 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.3 t -102.86 135.73 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -163.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.55 111.75 21.55 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.532 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.286 0.1 OUTLIER -78.6 171.46 15.09 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 124.116 1.912 . . . . 0.0 115.782 -176.704 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.34 -13.96 44.81 Favored 'General case' 0 CA--C 1.578 2.056 0 CA-C-N 112.454 -2.157 . . . . 0.0 114.652 167.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.532 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 46.0 t30 -83.64 -11.21 57.56 Favored 'General case' 0 CA--C 1.587 2.371 0 CA-C-N 119.334 0.97 . . . . 0.0 113.337 164.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.84 -22.18 40.76 Favored Glycine 0 CA--C 1.549 2.216 0 N-CA-C 118.351 2.1 . . . . 0.0 118.351 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -79.71 143.38 34.61 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.122 0.969 . . . . 0.0 112.168 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.7 t -83.75 121.33 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 122.447 1.118 . . . . 0.0 109.507 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.54 144.36 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.801 -175.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.7 m -86.79 126.33 34.54 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.489 -1.382 . . . . 0.0 110.574 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.93 159.37 42.29 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -119.5 164.86 15.17 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 168.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -78.47 171.8 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.594 2.65 0 O-C-N 120.562 -1.336 . . . . 0.0 110.906 168.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.1 p -76.19 14.11 0.79 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 120.353 3.464 . . . . 0.0 120.353 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.83 -47.86 0.78 Allowed Glycine 0 N--CA 1.5 2.953 0 N-CA-C 117.819 1.888 . . . . 0.0 117.819 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -63.21 -51.13 67.54 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 126.54 1.936 . . . . 0.0 115.289 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ptm -70.16 -17.94 63.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 118.607 2.817 . . . . 0.0 118.607 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -39.14 -34.05 0.16 Allowed 'General case' 0 CA--C 1.583 2.244 0 CA-C-N 121.772 2.078 . . . . 0.0 116.443 167.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm -93.56 40.52 1.07 Allowed 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 173.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -157.56 -68.81 0.1 Allowed 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -93.38 101.18 13.4 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 165.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.27 20.9 mt -72.66 -77.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.768 -1.207 . . . . 0.0 111.444 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -136.61 171.09 15.0 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-O 125.988 2.804 . . . . 0.0 114.013 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.493 HD11 ' CE1' ' A' ' 21' ' ' PHE . 1.8 pt -147.08 167.18 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 109.959 -3.291 . . . . 0.0 109.581 -172.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.279 1.3 pt? -122.73 -174.71 2.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 111.262 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.255 94.2 m -75.25 87.12 2.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 123.376 1.56 . . . . 0.0 113.399 -175.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.43 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 133.77 22.7 0.74 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.62 170.33 9.28 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 125.389 1.475 . . . . 0.0 114.77 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -81.6 118.55 22.87 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 125.342 2.496 . . . . 0.0 112.402 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.08 149.1 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 109.761 -3.381 . . . . 0.0 111.265 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.557 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.311 89.3 m -94.42 162.39 13.84 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 162.548 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.455 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -158.07 87.03 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 O-C-N 118.452 -2.655 . . . . 0.0 105.104 -179.234 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -76.86 140.62 40.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.09 -1.006 . . . . 0.0 110.059 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.96 -167.53 2.8 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 121.7 0.762 . . . . 0.0 112.582 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -99.52 160.46 27.39 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -56.8 -42.53 63.74 Favored 'Trans proline' 0 CA--C 1.57 2.312 0 N-CA-C 118.756 2.56 . . . . 0.0 118.756 164.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -92.24 -45.02 8.44 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -174.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -102.0 81.9 2.17 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.068 0.937 . . . . 0.0 112.685 -173.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.05 41.04 0.73 Allowed 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.7 m -101.47 -20.98 14.89 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -137.52 178.77 6.85 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 124.761 1.225 . . . . 0.0 113.593 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.0 -171.08 43.11 Favored Glycine 0 CA--C 1.551 2.314 0 O-C-N 121.468 -0.77 . . . . 0.0 114.687 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.96 121.53 2.81 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.584 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -40.0 92.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 119.346 -2.096 . . . . 0.0 116.216 166.471 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.272 0.2 OUTLIER . . . . . 0 CA--C 1.568 1.652 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.931 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 . . . . . 0 CA--C 1.576 1.953 0 CA-C-O 120.732 0.301 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.02 140.31 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.492 -1.38 . . . . 0.0 110.249 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.382 11.3 pt-20 -99.23 120.48 39.61 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 124.466 2.079 . . . . 0.0 110.778 169.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 20.2 ttt -170.69 76.94 0.07 Allowed 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 110.565 -3.016 . . . . 0.0 110.764 -149.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.587 ' HB2' ' HB ' ' A' ' 54' ' ' VAL 0.608 0.0 OUTLIER -143.13 -166.13 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 119.231 3.049 . . . . 0.0 119.231 175.548 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 -111.16 1.19 Allowed Glycine 0 CA--C 1.542 1.764 0 N-CA-C 121.871 3.508 . . . . 0.0 121.871 -164.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -122.35 139.43 53.84 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.502 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 60.6 t -67.25 101.21 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.605 3.058 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.96 -44.2 61.41 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 117.947 -2.971 . . . . 0.0 113.39 171.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.25 148.89 47.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.305 1.05 . . . . 0.0 110.857 167.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 p -102.16 101.62 11.96 Favored 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 168.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.274 5.5 mt -79.86 150.55 72.43 Favored Pre-proline 0 CA--C 1.59 2.484 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.031 -164.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.413 3.0 Cg_exo 8.62 -77.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.351 2 C-N-CA 126.624 4.883 . . . . 0.0 124.378 -170.126 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -79.31 -81.67 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.017 1.281 . . . . 0.0 110.461 174.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.4 m -149.23 74.79 1.26 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.274 61.3 mtt -118.79 -175.83 2.98 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.221 -0.925 . . . . 0.0 111.521 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.601 ' HE2' HG22 ' A' ' 35' ' ' ILE . 58.1 m-85 -147.35 107.87 4.11 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 -166.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -86.35 96.21 9.92 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.7 t -103.81 133.04 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -162.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.38 110.19 21.49 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.301 0.5 OUTLIER -56.25 179.22 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 -175.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.44 -25.47 66.76 Favored 'General case' 0 CA--C 1.58 2.11 0 CA-C-N 113.55 -1.659 . . . . 0.0 114.375 165.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.25 1.5 m-20 -78.87 -12.46 60.03 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 169.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.41 5.98 74.75 Favored Glycine 0 CA--C 1.562 2.984 0 N-CA-C 117.432 1.733 . . . . 0.0 117.432 -169.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -90.94 132.36 36.0 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.391 1.596 . . . . 0.0 112.701 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.14 125.38 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.73 -1.231 . . . . 0.0 111.698 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.42 154.5 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 122.287 1.041 . . . . 0.0 113.126 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 m -88.36 127.19 35.49 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.178 -1.576 . . . . 0.0 111.095 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.2 168.88 18.69 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -138.87 141.21 38.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.675 0.79 . . . . 0.0 111.802 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.601 HG22 ' HE2' ' A' ' 21' ' ' PHE 0.3 0.0 OUTLIER -73.13 137.84 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 O-C-N 120.202 -1.561 . . . . 0.0 110.372 173.259 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.33 128.34 35.2 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 120.786 -1.196 . . . . 0.0 112.566 -171.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.39 -27.67 4.22 Favored Glycine 0 N--CA 1.508 3.491 0 N-CA-C 119.276 2.471 . . . . 0.0 119.276 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -58.22 -51.36 70.09 Favored 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 125.898 1.679 . . . . 0.0 114.243 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.4 ptm -78.53 -32.68 48.11 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -39.35 -38.0 0.5 Allowed 'General case' 0 CA--C 1.578 2.042 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -93.42 29.99 1.83 Allowed 'General case' 0 CA--C 1.583 2.223 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -144.01 -66.34 0.35 Allowed 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -75.86 96.84 3.79 Favored 'General case' 0 CA--C 1.571 1.764 0 C-N-CA 125.652 1.581 . . . . 0.0 109.571 167.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.62 111.44 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-O 124.026 1.869 . . . . 0.0 106.552 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -40.51 168.97 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.095 1 N-CA-C 124.101 4.852 . . . . 0.0 124.101 -166.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -106.67 165.24 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 109.32 -3.582 . . . . 0.0 116.749 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.1 tp -121.44 179.14 4.53 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 122.319 1.057 . . . . 0.0 112.204 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -69.47 97.07 0.96 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 123.415 1.578 . . . . 0.0 113.28 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.502 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 115.74 20.82 5.23 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 117.884 1.914 . . . . 0.0 117.884 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -91.78 160.72 15.19 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 123.119 1.437 . . . . 0.0 111.899 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -88.05 116.78 26.48 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 124.932 2.301 . . . . 0.0 112.561 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.52 152.22 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.92 0 CA-C-N 110.437 -3.074 . . . . 0.0 111.822 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.5 m -142.86 113.92 7.69 Favored 'General case' 0 N--CA 1.502 2.13 1 N-CA-C 100.052 -4.055 . . . . 0.0 100.052 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 9' ' ' GLN . 74.5 t -128.41 124.89 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 112.459 -2.155 . . . . 0.0 107.1 -155.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -78.58 135.33 37.25 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -133.88 -178.02 4.83 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.051 1.34 . . . . 0.0 108.518 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -94.72 164.12 20.57 Favored Pre-proline 0 CA--C 1.575 1.933 0 O-C-N 119.964 -1.71 . . . . 0.0 114.209 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -61.16 -38.2 68.73 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 C-N-CA 123.982 3.122 . . . . 0.0 116.709 166.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -89.91 -54.63 3.96 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.056 -1.883 . . . . 0.0 115.589 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -102.86 80.37 1.88 Allowed 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 122.423 1.106 . . . . 0.0 113.033 -171.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.5 mp -78.66 1.62 22.22 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 120.363 3.468 . . . . 0.0 120.363 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.3 t -70.37 -9.49 56.4 Favored 'General case' 0 CA--C 1.579 2.06 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -130.98 -177.12 4.24 Favored 'General case' 0 CA--C 1.576 1.95 0 CA-C-N 120.182 1.356 . . . . 0.0 113.069 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.5 174.55 40.54 Favored Glycine 0 CA--C 1.555 2.579 0 N-CA-C 117.919 1.928 . . . . 0.0 117.919 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -154.28 111.82 3.45 Favored 'General case' 0 CA--C 1.597 2.763 0 O-C-N 120.639 -1.507 . . . . 0.0 112.845 169.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.586 HD11 ' CG ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -47.52 103.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 O-C-N 118.554 -2.591 . . . . 0.0 115.204 172.435 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 CA--C 1.568 1.65 0 N-CA-C 120.01 3.337 . . . . 0.0 120.01 -175.539 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 . . . . . 0 CA--C 1.573 1.863 0 CA-C-O 121.349 0.595 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mt -87.04 141.63 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.436 -1.415 . . . . 0.0 111.521 -170.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.333 12.9 pt-20 -97.45 122.98 41.13 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 123.676 1.703 . . . . 0.0 110.092 169.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.29 13.1 ttt -155.49 10.02 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 -150.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.783 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.532 0.2 OUTLIER -98.55 -161.64 0.89 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 120.79 3.626 . . . . 0.0 120.79 -166.679 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.42 -106.06 0.52 Allowed Glycine 0 N--CA 1.487 2.067 1 N-CA-C 123.86 4.304 . . . . 0.0 123.86 -163.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m -106.52 131.32 53.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.561 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 65.6 t -66.54 105.43 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.608 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 172.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.308 82.6 mt -85.91 -29.18 23.83 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.555 -1.966 . . . . 0.0 112.254 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.4 tp10 -139.14 149.32 44.34 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.194 -0.941 . . . . 0.0 110.64 164.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' MET . 4.2 p -96.01 116.67 29.3 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 101.536 -3.505 . . . . 0.0 101.536 167.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' HB3' ' CD ' ' A' ' 17' ' ' PRO 0.394 6.5 mt -76.83 -108.22 0.0 OUTLIER Pre-proline 0 CA--C 1.598 2.818 0 CA-C-O 113.683 -3.056 . . . . 0.0 112.311 -158.295 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.47 ' CD ' ' HB3' ' A' ' 16' ' ' LEU . 92.9 Cg_endo -82.3 -69.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.574 2.494 1 CA-C-N 130.138 4.657 . . . . 0.0 115.038 177.207 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -83.45 -71.96 0.48 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 120.369 1.44 . . . . 0.0 111.945 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -151.24 71.56 1.01 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.374 74.4 mtp -114.23 -166.27 1.09 Allowed 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.073 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.556 ' HB3' HG22 ' A' ' 23' ' ' VAL . 52.6 m-85 -156.66 109.46 2.57 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 124.864 3.483 . . . . 0.0 109.859 -163.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -88.85 96.97 10.91 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.58 HG21 HG21 ' A' ' 54' ' ' VAL . 1.8 t -104.77 136.35 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -163.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -92.09 112.58 24.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 170.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.542 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.251 0.1 OUTLIER -69.13 176.32 3.3 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 179.425 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -15.11 53.5 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 167.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.542 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 39.8 t30 -89.98 -6.46 55.62 Favored 'General case' 0 CA--C 1.585 2.292 0 CA-C-N 118.895 0.771 . . . . 0.0 112.628 168.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.71 -13.7 61.95 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 118.598 2.199 . . . . 0.0 118.598 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -78.25 135.3 37.54 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.278 1.031 . . . . 0.0 110.945 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.3 t -85.69 129.57 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 CA-C-O 123.017 1.389 . . . . 0.0 111.629 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.24 156.3 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 114.113 -1.403 . . . . 0.0 112.804 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -98.29 124.57 42.98 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.581 -1.325 . . . . 0.0 110.152 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.02 161.16 39.48 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 118.316 2.709 . . . . 0.0 118.316 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.57 -179.87 4.04 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 164.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.73 169.66 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.557 0 O-C-N 119.588 -1.945 . . . . 0.0 107.82 157.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.3 p -73.24 17.05 0.14 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 117.671 -3.143 . . . . 0.0 119.362 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.15 -51.2 0.76 Allowed Glycine 0 N--CA 1.499 2.886 0 N-CA-C 118.01 1.964 . . . . 0.0 118.01 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.53 -46.26 89.19 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 126.39 1.876 . . . . 0.0 115.451 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.402 ' SD ' ' O ' ' A' ' 67' ' ' VAL . 1.0 OUTLIER -73.41 -17.02 61.31 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 175.352 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -38.67 -38.45 0.41 Allowed 'General case' 0 CA--C 1.582 2.178 0 CA-C-N 122.838 2.563 . . . . 0.0 116.895 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -94.17 33.96 1.31 Allowed 'General case' 0 CA--C 1.585 2.314 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -148.12 -64.52 0.25 Allowed 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -78.66 93.47 4.89 Favored 'General case' 0 CA--C 1.571 1.766 0 C-N-CA 125.346 1.458 . . . . 0.0 108.623 166.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.5 mt -69.54 107.02 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.535 0 CA-C-O 124.554 2.121 . . . . 0.0 105.939 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.16 174.97 0.01 OUTLIER 'General case' 0 CA--C 1.577 1.986 1 N-CA-C 121.891 4.034 . . . . 0.0 121.891 -161.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 pt -119.36 167.73 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 111.082 -2.781 . . . . 0.0 115.194 -164.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.2 tp -125.93 -177.58 3.99 Favored 'General case' 0 CA--C 1.573 1.847 0 CA-C-O 122.038 0.923 . . . . 0.0 112.662 -171.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 m -68.34 95.55 0.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.475 1.607 . . . . 0.0 113.712 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.561 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 119.08 19.39 4.35 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 118.281 2.073 . . . . 0.0 118.281 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.33 163.31 13.65 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 122.953 1.359 . . . . 0.0 112.919 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -86.54 117.55 25.39 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 124.772 2.225 . . . . 0.0 112.949 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -121.85 157.6 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.692 0 CA-C-N 110.654 -2.975 . . . . 0.0 111.484 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.4 m -150.4 106.83 3.49 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 100.506 -3.887 . . . . 0.0 100.506 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.783 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 27.3 t -112.21 130.73 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 111.413 -2.63 . . . . 0.0 107.945 -161.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -83.67 136.98 34.0 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 121.163 -0.961 . . . . 0.0 111.876 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.285 2.2 pt? -123.97 -168.59 1.81 Allowed 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 121.252 0.549 . . . . 0.0 110.705 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.0 p -118.48 160.57 39.33 Favored Pre-proline 0 CA--C 1.572 1.807 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.73 -41.15 63.46 Favored 'Trans proline' 0 CA--C 1.569 2.235 0 C-N-CA 123.626 2.884 . . . . 0.0 118.773 164.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -88.85 -54.45 4.13 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -99.66 79.49 2.26 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 122.421 1.105 . . . . 0.0 112.716 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mp -70.19 -22.49 62.94 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -72.31 4.4 3.74 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -124.22 -174.55 3.03 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.462 1.483 . . . . 0.0 114.538 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.02 168.05 39.7 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 120.068 2.787 . . . . 0.0 120.068 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -153.39 110.2 3.42 Favored 'General case' 0 CA--C 1.594 2.669 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 167.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.716 ' H ' HD12 ' A' ' 66' ' ' ILE . 3.2 mp -44.05 104.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 O-C-N 117.437 -3.289 . . . . 0.0 115.86 168.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.402 ' O ' ' SD ' ' A' ' 39' ' ' MET . 14.2 m . . . . . 0 CA--C 1.578 2.033 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.927 171.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 CA--C 1.577 1.994 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.55 151.84 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.372 1.069 . . . . 0.0 109.631 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.279 8.1 pt-20 -108.51 124.74 50.92 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 123.831 1.777 . . . . 0.0 109.833 168.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.3 10.2 ttt -153.17 3.66 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 -151.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.753 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.533 0.0 OUTLIER -86.04 -166.31 1.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 121.287 3.81 . . . . 0.0 121.287 -166.905 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.19 -112.4 0.99 Allowed Glycine 0 N--CA 1.48 1.613 0 N-CA-C 121.45 3.34 . . . . 0.0 121.45 -164.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -102.29 130.23 48.93 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.441 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 99.6 t -63.9 111.51 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.881 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 171.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.324 58.6 mt -92.85 -34.04 13.99 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 122.585 2.448 . . . . 0.0 112.21 172.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.03 148.38 50.54 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-O 122.776 1.274 . . . . 0.0 109.922 163.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.9 p -105.52 106.23 16.63 Favored 'General case' 0 N--CA 1.513 2.675 0 N-CA-C 100.75 -3.796 . . . . 0.0 100.75 171.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.507 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.441 4.4 mt -82.8 -138.4 0.0 OUTLIER Pre-proline 0 CA--C 1.604 3.056 0 CA-C-O 115.033 -2.413 . . . . 0.0 113.779 -160.707 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 62.8 Cg_endo -73.66 -73.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 1 CA-C-N 129.599 4.464 . . . . 0.0 117.766 -172.937 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -63.66 -67.35 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.979 -1.076 . . . . 0.0 111.965 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -169.7 79.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.5 mtt -119.93 177.37 5.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.607 0.763 . . . . 0.0 112.589 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HB3' HG22 ' A' ' 23' ' ' VAL . 57.2 m-85 -145.6 109.68 4.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -165.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -85.3 94.92 9.05 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 168.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -100.23 133.16 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -164.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -93.31 113.19 25.31 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 26' ' ' GLU 0.358 0.2 OUTLIER -53.93 -179.13 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 120.662 3.579 . . . . 0.0 120.662 -176.238 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.557 ' H ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -70.34 -28.72 65.37 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 112.212 -2.267 . . . . 0.0 114.347 167.312 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -90.91 4.54 51.61 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 168.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.18 8.22 78.79 Favored Glycine 0 CA--C 1.549 2.199 0 N-CA-C 119.432 2.533 . . . . 0.0 119.432 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -91.54 140.29 29.88 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.197 2.498 . . . . 0.0 113.081 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.61 123.85 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 O-C-N 120.799 -1.188 . . . . 0.0 112.029 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 m -131.33 152.14 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.0 m -91.46 130.25 37.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.548 -1.345 . . . . 0.0 110.712 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.14 155.49 43.33 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -104.32 177.49 4.83 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 123.349 1.547 . . . . 0.0 108.573 165.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.527 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -87.42 161.17 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.52 0 O-C-N 120.313 -1.492 . . . . 0.0 108.771 166.273 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 90.8 p -78.18 24.87 0.24 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 119.864 3.283 . . . . 0.0 119.864 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.52 -45.7 1.03 Allowed Glycine 0 N--CA 1.501 3.032 0 N-CA-C 116.645 1.418 . . . . 0.0 116.645 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -58.9 -48.56 81.0 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 127.061 2.144 . . . . 0.0 116.568 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.513 ' SD ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.85 -21.88 61.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 118.487 2.773 . . . . 0.0 118.487 177.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -41.97 -34.02 0.64 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 171.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -84.55 -11.17 56.57 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 118.795 2.887 . . . . 0.0 118.795 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -89.75 -72.63 0.55 Allowed 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -101.96 132.03 48.02 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.55 1.14 . . . . 0.0 109.38 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.7 mt -70.64 -51.06 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 O-C-N 120.285 -1.509 . . . . 0.0 110.235 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -130.52 174.63 9.71 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 124.634 2.159 . . . . 0.0 113.053 171.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.418 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.286 0.7 OUTLIER -135.05 161.11 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-N 112.685 -2.052 . . . . 0.0 108.773 175.363 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.48 159.74 18.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.717 -1.24 . . . . 0.0 113.923 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.1 m -75.08 79.12 2.24 Favored 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 123.884 1.802 . . . . 0.0 110.59 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 136.6 22.3 0.55 Allowed Glycine 0 N--CA 1.491 2.349 0 CA-C-N 113.182 -1.827 . . . . 0.0 116.802 -176.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -92.16 159.49 15.63 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 122.869 1.319 . . . . 0.0 112.81 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -90.57 85.5 6.13 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 125.598 2.618 . . . . 0.0 114.032 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.97 158.09 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.021 0 CA-C-N 109.818 -3.356 . . . . 0.0 111.771 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -146.89 112.7 5.71 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 101.387 -3.561 . . . . 0.0 101.387 174.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.753 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 40.3 t -117.77 131.19 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 111.988 -2.369 . . . . 0.0 107.354 -160.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -83.91 128.59 34.65 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.027 0.917 . . . . 0.0 111.593 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.76 -129.96 0.23 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -146.43 167.38 14.04 Favored Pre-proline 0 CA--C 1.569 1.709 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.16 -43.23 19.57 Favored 'Trans proline' 0 CA--C 1.576 2.624 0 C-N-CA 123.09 2.527 . . . . 0.0 115.518 164.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -80.4 -48.24 13.2 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 111.864 -2.426 . . . . 0.0 116.449 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -115.22 88.66 2.92 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 122.507 1.146 . . . . 0.0 112.425 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.32 12.61 5.15 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 118.909 2.929 . . . . 0.0 118.909 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.2 p -75.47 -30.5 59.94 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -140.27 167.82 21.24 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 124.305 1.042 . . . . 0.0 113.103 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.44 -166.61 32.03 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 117.272 1.669 . . . . 0.0 117.272 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -154.94 122.51 5.69 Favored 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.75 ' H ' HD12 ' A' ' 66' ' ' ILE . 1.5 mp -45.11 106.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 CA-C-N 121.753 2.07 . . . . 0.0 114.657 170.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.572 1.806 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.517 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 N--CA 1.501 2.097 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -95.39 148.81 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.112 -0.992 . . . . 0.0 111.001 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.314 6.6 pt-20 -98.09 120.26 38.18 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 125.573 2.606 . . . . 0.0 108.31 166.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 18.5 ttt -168.91 87.1 0.17 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 108.795 -3.82 . . . . 0.0 105.053 -150.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.702 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -110.35 -148.99 0.44 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 111.078 -2.783 . . . . 0.0 115.652 -156.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 179.79 -141.89 4.91 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 116.94 1.536 . . . . 0.0 116.94 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.2 m -122.17 134.34 54.73 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.481 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 42.4 t -59.07 114.74 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.871 0 O-C-N 121.689 -0.632 . . . . 0.0 110.187 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.1 mt -82.24 -32.8 29.53 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 119.641 -1.912 . . . . 0.0 111.956 166.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -146.56 141.74 27.29 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.024 1.392 . . . . 0.0 111.025 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.1 p -92.88 110.18 21.63 Favored 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 102.464 -3.161 . . . . 0.0 102.464 169.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.434 3.8 mt -81.83 -133.35 0.0 OUTLIER Pre-proline 0 CA--C 1.602 2.958 0 CA-C-O 114.609 -2.615 . . . . 0.0 114.191 -160.647 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 69.9 Cg_endo -73.43 -69.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.379 2.163 1 CA-C-N 129.994 4.605 . . . . 0.0 117.086 -174.653 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -73.01 -76.06 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.126 -0.984 . . . . 0.0 110.318 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -157.73 77.06 0.82 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.2 mtt -121.23 179.13 4.51 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.83 0.852 . . . . 0.0 112.242 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.529 ' CE1' HD11 ' A' ' 46' ' ' ILE . 55.8 m-85 -145.21 109.74 4.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.66 -1.9 . . . . 0.0 106.812 -166.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -84.57 101.92 12.48 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 167.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.4 t -109.77 141.11 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -163.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -93.36 108.04 19.77 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 171.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.57 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.261 0.1 OUTLIER -77.11 169.27 18.63 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 124.058 1.885 . . . . 0.0 115.047 -176.234 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.271 20.8 pt-20 -68.03 -8.9 41.54 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 112.555 -2.111 . . . . 0.0 114.703 169.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.57 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 15.3 t30 -91.14 -6.45 53.56 Favored 'General case' 0 CA--C 1.588 2.432 0 CA-C-N 119.124 0.874 . . . . 0.0 112.647 164.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.47 -20.9 45.78 Favored Glycine 0 CA--C 1.549 2.182 0 N-CA-C 118.961 2.345 . . . . 0.0 118.961 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -78.09 137.76 38.39 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.735 0.814 . . . . 0.0 111.486 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.45 112.99 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 122.879 1.323 . . . . 0.0 109.304 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 m -102.64 148.91 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 113.932 -1.486 . . . . 0.0 113.661 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.5 m -93.22 120.93 34.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.007 -1.058 . . . . 0.0 108.28 171.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.36 161.41 36.37 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -113.04 -160.6 0.72 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.436 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -115.1 173.79 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.07 0 O-C-N 120.584 -1.323 . . . . 0.0 108.524 166.673 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.1 p -78.54 100.69 7.03 Favored 'General case' 0 CA--C 1.561 1.382 0 O-C-N 119.254 -2.154 . . . . 0.0 108.39 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -31.69 -30.8 0.01 OUTLIER Glycine 0 N--CA 1.506 3.329 1 N-CA-C 123.852 4.301 . . . . 0.0 123.852 -175.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -62.46 -46.67 87.45 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 174.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 ptm -73.25 -17.82 61.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -39.75 -30.51 0.08 Allowed 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 118.348 2.721 . . . . 0.0 118.348 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -90.55 -5.93 55.34 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -103.9 -66.91 0.92 Allowed 'General case' 0 CA--C 1.578 2.026 0 C-N-CA 126.155 1.782 . . . . 0.0 106.617 169.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -81.6 98.24 8.25 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 125.509 1.524 . . . . 0.0 107.838 168.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.9 mt -73.3 -71.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.411 -0.805 . . . . 0.0 110.908 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -140.03 171.69 13.82 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 125.853 2.74 . . . . 0.0 115.491 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 21' ' ' PHE . 1.3 pt -142.86 167.86 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 110.56 -3.018 . . . . 0.0 108.483 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.54 177.35 4.71 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.838 1.304 . . . . 0.0 112.822 -173.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.8 m -76.0 83.65 2.88 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 123.36 1.552 . . . . 0.0 110.998 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.481 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 134.04 23.31 0.69 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 117.524 1.77 . . . . 0.0 117.524 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.76 160.53 14.72 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 122.858 1.313 . . . . 0.0 113.877 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -87.99 82.46 7.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 125.754 2.693 . . . . 0.0 113.368 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -71.93 163.83 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-N 110.088 -3.233 . . . . 0.0 115.504 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.669 HG23 ' HG3' ' A' ' 9' ' ' GLN 0.355 19.5 m -125.63 78.94 1.78 Allowed 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 124.261 1.981 . . . . 0.0 113.417 170.309 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.702 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.2 OUTLIER -75.99 101.3 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 125.813 1.645 . . . . 0.0 109.806 -173.409 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -82.75 140.97 32.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.709 -0.619 . . . . 0.0 109.354 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.21 -116.64 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 110.584 -171.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.42 166.32 17.15 Favored Pre-proline 0 CA--C 1.575 1.907 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -176.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -61.38 -47.36 12.07 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 C-N-CA 123.088 2.526 . . . . 0.0 117.425 166.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -97.46 -43.63 7.18 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -175.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -95.49 77.3 3.35 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.17 49.47 1.66 Allowed 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 94.5 p -106.92 -27.86 10.43 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 125.668 1.587 . . . . 0.0 114.744 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -126.24 -173.49 2.87 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 124.06 0.944 . . . . 0.0 112.736 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.424 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . 174.59 179.73 45.38 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.73 108.27 1.17 Allowed 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 118.895 2.924 . . . . 0.0 118.895 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.512 ' CD1' ' H ' ' A' ' 66' ' ' ILE . 0.9 OUTLIER -26.71 91.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.118 0 N-CA-C 118.889 2.922 . . . . 0.0 118.889 162.82 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 CA--C 1.58 2.117 0 N-CA-C 117.271 2.322 . . . . 0.0 117.271 176.408 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 . . . . . 0 CA--C 1.572 1.812 0 CA-C-O 120.891 0.377 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.14 141.97 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.107 -0.996 . . . . 0.0 111.411 -174.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.328 12.5 pt-20 -99.14 124.35 44.1 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.636 1.684 . . . . 0.0 110.224 168.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.284 11.4 ttt -154.71 -8.06 0.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 120.539 3.533 . . . . 0.0 120.539 -151.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.611 ' HB2' ' HB ' ' A' ' 54' ' ' VAL 0.574 0.0 OUTLIER -78.9 -165.35 0.72 Allowed 'General case' 0 N--CA 1.491 1.583 1 N-CA-C 122.053 4.094 . . . . 0.0 122.053 -165.11 . . . . . . . . 5 4 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.39 -112.61 1.53 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 122.42 3.728 . . . . 0.0 122.42 -166.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.3 m -110.78 141.11 44.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.532 -0.981 . . . . 0.0 108.363 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.543 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 90.4 t -69.51 101.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.602 2.948 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 174.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 24' ' ' GLU . 2.8 mm? -77.12 -38.38 52.25 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 117.923 -2.985 . . . . 0.0 112.828 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -128.93 145.71 51.15 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.761 1.267 . . . . 0.0 110.762 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 p -95.77 106.0 18.07 Favored 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 101.775 -3.417 . . . . 0.0 101.775 167.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.288 5.7 mt -78.47 166.47 42.64 Favored Pre-proline 0 CA--C 1.593 2.626 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.482 -167.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.385 6.0 Cg_endo -20.54 -57.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.57 2.302 2 N-CA-C 125.459 5.138 . . . . 0.0 125.459 -164.798 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -82.71 -78.34 0.21 Allowed 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 120.651 1.569 . . . . 0.0 109.782 172.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -158.13 72.81 0.64 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.255 67.3 mtm -115.98 -169.61 1.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.681 0.792 . . . . 0.0 110.588 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.531 ' HE2' HG23 ' A' ' 35' ' ' ILE . 62.0 m-85 -148.49 108.15 3.99 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 119.114 -2.241 . . . . 0.0 106.952 -166.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -84.48 97.59 9.62 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -103.78 133.7 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -164.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' H ' HD23 ' A' ' 13' ' ' LEU . 32.2 tt0 -95.96 111.49 23.47 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 172.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 26' ' ' GLU 0.365 0.2 OUTLIER -52.26 -178.54 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 120.608 3.558 . . . . 0.0 120.608 -176.11 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.62 ' H ' HD23 ' A' ' 25' ' ' LEU . 11.0 pt-20 -69.62 -31.45 69.57 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 112.729 -2.032 . . . . 0.0 113.949 167.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -88.68 6.74 37.05 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.19 13.41 79.06 Favored Glycine 0 CA--C 1.549 2.165 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -95.1 130.01 41.96 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 120.821 2.31 . . . . 0.0 112.561 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.0 t -82.76 124.9 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.438 -1.414 . . . . 0.0 112.333 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.16 149.76 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 114.705 -1.134 . . . . 0.0 113.499 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 m -87.45 127.08 35.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.487 -1.383 . . . . 0.0 110.396 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.4 139.98 28.75 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.71 155.73 17.47 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 168.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.531 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -64.31 170.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.536 0 O-C-N 120.456 -1.402 . . . . 0.0 112.166 168.775 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -75.68 92.9 3.01 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 119.226 -2.171 . . . . 0.0 107.902 169.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.81 -38.23 0.01 OUTLIER Glycine 0 N--CA 1.505 3.266 1 N-CA-C 123.314 4.086 . . . . 0.0 123.314 -174.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -54.32 -45.54 72.65 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -73.18 -21.87 60.59 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 173.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -37.06 -39.68 0.25 Allowed 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 123.718 2.963 . . . . 0.0 117.524 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -91.07 47.41 1.4 Allowed 'General case' 0 CA--C 1.582 2.183 0 CA-C-O 124.231 1.967 . . . . 0.0 114.402 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -168.12 -60.36 0.02 OUTLIER 'General case' 0 CA--C 1.581 2.17 0 C-N-CA 128.151 2.581 . . . . 0.0 105.193 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -83.43 68.45 9.73 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 127.144 2.178 . . . . 0.0 114.017 175.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 mt -88.33 71.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.389 84.8 mmt-85 -100.98 -76.02 0.57 Allowed 'General case' 0 N--CA 1.489 1.488 1 N-CA-C 124.465 4.987 . . . . 0.0 124.465 -164.003 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pt -99.77 162.47 3.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 112.116 -2.311 . . . . 0.0 116.678 -157.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -129.45 -174.55 3.32 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.528 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.8 m -70.52 84.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.768 1.27 . . . . 0.0 112.585 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.543 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 132.68 19.22 1.06 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 118.218 2.047 . . . . 0.0 118.218 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.03 157.73 16.62 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-O 123.014 1.388 . . . . 0.0 111.803 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -90.61 94.11 9.56 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 125.217 2.437 . . . . 0.0 113.429 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -97.01 142.46 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.827 0 CA-C-N 109.733 -3.394 . . . . 0.0 111.836 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 m -126.48 119.15 26.47 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 100.62 -3.844 . . . . 0.0 100.62 171.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.611 ' HB ' ' HB2' ' A' ' 9' ' ' GLN 0.252 93.6 t -127.86 125.42 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 112.9 -1.955 . . . . 0.0 106.345 -157.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -79.09 137.97 37.74 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -172.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.275 2.3 pt? -129.03 -171.19 2.42 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 121.625 0.726 . . . . 0.0 111.14 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 p -106.13 164.87 14.05 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -43.04 -51.66 5.38 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 N-CA-C 122.212 3.889 . . . . 0.0 122.212 161.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -110.75 -41.4 4.29 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.61 69.14 6.69 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.859 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.42 -9.09 58.33 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.3 t -69.71 -6.57 32.64 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -124.05 -176.62 3.53 Favored 'General case' 0 CA--C 1.575 1.928 0 CA-C-O 123.211 1.482 . . . . 0.0 113.259 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.89 174.47 43.46 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -153.7 106.74 2.92 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 171.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.525 HD11 ' CD2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -41.3 110.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 117.973 2.582 . . . . 0.0 117.973 173.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.572 1.82 0 C-N-CA 124.708 1.203 . . . . 0.0 110.444 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 m120 . . . . . 0 CA--C 1.582 2.203 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mt -97.21 144.82 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.112 -1.617 . . . . 0.0 111.095 -170.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.279 7.2 pt-20 -99.84 119.56 38.38 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 124.219 1.961 . . . . 0.0 109.219 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.295 10.8 ttt -154.26 -4.77 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 110.399 -3.091 . . . . 0.0 119.322 -152.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.758 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.603 0.0 OUTLIER -75.89 -157.85 0.08 Allowed 'General case' 0 CA--C 1.566 1.584 1 N-CA-C 125.778 5.473 . . . . 0.0 125.778 -162.18 . . . . . . . . 5 4 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.43 -150.75 10.2 Favored Glycine 0 CA--C 1.535 1.292 1 N-CA-C 126.29 5.276 . . . . 0.0 126.29 -157.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -101.79 136.53 41.47 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.541 HG22 ' HD1' ' A' ' 21' ' ' PHE . 63.1 t -64.56 111.66 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.588 0 O-C-N 121.074 -1.017 . . . . 0.0 109.332 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.9 -36.56 64.77 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-N 122.738 2.517 . . . . 0.0 111.943 168.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -146.07 147.3 31.46 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 122.32 1.057 . . . . 0.0 111.789 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.93 116.23 28.66 Favored 'General case' 0 N--CA 1.511 2.593 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 169.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.604 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.454 1.2 mm? -79.79 -127.71 0.0 OUTLIER Pre-proline 0 CA--C 1.597 2.779 0 CA-C-O 114.369 -2.729 . . . . 0.0 114.81 -164.682 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 90.9 Cg_endo -67.55 -67.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.566 2.113 1 CA-C-N 130.159 4.664 . . . . 0.0 116.966 -176.701 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -81.24 -72.94 0.4 Allowed 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.387 -0.82 . . . . 0.0 110.603 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m -157.43 74.31 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.26 89.4 mtp -113.98 -169.57 1.54 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 117.326 -1.321 . . . . 0.0 111.901 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.583 ' HB3' HG22 ' A' ' 23' ' ' VAL . 57.9 m-85 -154.92 112.01 3.33 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 123.366 2.803 . . . . 0.0 111.337 -166.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -93.89 97.61 10.5 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 167.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 21' ' ' PHE . 2.5 t -101.52 141.2 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -163.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -98.35 107.86 20.42 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.0 171.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.264 0.6 OUTLIER -50.47 176.56 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 118.718 2.859 . . . . 0.0 118.718 -177.089 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -22.68 66.31 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 168.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -95.47 6.11 49.84 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.47 -1.58 85.96 Favored Glycine 0 CA--C 1.554 2.52 0 N-CA-C 119.955 2.742 . . . . 0.0 119.955 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -82.63 140.44 33.18 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.834 1.817 . . . . 0.0 113.04 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.3 130.18 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 CA-C-O 122.846 1.307 . . . . 0.0 111.374 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.27 153.03 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.376 -1.284 . . . . 0.0 113.168 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.8 m -98.16 126.1 43.48 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.439 -1.413 . . . . 0.0 110.256 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.42 163.39 34.77 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.6 176.14 5.14 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.825 -1.534 . . . . 0.0 107.63 164.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.497 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -85.14 171.0 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.59 2.49 0 O-C-N 119.731 -1.856 . . . . 0.0 108.84 161.581 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 p -74.91 27.48 0.09 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 118.26 -2.775 . . . . 0.0 117.988 177.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.06 -49.78 0.18 Allowed Glycine 0 N--CA 1.502 3.048 0 N-CA-C 119.937 2.735 . . . . 0.0 119.937 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -65.62 -52.34 52.73 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.044 2.138 . . . . 0.0 115.499 -177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -18.1 65.1 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -38.43 -39.21 0.43 Allowed 'General case' 0 CA--C 1.575 1.922 0 CA-C-N 122.419 2.372 . . . . 0.0 116.492 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -92.28 32.4 1.19 Allowed 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -149.73 -54.98 0.17 Allowed 'General case' 0 CA--C 1.577 1.991 0 C-N-CA 127.25 2.22 . . . . 0.0 107.141 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -76.46 63.47 2.02 Favored 'General case' 0 CA--C 1.58 2.107 0 C-N-CA 125.605 1.562 . . . . 0.0 112.947 171.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mt -84.98 72.18 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 CA-C-O 124.752 2.215 . . . . 0.0 108.788 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -112.19 -43.19 3.58 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 120.811 3.634 . . . . 0.0 120.811 -169.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.403 0.0 OUTLIER -120.23 160.82 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 1 N-CA-C 122.992 4.442 . . . . 0.0 122.992 -138.901 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.9 tp -159.15 178.67 9.76 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 110.203 -3.18 . . . . 0.0 112.387 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.1 m -68.55 116.02 8.61 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.615 1.198 . . . . 0.0 111.709 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.401 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 95.27 14.37 48.42 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 119.371 2.508 . . . . 0.0 119.371 -175.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.46 172.97 8.04 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 124.96 1.304 . . . . 0.0 111.757 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -97.59 136.62 37.72 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 124.516 2.103 . . . . 0.0 115.87 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.06 153.95 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.954 0 CA-C-N 111.51 -2.587 . . . . 0.0 110.901 -171.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.8 m -143.71 102.89 3.99 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 101.978 -3.341 . . . . 0.0 101.978 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.758 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 19.7 t -105.87 132.14 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 111.107 -2.77 . . . . 0.0 108.056 -164.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -82.86 127.54 33.59 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.665 -1.272 . . . . 0.0 111.771 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.461 HD22 HE22 ' A' ' 9' ' ' GLN 0.321 2.2 pt? -102.0 -165.53 1.2 Allowed 'General case' 0 CA--C 1.566 1.574 0 CA-C-O 121.26 0.552 . . . . 0.0 111.385 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 p -131.74 161.49 62.08 Favored Pre-proline 0 CA--C 1.572 1.813 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -51.54 -43.74 48.37 Favored 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 123.999 3.133 . . . . 0.0 118.843 164.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -95.57 -57.2 2.45 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -95.16 74.08 3.4 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.343 1.068 . . . . 0.0 113.342 -172.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.51 -20.0 65.94 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 118.377 2.732 . . . . 0.0 118.377 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 t -74.98 4.53 6.44 Favored 'General case' 0 CA--C 1.583 2.241 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 171.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 170.71 15.6 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 121.093 1.769 . . . . 0.0 115.516 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.53 -169.19 42.13 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.98 124.9 7.89 Favored 'General case' 0 CA--C 1.59 2.49 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 173.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.776 ' H ' HD12 ' A' ' 66' ' ' ILE . 2.8 mp -43.71 104.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 171.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.1 m . . . . . 0 CA--C 1.579 2.069 0 CA-C-N 113.891 -1.504 . . . . 0.0 114.054 174.479 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.561 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -123.72 -87.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.882 0.764 . . . . 0.0 109.385 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -87.18 56.38 3.96 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.34 155.28 27.29 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 123.397 1.57 . . . . 0.0 114.079 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -76.91 128.91 35.41 Favored 'General case' 0 CA--C 1.571 1.772 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.82 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -96.66 141.13 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 124.187 0.995 . . . . 0.0 110.104 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.378 14.7 pt-20 -92.29 126.21 37.27 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 124.858 2.266 . . . . 0.0 109.536 165.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.283 20.4 ttt -168.46 82.96 0.16 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 109.968 -3.287 . . . . 0.0 104.765 -152.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -98.47 -153.03 0.42 Allowed 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 -159.097 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -167.36 -174.37 36.39 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 120.487 2.955 . . . . 0.0 120.487 -170.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.7 m -100.54 124.97 46.81 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.503 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 67.3 t -60.66 117.54 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.763 0 CA-C-N 121.096 1.771 . . . . 0.0 107.294 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.302 73.3 mt -100.95 -26.43 13.74 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.169 -1.582 . . . . 0.0 112.773 171.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -136.42 145.86 45.74 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 123.09 1.424 . . . . 0.0 109.487 162.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 20' ' ' MET . 5.8 p -96.61 110.27 22.72 Favored 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 100.827 -3.768 . . . . 0.0 100.827 168.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.429 2.5 mt -79.65 -124.89 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.91 0 CA-C-O 113.986 -2.911 . . . . 0.0 115.655 -159.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 95.6 Cg_endo -73.36 -70.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.185 1 CA-C-N 130.561 4.807 . . . . 0.0 116.243 -176.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -78.67 -70.31 0.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.251 -0.906 . . . . 0.0 110.731 175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 m -159.33 75.89 0.67 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.415 ' O ' ' HA ' ' A' ' 15' ' ' THR . 67.9 mtt -118.58 -175.42 2.88 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.512 0.725 . . . . 0.0 111.426 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CE1' HD11 ' A' ' 46' ' ' ILE . 60.5 m-85 -144.29 109.88 5.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 119.454 -2.029 . . . . 0.0 106.398 -166.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -85.32 93.86 8.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 170.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.2 t -100.94 135.21 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -163.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -85.91 116.18 23.99 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.298 4.7 mt -70.52 174.95 5.2 Favored 'General case' 0 CA--C 1.577 1.99 0 CA-C-O 124.112 1.91 . . . . 0.0 112.569 -172.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -24.17 63.21 Favored 'General case' 0 CA--C 1.586 2.355 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.908 165.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.6 -8.25 56.3 Favored 'General case' 0 CA--C 1.586 2.365 0 C-N-CA 126.186 1.794 . . . . 0.0 115.398 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.72 9.31 75.08 Favored Glycine 0 CA--C 1.554 2.521 0 N-CA-C 119.496 2.558 . . . . 0.0 119.496 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -114.36 147.45 39.14 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 118.665 1.232 . . . . 0.0 112.452 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.4 t -82.27 126.88 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.861 -1.149 . . . . 0.0 111.216 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.3 147.68 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.598 1.19 . . . . 0.0 112.791 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.9 m -89.59 123.64 33.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.72 -1.238 . . . . 0.0 109.08 172.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.31 155.17 47.9 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 159.71 19.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 172.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.481 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -73.0 176.33 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.631 0 O-C-N 119.973 -1.704 . . . . 0.0 110.758 166.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 92.5 p -79.9 25.24 0.37 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 121.086 3.735 . . . . 0.0 121.086 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.85 -52.44 1.63 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.295 64.4 pttt -59.83 -58.17 9.73 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 118.061 2.615 . . . . 0.0 118.061 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -21.5 62.97 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -38.44 -39.02 0.42 Allowed 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . 0.258 14.4 mptt -98.02 -4.55 35.87 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 121.639 3.94 . . . . 0.0 121.639 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -93.46 53.25 1.86 Allowed 'General case' 0 CA--C 1.587 2.404 0 N-CA-C 102.316 -3.216 . . . . 0.0 102.316 153.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.416 1.8 t80 -45.74 98.11 0.01 OUTLIER 'General case' 0 C--N 1.379 1.86 0 N-CA-C 118.679 2.844 . . . . 0.0 118.679 -152.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mt -82.07 74.53 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 109.175 -3.648 . . . . 0.0 107.562 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 137.96 58.03 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 -170.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.559 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.274 1.4 pt -141.78 154.96 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 CA-C-N 111.466 -2.606 . . . . 0.0 111.87 -176.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 tp -131.39 -174.44 3.4 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.128 0.966 . . . . 0.0 111.033 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -72.87 84.88 1.24 Allowed 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 123.317 1.532 . . . . 0.0 113.074 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.503 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 130.34 25.23 0.88 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 117.631 1.812 . . . . 0.0 117.631 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.55 165.62 12.44 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 123.2 1.476 . . . . 0.0 114.131 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -84.73 82.65 8.33 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 125.583 2.611 . . . . 0.0 113.674 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 m -79.03 152.82 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 CA-C-N 110.595 -3.002 . . . . 0.0 113.284 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.489 ' HA ' ' HB3' ' A' ' 9' ' ' GLN . 63.8 m -94.76 161.15 14.29 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 160.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.459 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -157.35 86.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 O-C-N 118.128 -2.858 . . . . 0.0 105.658 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -78.19 138.6 38.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.102 -0.999 . . . . 0.0 109.743 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -136.0 -179.32 5.59 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.665 1.221 . . . . 0.0 111.699 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 p -100.36 161.06 25.28 Favored Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -53.9 -43.48 57.7 Favored 'Trans proline' 0 CA--C 1.572 2.388 0 C-N-CA 123.231 2.621 . . . . 0.0 118.22 163.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -82.87 -49.39 9.71 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.72 83.25 2.23 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 122.25 1.024 . . . . 0.0 112.049 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -17.1 61.17 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.2 p -68.97 -7.97 40.26 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -122.73 -177.74 3.73 Favored 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 119.963 1.256 . . . . 0.0 114.056 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . -177.33 177.0 48.29 Favored Glycine 0 CA--C 1.548 2.127 0 N-CA-C 117.686 1.834 . . . . 0.0 117.686 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -162.69 115.86 1.67 Allowed 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 172.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.618 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -38.99 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 118.929 -2.357 . . . . 0.0 116.912 165.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.279 2.1 m -77.19 -87.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.538 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -116.96 145.91 43.34 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -60.64 99.86 0.09 Allowed 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.0 m -110.82 -29.76 7.83 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -175.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 . . . . . 0 CA--C 1.56 1.331 0 CA-C-O 124.799 2.238 . . . . 0.0 112.472 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.56 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -79.25 84.31 5.21 Favored 'General case' 0 CA--C 1.574 1.883 0 O-C-N 120.919 -1.113 . . . . 0.0 113.309 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.46 47.97 2.21 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -133.32 113.48 12.65 Favored 'General case' 0 CA--C 1.568 1.656 0 C-N-CA 124.357 1.063 . . . . 0.0 112.914 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -83.98 107.75 16.54 Favored 'General case' 0 CA--C 1.575 1.925 0 O-C-N 120.985 -1.072 . . . . 0.0 108.818 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -89.16 138.44 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.427 -1.421 . . . . 0.0 111.741 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.332 10.5 pt-20 -93.74 123.29 36.99 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 125.257 2.456 . . . . 0.0 109.219 168.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.26 20.5 ttt -170.34 85.08 0.11 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 109.173 -3.649 . . . . 0.0 104.626 -151.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -105.16 -149.24 0.41 Allowed 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -162.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 179.29 -142.44 5.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.8 m -122.86 135.26 54.46 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.513 HG11 HG23 ' A' ' 15' ' ' THR . 54.0 t -58.99 124.6 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.607 3.168 0 O-C-N 121.364 -0.835 . . . . 0.0 109.528 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.5 mt -90.66 -27.6 18.92 Favored 'General case' 0 N--CA 1.514 2.737 0 O-C-N 119.314 -2.116 . . . . 0.0 112.031 163.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.4 tp10 -148.47 143.51 26.77 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 120.83 -1.169 . . . . 0.0 111.736 166.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.513 HG23 HG11 ' A' ' 12' ' ' VAL . 33.1 p -103.94 103.76 13.64 Favored 'General case' 0 N--CA 1.518 2.958 0 N-CA-C 102.087 -3.301 . . . . 0.0 102.087 173.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.393 0.2 OUTLIER -77.08 178.6 1.97 Allowed Pre-proline 0 CA--C 1.593 2.626 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -168.443 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -54.41 -36.15 86.81 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 N-CA-C 121.25 3.519 . . . . 0.0 121.25 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -79.74 -100.78 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.4 m -152.97 72.77 0.97 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 76.0 mtp -126.04 162.7 24.68 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 46' ' ' ILE . 56.7 m-85 -132.77 114.48 14.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.141 -1.6 . . . . 0.0 107.087 -163.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.2 ttm105 -85.67 89.41 7.73 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.3 t -96.3 137.29 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -162.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.7 111.82 22.4 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.302 4.9 mt -72.3 174.24 7.56 Favored 'General case' 0 CA--C 1.577 2.002 0 CA-C-O 124.135 1.921 . . . . 0.0 112.779 -173.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.96 -22.59 61.43 Favored 'General case' 0 CA--C 1.585 2.298 0 CA-C-N 113.804 -1.544 . . . . 0.0 114.128 166.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -74.58 -9.09 58.23 Favored 'General case' 0 CA--C 1.587 2.366 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.68 23.79 55.09 Favored Glycine 0 CA--C 1.555 2.54 0 N-CA-C 118.632 2.213 . . . . 0.0 118.632 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -125.94 145.71 50.16 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.309 1.044 . . . . 0.0 111.224 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.0 t -86.04 117.5 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.728 -1.232 . . . . 0.0 110.123 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.7 148.9 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.1 m -92.54 125.5 37.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.405 -1.434 . . . . 0.0 110.062 173.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.32 159.84 40.79 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 177.11 4.75 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 165.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.514 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.2 pt -88.99 -178.27 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.36 0 O-C-N 119.211 -2.181 . . . . 0.0 110.632 165.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.4 p -82.49 122.32 27.9 Favored 'General case' 0 CA--C 1.56 1.33 0 O-C-N 119.714 -1.866 . . . . 0.0 109.205 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.49 -20.34 0.59 Allowed Glycine 0 N--CA 1.503 3.161 0 N-CA-C 122.312 3.685 . . . . 0.0 122.312 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -71.24 -55.75 7.46 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 125.641 1.577 . . . . 0.0 114.405 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 ptm -69.39 -20.54 63.81 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -37.93 -35.66 0.16 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -94.47 33.58 1.4 Allowed 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -150.93 -69.93 0.18 Allowed 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.64 101.04 10.55 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 163.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.83 -73.55 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.439 -0.788 . . . . 0.0 109.381 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -132.1 -179.27 5.31 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-O 124.512 2.101 . . . . 0.0 114.316 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.258 1.1 pt -143.39 175.67 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 C-N-CA 126.932 2.093 . . . . 0.0 110.858 -173.179 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.4 158.5 16.3 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.256 1.027 . . . . 0.0 111.115 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 m -71.58 86.84 0.9 Allowed 'General case' 0 CA--C 1.572 1.807 0 CA-C-O 123.577 1.655 . . . . 0.0 110.423 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 130.36 24.2 0.95 Allowed Glycine 0 N--CA 1.492 2.423 0 CA-C-N 113.02 -1.9 . . . . 0.0 117.049 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -94.57 162.3 13.86 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-O 122.976 1.37 . . . . 0.0 114.166 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -85.59 81.35 8.7 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 125.575 2.607 . . . . 0.0 113.796 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -77.79 158.15 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 110.324 -3.126 . . . . 0.0 113.839 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.299 35.3 m -95.44 162.78 13.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 160.508 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -158.44 89.55 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 118.473 -2.642 . . . . 0.0 104.897 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.55 134.87 36.5 Favored 'General case' 0 CA--C 1.563 1.47 0 O-C-N 121.17 -0.956 . . . . 0.0 110.014 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 mp -101.06 -171.76 2.05 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 125.972 2.796 . . . . 0.0 111.878 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 p -122.5 162.04 40.32 Favored Pre-proline 0 CA--C 1.577 1.987 0 CA-C-N 109.657 -3.429 . . . . 0.0 112.657 173.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -52.85 -41.27 71.6 Favored 'Trans proline' 0 CA--C 1.569 2.249 0 C-N-CA 123.656 2.904 . . . . 0.0 119.166 164.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -95.21 -52.81 4.03 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -91.39 77.03 5.87 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 122.528 1.156 . . . . 0.0 112.779 -172.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.5 mt -70.89 -22.86 62.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 117.643 2.46 . . . . 0.0 117.643 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.5 t -75.89 6.95 4.41 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -139.8 166.48 24.5 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 120.564 1.529 . . . . 0.0 113.475 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.14 -164.08 29.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 115.633 1.013 . . . . 0.0 115.633 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.95 122.31 2.57 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.607 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -35.64 91.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 166.326 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.268 2.8 m -77.94 -71.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.412 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.288 47.4 t80 61.69 -84.25 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 173.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -153.52 148.79 26.99 Favored 'General case' 0 CA--C 1.57 1.726 0 C-N-CA 124.262 1.025 . . . . 0.0 110.885 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 99.6 p -64.23 -48.25 76.54 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 124.935 2.302 . . . . 0.0 108.82 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.553 0 CA-C-O 121.656 0.741 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -83.21 79.15 9.48 Favored 'General case' 0 CA--C 1.572 1.81 0 O-C-N 120.953 -1.092 . . . . 0.0 112.84 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -104.33 66.11 0.8 Allowed 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 122.321 1.057 . . . . 0.0 112.172 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.19 125.1 24.47 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -64.58 124.3 21.51 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.08 142.24 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.615 1.166 . . . . 0.0 109.661 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.409 16.3 pt-20 -95.03 122.27 37.51 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 125.036 2.351 . . . . 0.0 109.82 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.275 18.6 ttt -168.34 81.2 0.16 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 109.777 -3.374 . . . . 0.0 105.683 -149.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -96.04 -149.86 0.32 Allowed 'General case' 0 CA--C 1.563 1.456 0 N-CA-C 118.713 2.857 . . . . 0.0 118.713 -157.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -166.88 -178.34 39.27 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 121.951 3.54 . . . . 0.0 121.951 -168.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.6 m -99.73 124.88 45.43 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 15' ' ' THR . 61.4 t -60.2 122.14 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.989 0 CA-C-N 120.487 1.494 . . . . 0.0 107.253 175.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.299 62.6 mt -99.51 -22.06 15.65 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 119.823 -1.798 . . . . 0.0 112.844 168.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.9 tp10 -145.01 143.84 30.7 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 122.372 1.082 . . . . 0.0 110.833 161.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.485 HG23 HG11 ' A' ' 12' ' ' VAL . 24.7 p -106.17 106.58 17.16 Favored 'General case' 0 N--CA 1.515 2.798 0 N-CA-C 101.395 -3.557 . . . . 0.0 101.395 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.374 0.3 OUTLIER -76.48 174.37 5.81 Favored Pre-proline 0 CA--C 1.591 2.544 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -167.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -47.11 -42.22 26.42 Favored 'Trans proline' 0 CA--C 1.565 2.064 0 N-CA-C 121.493 3.613 . . . . 0.0 121.493 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -80.49 -93.21 0.05 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.9 m -159.5 75.38 0.64 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 69.6 mtm -126.78 167.87 15.19 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.795 0.838 . . . . 0.0 112.512 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.545 ' CE1' HD11 ' A' ' 46' ' ' ILE . 59.8 m-85 -132.22 114.89 15.0 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 118.703 -2.498 . . . . 0.0 108.815 -163.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -87.05 95.89 10.1 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 170.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.4 t -105.13 139.97 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -162.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.87 111.57 18.88 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 167.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.257 0.1 OUTLIER -79.84 166.21 21.93 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 121.879 2.127 . . . . 0.0 113.082 -179.971 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.308 18.1 pt-20 -67.41 -6.35 18.78 Favored 'General case' 0 CA--C 1.579 2.065 0 CA-C-N 112.677 -2.056 . . . . 0.0 114.959 169.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.573 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 45.8 t-20 -86.41 -15.47 40.23 Favored 'General case' 0 CA--C 1.588 2.408 0 O-C-N 121.129 -0.982 . . . . 0.0 112.721 162.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.51 -25.73 24.89 Favored Glycine 0 CA--C 1.549 2.178 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -75.17 140.2 43.18 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 124.292 1.037 . . . . 0.0 112.334 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.4 t -81.53 112.69 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 122.688 1.232 . . . . 0.0 108.947 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.91 147.63 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 114.129 -1.396 . . . . 0.0 113.465 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 m -87.3 127.19 35.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.805 -1.184 . . . . 0.0 108.54 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.16 152.3 49.78 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.1 151.29 42.2 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 170.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.465 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.7 OUTLIER -69.57 162.68 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.437 0 O-C-N 120.738 -1.226 . . . . 0.0 111.287 173.264 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.7 p -76.52 98.4 4.63 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 119.246 -2.159 . . . . 0.0 109.937 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -16.52 -50.19 0.01 OUTLIER Glycine 0 N--CA 1.505 3.234 1 N-CA-C 123.761 4.264 . . . . 0.0 123.761 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -47.69 -49.51 27.57 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 119.065 2.987 . . . . 0.0 119.065 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ptm -70.89 -18.08 62.69 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -39.6 -35.54 0.32 Allowed 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 169.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -92.79 34.06 1.11 Allowed 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -150.23 -71.63 0.18 Allowed 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 102.958 -2.978 . . . . 0.0 102.958 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -81.09 93.49 6.43 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.802 1.241 . . . . 0.0 107.771 164.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mt -74.01 -70.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.217 -0.927 . . . . 0.0 111.491 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -134.78 171.94 13.67 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 125.284 2.469 . . . . 0.0 115.009 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.265 1.0 OUTLIER -148.73 170.36 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 CA-C-N 110.85 -2.886 . . . . 0.0 109.777 -175.899 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.6 tp -109.43 163.41 13.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.891 -1.13 . . . . 0.0 112.986 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.8 m -71.48 85.15 0.84 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 123.813 1.768 . . . . 0.0 111.095 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 131.77 23.15 0.89 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 112.8 -2.0 . . . . 0.0 117.053 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -94.5 160.89 14.44 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 123.043 1.401 . . . . 0.0 113.145 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -88.78 83.63 6.69 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 124.999 2.333 . . . . 0.0 112.475 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -71.76 163.35 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 CA-C-N 110.802 -2.908 . . . . 0.0 114.34 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.306 75.3 m -95.13 160.2 14.67 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 159.224 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -158.44 84.55 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 O-C-N 118.37 -2.706 . . . . 0.0 105.769 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -76.77 134.8 39.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.019 -1.051 . . . . 0.0 109.838 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -137.61 -172.14 3.16 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.821 0.82 . . . . 0.0 111.299 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -104.79 155.74 37.04 Favored Pre-proline 0 CA--C 1.573 1.833 0 O-C-N 120.993 -1.067 . . . . 0.0 113.259 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -54.34 -42.03 71.2 Favored 'Trans proline' 0 CA--C 1.572 2.392 0 C-N-CA 123.738 2.959 . . . . 0.0 118.387 164.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -79.42 -47.38 15.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -108.22 89.24 2.93 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 122.195 0.998 . . . . 0.0 110.308 -174.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.82 -14.9 57.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 118.996 2.962 . . . . 0.0 118.996 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.9 t -73.46 -1.28 17.74 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -129.56 -177.5 4.29 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 120.276 1.398 . . . . 0.0 113.277 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.0 -173.86 45.22 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -161.63 113.65 1.77 Allowed 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 119.595 3.183 . . . . 0.0 119.595 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.581 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -36.45 94.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 118.762 -2.461 . . . . 0.0 117.556 166.461 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.33 -64.48 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.737 0 CA-C-N 114.062 -1.426 . . . . 0.0 112.847 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.251 32.6 m-85 63.9 -54.84 0.23 Allowed 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -177.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mmt-85 -75.45 60.59 1.18 Allowed 'General case' 0 CA--C 1.582 2.207 0 C-N-CA 124.746 1.218 . . . . 0.0 113.196 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.9 p -168.96 -34.45 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 124.037 1.875 . . . . 0.0 115.846 -178.197 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 1.698 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -81.81 80.62 8.07 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 120.804 1.638 . . . . 0.0 111.396 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -125.0 53.68 1.48 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.35 108.96 18.68 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 120.459 -1.401 . . . . 0.0 111.979 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -86.29 119.34 26.46 Favored 'General case' 0 CA--C 1.568 1.667 0 O-C-N 121.748 -0.595 . . . . 0.0 111.322 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -91.33 142.05 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.847 -1.158 . . . . 0.0 111.227 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.337 13.2 pt-20 -100.28 123.17 44.18 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 123.705 1.717 . . . . 0.0 110.177 169.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.261 13.9 ttt -155.15 -12.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 119.315 3.08 . . . . 0.0 119.315 -151.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.725 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.503 0.0 OUTLIER -69.68 -173.02 0.55 Allowed 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 121.765 3.987 . . . . 0.0 121.765 -169.915 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.56 -108.64 1.78 Allowed Glycine 0 N--CA 1.48 1.567 0 N-CA-C 122.442 3.737 . . . . 0.0 122.442 -164.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.7 m -121.43 136.92 54.91 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.506 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 79.1 t -62.76 117.05 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.91 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.7 mt -79.34 -37.36 37.71 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 122.107 2.231 . . . . 0.0 111.236 165.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.5 tp10 -143.31 144.96 32.31 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 122.062 0.934 . . . . 0.0 112.346 169.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.526 HG22 ' HE1' ' A' ' 21' ' ' PHE . 32.2 p -104.2 109.3 21.06 Favored 'General case' 0 N--CA 1.513 2.725 0 N-CA-C 101.763 -3.421 . . . . 0.0 101.763 171.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.376 0.5 OUTLIER -77.32 -177.51 0.81 Allowed Pre-proline 0 CA--C 1.592 2.559 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -167.409 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -54.38 -36.59 87.8 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 N-CA-C 120.893 3.382 . . . . 0.0 120.893 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -85.72 -93.83 0.08 Allowed 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -156.23 74.89 0.86 Allowed 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.9 mtt -130.23 162.25 29.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.976 -1.077 . . . . 0.0 112.76 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.691 ' CE2' HG23 ' A' ' 35' ' ' ILE . 62.3 m-85 -128.75 113.3 15.16 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 118.723 -2.485 . . . . 0.0 106.979 -162.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -85.76 96.11 9.62 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 167.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 21' ' ' PHE . 2.1 t -99.95 140.13 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -164.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.06 114.92 26.67 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.256 0.5 OUTLIER -58.4 178.07 0.11 Allowed 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -177.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.49 -24.57 66.42 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 167.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -92.63 6.96 45.44 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 170.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.9 -1.74 87.86 Favored Glycine 0 CA--C 1.554 2.519 0 N-CA-C 119.911 2.725 . . . . 0.0 119.911 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -83.9 143.19 30.04 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.641 1.72 . . . . 0.0 113.262 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.5 t -89.05 130.84 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.663 0 CA-C-O 122.578 1.18 . . . . 0.0 111.52 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.86 153.92 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.54 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.0 m -99.51 122.0 41.97 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.495 -1.378 . . . . 0.0 109.853 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.39 149.36 32.6 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 119.733 3.235 . . . . 0.0 119.733 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -99.95 158.26 15.94 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.509 -1.37 . . . . 0.0 111.206 170.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.691 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -71.17 178.21 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.752 0 O-C-N 120.444 -1.41 . . . . 0.0 111.981 164.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.2 p -80.08 15.72 1.42 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 120.07 3.359 . . . . 0.0 120.07 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.67 -25.66 0.06 OUTLIER Glycine 0 N--CA 1.506 3.33 0 N-CA-C 121.842 3.497 . . . . 0.0 121.842 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -79.99 -45.95 17.51 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -46.25 89.42 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 118.537 2.792 . . . . 0.0 118.537 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HB3' HD11 ' A' ' 35' ' ' ILE . 7.6 ptm85 -36.28 -45.99 0.5 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.806 3.262 . . . . 0.0 119.806 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -92.0 0.6 57.47 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-N 110.048 -3.251 . . . . 0.0 118.929 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -96.57 -71.58 0.67 Allowed 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 167.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.27 125.81 37.09 Favored 'General case' 0 CA--C 1.57 1.744 0 C-N-CA 124.154 0.982 . . . . 0.0 109.122 170.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.57 108.99 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.722 0 CA-C-O 124.429 2.061 . . . . 0.0 107.747 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -44.66 174.62 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.878 1 N-CA-C 124.267 4.914 . . . . 0.0 124.267 -165.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' A' ' 21' ' ' PHE . 1.1 pt -75.57 159.79 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 109.845 -3.343 . . . . 0.0 116.604 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -122.44 174.77 6.82 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.184 0.993 . . . . 0.0 112.285 -171.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -68.47 100.61 1.11 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 123.494 1.616 . . . . 0.0 112.576 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.506 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 113.36 20.47 6.22 Favored Glycine 0 N--CA 1.489 2.224 0 CA-C-N 112.837 -1.983 . . . . 0.0 117.883 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.55 158.58 15.92 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-O 122.917 1.341 . . . . 0.0 112.764 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -87.75 94.54 9.78 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 125.764 2.697 . . . . 0.0 113.106 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.419 ' CG1' HD13 ' A' ' 46' ' ' ILE . 19.7 m -94.56 148.12 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 CA-C-N 109.594 -3.457 . . . . 0.0 110.986 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.2 m -140.94 107.19 5.23 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 100.33 -3.952 . . . . 0.0 100.33 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.725 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.252 51.0 t -117.17 128.45 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 111.177 -2.738 . . . . 0.0 106.042 -159.515 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -80.65 134.32 35.86 Favored 'General case' 0 CA--C 1.558 1.266 0 O-C-N 121.345 -0.847 . . . . 0.0 112.182 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.56 -176.38 3.37 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.488 1.137 . . . . 0.0 110.707 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 p -108.56 164.12 15.44 Favored Pre-proline 0 CA--C 1.571 1.772 0 O-C-N 120.987 -1.071 . . . . 0.0 113.883 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -51.09 -40.77 59.26 Favored 'Trans proline' 0 CA--C 1.572 2.393 0 N-CA-C 118.976 2.645 . . . . 0.0 118.976 163.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -94.98 -53.39 3.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -89.63 79.87 6.73 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.576 1.179 . . . . 0.0 111.924 -172.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.65 -21.23 57.88 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.2 t -77.64 11.75 1.95 Allowed 'General case' 0 CA--C 1.58 2.127 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 173.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 mtmm -137.56 177.38 7.91 Favored 'General case' 0 CA--C 1.57 1.742 0 CA-C-N 120.249 1.386 . . . . 0.0 114.612 -175.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.2 -176.25 45.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.22 114.85 3.69 Favored 'General case' 0 CA--C 1.592 2.58 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 168.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.64 ' H ' HD12 ' A' ' 66' ' ' ILE . 1.3 mp -45.13 108.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 O-C-N 119.076 -2.265 . . . . 0.0 114.893 171.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -90.6 -40.81 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.87 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.799 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.6 t80 67.85 148.7 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 171.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.33 52.77 2.11 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.0 t -160.15 -84.7 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 . . . . . 0 CA--C 1.566 1.583 0 CA-C-O 125.018 2.342 . . . . 0.0 107.9 171.487 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.532 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -69.76 -27.33 64.84 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.37 56.11 3.43 Favored 'General case' 0 CA--C 1.579 2.082 0 CA-C-N 120.256 1.389 . . . . 0.0 114.323 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -104.26 114.95 29.53 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -85.46 105.89 16.41 Favored 'General case' 0 CA--C 1.579 2.066 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mt -88.99 138.73 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.294 -1.504 . . . . 0.0 112.298 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.328 8.6 pt-20 -88.56 121.63 31.15 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 125.052 2.358 . . . . 0.0 109.235 170.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.407 ' HB3' HD23 ' A' ' 56' ' ' LEU . 18.0 ttt -172.01 84.79 0.07 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 109.289 -3.596 . . . . 0.0 104.852 -148.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.643 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -110.92 -149.03 0.44 Allowed 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -156.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 179.82 -150.72 9.44 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 117.967 1.947 . . . . 0.0 117.967 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.9 m -115.89 133.79 55.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.516 HG11 HG23 ' A' ' 15' ' ' THR . 46.9 t -60.06 118.31 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.003 0 O-C-N 121.384 -0.822 . . . . 0.0 109.102 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -84.24 -31.44 25.01 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.599 -1.938 . . . . 0.0 111.874 165.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -147.04 143.88 28.7 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 122.726 1.251 . . . . 0.0 111.807 167.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.516 HG23 HG11 ' A' ' 12' ' ' VAL . 24.3 p -104.16 105.68 15.93 Favored 'General case' 0 N--CA 1.516 2.862 0 N-CA-C 100.793 -3.781 . . . . 0.0 100.793 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.371 0.3 OUTLIER -75.26 173.39 7.06 Favored Pre-proline 0 CA--C 1.591 2.526 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -167.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -47.58 -35.26 22.14 Favored 'Trans proline' 0 CA--C 1.567 2.128 0 N-CA-C 122.103 3.847 . . . . 0.0 122.103 -174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -85.3 -96.34 0.07 Allowed 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 m -157.68 73.38 0.7 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 95.9 mtp -125.38 167.27 15.19 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.385 1.074 . . . . 0.0 112.529 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.534 ' CE1' HD11 ' A' ' 46' ' ' ILE . 55.3 m-85 -130.04 114.06 15.32 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 118.883 -2.386 . . . . 0.0 108.363 -164.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.2 ttm105 -85.34 97.95 10.26 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.5 t -106.75 143.03 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -162.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -88.13 106.73 18.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 171.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.285 3.8 mt -72.31 176.37 5.34 Favored 'General case' 0 CA--C 1.58 2.107 0 CA-C-O 123.995 1.855 . . . . 0.0 113.208 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.77 -25.12 62.75 Favored 'General case' 0 CA--C 1.585 2.304 0 CA-C-N 114.088 -1.415 . . . . 0.0 114.101 166.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -72.02 -5.83 37.84 Favored 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.72 -4.47 79.0 Favored Glycine 0 CA--C 1.557 2.706 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -88.33 147.71 24.64 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.77 1.228 . . . . 0.0 112.903 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.44 106.84 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.95 151.32 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.1 m -92.53 124.83 36.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.525 -1.359 . . . . 0.0 109.005 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.53 159.59 41.34 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -113.25 -164.28 0.91 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 169.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -108.34 -177.94 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.384 0 O-C-N 120.254 -1.529 . . . . 0.0 108.369 166.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 84.8 p -76.79 20.08 0.26 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.98 -55.18 0.79 Allowed Glycine 0 N--CA 1.499 2.871 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -57.11 -52.54 64.9 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.259 0.7 OUTLIER -70.11 -19.48 63.24 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 117.611 2.449 . . . . 0.0 117.611 177.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -39.43 -35.59 0.29 Allowed 'General case' 0 CA--C 1.578 2.056 0 N-CA-C 117.338 2.347 . . . . 0.0 117.338 170.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.8 38.62 1.21 Allowed 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 171.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -152.93 -74.82 0.13 Allowed 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.44 99.75 11.87 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 164.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mt -76.39 -64.59 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 O-C-N 121.666 -0.646 . . . . 0.0 111.773 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -128.47 167.42 17.08 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 119.94 3.311 . . . . 0.0 119.94 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.534 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.268 1.5 pt -142.65 170.83 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 109.57 -3.468 . . . . 0.0 110.666 176.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.3 tp -111.22 163.27 14.1 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.147 0.975 . . . . 0.0 111.406 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.1 m -69.97 88.41 0.57 Allowed 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 123.451 1.596 . . . . 0.0 111.206 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.499 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 129.49 22.17 1.22 Allowed Glycine 0 N--CA 1.493 2.473 0 CA-C-N 113.184 -1.825 . . . . 0.0 117.304 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -93.42 160.33 14.86 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 122.891 1.329 . . . . 0.0 113.478 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -88.35 84.54 6.83 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 125.438 2.542 . . . . 0.0 112.765 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -71.13 166.63 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-N 110.156 -3.202 . . . . 0.0 115.218 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.321 14.3 m -125.95 75.71 1.53 Allowed 'General case' 0 N--CA 1.508 2.445 0 CA-C-O 123.798 1.761 . . . . 0.0 113.54 171.283 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.643 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -75.04 101.3 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.315 1.446 . . . . 0.0 109.528 -172.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -80.65 146.01 31.36 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.277 1.037 . . . . 0.0 109.911 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 8' ' ' MET . 3.1 mm? -98.39 -173.46 2.57 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 124.623 2.154 . . . . 0.0 116.405 -171.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 p -131.32 153.84 81.76 Favored Pre-proline 0 CA--C 1.578 2.045 0 CA-C-N 111.027 -2.806 . . . . 0.0 111.421 165.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.2 -42.85 61.93 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 123.734 2.956 . . . . 0.0 118.352 165.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -87.27 -54.4 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -96.86 74.25 2.65 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -171.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.8 mp -66.11 -20.99 66.33 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.3 m -73.36 1.55 9.38 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -135.36 169.89 16.78 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 123.333 1.54 . . . . 0.0 111.963 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.55 -164.83 31.69 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 115.87 1.108 . . . . 0.0 115.87 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.24 110.83 1.21 Allowed 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 119.234 3.049 . . . . 0.0 119.234 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.513 ' CD1' ' H ' ' A' ' 66' ' ' ILE 0.264 0.7 OUTLIER -25.1 89.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 163.924 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -82.0 -56.9 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.459 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.1 t80 58.34 91.95 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -80.61 64.56 5.44 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 t -156.83 -76.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.094 0.958 . . . . 0.0 110.211 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 124.894 2.283 . . . . 0.0 108.866 178.821 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.536 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.0 90.36 6.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.981 -1.075 . . . . 0.0 112.03 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.3 57.95 4.73 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 122.399 1.095 . . . . 0.0 113.763 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -148.25 153.72 39.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 123.302 1.525 . . . . 0.0 111.18 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -77.46 129.47 35.78 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.143 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.5 140.11 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.58 1.152 . . . . 0.0 110.444 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.375 11.4 pt-20 -92.21 123.48 35.58 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 124.644 2.164 . . . . 0.0 109.81 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.259 25.2 ttt -172.62 86.93 0.07 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 110.143 -3.208 . . . . 0.0 105.228 -147.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.657 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -116.24 -147.07 0.41 Allowed 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -156.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.88 -144.59 9.02 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 121.23 3.252 . . . . 0.0 121.23 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.2 m -102.74 129.54 49.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.235 -0.568 . . . . 0.0 109.611 -176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.484 HG11 HG23 ' A' ' 15' ' ' THR . 56.0 t -61.64 123.46 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.773 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 173.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.296 63.3 mt -101.68 -17.53 16.26 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 119.816 -1.803 . . . . 0.0 112.99 167.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 6.1 tp10 -148.18 143.35 27.0 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.512 1.149 . . . . 0.0 110.598 161.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.484 HG23 HG11 ' A' ' 12' ' ' VAL . 22.8 p -106.18 106.09 16.43 Favored 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 100.545 -3.872 . . . . 0.0 100.545 171.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.364 0.3 OUTLIER -75.23 173.58 6.74 Favored Pre-proline 0 CA--C 1.592 2.56 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -167.125 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -48.65 -34.48 27.19 Favored 'Trans proline' 0 CA--C 1.567 2.148 0 N-CA-C 121.729 3.704 . . . . 0.0 121.729 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -84.69 -95.46 0.07 Allowed 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -158.97 73.53 0.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 58.8 mtt -126.92 167.3 16.04 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.703 0.801 . . . . 0.0 112.264 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.601 ' CE2' HG23 ' A' ' 35' ' ' ILE . 57.7 m-85 -128.82 114.59 16.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 118.544 -2.598 . . . . 0.0 108.205 -163.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -87.28 91.35 8.69 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.5 t -99.3 142.02 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -162.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -82.98 124.37 30.33 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 165.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.269 3.0 mt -74.47 -173.89 1.88 Allowed 'General case' 0 CA--C 1.579 2.066 0 CA-C-O 123.76 1.743 . . . . 0.0 112.016 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -26.03 63.65 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 171.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -90.77 8.72 33.23 Favored 'General case' 0 CA--C 1.582 2.209 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 169.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.55 6.55 89.26 Favored Glycine 0 CA--C 1.552 2.393 0 N-CA-C 119.61 2.604 . . . . 0.0 119.61 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -89.48 142.69 27.44 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 119.908 1.854 . . . . 0.0 112.001 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 t -84.57 124.35 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 122.087 0.946 . . . . 0.0 110.805 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.41 145.69 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.745 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 m -91.24 122.1 33.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.533 -1.354 . . . . 0.0 108.547 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.91 153.68 44.56 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -114.51 148.34 38.05 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.511 1.148 . . . . 0.0 109.129 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.601 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.1 pt -66.94 179.24 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.598 2.798 0 O-C-N 121.025 -1.047 . . . . 0.0 112.521 166.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.7 p -102.82 157.3 17.06 Favored 'General case' 0 CA--C 1.558 1.287 0 O-C-N 119.513 -1.992 . . . . 0.0 115.048 -176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.31 -3.98 27.73 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 119.297 2.479 . . . . 0.0 119.297 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.282 21.9 pttm -95.31 -54.26 3.47 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.691 1.738 . . . . 0.0 115.691 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -31.47 66.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 118.197 2.665 . . . . 0.0 118.197 175.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -35.58 -42.25 0.23 Allowed 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 120.344 3.461 . . . . 0.0 120.344 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.83 34.79 0.72 Allowed 'General case' 0 CA--C 1.581 2.149 0 CA-C-N 111.306 -2.679 . . . . 0.0 116.567 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -155.53 -74.9 0.11 Allowed 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 102.226 -3.25 . . . . 0.0 102.226 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.4 97.44 8.95 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.485 1.514 . . . . 0.0 107.943 165.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mt -74.26 -63.44 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.255 -0.903 . . . . 0.0 111.768 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -129.24 170.45 13.57 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.548 HD11 ' CE1' ' A' ' 21' ' ' PHE . 2.8 pt -146.73 171.56 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 109.507 -3.497 . . . . 0.0 111.363 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.5 tp -116.39 167.03 11.4 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.179 0.99 . . . . 0.0 110.973 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.1 m -70.74 86.17 0.67 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 123.539 1.638 . . . . 0.0 111.905 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.453 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 133.83 19.43 0.92 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 117.726 1.85 . . . . 0.0 117.726 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -94.79 165.71 12.34 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.985 1.314 . . . . 0.0 113.312 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -88.29 121.87 31.18 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 124.178 1.942 . . . . 0.0 111.945 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.69 163.98 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.881 0 CA-C-N 111.183 -2.735 . . . . 0.0 113.109 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 9' ' ' GLN 0.361 22.7 m -121.85 75.3 1.2 Allowed 'General case' 0 N--CA 1.514 2.743 0 CA-C-O 124.543 2.116 . . . . 0.0 114.754 172.047 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.657 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -75.84 100.56 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 126.82 2.048 . . . . 0.0 110.56 -174.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -83.25 144.34 29.81 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 120.842 -1.161 . . . . 0.0 109.081 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.4 -175.01 4.61 Favored 'General case' 0 CA--C 1.564 1.495 0 O-C-N 120.863 -1.148 . . . . 0.0 112.042 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -94.28 159.95 32.95 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -52.14 -41.45 65.0 Favored 'Trans proline' 0 CA--C 1.57 2.297 0 C-N-CA 123.443 2.762 . . . . 0.0 118.868 164.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -91.18 -54.55 3.89 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -93.64 78.9 4.28 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 122.507 1.146 . . . . 0.0 113.234 -171.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.16 -8.82 57.46 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 119.711 3.226 . . . . 0.0 119.711 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -75.96 -0.82 22.87 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -129.86 179.99 5.54 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.89 1.677 . . . . 0.0 113.053 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.18 -177.58 46.2 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 117.522 1.769 . . . . 0.0 117.522 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.34 111.27 1.64 Allowed 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.801 ' H ' HD12 ' A' ' 66' ' ' ILE 0.351 1.3 mp -38.57 89.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 119.152 -2.217 . . . . 0.0 116.547 164.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -75.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 CA-C-N 114.246 -1.343 . . . . 0.0 114.273 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -145.8 77.68 1.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.903 1.683 . . . . 0.0 114.568 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.3 ttm-85 -95.97 66.58 2.6 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.9 t -146.33 -98.74 0.09 Allowed 'General case' 0 CA--C 1.569 1.692 0 O-C-N 120.863 -1.148 . . . . 0.0 112.426 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 125.02 2.343 . . . . 0.0 112.32 -177.059 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.547 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.277 59.5 mtpt 68.46 -76.3 0.06 Allowed 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.89 78.33 6.06 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.339 1.066 . . . . 0.0 110.714 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.71 160.05 26.41 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.871 1.32 . . . . 0.0 114.225 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -94.64 136.41 34.98 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.563 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.97 155.49 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.705 -1.247 . . . . 0.0 110.246 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.331 12.4 pt-20 -113.78 119.32 36.93 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 124.128 1.918 . . . . 0.0 111.565 170.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.276 25.8 ttt -164.43 68.98 0.17 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 110.807 -2.906 . . . . 0.0 112.48 -152.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.665 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.597 0.3 OUTLIER -133.69 -167.86 2.01 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 177.075 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.45 -112.39 0.89 Allowed Glycine 0 N--CA 1.483 1.798 0 N-CA-C 122.226 3.65 . . . . 0.0 122.226 -167.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.2 m -103.97 136.32 43.84 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.682 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 45.9 t -71.49 100.01 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.615 3.451 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -64.5 -44.58 90.47 Favored 'General case' 0 N--CA 1.521 3.084 2 CA-C-N 127.163 4.529 . . . . 0.0 112.81 174.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -129.76 150.35 51.1 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 122.921 1.343 . . . . 0.0 110.464 171.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 p -104.34 97.9 7.77 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 101.391 -3.559 . . . . 0.0 101.391 171.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.281 5.2 mt -78.76 155.98 77.85 Favored Pre-proline 0 CA--C 1.595 2.68 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.259 -163.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.347 6.1 Cg_endo -14.15 -62.62 0.01 OUTLIER 'Trans proline' 0 CA--C 1.567 2.145 2 N-CA-C 125.343 5.093 . . . . 0.0 125.343 -169.676 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -75.81 -85.87 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.152 1.342 . . . . 0.0 109.108 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.6 m -155.94 75.11 0.89 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 81.3 mtp -120.24 179.37 4.31 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.756 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.476 ' HB3' HG22 ' A' ' 23' ' ' VAL . 58.3 m-85 -145.29 106.52 4.19 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 -165.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.3 ttt85 -84.2 93.94 8.29 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 170.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.6 t -98.57 136.0 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -162.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -96.03 108.42 20.82 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 26' ' ' GLU 0.345 0.3 OUTLIER -48.8 178.39 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 N-CA-C 121.473 3.879 . . . . 0.0 121.473 -177.15 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.554 ' H ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -75.43 -23.13 56.93 Favored 'General case' 0 CA--C 1.579 2.074 0 CA-C-N 112.462 -2.154 . . . . 0.0 113.704 166.437 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.264 0.1 OUTLIER -93.45 4.89 53.23 Favored 'General case' 0 CA--C 1.595 2.707 0 C-N-CA 124.703 1.201 . . . . 0.0 112.481 168.262 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.79 15.36 79.47 Favored Glycine 0 CA--C 1.547 2.056 0 N-CA-C 119.634 2.613 . . . . 0.0 119.634 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -101.08 136.12 41.44 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.007 1.904 . . . . 0.0 111.62 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.67 128.12 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 119.926 -1.734 . . . . 0.0 112.398 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -122.47 169.76 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.281 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -112.04 121.88 46.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.909 -1.12 . . . . 0.0 109.793 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.81 158.74 43.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 118.377 2.732 . . . . 0.0 118.377 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -106.74 166.21 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.806 1.289 . . . . 0.0 109.499 167.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.427 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.1 pt -78.55 -176.37 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.58 0 O-C-N 119.854 -1.779 . . . . 0.0 111.414 168.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.8 p -102.42 97.05 7.34 Favored 'General case' 0 CA--C 1.552 1.04 0 O-C-N 120.173 -1.58 . . . . 0.0 107.347 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -39.41 -30.43 0.16 Allowed Glycine 0 N--CA 1.499 2.868 0 N-CA-C 122.914 3.926 . . . . 0.0 122.914 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -66.13 -50.45 63.97 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -52.78 5.18 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 124.759 1.224 . . . . 0.0 113.596 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . 0.314 37.7 mmt180 -70.37 -47.84 59.1 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -171.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -94.13 46.21 1.16 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 123.855 1.788 . . . . 0.0 114.891 169.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -103.69 -53.38 2.79 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 167.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.264 39.4 p90 -72.33 -138.82 0.01 OUTLIER 'General case' 0 CA--C 1.592 2.594 0 CA-C-O 122.149 0.976 . . . . 0.0 108.96 154.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -118.62 -82.03 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 O-C-N 119.986 -1.696 . . . . 0.0 111.509 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -141.87 166.71 23.97 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 123.895 1.807 . . . . 0.0 114.802 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.284 2.4 pp -105.58 151.01 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.32 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.3 tp -86.64 162.49 17.92 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -165.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -65.43 99.33 0.41 Allowed 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 123.893 1.806 . . . . 0.0 112.069 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.682 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 113.66 -4.34 24.57 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 120.428 2.931 . . . . 0.0 120.428 -175.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -60.55 155.45 18.58 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -83.17 87.97 6.91 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 126.08 2.848 . . . . 0.0 113.235 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.19 146.06 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 108.987 -3.733 . . . . 0.0 110.314 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.3 m -137.02 115.91 12.28 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 100.421 -3.918 . . . . 0.0 100.421 171.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.665 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.26 92.3 t -121.46 127.05 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 112.779 -2.01 . . . . 0.0 107.429 -158.128 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -80.46 125.64 30.2 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.449 0.642 . . . . 0.0 111.955 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.263 0.3 OUTLIER -111.85 -110.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.209 -171.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.15 166.32 15.4 Favored Pre-proline 0 CA--C 1.582 2.183 0 C-N-CA 123.793 0.837 . . . . 0.0 112.924 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -60.09 -46.33 19.49 Favored 'Trans proline' 0 CA--C 1.568 2.22 0 C-N-CA 123.412 2.741 . . . . 0.0 117.759 166.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -100.5 -55.55 2.57 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -93.62 70.19 4.17 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.1 mp -68.63 2.24 2.61 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -69.31 -11.17 60.58 Favored 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -142.96 159.14 42.81 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 125.824 1.65 . . . . 0.0 113.223 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.47 -158.97 19.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 117.016 1.566 . . . . 0.0 117.016 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.26 124.29 7.43 Favored 'General case' 0 CA--C 1.59 2.498 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.486 ' CD1' ' H ' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -41.29 99.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 174.187 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -96.37 -30.87 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.095 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -124.47 146.2 49.08 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -89.47 111.09 21.88 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.926 0.89 . . . . 0.0 110.025 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 m -97.3 -0.16 47.01 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 . . . . . 0 CA--C 1.563 1.443 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 179.486 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 1.465 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -126.99 79.79 1.9 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.983 1.265 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.281 24.9 tt0 -130.46 -130.1 0.2 Allowed 'General case' 0 CA--C 1.57 1.726 0 CA-C-O 122.526 1.155 . . . . 0.0 108.887 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -109.06 149.68 28.93 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.17 1.388 . . . . 0.0 111.128 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -64.86 119.25 10.32 Favored 'General case' 0 CA--C 1.577 2.004 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.459 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.84 156.97 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.457 -1.402 . . . . 0.0 111.878 -171.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.35 9.8 pt-20 -106.29 120.78 42.76 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 124.537 2.113 . . . . 0.0 110.684 165.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 21.0 ttt -169.61 78.74 0.11 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 110.601 -3.0 . . . . 0.0 109.08 -155.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.669 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.612 0.0 OUTLIER -139.24 -168.42 2.44 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 173.274 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.64 -108.51 1.0 Allowed Glycine 0 N--CA 1.478 1.497 0 N-CA-C 121.198 3.239 . . . . 0.0 121.198 -165.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 98.9 m -121.88 135.31 54.88 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.497 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 73.7 t -61.49 117.57 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.612 3.327 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.7 mt -81.14 -45.23 16.72 Favored 'General case' 0 N--CA 1.511 2.577 0 CA-C-N 123.091 2.678 . . . . 0.0 110.809 167.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 6.1 tp10 -129.53 143.03 50.66 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 122.752 1.263 . . . . 0.0 111.535 170.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.458 HG23 HG11 ' A' ' 12' ' ' VAL . 20.4 p -103.01 107.56 18.4 Favored 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 101.03 -3.693 . . . . 0.0 101.03 171.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.391 0.2 OUTLIER -75.45 -175.35 0.46 Allowed Pre-proline 0 CA--C 1.594 2.646 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -167.086 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -52.35 -51.1 11.9 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 124.091 3.194 . . . . 0.0 119.493 -173.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.39 -86.75 0.05 OUTLIER 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -163.02 75.1 0.39 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 172.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 69.1 mtm -123.28 175.9 6.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.464 -0.772 . . . . 0.0 111.551 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.705 ' CE2' HG23 ' A' ' 35' ' ' ILE . 60.0 m-85 -140.68 113.67 8.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 118.908 -2.37 . . . . 0.0 107.29 -163.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -86.59 96.34 10.06 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 169.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -100.2 136.54 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -162.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -94.07 113.14 25.05 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 171.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.256 0.5 OUTLIER -56.5 178.77 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 -175.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.77 -25.63 66.57 Favored 'General case' 0 CA--C 1.573 1.844 0 CA-C-N 113.564 -1.653 . . . . 0.0 114.976 167.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -93.26 8.01 42.05 Favored 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 168.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.89 8.78 85.37 Favored Glycine 0 CA--C 1.556 2.639 0 N-CA-C 120.333 2.893 . . . . 0.0 120.333 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -93.67 138.97 31.35 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 119.275 1.537 . . . . 0.0 112.789 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.9 t -85.56 130.34 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.209 -1.557 . . . . 0.0 112.805 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.3 m -126.72 167.42 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 114.359 -1.291 . . . . 0.0 113.571 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 m -109.29 123.26 48.98 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.966 -1.084 . . . . 0.0 110.152 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.26 151.95 39.17 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 119.171 3.026 . . . . 0.0 119.171 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.33 170.16 8.62 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.036 -1.04 . . . . 0.0 109.594 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.705 HG23 ' CE2' ' A' ' 21' ' ' PHE . 6.4 pt -76.76 -177.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.552 0 O-C-N 119.531 -1.981 . . . . 0.0 110.97 164.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.2 p -100.73 144.52 29.6 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 119.646 -1.909 . . . . 0.0 110.761 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.93 -23.2 6.89 Favored Glycine 0 N--CA 1.508 3.463 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -63.78 -55.78 20.52 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.246 1.818 . . . . 0.0 114.768 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.6 ptp -73.77 -36.14 65.05 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 116.148 -1.882 . . . . 0.0 115.791 172.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HG2' HD11 ' A' ' 35' ' ' ILE . 51.4 mtt85 -37.33 -41.03 0.39 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.549 2.425 . . . . 0.0 117.549 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -93.19 -1.44 56.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -94.34 -68.68 0.79 Allowed 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.61 130.8 55.29 Favored 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 125.501 1.52 . . . . 0.0 107.717 170.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.6 mt -73.54 -65.37 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.044 0 O-C-N 120.004 -1.685 . . . . 0.0 111.166 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -105.33 164.52 11.79 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 120.954 3.687 . . . . 0.0 120.954 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.275 0.5 OUTLIER -133.97 168.6 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-N 109.545 -3.479 . . . . 0.0 109.457 173.701 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.59 163.81 12.17 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.445 1.117 . . . . 0.0 113.206 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 m -72.67 89.64 1.34 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 123.351 1.548 . . . . 0.0 110.955 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.497 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 121.64 24.17 2.41 Favored Glycine 0 N--CA 1.489 2.213 0 CA-C-N 113.382 -1.736 . . . . 0.0 116.749 -174.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -92.28 156.64 17.14 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-O 122.634 1.207 . . . . 0.0 112.224 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -86.69 91.67 8.68 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 125.76 2.695 . . . . 0.0 113.685 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -93.17 151.3 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.038 0 CA-C-N 109.59 -3.459 . . . . 0.0 111.503 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -143.55 112.18 6.47 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 100.34 -3.948 . . . . 0.0 100.34 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.669 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.278 94.1 t -120.54 125.5 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 112.108 -2.314 . . . . 0.0 107.066 -156.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -78.0 120.61 23.1 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.671 0.748 . . . . 0.0 111.102 -174.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.278 0.2 OUTLIER -105.2 -122.87 0.22 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.858 -175.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.4 169.05 11.22 Favored Pre-proline 0 CA--C 1.584 2.257 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.98 -49.31 0.69 Allowed 'Trans proline' 0 CA--C 1.551 1.346 0 C-N-CA 124.766 3.644 . . . . 0.0 118.517 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -96.24 -34.14 11.74 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.048 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -103.56 81.33 1.9 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.971 -173.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.13 -19.47 34.14 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 118.815 2.894 . . . . 0.0 118.815 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.0 m -65.69 -6.37 11.23 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 160.19 41.05 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 125.746 1.618 . . . . 0.0 113.654 -177.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.81 -159.32 17.84 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -157.07 117.96 3.63 Favored 'General case' 0 CA--C 1.586 2.332 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -38.79 97.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 174.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -95.99 -48.07 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 C-N-CA 124.388 1.075 . . . . 0.0 112.455 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.281 15.8 t80 71.95 -72.03 0.12 Allowed 'General case' 0 CA--C 1.572 1.816 0 C-N-CA 125.527 1.531 . . . . 0.0 112.782 -175.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -108.44 55.94 0.63 Allowed 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.9 p -80.67 -35.26 34.01 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? . . . . . 0 CA--C 1.558 1.283 0 CA-C-O 124.679 2.18 . . . . 0.0 110.758 -179.84 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.539 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -63.26 -55.29 26.04 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.46 73.24 4.45 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 121.475 -0.766 . . . . 0.0 110.042 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -71.61 151.63 43.59 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-O 123.679 1.704 . . . . 0.0 114.152 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -77.56 126.98 31.75 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 113.604 -1.635 . . . . 0.0 113.44 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.14 139.75 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.561 1.144 . . . . 0.0 109.663 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.308 6.6 pt-20 -97.56 116.51 29.92 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 124.89 2.281 . . . . 0.0 109.115 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 21.7 ttt -168.22 76.32 0.13 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 109.392 -3.549 . . . . 0.0 110.208 -148.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.662 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.613 0.0 OUTLIER -140.1 -166.92 2.2 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 174.691 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.16 -112.02 1.1 Allowed Glycine 0 N--CA 1.479 1.546 0 N-CA-C 120.633 3.013 . . . . 0.0 120.633 -165.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.8 m -118.26 137.53 52.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.473 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 58.8 t -64.57 105.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.608 3.176 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 mp -77.0 -45.0 28.83 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 117.966 -2.959 . . . . 0.0 113.175 170.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -122.56 148.84 44.73 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.354 1.074 . . . . 0.0 111.029 167.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 p -103.3 98.35 8.28 Favored 'General case' 0 N--CA 1.516 2.86 0 N-CA-C 101.667 -3.457 . . . . 0.0 101.667 170.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.27 5.3 mt -79.38 151.7 75.23 Favored Pre-proline 0 CA--C 1.591 2.535 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.482 -163.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.415 3.8 Cg_exo 8.61 -80.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.268 2 C-N-CA 126.686 4.924 . . . . 0.0 124.283 -170.696 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -76.04 -75.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 120.435 1.47 . . . . 0.0 110.869 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -158.34 75.96 0.75 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.258 61.9 mtt -118.37 -174.11 2.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 0.0 111.011 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.712 ' CE2' HG23 ' A' ' 35' ' ' ILE . 61.8 m-85 -148.3 108.83 4.16 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 118.919 -2.363 . . . . 0.0 105.152 -165.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -86.57 92.76 8.99 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 103.725 -2.695 . . . . 0.0 103.725 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -99.37 135.53 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -163.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.94 113.93 26.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 170.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.29 0.5 OUTLIER -58.46 -179.92 0.07 Allowed 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -176.265 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.79 -24.29 64.39 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-N 113.46 -1.7 . . . . 0.0 115.01 168.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -90.21 5.09 48.53 Favored 'General case' 0 CA--C 1.585 2.308 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.37 5.24 82.69 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 120.165 2.826 . . . . 0.0 120.165 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -94.93 142.46 27.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.616 1.708 . . . . 0.0 113.346 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.86 129.76 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-O 122.153 0.977 . . . . 0.0 112.384 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 m -139.83 152.6 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-O 122.208 1.004 . . . . 0.0 113.185 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -89.87 128.52 36.2 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.156 -1.59 . . . . 0.0 111.594 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.59 150.48 36.45 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -103.32 155.43 18.47 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.081 0.943 . . . . 0.0 110.595 170.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.712 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.1 pt -66.15 175.32 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.601 2.942 0 CA-C-O 122.913 1.339 . . . . 0.0 112.053 165.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.2 p -103.38 140.43 37.46 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 119.826 -1.796 . . . . 0.0 109.655 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.13 -16.27 6.17 Favored Glycine 0 N--CA 1.505 3.273 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -72.1 -49.64 34.62 Favored 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 126.656 1.982 . . . . 0.0 114.74 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.7 ptp -73.04 -24.16 60.68 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -38.74 -33.25 0.1 Allowed 'General case' 0 CA--C 1.587 2.381 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -91.85 -4.78 54.4 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -89.16 -72.97 0.52 Allowed 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 168.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -101.35 135.13 43.35 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 124.41 1.084 . . . . 0.0 108.759 166.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mt -71.5 -53.38 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.76 -1.212 . . . . 0.0 110.803 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -135.6 175.26 9.75 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-O 124.516 2.103 . . . . 0.0 112.792 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.403 HD11 ' CE1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -137.11 156.15 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 113.138 -1.846 . . . . 0.0 108.758 177.19 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.8 mp -95.77 166.51 11.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -73.69 87.14 1.68 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 123.48 1.609 . . . . 0.0 111.18 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.473 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 124.6 18.86 2.63 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-N 113.308 -1.769 . . . . 0.0 117.233 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -91.26 167.0 12.63 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 122.781 1.276 . . . . 0.0 111.234 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -90.08 129.67 36.35 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 124.951 2.31 . . . . 0.0 114.306 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.5 m -134.14 152.53 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.827 0 CA-C-N 110.511 -3.041 . . . . 0.0 110.693 -173.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.9 m -142.99 111.6 6.32 Favored 'General case' 0 N--CA 1.501 2.103 1 N-CA-C 100.19 -4.004 . . . . 0.0 100.19 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.662 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.276 71.7 t -125.35 123.85 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 112.261 -2.245 . . . . 0.0 107.182 -156.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -79.32 141.58 36.86 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.45 -175.81 4.93 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 122.125 0.964 . . . . 0.0 110.864 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -90.41 158.48 43.22 Favored Pre-proline 0 CA--C 1.573 1.835 0 O-C-N 120.611 -1.306 . . . . 0.0 112.999 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -54.86 -42.65 66.79 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 123.068 2.512 . . . . 0.0 118.422 164.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -90.39 -45.73 8.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -102.74 81.44 2.01 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 122.35 1.072 . . . . 0.0 113.031 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.67 43.06 0.81 Allowed 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 64.2 m -95.32 -28.6 14.89 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -132.29 -178.23 4.82 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-O 122.749 1.261 . . . . 0.0 114.049 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.49 177.25 40.2 Favored Glycine 0 CA--C 1.554 2.514 0 N-CA-C 117.145 1.618 . . . . 0.0 117.145 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.3 113.21 3.15 Favored 'General case' 0 CA--C 1.596 2.732 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 168.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.48 ' CD1' ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -45.5 104.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 CA-C-N 122.495 2.407 . . . . 0.0 113.968 173.227 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m -94.67 145.25 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -109.46 28.61 8.36 Favored 'General case' 0 CA--C 1.586 2.36 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -147.44 164.21 34.07 Favored 'General case' 0 CA--C 1.574 1.894 0 C-N-CA 125.488 1.515 . . . . 0.0 110.502 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.5 p -94.39 71.59 3.77 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.058 -1.651 . . . . 0.0 112.569 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 123.326 1.536 . . . . 0.0 113.616 -177.796 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.583 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.287 60.8 mttp 74.78 -55.36 0.65 Allowed 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.08 33.76 0.29 Allowed 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.256 4.8 p-10 -109.0 -151.13 0.47 Allowed 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 125.795 1.638 . . . . 0.0 111.802 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -76.0 97.2 3.95 Favored 'General case' 0 CA--C 1.577 1.991 0 O-C-N 120.484 -1.385 . . . . 0.0 108.472 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 mt -92.3 143.95 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.773 -1.204 . . . . 0.0 110.84 -171.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.293 8.8 pt-20 -99.22 122.57 42.59 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 124.664 2.173 . . . . 0.0 109.512 170.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.293 6.5 ttt -152.95 -4.49 0.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 109.898 -3.319 . . . . 0.0 119.283 -151.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.848 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.537 0.5 OUTLIER -75.8 -164.03 0.32 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 121.657 3.947 . . . . 0.0 121.657 -166.607 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.42 -112.54 1.08 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 122.514 3.766 . . . . 0.0 122.514 -163.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.8 m -108.78 135.97 49.12 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.712 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 78.3 t -71.81 107.38 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.981 0 CA-C-N 120.379 1.445 . . . . 0.0 107.327 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.13 -42.56 72.45 Favored 'General case' 0 N--CA 1.516 2.843 0 CA-C-N 124.814 3.461 . . . . 0.0 112.056 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -132.6 147.83 52.35 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.151 0.977 . . . . 0.0 110.988 170.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.409 HG23 HG11 ' A' ' 12' ' ' VAL . 11.0 p -102.66 102.99 13.23 Favored 'General case' 0 N--CA 1.514 2.728 0 N-CA-C 101.94 -3.356 . . . . 0.0 101.94 170.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.347 5.4 mt -80.82 -179.03 1.3 Allowed Pre-proline 0 CA--C 1.598 2.797 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -164.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.273 21.1 Cg_endo -47.51 -45.55 22.79 Favored 'Trans proline' 0 CA--C 1.568 2.185 1 N-CA-C 123.786 4.495 . . . . 0.0 123.786 -167.963 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.58 -89.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.38 1.445 . . . . 0.0 108.31 172.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.4 m -153.03 76.22 1.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 171.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.4 mtt -120.61 176.25 5.6 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.521 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CE2' HG23 ' A' ' 35' ' ' ILE . 55.6 m-85 -146.05 108.71 4.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -164.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 tpt85 -83.51 94.63 8.08 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.9 t -100.72 139.09 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -162.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -92.36 115.24 27.92 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.27 0.6 OUTLIER -64.7 178.92 0.7 Allowed 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -177.421 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -67.66 -27.37 66.8 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 168.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -91.79 8.86 35.19 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 171.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.06 16.62 78.46 Favored Glycine 0 CA--C 1.555 2.549 0 N-CA-C 119.929 2.731 . . . . 0.0 119.929 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -98.58 131.46 44.78 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.188 1.494 . . . . 0.0 111.823 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -83.89 127.61 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 123.17 1.462 . . . . 0.0 111.435 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.73 HG21 HE21 ' A' ' 9' ' ' GLN . 18.7 m -123.38 159.77 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.882 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 m -106.73 123.24 47.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.54 -1.35 . . . . 0.0 109.432 172.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.57 157.85 44.28 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 118.881 2.919 . . . . 0.0 118.881 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -104.47 167.58 9.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 163.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.58 HG23 ' CE2' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -77.12 177.19 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.526 0 O-C-N 119.98 -1.7 . . . . 0.0 110.295 162.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.3 p -77.97 87.83 4.14 Favored 'General case' 0 CA--C 1.573 1.829 0 O-C-N 119.062 -2.274 . . . . 0.0 108.591 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -17.93 -47.61 0.01 OUTLIER Glycine 0 N--CA 1.505 3.26 1 N-CA-C 124.297 4.479 . . . . 0.0 124.297 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -45.36 -46.16 12.93 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 118.776 2.88 . . . . 0.0 118.776 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.27 0.0 OUTLIER -69.46 -23.87 63.71 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 177.113 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.454 ' HG3' HD11 ' A' ' 35' ' ' ILE . 98.7 mtt180 -37.97 -41.18 0.53 Allowed 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 122.9 2.591 . . . . 0.0 117.159 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -96.76 3.93 52.06 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 119.804 3.261 . . . . 0.0 119.804 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -110.37 -63.12 1.42 Allowed 'General case' 0 CA--C 1.571 1.764 0 C-N-CA 125.605 1.562 . . . . 0.0 107.062 172.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.88 104.08 10.22 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 169.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -67.91 112.64 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-O 124.426 2.06 . . . . 0.0 107.906 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -41.84 161.34 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.851 1 N-CA-C 123.557 4.651 . . . . 0.0 123.557 -167.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.46 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.255 1.1 pt -89.61 160.82 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.78 0 CA-C-N 109.26 -3.609 . . . . 0.0 115.409 -175.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 tp -115.14 175.54 5.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.378 -170.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -67.7 91.84 0.32 Allowed 'General case' 0 CA--C 1.575 1.917 0 CA-C-O 124.389 2.042 . . . . 0.0 114.296 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.712 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 124.04 -2.15 9.13 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -65.32 156.89 30.67 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -81.91 90.75 6.47 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 125.699 2.666 . . . . 0.0 113.962 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 m -93.07 154.67 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 CA-C-N 109.435 -3.529 . . . . 0.0 110.766 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.3 m -147.9 103.25 3.48 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 100.609 -3.848 . . . . 0.0 100.609 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.848 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 23.7 t -109.06 131.63 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 111.076 -2.784 . . . . 0.0 107.305 -162.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -83.77 130.16 34.94 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.908 -1.12 . . . . 0.0 111.991 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.275 0.5 OUTLIER -108.28 -155.81 0.56 Allowed 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 122.047 0.927 . . . . 0.0 110.962 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.4 p -138.12 161.39 59.77 Favored Pre-proline 0 CA--C 1.572 1.789 0 O-C-N 121.021 -1.049 . . . . 0.0 112.064 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.99 -42.16 59.99 Favored 'Trans proline' 0 CA--C 1.573 2.441 0 C-N-CA 123.315 2.677 . . . . 0.0 118.459 163.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -87.49 -50.42 6.55 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -102.37 80.68 1.97 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.314 1.054 . . . . 0.0 112.337 -172.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -28.51 64.89 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.9 t -76.75 13.62 0.98 Allowed 'General case' 0 CA--C 1.587 2.374 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -139.14 172.75 12.38 Favored 'General case' 0 CA--C 1.57 1.732 0 O-C-N 119.643 -1.911 . . . . 0.0 114.353 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.57 -165.84 38.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.52 122.67 5.46 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.768 ' H ' HD12 ' A' ' 66' ' ' ILE . 2.2 mp -46.62 104.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.933 0 CA-C-N 121.734 2.061 . . . . 0.0 114.475 170.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 m -96.43 142.28 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.164 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -88.1 70.16 9.3 Favored 'General case' 0 CA--C 1.578 2.049 0 O-C-N 121.045 -1.035 . . . . 0.0 110.67 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.637 ' HE ' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -160.02 173.58 15.64 Favored 'General case' 0 CA--C 1.575 1.942 0 C-N-CA 124.358 1.063 . . . . 0.0 111.779 -176.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.637 ' H ' ' HE ' ' A' ' 69' ' ' ARG . 83.2 p -123.3 76.13 1.37 Allowed 'General case' 0 CA--C 1.571 1.771 0 O-C-N 120.782 -1.198 . . . . 0.0 113.257 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 125.062 2.363 . . . . 0.0 110.897 178.686 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.572 0 CA-C-O 121.874 0.845 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -84.42 91.31 7.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.999 -1.063 . . . . 0.0 111.926 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -89.69 62.03 5.67 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-O 122.727 1.251 . . . . 0.0 113.741 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.77 143.74 43.9 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -67.93 122.98 19.34 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -95.37 141.33 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.098 0.959 . . . . 0.0 110.222 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.303 9.1 pt-20 -96.4 122.09 38.91 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 125.068 2.366 . . . . 0.0 108.62 169.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 22.0 ttt -172.61 89.06 0.09 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 109.471 -3.513 . . . . 0.0 105.035 -149.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.711 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -117.19 -151.15 0.47 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -157.282 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 177.56 -137.65 3.52 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 117.348 1.699 . . . . 0.0 117.348 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.8 m -124.71 133.72 53.09 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.511 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 59.7 t -59.22 116.53 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.602 2.959 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.561 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.1 mt -83.9 -42.07 16.73 Favored 'General case' 0 N--CA 1.509 2.504 0 CA-C-N 122.299 2.318 . . . . 0.0 110.941 166.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 6.1 tt0 -133.97 143.97 48.49 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.829 1.299 . . . . 0.0 111.576 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.4 p -97.8 105.1 17.19 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 170.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.324 5.2 mt -78.86 179.77 1.65 Allowed Pre-proline 0 CA--C 1.596 2.718 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -164.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.266 27.8 Cg_endo -47.89 -45.91 23.24 Favored 'Trans proline' 0 CA--C 1.568 2.191 1 N-CA-C 122.552 4.02 . . . . 0.0 122.552 -169.591 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -82.84 -92.33 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.1 1.318 . . . . 0.0 107.735 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -151.61 73.28 1.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 171.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.7 mtp -119.78 176.52 5.36 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.641 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.48 ' HB3' HG22 ' A' ' 23' ' ' VAL . 56.9 m-85 -140.68 112.04 7.32 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -166.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -83.28 94.26 7.88 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 169.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.1 t -100.96 136.91 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -163.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -88.48 113.06 23.68 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.268 4.3 mt -73.39 -179.54 3.48 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 124.1 1.905 . . . . 0.0 112.554 -172.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.37 -22.18 61.18 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -90.11 6.37 42.77 Favored 'General case' 0 CA--C 1.585 2.292 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.95 15.79 76.52 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 119.828 2.691 . . . . 0.0 119.828 -176.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -102.91 139.9 37.88 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 119.248 1.524 . . . . 0.0 111.837 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -87.42 113.39 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.762 -1.211 . . . . 0.0 109.93 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.7 m -109.93 153.93 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -96.23 118.42 32.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.813 -1.179 . . . . 0.0 109.588 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.11 158.59 44.11 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.72 2.118 . . . . 0.0 116.72 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -105.68 -176.51 3.1 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.492 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -90.45 175.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.367 0 O-C-N 119.899 -1.751 . . . . 0.0 109.215 161.647 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.6 p -75.12 20.07 0.14 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 120.612 3.56 . . . . 0.0 120.612 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.79 -45.79 1.1 Allowed Glycine 0 N--CA 1.499 2.844 0 N-CA-C 118.644 2.218 . . . . 0.0 118.644 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -63.62 -54.07 41.68 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -22.8 64.79 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.9 mtp-105 -39.81 -35.81 0.38 Allowed 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -90.63 4.78 50.42 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 118.965 2.95 . . . . 0.0 118.965 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -97.15 -74.07 0.58 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 167.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -110.87 138.47 47.23 Favored 'General case' 0 CA--C 1.579 2.061 0 C-N-CA 125.334 1.453 . . . . 0.0 107.217 166.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.4 mt -73.66 -68.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 119.976 -1.702 . . . . 0.0 111.275 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -113.54 168.14 10.01 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 119.755 3.243 . . . . 0.0 119.755 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.357 1.8 pp -119.12 169.66 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 110.017 -3.265 . . . . 0.0 108.873 171.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.6 tp -100.98 163.2 12.4 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -168.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 m -69.73 92.94 0.69 Allowed 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 123.783 1.754 . . . . 0.0 111.49 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.511 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 117.01 22.92 4.07 Favored Glycine 0 N--CA 1.488 2.148 0 CA-C-N 112.678 -2.055 . . . . 0.0 117.439 -175.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -93.11 156.68 16.71 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.881 1.324 . . . . 0.0 113.33 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -88.66 83.32 6.74 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 125.231 2.444 . . . . 0.0 112.967 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.512 ' HB ' HD12 ' A' ' 66' ' ' ILE . 6.9 m -73.64 165.24 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 CA-C-N 110.436 -3.075 . . . . 0.0 114.972 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.801 ' H ' HG23 ' A' ' 66' ' ' ILE 0.274 5.1 m -120.52 77.23 1.25 Allowed 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 124.079 1.895 . . . . 0.0 112.434 173.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.711 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -75.47 94.05 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 O-C-N 120.219 -1.551 . . . . 0.0 110.328 -171.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -81.97 136.41 35.28 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.059 -1.026 . . . . 0.0 109.049 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.251 2.4 pt? -136.62 -165.01 1.66 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.844 -1.16 . . . . 0.0 112.351 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 p -110.29 159.5 31.82 Favored Pre-proline 0 CA--C 1.573 1.856 0 O-C-N 120.731 -1.231 . . . . 0.0 113.342 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.18 -38.91 81.76 Favored 'Trans proline' 0 CA--C 1.569 2.258 0 C-N-CA 123.39 2.727 . . . . 0.0 119.094 163.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -87.06 -52.23 5.55 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -96.86 78.87 2.88 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 122.323 1.058 . . . . 0.0 113.286 -172.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.36 -11.2 60.19 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 120.316 3.45 . . . . 0.0 120.316 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.0 m -73.69 -2.96 25.41 Favored 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 173.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.58 178.85 6.18 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.451 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . -178.31 -172.4 42.67 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 116.942 1.537 . . . . 0.0 116.942 175.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.3 105.9 1.0 Allowed 'General case' 0 CA--C 1.583 2.234 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.819 HD13 ' H ' ' A' ' 66' ' ' ILE 0.26 0.0 OUTLIER -28.08 87.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.063 0 N-CA-C 119.276 3.065 . . . . 0.0 119.276 167.261 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -88.67 140.5 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 C-N-CA 124.483 1.113 . . . . 0.0 112.88 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -80.53 96.3 6.75 Favored 'General case' 0 CA--C 1.569 1.7 0 O-C-N 120.806 -1.184 . . . . 0.0 111.399 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.33 141.35 39.75 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.482 0.658 . . . . 0.0 112.415 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.2 p -84.28 66.75 9.51 Favored 'General case' 0 CA--C 1.571 1.788 0 O-C-N 120.828 -1.17 . . . . 0.0 113.284 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 . . . . . 0 CA--C 1.56 1.365 0 CA-C-O 125.109 2.385 . . . . 0.0 114.279 -179.057 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.567 1.622 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -81.91 -29.57 32.29 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.44 59.26 2.86 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -91.38 20.84 4.9 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 118.997 2.962 . . . . 0.0 118.997 -175.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.85 128.36 35.37 Favored 'General case' 0 CA--C 1.577 2.0 0 C-N-CA 123.976 0.91 . . . . 0.0 113.235 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mt -109.35 141.55 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.885 -1.134 . . . . 0.0 110.356 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.339 12.7 pt-20 -100.78 118.7 37.38 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 124.014 1.864 . . . . 0.0 110.664 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.285 21.2 ttt -159.26 38.5 0.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.603 -2.544 . . . . 0.0 117.312 -148.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.783 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.531 0.0 OUTLIER -123.11 -175.91 3.29 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 120.01 3.337 . . . . 0.0 120.01 -173.201 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.9 -110.97 1.09 Allowed Glycine 0 N--CA 1.481 1.7 1 N-CA-C 123.653 4.221 . . . . 0.0 123.653 -163.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.1 m -102.89 131.01 50.11 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.476 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 83.8 t -63.46 107.19 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.601 2.913 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.318 98.4 mt -86.33 -36.02 19.51 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 118.813 -2.429 . . . . 0.0 111.98 173.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -128.21 147.05 50.56 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 123.149 1.452 . . . . 0.0 110.563 164.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.3 p -108.89 105.08 14.48 Favored 'General case' 0 N--CA 1.511 2.615 1 N-CA-C 99.889 -4.115 . . . . 0.0 99.889 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.356 0.4 OUTLIER -74.06 -178.78 0.82 Allowed Pre-proline 0 CA--C 1.592 2.584 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -165.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -55.24 -40.91 83.21 Favored 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 123.886 3.057 . . . . 0.0 120.036 -174.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -83.13 -92.95 0.07 Allowed 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.4 m -157.58 73.87 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.7 mtt -124.14 166.63 15.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.964 0.887 . . . . 0.0 112.658 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 46' ' ' ILE . 57.5 m-85 -127.84 110.88 13.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -165.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -84.22 92.02 7.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 171.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.495 HG21 HG21 ' A' ' 54' ' ' VAL . 1.4 t -99.72 134.03 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -164.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -83.26 115.11 21.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.567 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.264 0.1 OUTLIER -69.54 177.05 3.1 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 178.881 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.6 -14.24 40.66 Favored 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 167.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.567 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 23.7 t30 -92.12 -3.82 55.15 Favored 'General case' 0 CA--C 1.586 2.362 0 O-C-N 121.352 -0.843 . . . . 0.0 112.845 167.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.46 -5.38 81.28 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 119.182 2.433 . . . . 0.0 119.182 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -86.93 142.17 28.19 Favored 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 124.071 0.948 . . . . 0.0 110.388 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.8 131.4 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 CA-C-O 122.476 1.131 . . . . 0.0 112.831 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 m -130.97 150.25 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.5 m -92.62 124.88 36.96 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.263 -1.523 . . . . 0.0 110.801 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.77 170.16 16.4 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -120.23 136.04 54.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.736 -1.227 . . . . 0.0 112.518 174.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.559 HD13 ' HG3' ' A' ' 40' ' ' ARG 0.349 0.0 OUTLIER -79.56 146.92 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.068 0 O-C-N 120.541 -1.349 . . . . 0.0 109.304 176.211 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.97 92.25 1.63 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 119.434 -2.041 . . . . 0.0 113.88 -170.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -42.69 -30.34 0.91 Allowed Glycine 0 N--CA 1.491 2.327 1 N-CA-C 123.944 4.338 . . . . 0.0 123.944 -173.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -54.32 -49.46 69.64 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.94 -45.2 11.03 Favored 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 125.903 1.681 . . . . 0.0 114.717 170.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.559 ' HG3' HD13 ' A' ' 35' ' ' ILE 0.28 3.9 mmp_? -82.42 -40.58 21.03 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.203 1.801 . . . . 0.0 115.185 -166.035 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -92.91 40.03 1.05 Allowed 'General case' 0 CA--C 1.586 2.358 0 CA-C-O 122.52 1.152 . . . . 0.0 113.284 164.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -96.55 -43.93 7.38 Favored 'General case' 0 CA--C 1.576 1.945 0 C-N-CA 124.949 1.299 . . . . 0.0 108.45 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.278 35.2 p90 -68.54 -113.34 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 126.04 1.736 . . . . 0.0 109.81 162.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.45 -91.26 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.71 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -147.85 172.41 14.19 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 124.035 1.874 . . . . 0.0 109.957 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.508 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.252 1.1 pp -89.79 152.67 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.984 170.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -86.93 160.32 18.73 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 -166.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 m -73.57 83.81 1.54 Allowed 'General case' 0 CA--C 1.571 1.751 0 CA-C-O 123.854 1.787 . . . . 0.0 111.001 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.476 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 129.47 22.2 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 CA-C-N 112.982 -1.917 . . . . 0.0 116.813 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -91.61 160.14 15.54 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 123.331 1.538 . . . . 0.0 112.332 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -87.71 94.35 9.71 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 125.719 2.676 . . . . 0.0 113.518 -175.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.41 HG23 HG11 ' A' ' 23' ' ' VAL . 21.7 m -99.8 145.78 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-N 109.757 -3.383 . . . . 0.0 110.122 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.7 m -137.07 112.02 8.93 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.783 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.251 24.2 t -116.32 130.64 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.531 -159.38 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -88.4 136.46 32.97 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.006 0.907 . . . . 0.0 112.397 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.25 -169.98 2.24 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.64 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 58' ' ' PRO . 0.5 OUTLIER -153.83 166.0 16.66 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 120.321 -1.487 . . . . 0.0 111.395 175.101 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -35.1 -48.87 0.77 Allowed 'Trans proline' 0 CA--C 1.561 1.828 1 N-CA-C 122.778 4.107 . . . . 0.0 122.778 173.348 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.5 -29.76 52.67 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.825 1.298 . . . . 0.0 113.992 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -96.65 69.91 2.54 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 114.106 -1.406 . . . . 0.0 113.474 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.5 mt -87.09 -41.3 13.92 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -76.88 5.56 7.67 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -143.09 173.77 11.27 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 120.991 1.723 . . . . 0.0 114.953 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.95 -165.53 34.0 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -155.86 122.64 5.28 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.539 -1.565 . . . . 0.0 113.554 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.725 HD12 ' H ' ' A' ' 66' ' ' ILE . 1.8 mp -45.81 113.15 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 172.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -94.06 -70.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.21 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -165.73 132.11 2.66 Favored 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.68 1.192 . . . . 0.0 110.183 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.0 ttt85 -87.19 71.5 10.07 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.456 -1.402 . . . . 0.0 112.111 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.4 m -163.26 74.75 0.36 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.436 1.094 . . . . 0.0 109.257 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 123.839 1.78 . . . . 0.0 112.169 -178.423 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.564 1.494 0 CA-C-O 121.628 0.728 . . . . 0.0 112.574 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -152.42 -74.94 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.453 -0.779 . . . . 0.0 110.375 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.32 8.3 tp10 -115.31 -117.06 0.32 Allowed 'General case' 0 CA--C 1.565 1.528 0 CA-C-O 122.766 1.27 . . . . 0.0 109.915 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -100.65 134.38 43.7 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 125.63 1.572 . . . . 0.0 114.881 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -72.65 116.1 12.72 Favored 'General case' 0 CA--C 1.573 1.839 0 O-C-N 121.071 -1.018 . . . . 0.0 111.53 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -97.48 143.96 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.287 1.035 . . . . 0.0 111.29 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.325 11.1 pt-20 -92.86 120.45 33.22 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 125.525 2.583 . . . . 0.0 108.305 168.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.282 16.1 ttt -167.16 81.29 0.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 108.873 -3.785 . . . . 0.0 105.308 -150.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.557 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -97.33 -152.55 0.39 Allowed 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -158.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -164.38 -173.42 33.01 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 120.411 2.924 . . . . 0.0 120.411 -172.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.8 m -98.49 127.96 44.64 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 57.4 t -60.55 117.09 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.912 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 175.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.285 68.2 mt -101.34 -16.88 16.77 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 119.786 -1.822 . . . . 0.0 113.467 170.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -146.8 141.52 26.77 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.956 1.36 . . . . 0.0 109.621 160.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.3 p -94.56 100.62 12.56 Favored 'General case' 0 N--CA 1.516 2.825 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 169.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.282 6.0 mt -79.78 154.26 75.7 Favored Pre-proline 0 CA--C 1.594 2.644 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.873 -166.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.399 2.3 Cg_endo 2.11 -78.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.57 2.324 2 C-N-CA 126.777 4.985 . . . . 0.0 124.997 -171.618 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.29 -77.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 120.64 1.564 . . . . 0.0 110.877 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -156.38 76.03 0.88 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtt -119.69 -177.3 3.36 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.517 0.727 . . . . 0.0 111.708 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.493 ' CE1' HD11 ' A' ' 46' ' ' ILE . 57.1 m-85 -146.74 108.32 4.31 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 119.669 -1.894 . . . . 0.0 106.735 -166.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -86.9 94.52 9.61 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.3 t -102.86 135.73 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -163.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.55 111.75 21.55 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.532 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.286 0.1 OUTLIER -78.6 171.46 15.09 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 124.116 1.912 . . . . 0.0 115.782 -176.704 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.34 -13.96 44.81 Favored 'General case' 0 CA--C 1.578 2.056 0 CA-C-N 112.454 -2.157 . . . . 0.0 114.652 167.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.532 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 46.0 t30 -83.64 -11.21 57.56 Favored 'General case' 0 CA--C 1.587 2.371 0 CA-C-N 119.334 0.97 . . . . 0.0 113.337 164.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.84 -22.18 40.76 Favored Glycine 0 CA--C 1.549 2.216 0 N-CA-C 118.351 2.1 . . . . 0.0 118.351 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -79.71 143.38 34.61 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.122 0.969 . . . . 0.0 112.168 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.7 t -83.75 121.33 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 122.447 1.118 . . . . 0.0 109.507 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.54 144.36 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.801 -175.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.7 m -86.79 126.33 34.54 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.489 -1.382 . . . . 0.0 110.574 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.93 159.37 42.29 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -119.5 164.86 15.17 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 168.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -78.47 171.8 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.594 2.65 0 O-C-N 120.562 -1.336 . . . . 0.0 110.906 168.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.1 p -76.19 14.11 0.79 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 120.353 3.464 . . . . 0.0 120.353 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.83 -47.86 0.78 Allowed Glycine 0 N--CA 1.5 2.953 0 N-CA-C 117.819 1.888 . . . . 0.0 117.819 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -63.21 -51.13 67.54 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 126.54 1.936 . . . . 0.0 115.289 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ptm -70.16 -17.94 63.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 118.607 2.817 . . . . 0.0 118.607 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -39.14 -34.05 0.16 Allowed 'General case' 0 CA--C 1.583 2.244 0 CA-C-N 121.772 2.078 . . . . 0.0 116.443 167.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm -93.56 40.52 1.07 Allowed 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 173.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -157.56 -68.81 0.1 Allowed 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -93.38 101.18 13.4 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 165.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.27 20.9 mt -72.66 -77.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.768 -1.207 . . . . 0.0 111.444 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -136.61 171.09 15.0 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-O 125.988 2.804 . . . . 0.0 114.013 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.493 HD11 ' CE1' ' A' ' 21' ' ' PHE . 1.8 pt -147.08 167.18 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 109.959 -3.291 . . . . 0.0 109.581 -172.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.279 1.3 pt? -122.73 -174.71 2.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 111.262 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.255 94.2 m -75.25 87.12 2.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 123.376 1.56 . . . . 0.0 113.399 -175.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 133.77 22.7 0.74 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.62 170.33 9.28 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 125.389 1.475 . . . . 0.0 114.77 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -81.6 118.55 22.87 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 125.342 2.496 . . . . 0.0 112.402 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.08 149.1 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 109.761 -3.381 . . . . 0.0 111.265 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.557 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.311 89.3 m -94.42 162.39 13.84 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 162.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.455 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -158.07 87.03 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 O-C-N 118.452 -2.655 . . . . 0.0 105.104 -179.234 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -76.86 140.62 40.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.09 -1.006 . . . . 0.0 110.059 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.96 -167.53 2.8 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 121.7 0.762 . . . . 0.0 112.582 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -99.52 160.46 27.39 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -56.8 -42.53 63.74 Favored 'Trans proline' 0 CA--C 1.57 2.312 0 N-CA-C 118.756 2.56 . . . . 0.0 118.756 164.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -92.24 -45.02 8.44 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -174.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -102.0 81.9 2.17 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.068 0.937 . . . . 0.0 112.685 -173.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.05 41.04 0.73 Allowed 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.7 m -101.47 -20.98 14.89 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -137.52 178.77 6.85 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 124.761 1.225 . . . . 0.0 113.593 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.0 -171.08 43.11 Favored Glycine 0 CA--C 1.551 2.314 0 O-C-N 121.468 -0.77 . . . . 0.0 114.687 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.96 121.53 2.81 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.584 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -40.0 92.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 119.346 -2.096 . . . . 0.0 116.216 166.471 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.272 0.2 OUTLIER -70.92 -67.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.652 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.931 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -140.41 84.43 1.95 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.404 1.456 . . . . 0.0 112.513 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -108.49 86.42 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.2 m -152.75 -80.47 0.1 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.597 -1.314 . . . . 0.0 112.012 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 . . . . . 0 CA--C 1.555 1.155 0 CA-C-O 124.842 2.258 . . . . 0.0 111.428 -176.307 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.328 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.292 56.2 mtpt 69.47 -74.7 0.08 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.297 0.3 OUTLIER -112.14 -113.67 0.33 Allowed 'General case' 0 CA--C 1.564 1.49 0 CA-C-O 122.522 1.153 . . . . 0.0 109.463 179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -100.5 113.87 27.01 Favored 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 125.206 1.402 . . . . 0.0 114.395 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -157.14 139.99 15.17 Favored 'General case' 0 CA--C 1.576 1.953 0 C-N-CA 124.079 0.952 . . . . 0.0 110.489 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.02 140.31 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.492 -1.38 . . . . 0.0 110.249 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.382 11.3 pt-20 -99.23 120.48 39.61 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 124.466 2.079 . . . . 0.0 110.778 169.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 20.2 ttt -170.69 76.94 0.07 Allowed 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 110.565 -3.016 . . . . 0.0 110.764 -149.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.587 ' HB2' ' HB ' ' A' ' 54' ' ' VAL 0.608 0.0 OUTLIER -143.13 -166.13 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 119.231 3.049 . . . . 0.0 119.231 175.548 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 -111.16 1.19 Allowed Glycine 0 CA--C 1.542 1.764 0 N-CA-C 121.871 3.508 . . . . 0.0 121.871 -164.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -122.35 139.43 53.84 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.502 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 60.6 t -67.25 101.21 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.605 3.058 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.96 -44.2 61.41 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 117.947 -2.971 . . . . 0.0 113.39 171.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.25 148.89 47.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.305 1.05 . . . . 0.0 110.857 167.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 p -102.16 101.62 11.96 Favored 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 168.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.274 5.5 mt -79.86 150.55 72.43 Favored Pre-proline 0 CA--C 1.59 2.484 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.031 -164.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.413 3.0 Cg_exo 8.62 -77.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.351 2 C-N-CA 126.624 4.883 . . . . 0.0 124.378 -170.126 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -79.31 -81.67 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.017 1.281 . . . . 0.0 110.461 174.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.4 m -149.23 74.79 1.26 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.274 61.3 mtt -118.79 -175.83 2.98 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.221 -0.925 . . . . 0.0 111.521 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.601 ' HE2' HG22 ' A' ' 35' ' ' ILE . 58.1 m-85 -147.35 107.87 4.11 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 -166.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -86.35 96.21 9.92 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.7 t -103.81 133.04 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -162.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.38 110.19 21.49 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.301 0.5 OUTLIER -56.25 179.22 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 -175.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.44 -25.47 66.76 Favored 'General case' 0 CA--C 1.58 2.11 0 CA-C-N 113.55 -1.659 . . . . 0.0 114.375 165.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.25 1.5 m-20 -78.87 -12.46 60.03 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 169.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.41 5.98 74.75 Favored Glycine 0 CA--C 1.562 2.984 0 N-CA-C 117.432 1.733 . . . . 0.0 117.432 -169.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -90.94 132.36 36.0 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.391 1.596 . . . . 0.0 112.701 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.14 125.38 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.73 -1.231 . . . . 0.0 111.698 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.42 154.5 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 122.287 1.041 . . . . 0.0 113.126 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 m -88.36 127.19 35.49 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.178 -1.576 . . . . 0.0 111.095 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.2 168.88 18.69 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -138.87 141.21 38.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.675 0.79 . . . . 0.0 111.802 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.601 HG22 ' HE2' ' A' ' 21' ' ' PHE 0.3 0.0 OUTLIER -73.13 137.84 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 O-C-N 120.202 -1.561 . . . . 0.0 110.372 173.259 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.33 128.34 35.2 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 120.786 -1.196 . . . . 0.0 112.566 -171.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.39 -27.67 4.22 Favored Glycine 0 N--CA 1.508 3.491 0 N-CA-C 119.276 2.471 . . . . 0.0 119.276 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -58.22 -51.36 70.09 Favored 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 125.898 1.679 . . . . 0.0 114.243 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.4 ptm -78.53 -32.68 48.11 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -39.35 -38.0 0.5 Allowed 'General case' 0 CA--C 1.578 2.042 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -93.42 29.99 1.83 Allowed 'General case' 0 CA--C 1.583 2.223 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -144.01 -66.34 0.35 Allowed 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -75.86 96.84 3.79 Favored 'General case' 0 CA--C 1.571 1.764 0 C-N-CA 125.652 1.581 . . . . 0.0 109.571 167.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.62 111.44 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-O 124.026 1.869 . . . . 0.0 106.552 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -40.51 168.97 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.095 1 N-CA-C 124.101 4.852 . . . . 0.0 124.101 -166.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -106.67 165.24 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 109.32 -3.582 . . . . 0.0 116.749 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.1 tp -121.44 179.14 4.53 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 122.319 1.057 . . . . 0.0 112.204 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -69.47 97.07 0.96 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 123.415 1.578 . . . . 0.0 113.28 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.502 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 115.74 20.82 5.23 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 117.884 1.914 . . . . 0.0 117.884 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -91.78 160.72 15.19 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 123.119 1.437 . . . . 0.0 111.899 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -88.05 116.78 26.48 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 124.932 2.301 . . . . 0.0 112.561 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.52 152.22 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.92 0 CA-C-N 110.437 -3.074 . . . . 0.0 111.822 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.5 m -142.86 113.92 7.69 Favored 'General case' 0 N--CA 1.502 2.13 1 N-CA-C 100.052 -4.055 . . . . 0.0 100.052 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 9' ' ' GLN . 74.5 t -128.41 124.89 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 112.459 -2.155 . . . . 0.0 107.1 -155.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -78.58 135.33 37.25 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -133.88 -178.02 4.83 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.051 1.34 . . . . 0.0 108.518 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -94.72 164.12 20.57 Favored Pre-proline 0 CA--C 1.575 1.933 0 O-C-N 119.964 -1.71 . . . . 0.0 114.209 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -61.16 -38.2 68.73 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 C-N-CA 123.982 3.122 . . . . 0.0 116.709 166.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -89.91 -54.63 3.96 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.056 -1.883 . . . . 0.0 115.589 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -102.86 80.37 1.88 Allowed 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 122.423 1.106 . . . . 0.0 113.033 -171.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.5 mp -78.66 1.62 22.22 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 120.363 3.468 . . . . 0.0 120.363 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.3 t -70.37 -9.49 56.4 Favored 'General case' 0 CA--C 1.579 2.06 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -130.98 -177.12 4.24 Favored 'General case' 0 CA--C 1.576 1.95 0 CA-C-N 120.182 1.356 . . . . 0.0 113.069 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.5 174.55 40.54 Favored Glycine 0 CA--C 1.555 2.579 0 N-CA-C 117.919 1.928 . . . . 0.0 117.919 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -154.28 111.82 3.45 Favored 'General case' 0 CA--C 1.597 2.763 0 O-C-N 120.639 -1.507 . . . . 0.0 112.845 169.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.586 HD11 ' CG ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -47.52 103.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 O-C-N 118.554 -2.591 . . . . 0.0 115.204 172.435 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 m -96.45 -15.48 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 N-CA-C 120.01 3.337 . . . . 0.0 120.01 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -14.24 -68.65 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 121.071 3.73 . . . . 0.0 121.071 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -101.28 45.51 0.97 Allowed 'General case' 0 CA--C 1.579 2.09 0 CA-C-N 119.475 1.034 . . . . 0.0 113.538 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.3 p -148.8 -95.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.411 -1.43 . . . . 0.0 112.523 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 . . . . . 0 CA--C 1.56 1.36 0 CA-C-O 124.945 2.307 . . . . 0.0 111.214 -175.635 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.52 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -72.06 -39.13 69.25 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -79.47 31.0 0.23 Allowed 'General case' 0 CA--C 1.582 2.19 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -148.78 -160.6 1.2 Allowed 'General case' 0 CA--C 1.575 1.92 0 O-C-N 120.642 -1.286 . . . . 0.0 108.951 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -77.46 101.41 6.41 Favored 'General case' 0 CA--C 1.573 1.863 0 O-C-N 120.132 -1.605 . . . . 0.0 109.411 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mt -87.04 141.63 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.436 -1.415 . . . . 0.0 111.521 -170.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.333 12.9 pt-20 -97.45 122.98 41.13 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 123.676 1.703 . . . . 0.0 110.092 169.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.29 13.1 ttt -155.49 10.02 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 -150.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.783 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.532 0.2 OUTLIER -98.55 -161.64 0.89 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 120.79 3.626 . . . . 0.0 120.79 -166.679 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.42 -106.06 0.52 Allowed Glycine 0 N--CA 1.487 2.067 1 N-CA-C 123.86 4.304 . . . . 0.0 123.86 -163.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m -106.52 131.32 53.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.561 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 65.6 t -66.54 105.43 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.608 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 172.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.308 82.6 mt -85.91 -29.18 23.83 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.555 -1.966 . . . . 0.0 112.254 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.4 tp10 -139.14 149.32 44.34 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.194 -0.941 . . . . 0.0 110.64 164.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' MET . 4.2 p -96.01 116.67 29.3 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 101.536 -3.505 . . . . 0.0 101.536 167.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' HB3' ' CD ' ' A' ' 17' ' ' PRO 0.394 6.5 mt -76.83 -108.22 0.0 OUTLIER Pre-proline 0 CA--C 1.598 2.818 0 CA-C-O 113.683 -3.056 . . . . 0.0 112.311 -158.295 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.47 ' CD ' ' HB3' ' A' ' 16' ' ' LEU . 92.9 Cg_endo -82.3 -69.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.574 2.494 1 CA-C-N 130.138 4.657 . . . . 0.0 115.038 177.207 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -83.45 -71.96 0.48 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 120.369 1.44 . . . . 0.0 111.945 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -151.24 71.56 1.01 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.374 74.4 mtp -114.23 -166.27 1.09 Allowed 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.073 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.556 ' HB3' HG22 ' A' ' 23' ' ' VAL . 52.6 m-85 -156.66 109.46 2.57 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 124.864 3.483 . . . . 0.0 109.859 -163.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -88.85 96.97 10.91 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.58 HG21 HG21 ' A' ' 54' ' ' VAL . 1.8 t -104.77 136.35 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -163.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -92.09 112.58 24.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 170.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.542 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.251 0.1 OUTLIER -69.13 176.32 3.3 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 179.425 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -15.11 53.5 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 167.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.542 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 39.8 t30 -89.98 -6.46 55.62 Favored 'General case' 0 CA--C 1.585 2.292 0 CA-C-N 118.895 0.771 . . . . 0.0 112.628 168.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.71 -13.7 61.95 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 118.598 2.199 . . . . 0.0 118.598 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -78.25 135.3 37.54 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.278 1.031 . . . . 0.0 110.945 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.3 t -85.69 129.57 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 CA-C-O 123.017 1.389 . . . . 0.0 111.629 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.24 156.3 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 114.113 -1.403 . . . . 0.0 112.804 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -98.29 124.57 42.98 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.581 -1.325 . . . . 0.0 110.152 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.02 161.16 39.48 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 118.316 2.709 . . . . 0.0 118.316 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.57 -179.87 4.04 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 164.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.73 169.66 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.557 0 O-C-N 119.588 -1.945 . . . . 0.0 107.82 157.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.3 p -73.24 17.05 0.14 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 117.671 -3.143 . . . . 0.0 119.362 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.15 -51.2 0.76 Allowed Glycine 0 N--CA 1.499 2.886 0 N-CA-C 118.01 1.964 . . . . 0.0 118.01 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.53 -46.26 89.19 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 126.39 1.876 . . . . 0.0 115.451 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.402 ' SD ' ' O ' ' A' ' 67' ' ' VAL . 1.0 OUTLIER -73.41 -17.02 61.31 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 175.352 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -38.67 -38.45 0.41 Allowed 'General case' 0 CA--C 1.582 2.178 0 CA-C-N 122.838 2.563 . . . . 0.0 116.895 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -94.17 33.96 1.31 Allowed 'General case' 0 CA--C 1.585 2.314 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -148.12 -64.52 0.25 Allowed 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -78.66 93.47 4.89 Favored 'General case' 0 CA--C 1.571 1.766 0 C-N-CA 125.346 1.458 . . . . 0.0 108.623 166.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.5 mt -69.54 107.02 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.535 0 CA-C-O 124.554 2.121 . . . . 0.0 105.939 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.16 174.97 0.01 OUTLIER 'General case' 0 CA--C 1.577 1.986 1 N-CA-C 121.891 4.034 . . . . 0.0 121.891 -161.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 pt -119.36 167.73 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 111.082 -2.781 . . . . 0.0 115.194 -164.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.2 tp -125.93 -177.58 3.99 Favored 'General case' 0 CA--C 1.573 1.847 0 CA-C-O 122.038 0.923 . . . . 0.0 112.662 -171.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 m -68.34 95.55 0.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.475 1.607 . . . . 0.0 113.712 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.561 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 119.08 19.39 4.35 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 118.281 2.073 . . . . 0.0 118.281 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.33 163.31 13.65 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 122.953 1.359 . . . . 0.0 112.919 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -86.54 117.55 25.39 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 124.772 2.225 . . . . 0.0 112.949 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -121.85 157.6 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.692 0 CA-C-N 110.654 -2.975 . . . . 0.0 111.484 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.4 m -150.4 106.83 3.49 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 100.506 -3.887 . . . . 0.0 100.506 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.783 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 27.3 t -112.21 130.73 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 111.413 -2.63 . . . . 0.0 107.945 -161.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -83.67 136.98 34.0 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 121.163 -0.961 . . . . 0.0 111.876 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.285 2.2 pt? -123.97 -168.59 1.81 Allowed 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 121.252 0.549 . . . . 0.0 110.705 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.0 p -118.48 160.57 39.33 Favored Pre-proline 0 CA--C 1.572 1.807 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.73 -41.15 63.46 Favored 'Trans proline' 0 CA--C 1.569 2.235 0 C-N-CA 123.626 2.884 . . . . 0.0 118.773 164.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -88.85 -54.45 4.13 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -99.66 79.49 2.26 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 122.421 1.105 . . . . 0.0 112.716 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mp -70.19 -22.49 62.94 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -72.31 4.4 3.74 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -124.22 -174.55 3.03 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.462 1.483 . . . . 0.0 114.538 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.02 168.05 39.7 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 120.068 2.787 . . . . 0.0 120.068 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -153.39 110.2 3.42 Favored 'General case' 0 CA--C 1.594 2.669 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 167.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.716 ' H ' HD12 ' A' ' 66' ' ' ILE . 3.2 mp -44.05 104.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 O-C-N 117.437 -3.289 . . . . 0.0 115.86 168.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' O ' ' SD ' ' A' ' 39' ' ' MET . 14.2 m -95.83 -43.05 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.033 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.927 171.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.285 1.2 t80 55.05 -88.15 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 172.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -134.47 27.98 3.69 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.1 t -152.71 -77.82 0.12 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.644 -1.285 . . . . 0.0 112.693 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 124.308 2.004 . . . . 0.0 110.382 -174.033 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.559 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -72.89 -79.52 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.163 -0.96 . . . . 0.0 113.002 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pm0 -79.94 45.51 0.72 Allowed 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -119.06 47.79 1.6 Allowed 'General case' 0 CA--C 1.58 2.116 0 CA-C-O 123.971 1.843 . . . . 0.0 111.667 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -49.3 125.53 11.15 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -170.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.55 151.84 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.372 1.069 . . . . 0.0 109.631 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.279 8.1 pt-20 -108.51 124.74 50.92 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 123.831 1.777 . . . . 0.0 109.833 168.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.3 10.2 ttt -153.17 3.66 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 -151.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.753 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.533 0.0 OUTLIER -86.04 -166.31 1.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 121.287 3.81 . . . . 0.0 121.287 -166.905 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.19 -112.4 0.99 Allowed Glycine 0 N--CA 1.48 1.613 0 N-CA-C 121.45 3.34 . . . . 0.0 121.45 -164.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -102.29 130.23 48.93 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.441 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 99.6 t -63.9 111.51 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.881 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 171.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.324 58.6 mt -92.85 -34.04 13.99 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 122.585 2.448 . . . . 0.0 112.21 172.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.03 148.38 50.54 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-O 122.776 1.274 . . . . 0.0 109.922 163.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.9 p -105.52 106.23 16.63 Favored 'General case' 0 N--CA 1.513 2.675 0 N-CA-C 100.75 -3.796 . . . . 0.0 100.75 171.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.507 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.441 4.4 mt -82.8 -138.4 0.0 OUTLIER Pre-proline 0 CA--C 1.604 3.056 0 CA-C-O 115.033 -2.413 . . . . 0.0 113.779 -160.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 62.8 Cg_endo -73.66 -73.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 1 CA-C-N 129.599 4.464 . . . . 0.0 117.766 -172.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -63.66 -67.35 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.979 -1.076 . . . . 0.0 111.965 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -169.7 79.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.5 mtt -119.93 177.37 5.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.607 0.763 . . . . 0.0 112.589 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HB3' HG22 ' A' ' 23' ' ' VAL . 57.2 m-85 -145.6 109.68 4.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -165.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -85.3 94.92 9.05 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 168.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -100.23 133.16 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -164.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -93.31 113.19 25.31 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 26' ' ' GLU 0.358 0.2 OUTLIER -53.93 -179.13 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 120.662 3.579 . . . . 0.0 120.662 -176.238 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.557 ' H ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -70.34 -28.72 65.37 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 112.212 -2.267 . . . . 0.0 114.347 167.312 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -90.91 4.54 51.61 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 168.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.18 8.22 78.79 Favored Glycine 0 CA--C 1.549 2.199 0 N-CA-C 119.432 2.533 . . . . 0.0 119.432 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -91.54 140.29 29.88 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.197 2.498 . . . . 0.0 113.081 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.61 123.85 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 O-C-N 120.799 -1.188 . . . . 0.0 112.029 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 m -131.33 152.14 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.0 m -91.46 130.25 37.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.548 -1.345 . . . . 0.0 110.712 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.14 155.49 43.33 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -104.32 177.49 4.83 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 123.349 1.547 . . . . 0.0 108.573 165.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.527 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -87.42 161.17 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.52 0 O-C-N 120.313 -1.492 . . . . 0.0 108.771 166.273 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 90.8 p -78.18 24.87 0.24 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 119.864 3.283 . . . . 0.0 119.864 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.52 -45.7 1.03 Allowed Glycine 0 N--CA 1.501 3.032 0 N-CA-C 116.645 1.418 . . . . 0.0 116.645 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -58.9 -48.56 81.0 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 127.061 2.144 . . . . 0.0 116.568 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.513 ' SD ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.85 -21.88 61.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 118.487 2.773 . . . . 0.0 118.487 177.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -41.97 -34.02 0.64 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 171.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -84.55 -11.17 56.57 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 118.795 2.887 . . . . 0.0 118.795 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -89.75 -72.63 0.55 Allowed 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -101.96 132.03 48.02 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.55 1.14 . . . . 0.0 109.38 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.7 mt -70.64 -51.06 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 O-C-N 120.285 -1.509 . . . . 0.0 110.235 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -130.52 174.63 9.71 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 124.634 2.159 . . . . 0.0 113.053 171.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.418 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.286 0.7 OUTLIER -135.05 161.11 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-N 112.685 -2.052 . . . . 0.0 108.773 175.363 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.48 159.74 18.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.717 -1.24 . . . . 0.0 113.923 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.1 m -75.08 79.12 2.24 Favored 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 123.884 1.802 . . . . 0.0 110.59 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 136.6 22.3 0.55 Allowed Glycine 0 N--CA 1.491 2.349 0 CA-C-N 113.182 -1.827 . . . . 0.0 116.802 -176.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -92.16 159.49 15.63 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 122.869 1.319 . . . . 0.0 112.81 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -90.57 85.5 6.13 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 125.598 2.618 . . . . 0.0 114.032 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.97 158.09 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.021 0 CA-C-N 109.818 -3.356 . . . . 0.0 111.771 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -146.89 112.7 5.71 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 101.387 -3.561 . . . . 0.0 101.387 174.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.753 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 40.3 t -117.77 131.19 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 111.988 -2.369 . . . . 0.0 107.354 -160.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -83.91 128.59 34.65 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.027 0.917 . . . . 0.0 111.593 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.76 -129.96 0.23 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -146.43 167.38 14.04 Favored Pre-proline 0 CA--C 1.569 1.709 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.16 -43.23 19.57 Favored 'Trans proline' 0 CA--C 1.576 2.624 0 C-N-CA 123.09 2.527 . . . . 0.0 115.518 164.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -80.4 -48.24 13.2 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 111.864 -2.426 . . . . 0.0 116.449 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -115.22 88.66 2.92 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 122.507 1.146 . . . . 0.0 112.425 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.32 12.61 5.15 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 118.909 2.929 . . . . 0.0 118.909 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.2 p -75.47 -30.5 59.94 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -140.27 167.82 21.24 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 124.305 1.042 . . . . 0.0 113.103 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.44 -166.61 32.03 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 117.272 1.669 . . . . 0.0 117.272 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -154.94 122.51 5.69 Favored 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.75 ' H ' HD12 ' A' ' 66' ' ' ILE . 1.5 mp -45.11 106.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 CA-C-N 121.753 2.07 . . . . 0.0 114.657 170.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.37 170.05 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.517 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -71.82 80.83 0.88 Allowed 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -94.03 119.06 32.38 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.243 1.017 . . . . 0.0 109.93 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.0 m -81.77 -59.85 2.45 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.619 -0.676 . . . . 0.0 112.744 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 . . . . . 0 CA--C 1.564 1.509 0 CA-C-O 123.686 1.708 . . . . 0.0 113.732 175.629 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.529 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.295 61.4 mtpt 71.33 -73.81 0.09 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -86.29 70.91 10.56 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 122.565 1.174 . . . . 0.0 111.594 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -95.67 -161.22 0.85 Allowed 'General case' 0 CA--C 1.575 1.94 0 C-N-CA 124.029 0.931 . . . . 0.0 111.862 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -61.14 114.77 3.31 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 119.454 -2.029 . . . . 0.0 112.162 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -95.39 148.81 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.112 -0.992 . . . . 0.0 111.001 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.314 6.6 pt-20 -98.09 120.26 38.18 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 125.573 2.606 . . . . 0.0 108.31 166.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 18.5 ttt -168.91 87.1 0.17 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 108.795 -3.82 . . . . 0.0 105.053 -150.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.702 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -110.35 -148.99 0.44 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 111.078 -2.783 . . . . 0.0 115.652 -156.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 179.79 -141.89 4.91 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 116.94 1.536 . . . . 0.0 116.94 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.2 m -122.17 134.34 54.73 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.481 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 42.4 t -59.07 114.74 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.871 0 O-C-N 121.689 -0.632 . . . . 0.0 110.187 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.1 mt -82.24 -32.8 29.53 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 119.641 -1.912 . . . . 0.0 111.956 166.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -146.56 141.74 27.29 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.024 1.392 . . . . 0.0 111.025 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.1 p -92.88 110.18 21.63 Favored 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 102.464 -3.161 . . . . 0.0 102.464 169.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.434 3.8 mt -81.83 -133.35 0.0 OUTLIER Pre-proline 0 CA--C 1.602 2.958 0 CA-C-O 114.609 -2.615 . . . . 0.0 114.191 -160.647 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 69.9 Cg_endo -73.43 -69.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.379 2.163 1 CA-C-N 129.994 4.605 . . . . 0.0 117.086 -174.653 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -73.01 -76.06 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.126 -0.984 . . . . 0.0 110.318 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -157.73 77.06 0.82 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.2 mtt -121.23 179.13 4.51 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.83 0.852 . . . . 0.0 112.242 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.529 ' CE1' HD11 ' A' ' 46' ' ' ILE . 55.8 m-85 -145.21 109.74 4.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.66 -1.9 . . . . 0.0 106.812 -166.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -84.57 101.92 12.48 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 167.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.4 t -109.77 141.11 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -163.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -93.36 108.04 19.77 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 171.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.57 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.261 0.1 OUTLIER -77.11 169.27 18.63 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 124.058 1.885 . . . . 0.0 115.047 -176.234 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.271 20.8 pt-20 -68.03 -8.9 41.54 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 112.555 -2.111 . . . . 0.0 114.703 169.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.57 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 15.3 t30 -91.14 -6.45 53.56 Favored 'General case' 0 CA--C 1.588 2.432 0 CA-C-N 119.124 0.874 . . . . 0.0 112.647 164.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.47 -20.9 45.78 Favored Glycine 0 CA--C 1.549 2.182 0 N-CA-C 118.961 2.345 . . . . 0.0 118.961 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -78.09 137.76 38.39 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.735 0.814 . . . . 0.0 111.486 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.45 112.99 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 122.879 1.323 . . . . 0.0 109.304 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 m -102.64 148.91 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 113.932 -1.486 . . . . 0.0 113.661 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.5 m -93.22 120.93 34.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.007 -1.058 . . . . 0.0 108.28 171.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.36 161.41 36.37 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -113.04 -160.6 0.72 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.436 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -115.1 173.79 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.07 0 O-C-N 120.584 -1.323 . . . . 0.0 108.524 166.673 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.1 p -78.54 100.69 7.03 Favored 'General case' 0 CA--C 1.561 1.382 0 O-C-N 119.254 -2.154 . . . . 0.0 108.39 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -31.69 -30.8 0.01 OUTLIER Glycine 0 N--CA 1.506 3.329 1 N-CA-C 123.852 4.301 . . . . 0.0 123.852 -175.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -62.46 -46.67 87.45 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 174.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 ptm -73.25 -17.82 61.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -39.75 -30.51 0.08 Allowed 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 118.348 2.721 . . . . 0.0 118.348 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -90.55 -5.93 55.34 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.9 -66.91 0.92 Allowed 'General case' 0 CA--C 1.578 2.026 0 C-N-CA 126.155 1.782 . . . . 0.0 106.617 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -81.6 98.24 8.25 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 125.509 1.524 . . . . 0.0 107.838 168.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.9 mt -73.3 -71.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.411 -0.805 . . . . 0.0 110.908 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -140.03 171.69 13.82 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 125.853 2.74 . . . . 0.0 115.491 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 21' ' ' PHE . 1.3 pt -142.86 167.86 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 110.56 -3.018 . . . . 0.0 108.483 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.54 177.35 4.71 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.838 1.304 . . . . 0.0 112.822 -173.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.8 m -76.0 83.65 2.88 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 123.36 1.552 . . . . 0.0 110.998 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 134.04 23.31 0.69 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 117.524 1.77 . . . . 0.0 117.524 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.76 160.53 14.72 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 122.858 1.313 . . . . 0.0 113.877 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -87.99 82.46 7.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 125.754 2.693 . . . . 0.0 113.368 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -71.93 163.83 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-N 110.088 -3.233 . . . . 0.0 115.504 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.669 HG23 ' HG3' ' A' ' 9' ' ' GLN 0.355 19.5 m -125.63 78.94 1.78 Allowed 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 124.261 1.981 . . . . 0.0 113.417 170.309 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.702 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.2 OUTLIER -75.99 101.3 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 125.813 1.645 . . . . 0.0 109.806 -173.409 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -82.75 140.97 32.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.709 -0.619 . . . . 0.0 109.354 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.21 -116.64 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 110.584 -171.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.42 166.32 17.15 Favored Pre-proline 0 CA--C 1.575 1.907 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -176.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -61.38 -47.36 12.07 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 C-N-CA 123.088 2.526 . . . . 0.0 117.425 166.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -97.46 -43.63 7.18 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -175.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -95.49 77.3 3.35 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.17 49.47 1.66 Allowed 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 94.5 p -106.92 -27.86 10.43 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 125.668 1.587 . . . . 0.0 114.744 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -126.24 -173.49 2.87 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 124.06 0.944 . . . . 0.0 112.736 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.424 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . 174.59 179.73 45.38 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.73 108.27 1.17 Allowed 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 118.895 2.924 . . . . 0.0 118.895 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.512 ' CD1' ' H ' ' A' ' 66' ' ' ILE . 0.9 OUTLIER -26.71 91.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.118 0 N-CA-C 118.889 2.922 . . . . 0.0 118.889 162.82 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 m -92.14 -18.77 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 N-CA-C 117.271 2.322 . . . . 0.0 117.271 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -79.74 120.55 24.18 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -176.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.0 mtt85 -76.42 96.61 4.07 Favored 'General case' 0 CA--C 1.569 1.711 0 O-C-N 121.664 -0.648 . . . . 0.0 111.926 174.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.4 m -75.65 -28.33 58.72 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? . . . . . 0 CA--C 1.561 1.395 0 CA-C-O 125.238 2.447 . . . . 0.0 111.324 178.003 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.565 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.317 21.7 ptmt 47.8 54.47 9.88 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -88.21 69.87 9.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.221 -1.549 . . . . 0.0 110.933 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -107.91 164.94 11.83 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-O 122.708 1.242 . . . . 0.0 112.817 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -79.79 116.17 19.81 Favored 'General case' 0 CA--C 1.572 1.812 0 O-C-N 121.042 -1.036 . . . . 0.0 110.746 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.14 141.97 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.107 -0.996 . . . . 0.0 111.411 -174.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.328 12.5 pt-20 -99.14 124.35 44.1 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.636 1.684 . . . . 0.0 110.224 168.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.284 11.4 ttt -154.71 -8.06 0.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 120.539 3.533 . . . . 0.0 120.539 -151.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.611 ' HB2' ' HB ' ' A' ' 54' ' ' VAL 0.574 0.0 OUTLIER -78.9 -165.35 0.72 Allowed 'General case' 0 N--CA 1.491 1.583 1 N-CA-C 122.053 4.094 . . . . 0.0 122.053 -165.11 . . . . . . . . 5 4 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.39 -112.61 1.53 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 122.42 3.728 . . . . 0.0 122.42 -166.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.3 m -110.78 141.11 44.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.532 -0.981 . . . . 0.0 108.363 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.543 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 90.4 t -69.51 101.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.602 2.948 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 174.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 24' ' ' GLU . 2.8 mm? -77.12 -38.38 52.25 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 117.923 -2.985 . . . . 0.0 112.828 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -128.93 145.71 51.15 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.761 1.267 . . . . 0.0 110.762 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 p -95.77 106.0 18.07 Favored 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 101.775 -3.417 . . . . 0.0 101.775 167.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.288 5.7 mt -78.47 166.47 42.64 Favored Pre-proline 0 CA--C 1.593 2.626 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.482 -167.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.385 6.0 Cg_endo -20.54 -57.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.57 2.302 2 N-CA-C 125.459 5.138 . . . . 0.0 125.459 -164.798 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -82.71 -78.34 0.21 Allowed 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 120.651 1.569 . . . . 0.0 109.782 172.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -158.13 72.81 0.64 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.255 67.3 mtm -115.98 -169.61 1.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.681 0.792 . . . . 0.0 110.588 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.531 ' HE2' HG23 ' A' ' 35' ' ' ILE . 62.0 m-85 -148.49 108.15 3.99 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 119.114 -2.241 . . . . 0.0 106.952 -166.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -84.48 97.59 9.62 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -103.78 133.7 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -164.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' H ' HD23 ' A' ' 13' ' ' LEU . 32.2 tt0 -95.96 111.49 23.47 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 172.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 26' ' ' GLU 0.365 0.2 OUTLIER -52.26 -178.54 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 120.608 3.558 . . . . 0.0 120.608 -176.11 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.62 ' H ' HD23 ' A' ' 25' ' ' LEU . 11.0 pt-20 -69.62 -31.45 69.57 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 112.729 -2.032 . . . . 0.0 113.949 167.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -88.68 6.74 37.05 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.19 13.41 79.06 Favored Glycine 0 CA--C 1.549 2.165 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -95.1 130.01 41.96 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 120.821 2.31 . . . . 0.0 112.561 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.0 t -82.76 124.9 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.438 -1.414 . . . . 0.0 112.333 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.16 149.76 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 114.705 -1.134 . . . . 0.0 113.499 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 m -87.45 127.08 35.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.487 -1.383 . . . . 0.0 110.396 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.4 139.98 28.75 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.71 155.73 17.47 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 168.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.531 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -64.31 170.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.536 0 O-C-N 120.456 -1.402 . . . . 0.0 112.166 168.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -75.68 92.9 3.01 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 119.226 -2.171 . . . . 0.0 107.902 169.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.81 -38.23 0.01 OUTLIER Glycine 0 N--CA 1.505 3.266 1 N-CA-C 123.314 4.086 . . . . 0.0 123.314 -174.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -54.32 -45.54 72.65 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -73.18 -21.87 60.59 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 173.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -37.06 -39.68 0.25 Allowed 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 123.718 2.963 . . . . 0.0 117.524 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -91.07 47.41 1.4 Allowed 'General case' 0 CA--C 1.582 2.183 0 CA-C-O 124.231 1.967 . . . . 0.0 114.402 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -168.12 -60.36 0.02 OUTLIER 'General case' 0 CA--C 1.581 2.17 0 C-N-CA 128.151 2.581 . . . . 0.0 105.193 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -83.43 68.45 9.73 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 127.144 2.178 . . . . 0.0 114.017 175.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 mt -88.33 71.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.389 84.8 mmt-85 -100.98 -76.02 0.57 Allowed 'General case' 0 N--CA 1.489 1.488 1 N-CA-C 124.465 4.987 . . . . 0.0 124.465 -164.003 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pt -99.77 162.47 3.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 112.116 -2.311 . . . . 0.0 116.678 -157.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -129.45 -174.55 3.32 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.528 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.8 m -70.52 84.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.768 1.27 . . . . 0.0 112.585 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.543 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 132.68 19.22 1.06 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 118.218 2.047 . . . . 0.0 118.218 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.03 157.73 16.62 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-O 123.014 1.388 . . . . 0.0 111.803 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -90.61 94.11 9.56 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 125.217 2.437 . . . . 0.0 113.429 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -97.01 142.46 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.827 0 CA-C-N 109.733 -3.394 . . . . 0.0 111.836 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 m -126.48 119.15 26.47 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 100.62 -3.844 . . . . 0.0 100.62 171.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.611 ' HB ' ' HB2' ' A' ' 9' ' ' GLN 0.252 93.6 t -127.86 125.42 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 112.9 -1.955 . . . . 0.0 106.345 -157.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -79.09 137.97 37.74 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -172.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.275 2.3 pt? -129.03 -171.19 2.42 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 121.625 0.726 . . . . 0.0 111.14 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 p -106.13 164.87 14.05 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -43.04 -51.66 5.38 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 N-CA-C 122.212 3.889 . . . . 0.0 122.212 161.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -110.75 -41.4 4.29 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.61 69.14 6.69 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.859 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.42 -9.09 58.33 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.3 t -69.71 -6.57 32.64 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -124.05 -176.62 3.53 Favored 'General case' 0 CA--C 1.575 1.928 0 CA-C-O 123.211 1.482 . . . . 0.0 113.259 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.89 174.47 43.46 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -153.7 106.74 2.92 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 171.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.525 HD11 ' CD2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -41.3 110.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 117.973 2.582 . . . . 0.0 117.973 173.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.32 -55.83 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 C-N-CA 124.708 1.203 . . . . 0.0 110.444 172.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.254 0.6 OUTLIER 72.7 -50.62 0.7 Allowed 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 118.481 2.771 . . . . 0.0 118.481 174.242 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 66.54 3.31 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 121.139 1.791 . . . . 0.0 113.943 177.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 m -176.37 -65.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 127.082 2.153 . . . . 0.0 107.17 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 . . . . . 0 CA--C 1.565 1.534 0 CA-C-O 124.919 2.295 . . . . 0.0 107.492 174.83 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.571 1.775 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.283 66.0 mttm 68.06 -75.19 0.07 Allowed 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.23 59.96 5.95 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -127.93 172.65 10.7 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 122.779 1.276 . . . . 0.0 111.259 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -83.42 77.63 9.78 Favored 'General case' 0 CA--C 1.582 2.203 0 O-C-N 120.157 -1.59 . . . . 0.0 108.66 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mt -97.21 144.82 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.112 -1.617 . . . . 0.0 111.095 -170.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.279 7.2 pt-20 -99.84 119.56 38.38 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 124.219 1.961 . . . . 0.0 109.219 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.295 10.8 ttt -154.26 -4.77 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 110.399 -3.091 . . . . 0.0 119.322 -152.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.758 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.603 0.0 OUTLIER -75.89 -157.85 0.08 Allowed 'General case' 0 CA--C 1.566 1.584 1 N-CA-C 125.778 5.473 . . . . 0.0 125.778 -162.18 . . . . . . . . 5 4 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.43 -150.75 10.2 Favored Glycine 0 CA--C 1.535 1.292 1 N-CA-C 126.29 5.276 . . . . 0.0 126.29 -157.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -101.79 136.53 41.47 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.541 HG22 ' HD1' ' A' ' 21' ' ' PHE . 63.1 t -64.56 111.66 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.588 0 O-C-N 121.074 -1.017 . . . . 0.0 109.332 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.9 -36.56 64.77 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-N 122.738 2.517 . . . . 0.0 111.943 168.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -146.07 147.3 31.46 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 122.32 1.057 . . . . 0.0 111.789 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.93 116.23 28.66 Favored 'General case' 0 N--CA 1.511 2.593 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 169.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.604 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.454 1.2 mm? -79.79 -127.71 0.0 OUTLIER Pre-proline 0 CA--C 1.597 2.779 0 CA-C-O 114.369 -2.729 . . . . 0.0 114.81 -164.682 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 90.9 Cg_endo -67.55 -67.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.566 2.113 1 CA-C-N 130.159 4.664 . . . . 0.0 116.966 -176.701 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -81.24 -72.94 0.4 Allowed 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.387 -0.82 . . . . 0.0 110.603 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m -157.43 74.31 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.26 89.4 mtp -113.98 -169.57 1.54 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 117.326 -1.321 . . . . 0.0 111.901 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.583 ' HB3' HG22 ' A' ' 23' ' ' VAL . 57.9 m-85 -154.92 112.01 3.33 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 123.366 2.803 . . . . 0.0 111.337 -166.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -93.89 97.61 10.5 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 167.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 21' ' ' PHE . 2.5 t -101.52 141.2 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -163.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -98.35 107.86 20.42 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.0 171.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.264 0.6 OUTLIER -50.47 176.56 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 118.718 2.859 . . . . 0.0 118.718 -177.089 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -22.68 66.31 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 168.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -95.47 6.11 49.84 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.47 -1.58 85.96 Favored Glycine 0 CA--C 1.554 2.52 0 N-CA-C 119.955 2.742 . . . . 0.0 119.955 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -82.63 140.44 33.18 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.834 1.817 . . . . 0.0 113.04 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.3 130.18 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 CA-C-O 122.846 1.307 . . . . 0.0 111.374 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.27 153.03 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.376 -1.284 . . . . 0.0 113.168 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.8 m -98.16 126.1 43.48 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.439 -1.413 . . . . 0.0 110.256 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.42 163.39 34.77 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.6 176.14 5.14 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.825 -1.534 . . . . 0.0 107.63 164.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.497 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -85.14 171.0 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.59 2.49 0 O-C-N 119.731 -1.856 . . . . 0.0 108.84 161.581 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 p -74.91 27.48 0.09 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 118.26 -2.775 . . . . 0.0 117.988 177.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.06 -49.78 0.18 Allowed Glycine 0 N--CA 1.502 3.048 0 N-CA-C 119.937 2.735 . . . . 0.0 119.937 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -65.62 -52.34 52.73 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.044 2.138 . . . . 0.0 115.499 -177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -18.1 65.1 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -38.43 -39.21 0.43 Allowed 'General case' 0 CA--C 1.575 1.922 0 CA-C-N 122.419 2.372 . . . . 0.0 116.492 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -92.28 32.4 1.19 Allowed 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -149.73 -54.98 0.17 Allowed 'General case' 0 CA--C 1.577 1.991 0 C-N-CA 127.25 2.22 . . . . 0.0 107.141 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -76.46 63.47 2.02 Favored 'General case' 0 CA--C 1.58 2.107 0 C-N-CA 125.605 1.562 . . . . 0.0 112.947 171.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mt -84.98 72.18 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 CA-C-O 124.752 2.215 . . . . 0.0 108.788 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -112.19 -43.19 3.58 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 120.811 3.634 . . . . 0.0 120.811 -169.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.403 0.0 OUTLIER -120.23 160.82 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 1 N-CA-C 122.992 4.442 . . . . 0.0 122.992 -138.901 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.9 tp -159.15 178.67 9.76 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 110.203 -3.18 . . . . 0.0 112.387 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.1 m -68.55 116.02 8.61 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.615 1.198 . . . . 0.0 111.709 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.401 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 95.27 14.37 48.42 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 119.371 2.508 . . . . 0.0 119.371 -175.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.46 172.97 8.04 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 124.96 1.304 . . . . 0.0 111.757 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -97.59 136.62 37.72 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 124.516 2.103 . . . . 0.0 115.87 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.06 153.95 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.954 0 CA-C-N 111.51 -2.587 . . . . 0.0 110.901 -171.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.8 m -143.71 102.89 3.99 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 101.978 -3.341 . . . . 0.0 101.978 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.758 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 19.7 t -105.87 132.14 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 111.107 -2.77 . . . . 0.0 108.056 -164.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -82.86 127.54 33.59 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.665 -1.272 . . . . 0.0 111.771 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.461 HD22 HE22 ' A' ' 9' ' ' GLN 0.321 2.2 pt? -102.0 -165.53 1.2 Allowed 'General case' 0 CA--C 1.566 1.574 0 CA-C-O 121.26 0.552 . . . . 0.0 111.385 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 p -131.74 161.49 62.08 Favored Pre-proline 0 CA--C 1.572 1.813 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -51.54 -43.74 48.37 Favored 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 123.999 3.133 . . . . 0.0 118.843 164.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -95.57 -57.2 2.45 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -95.16 74.08 3.4 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.343 1.068 . . . . 0.0 113.342 -172.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.51 -20.0 65.94 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 118.377 2.732 . . . . 0.0 118.377 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 t -74.98 4.53 6.44 Favored 'General case' 0 CA--C 1.583 2.241 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 171.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 170.71 15.6 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 121.093 1.769 . . . . 0.0 115.516 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.53 -169.19 42.13 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.98 124.9 7.89 Favored 'General case' 0 CA--C 1.59 2.49 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 173.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.776 ' H ' HD12 ' A' ' 66' ' ' ILE . 2.8 mp -43.71 104.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 171.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.1 m -102.23 -63.34 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.069 0 CA-C-N 113.891 -1.504 . . . . 0.0 114.054 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.442 0.0 OUTLIER 10.05 -102.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.049 1 N-CA-C 121.991 4.071 . . . . 0.0 121.991 -172.87 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -147.51 127.32 13.49 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 120.883 1.674 . . . . 0.0 111.635 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.7 p -104.61 81.86 1.83 Allowed 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 122.353 1.073 . . . . 0.0 109.271 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.526 ' HD3' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.225 0 CA-C-O 125.053 2.358 . . . . 0.0 112.332 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 . . . . . 0 CA--C 1.571 1.772 0 CA-C-O 121.302 0.572 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -96.66 141.13 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 124.187 0.995 . . . . 0.0 110.104 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.378 14.7 pt-20 -92.29 126.21 37.27 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 124.858 2.266 . . . . 0.0 109.536 165.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.283 20.4 ttt -168.46 82.96 0.16 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 109.968 -3.287 . . . . 0.0 104.765 -152.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -98.47 -153.03 0.42 Allowed 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 -159.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -167.36 -174.37 36.39 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 120.487 2.955 . . . . 0.0 120.487 -170.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.7 m -100.54 124.97 46.81 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.503 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 67.3 t -60.66 117.54 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.763 0 CA-C-N 121.096 1.771 . . . . 0.0 107.294 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.302 73.3 mt -100.95 -26.43 13.74 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.169 -1.582 . . . . 0.0 112.773 171.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -136.42 145.86 45.74 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 123.09 1.424 . . . . 0.0 109.487 162.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 20' ' ' MET . 5.8 p -96.61 110.27 22.72 Favored 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 100.827 -3.768 . . . . 0.0 100.827 168.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.429 2.5 mt -79.65 -124.89 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.91 0 CA-C-O 113.986 -2.911 . . . . 0.0 115.655 -159.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 95.6 Cg_endo -73.36 -70.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.185 1 CA-C-N 130.561 4.807 . . . . 0.0 116.243 -176.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -78.67 -70.31 0.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.251 -0.906 . . . . 0.0 110.731 175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 m -159.33 75.89 0.67 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.415 ' O ' ' HA ' ' A' ' 15' ' ' THR . 67.9 mtt -118.58 -175.42 2.88 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.512 0.725 . . . . 0.0 111.426 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CE1' HD11 ' A' ' 46' ' ' ILE . 60.5 m-85 -144.29 109.88 5.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 119.454 -2.029 . . . . 0.0 106.398 -166.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -85.32 93.86 8.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 170.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.2 t -100.94 135.21 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -163.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -85.91 116.18 23.99 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.298 4.7 mt -70.52 174.95 5.2 Favored 'General case' 0 CA--C 1.577 1.99 0 CA-C-O 124.112 1.91 . . . . 0.0 112.569 -172.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -24.17 63.21 Favored 'General case' 0 CA--C 1.586 2.355 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.908 165.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.6 -8.25 56.3 Favored 'General case' 0 CA--C 1.586 2.365 0 C-N-CA 126.186 1.794 . . . . 0.0 115.398 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.72 9.31 75.08 Favored Glycine 0 CA--C 1.554 2.521 0 N-CA-C 119.496 2.558 . . . . 0.0 119.496 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -114.36 147.45 39.14 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 118.665 1.232 . . . . 0.0 112.452 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.4 t -82.27 126.88 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.861 -1.149 . . . . 0.0 111.216 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.3 147.68 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.598 1.19 . . . . 0.0 112.791 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.9 m -89.59 123.64 33.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.72 -1.238 . . . . 0.0 109.08 172.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.31 155.17 47.9 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 159.71 19.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 172.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.481 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -73.0 176.33 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.631 0 O-C-N 119.973 -1.704 . . . . 0.0 110.758 166.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 92.5 p -79.9 25.24 0.37 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 121.086 3.735 . . . . 0.0 121.086 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.85 -52.44 1.63 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.295 64.4 pttt -59.83 -58.17 9.73 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 118.061 2.615 . . . . 0.0 118.061 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -21.5 62.97 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -38.44 -39.02 0.42 Allowed 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . 0.258 14.4 mptt -98.02 -4.55 35.87 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 121.639 3.94 . . . . 0.0 121.639 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -93.46 53.25 1.86 Allowed 'General case' 0 CA--C 1.587 2.404 0 N-CA-C 102.316 -3.216 . . . . 0.0 102.316 153.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.416 1.8 t80 -45.74 98.11 0.01 OUTLIER 'General case' 0 C--N 1.379 1.86 0 N-CA-C 118.679 2.844 . . . . 0.0 118.679 -152.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mt -82.07 74.53 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 109.175 -3.648 . . . . 0.0 107.562 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 137.96 58.03 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 -170.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.559 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.274 1.4 pt -141.78 154.96 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 CA-C-N 111.466 -2.606 . . . . 0.0 111.87 -176.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 tp -131.39 -174.44 3.4 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.128 0.966 . . . . 0.0 111.033 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -72.87 84.88 1.24 Allowed 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 123.317 1.532 . . . . 0.0 113.074 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.503 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 130.34 25.23 0.88 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 117.631 1.812 . . . . 0.0 117.631 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.55 165.62 12.44 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 123.2 1.476 . . . . 0.0 114.131 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -84.73 82.65 8.33 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 125.583 2.611 . . . . 0.0 113.674 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 m -79.03 152.82 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 CA-C-N 110.595 -3.002 . . . . 0.0 113.284 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.489 ' HA ' ' HB3' ' A' ' 9' ' ' GLN . 63.8 m -94.76 161.15 14.29 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 160.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.459 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -157.35 86.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 O-C-N 118.128 -2.858 . . . . 0.0 105.658 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -78.19 138.6 38.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.102 -0.999 . . . . 0.0 109.743 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -136.0 -179.32 5.59 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.665 1.221 . . . . 0.0 111.699 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 p -100.36 161.06 25.28 Favored Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -53.9 -43.48 57.7 Favored 'Trans proline' 0 CA--C 1.572 2.388 0 C-N-CA 123.231 2.621 . . . . 0.0 118.22 163.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -82.87 -49.39 9.71 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.72 83.25 2.23 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 122.25 1.024 . . . . 0.0 112.049 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -17.1 61.17 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.2 p -68.97 -7.97 40.26 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -122.73 -177.74 3.73 Favored 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 119.963 1.256 . . . . 0.0 114.056 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.405 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . -177.33 177.0 48.29 Favored Glycine 0 CA--C 1.548 2.127 0 N-CA-C 117.686 1.834 . . . . 0.0 117.686 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -162.69 115.86 1.67 Allowed 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 172.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.618 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -38.99 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 118.929 -2.357 . . . . 0.0 116.912 165.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.279 2.1 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.538 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 CA--C 1.575 1.925 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -89.16 138.44 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.427 -1.421 . . . . 0.0 111.741 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.332 10.5 pt-20 -93.74 123.29 36.99 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 125.257 2.456 . . . . 0.0 109.219 168.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.26 20.5 ttt -170.34 85.08 0.11 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 109.173 -3.649 . . . . 0.0 104.626 -151.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -105.16 -149.24 0.41 Allowed 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -162.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 179.29 -142.44 5.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.8 m -122.86 135.26 54.46 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.513 HG11 HG23 ' A' ' 15' ' ' THR . 54.0 t -58.99 124.6 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.607 3.168 0 O-C-N 121.364 -0.835 . . . . 0.0 109.528 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.5 mt -90.66 -27.6 18.92 Favored 'General case' 0 N--CA 1.514 2.737 0 O-C-N 119.314 -2.116 . . . . 0.0 112.031 163.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.4 tp10 -148.47 143.51 26.77 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 120.83 -1.169 . . . . 0.0 111.736 166.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.513 HG23 HG11 ' A' ' 12' ' ' VAL . 33.1 p -103.94 103.76 13.64 Favored 'General case' 0 N--CA 1.518 2.958 0 N-CA-C 102.087 -3.301 . . . . 0.0 102.087 173.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.393 0.2 OUTLIER -77.08 178.6 1.97 Allowed Pre-proline 0 CA--C 1.593 2.626 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -168.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -54.41 -36.15 86.81 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 N-CA-C 121.25 3.519 . . . . 0.0 121.25 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -79.74 -100.78 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.4 m -152.97 72.77 0.97 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 76.0 mtp -126.04 162.7 24.68 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 46' ' ' ILE . 56.7 m-85 -132.77 114.48 14.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.141 -1.6 . . . . 0.0 107.087 -163.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.2 ttm105 -85.67 89.41 7.73 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.3 t -96.3 137.29 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -162.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.7 111.82 22.4 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.302 4.9 mt -72.3 174.24 7.56 Favored 'General case' 0 CA--C 1.577 2.002 0 CA-C-O 124.135 1.921 . . . . 0.0 112.779 -173.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.96 -22.59 61.43 Favored 'General case' 0 CA--C 1.585 2.298 0 CA-C-N 113.804 -1.544 . . . . 0.0 114.128 166.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -74.58 -9.09 58.23 Favored 'General case' 0 CA--C 1.587 2.366 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.68 23.79 55.09 Favored Glycine 0 CA--C 1.555 2.54 0 N-CA-C 118.632 2.213 . . . . 0.0 118.632 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -125.94 145.71 50.16 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.309 1.044 . . . . 0.0 111.224 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.0 t -86.04 117.5 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.728 -1.232 . . . . 0.0 110.123 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.7 148.9 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.1 m -92.54 125.5 37.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.405 -1.434 . . . . 0.0 110.062 173.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.32 159.84 40.79 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 177.11 4.75 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 165.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.514 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.2 pt -88.99 -178.27 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.36 0 O-C-N 119.211 -2.181 . . . . 0.0 110.632 165.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.4 p -82.49 122.32 27.9 Favored 'General case' 0 CA--C 1.56 1.33 0 O-C-N 119.714 -1.866 . . . . 0.0 109.205 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.49 -20.34 0.59 Allowed Glycine 0 N--CA 1.503 3.161 0 N-CA-C 122.312 3.685 . . . . 0.0 122.312 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -71.24 -55.75 7.46 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 125.641 1.577 . . . . 0.0 114.405 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 ptm -69.39 -20.54 63.81 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -37.93 -35.66 0.16 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -94.47 33.58 1.4 Allowed 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -150.93 -69.93 0.18 Allowed 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.64 101.04 10.55 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 163.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.83 -73.55 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.439 -0.788 . . . . 0.0 109.381 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -132.1 -179.27 5.31 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-O 124.512 2.101 . . . . 0.0 114.316 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.258 1.1 pt -143.39 175.67 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 C-N-CA 126.932 2.093 . . . . 0.0 110.858 -173.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.4 158.5 16.3 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.256 1.027 . . . . 0.0 111.115 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 m -71.58 86.84 0.9 Allowed 'General case' 0 CA--C 1.572 1.807 0 CA-C-O 123.577 1.655 . . . . 0.0 110.423 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 130.36 24.2 0.95 Allowed Glycine 0 N--CA 1.492 2.423 0 CA-C-N 113.02 -1.9 . . . . 0.0 117.049 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -94.57 162.3 13.86 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-O 122.976 1.37 . . . . 0.0 114.166 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -85.59 81.35 8.7 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 125.575 2.607 . . . . 0.0 113.796 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -77.79 158.15 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 110.324 -3.126 . . . . 0.0 113.839 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.299 35.3 m -95.44 162.78 13.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 160.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.454 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -158.44 89.55 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 118.473 -2.642 . . . . 0.0 104.897 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.55 134.87 36.5 Favored 'General case' 0 CA--C 1.563 1.47 0 O-C-N 121.17 -0.956 . . . . 0.0 110.014 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 mp -101.06 -171.76 2.05 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 125.972 2.796 . . . . 0.0 111.878 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 p -122.5 162.04 40.32 Favored Pre-proline 0 CA--C 1.577 1.987 0 CA-C-N 109.657 -3.429 . . . . 0.0 112.657 173.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -52.85 -41.27 71.6 Favored 'Trans proline' 0 CA--C 1.569 2.249 0 C-N-CA 123.656 2.904 . . . . 0.0 119.166 164.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -95.21 -52.81 4.03 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -91.39 77.03 5.87 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 122.528 1.156 . . . . 0.0 112.779 -172.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.5 mt -70.89 -22.86 62.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 117.643 2.46 . . . . 0.0 117.643 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.5 t -75.89 6.95 4.41 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -139.8 166.48 24.5 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 120.564 1.529 . . . . 0.0 113.475 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.14 -164.08 29.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 115.633 1.013 . . . . 0.0 115.633 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.95 122.31 2.57 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.607 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -35.64 91.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 166.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.268 2.8 m . . . . . 0 CA--C 1.567 1.616 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.412 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 m120 . . . . . 0 CA--C 1.573 1.83 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.08 142.24 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.615 1.166 . . . . 0.0 109.661 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.409 16.3 pt-20 -95.03 122.27 37.51 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 125.036 2.351 . . . . 0.0 109.82 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.275 18.6 ttt -168.34 81.2 0.16 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 109.777 -3.374 . . . . 0.0 105.683 -149.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -96.04 -149.86 0.32 Allowed 'General case' 0 CA--C 1.563 1.456 0 N-CA-C 118.713 2.857 . . . . 0.0 118.713 -157.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -166.88 -178.34 39.27 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 121.951 3.54 . . . . 0.0 121.951 -168.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.6 m -99.73 124.88 45.43 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 15' ' ' THR . 61.4 t -60.2 122.14 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.989 0 CA-C-N 120.487 1.494 . . . . 0.0 107.253 175.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.299 62.6 mt -99.51 -22.06 15.65 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 119.823 -1.798 . . . . 0.0 112.844 168.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.9 tp10 -145.01 143.84 30.7 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 122.372 1.082 . . . . 0.0 110.833 161.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.485 HG23 HG11 ' A' ' 12' ' ' VAL . 24.7 p -106.17 106.58 17.16 Favored 'General case' 0 N--CA 1.515 2.798 0 N-CA-C 101.395 -3.557 . . . . 0.0 101.395 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.374 0.3 OUTLIER -76.48 174.37 5.81 Favored Pre-proline 0 CA--C 1.591 2.544 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -167.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -47.11 -42.22 26.42 Favored 'Trans proline' 0 CA--C 1.565 2.064 0 N-CA-C 121.493 3.613 . . . . 0.0 121.493 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -80.49 -93.21 0.05 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.9 m -159.5 75.38 0.64 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 69.6 mtm -126.78 167.87 15.19 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.795 0.838 . . . . 0.0 112.512 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.545 ' CE1' HD11 ' A' ' 46' ' ' ILE . 59.8 m-85 -132.22 114.89 15.0 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 118.703 -2.498 . . . . 0.0 108.815 -163.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -87.05 95.89 10.1 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 170.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.4 t -105.13 139.97 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -162.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.87 111.57 18.88 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 167.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.257 0.1 OUTLIER -79.84 166.21 21.93 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 121.879 2.127 . . . . 0.0 113.082 -179.971 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.308 18.1 pt-20 -67.41 -6.35 18.78 Favored 'General case' 0 CA--C 1.579 2.065 0 CA-C-N 112.677 -2.056 . . . . 0.0 114.959 169.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.573 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 45.8 t-20 -86.41 -15.47 40.23 Favored 'General case' 0 CA--C 1.588 2.408 0 O-C-N 121.129 -0.982 . . . . 0.0 112.721 162.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.51 -25.73 24.89 Favored Glycine 0 CA--C 1.549 2.178 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -75.17 140.2 43.18 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 124.292 1.037 . . . . 0.0 112.334 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.4 t -81.53 112.69 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 122.688 1.232 . . . . 0.0 108.947 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.91 147.63 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 114.129 -1.396 . . . . 0.0 113.465 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 m -87.3 127.19 35.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.805 -1.184 . . . . 0.0 108.54 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.16 152.3 49.78 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.1 151.29 42.2 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 170.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.465 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.7 OUTLIER -69.57 162.68 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.437 0 O-C-N 120.738 -1.226 . . . . 0.0 111.287 173.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.7 p -76.52 98.4 4.63 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 119.246 -2.159 . . . . 0.0 109.937 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -16.52 -50.19 0.01 OUTLIER Glycine 0 N--CA 1.505 3.234 1 N-CA-C 123.761 4.264 . . . . 0.0 123.761 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -47.69 -49.51 27.57 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 119.065 2.987 . . . . 0.0 119.065 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ptm -70.89 -18.08 62.69 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -39.6 -35.54 0.32 Allowed 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 169.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -92.79 34.06 1.11 Allowed 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -150.23 -71.63 0.18 Allowed 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 102.958 -2.978 . . . . 0.0 102.958 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -81.09 93.49 6.43 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.802 1.241 . . . . 0.0 107.771 164.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mt -74.01 -70.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.217 -0.927 . . . . 0.0 111.491 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -134.78 171.94 13.67 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 125.284 2.469 . . . . 0.0 115.009 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.265 1.0 OUTLIER -148.73 170.36 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 CA-C-N 110.85 -2.886 . . . . 0.0 109.777 -175.899 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.6 tp -109.43 163.41 13.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.891 -1.13 . . . . 0.0 112.986 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.8 m -71.48 85.15 0.84 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 123.813 1.768 . . . . 0.0 111.095 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 131.77 23.15 0.89 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 112.8 -2.0 . . . . 0.0 117.053 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -94.5 160.89 14.44 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 123.043 1.401 . . . . 0.0 113.145 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -88.78 83.63 6.69 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 124.999 2.333 . . . . 0.0 112.475 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -71.76 163.35 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 CA-C-N 110.802 -2.908 . . . . 0.0 114.34 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.306 75.3 m -95.13 160.2 14.67 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 159.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -158.44 84.55 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 O-C-N 118.37 -2.706 . . . . 0.0 105.769 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -76.77 134.8 39.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.019 -1.051 . . . . 0.0 109.838 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -137.61 -172.14 3.16 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.821 0.82 . . . . 0.0 111.299 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -104.79 155.74 37.04 Favored Pre-proline 0 CA--C 1.573 1.833 0 O-C-N 120.993 -1.067 . . . . 0.0 113.259 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -54.34 -42.03 71.2 Favored 'Trans proline' 0 CA--C 1.572 2.392 0 C-N-CA 123.738 2.959 . . . . 0.0 118.387 164.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -79.42 -47.38 15.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -108.22 89.24 2.93 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 122.195 0.998 . . . . 0.0 110.308 -174.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.82 -14.9 57.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 118.996 2.962 . . . . 0.0 118.996 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.9 t -73.46 -1.28 17.74 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -129.56 -177.5 4.29 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 120.276 1.398 . . . . 0.0 113.277 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.0 -173.86 45.22 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -161.63 113.65 1.77 Allowed 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 119.595 3.183 . . . . 0.0 119.595 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.581 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -36.45 94.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 118.762 -2.461 . . . . 0.0 117.556 166.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.57 1.737 0 CA-C-N 114.062 -1.426 . . . . 0.0 112.847 176.727 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 . . . . . 0 CA--C 1.568 1.667 0 CA-C-O 120.813 0.34 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -91.33 142.05 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.847 -1.158 . . . . 0.0 111.227 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.337 13.2 pt-20 -100.28 123.17 44.18 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 123.705 1.717 . . . . 0.0 110.177 169.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.261 13.9 ttt -155.15 -12.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 119.315 3.08 . . . . 0.0 119.315 -151.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.725 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.503 0.0 OUTLIER -69.68 -173.02 0.55 Allowed 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 121.765 3.987 . . . . 0.0 121.765 -169.915 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.56 -108.64 1.78 Allowed Glycine 0 N--CA 1.48 1.567 0 N-CA-C 122.442 3.737 . . . . 0.0 122.442 -164.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.7 m -121.43 136.92 54.91 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.506 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 79.1 t -62.76 117.05 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.91 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.7 mt -79.34 -37.36 37.71 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 122.107 2.231 . . . . 0.0 111.236 165.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.5 tp10 -143.31 144.96 32.31 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 122.062 0.934 . . . . 0.0 112.346 169.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.526 HG22 ' HE1' ' A' ' 21' ' ' PHE . 32.2 p -104.2 109.3 21.06 Favored 'General case' 0 N--CA 1.513 2.725 0 N-CA-C 101.763 -3.421 . . . . 0.0 101.763 171.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.376 0.5 OUTLIER -77.32 -177.51 0.81 Allowed Pre-proline 0 CA--C 1.592 2.559 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -167.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -54.38 -36.59 87.8 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 N-CA-C 120.893 3.382 . . . . 0.0 120.893 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -85.72 -93.83 0.08 Allowed 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -156.23 74.89 0.86 Allowed 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.9 mtt -130.23 162.25 29.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.976 -1.077 . . . . 0.0 112.76 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.691 ' CE2' HG23 ' A' ' 35' ' ' ILE . 62.3 m-85 -128.75 113.3 15.16 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 118.723 -2.485 . . . . 0.0 106.979 -162.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -85.76 96.11 9.62 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 167.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 21' ' ' PHE . 2.1 t -99.95 140.13 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -164.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.06 114.92 26.67 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.49 HD21 HE21 ' A' ' 9' ' ' GLN 0.256 0.5 OUTLIER -58.4 178.07 0.11 Allowed 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -177.751 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.49 -24.57 66.42 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 167.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -92.63 6.96 45.44 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 170.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.9 -1.74 87.86 Favored Glycine 0 CA--C 1.554 2.519 0 N-CA-C 119.911 2.725 . . . . 0.0 119.911 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -83.9 143.19 30.04 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.641 1.72 . . . . 0.0 113.262 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.5 t -89.05 130.84 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.663 0 CA-C-O 122.578 1.18 . . . . 0.0 111.52 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.86 153.92 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.54 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.0 m -99.51 122.0 41.97 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.495 -1.378 . . . . 0.0 109.853 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.39 149.36 32.6 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 119.733 3.235 . . . . 0.0 119.733 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -99.95 158.26 15.94 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.509 -1.37 . . . . 0.0 111.206 170.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.691 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -71.17 178.21 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.752 0 O-C-N 120.444 -1.41 . . . . 0.0 111.981 164.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.2 p -80.08 15.72 1.42 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 120.07 3.359 . . . . 0.0 120.07 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.67 -25.66 0.06 OUTLIER Glycine 0 N--CA 1.506 3.33 0 N-CA-C 121.842 3.497 . . . . 0.0 121.842 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -79.99 -45.95 17.51 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -46.25 89.42 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 118.537 2.792 . . . . 0.0 118.537 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HB3' HD11 ' A' ' 35' ' ' ILE . 7.6 ptm85 -36.28 -45.99 0.5 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.806 3.262 . . . . 0.0 119.806 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -92.0 0.6 57.47 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-N 110.048 -3.251 . . . . 0.0 118.929 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -96.57 -71.58 0.67 Allowed 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 167.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.27 125.81 37.09 Favored 'General case' 0 CA--C 1.57 1.744 0 C-N-CA 124.154 0.982 . . . . 0.0 109.122 170.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.57 108.99 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.722 0 CA-C-O 124.429 2.061 . . . . 0.0 107.747 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -44.66 174.62 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.878 1 N-CA-C 124.267 4.914 . . . . 0.0 124.267 -165.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' A' ' 21' ' ' PHE . 1.1 pt -75.57 159.79 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 109.845 -3.343 . . . . 0.0 116.604 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -122.44 174.77 6.82 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.184 0.993 . . . . 0.0 112.285 -171.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -68.47 100.61 1.11 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 123.494 1.616 . . . . 0.0 112.576 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.506 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 113.36 20.47 6.22 Favored Glycine 0 N--CA 1.489 2.224 0 CA-C-N 112.837 -1.983 . . . . 0.0 117.883 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.55 158.58 15.92 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-O 122.917 1.341 . . . . 0.0 112.764 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -87.75 94.54 9.78 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 125.764 2.697 . . . . 0.0 113.106 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.419 ' CG1' HD13 ' A' ' 46' ' ' ILE . 19.7 m -94.56 148.12 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 CA-C-N 109.594 -3.457 . . . . 0.0 110.986 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.2 m -140.94 107.19 5.23 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 100.33 -3.952 . . . . 0.0 100.33 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.725 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.252 51.0 t -117.17 128.45 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 111.177 -2.738 . . . . 0.0 106.042 -159.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -80.65 134.32 35.86 Favored 'General case' 0 CA--C 1.558 1.266 0 O-C-N 121.345 -0.847 . . . . 0.0 112.182 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.56 -176.38 3.37 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.488 1.137 . . . . 0.0 110.707 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 p -108.56 164.12 15.44 Favored Pre-proline 0 CA--C 1.571 1.772 0 O-C-N 120.987 -1.071 . . . . 0.0 113.883 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -51.09 -40.77 59.26 Favored 'Trans proline' 0 CA--C 1.572 2.393 0 N-CA-C 118.976 2.645 . . . . 0.0 118.976 163.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -94.98 -53.39 3.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -89.63 79.87 6.73 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.576 1.179 . . . . 0.0 111.924 -172.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.65 -21.23 57.88 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.2 t -77.64 11.75 1.95 Allowed 'General case' 0 CA--C 1.58 2.127 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 173.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 mtmm -137.56 177.38 7.91 Favored 'General case' 0 CA--C 1.57 1.742 0 CA-C-N 120.249 1.386 . . . . 0.0 114.612 -175.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.2 -176.25 45.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.22 114.85 3.69 Favored 'General case' 0 CA--C 1.592 2.58 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 168.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.64 ' H ' HD12 ' A' ' 66' ' ' ILE . 1.3 mp -45.13 108.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 O-C-N 119.076 -2.265 . . . . 0.0 114.893 171.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.574 1.87 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.799 173.74 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 . . . . . 0 CA--C 1.579 2.066 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mt -88.99 138.73 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.294 -1.504 . . . . 0.0 112.298 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.328 8.6 pt-20 -88.56 121.63 31.15 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 125.052 2.358 . . . . 0.0 109.235 170.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.407 ' HB3' HD23 ' A' ' 56' ' ' LEU . 18.0 ttt -172.01 84.79 0.07 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 109.289 -3.596 . . . . 0.0 104.852 -148.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.643 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -110.92 -149.03 0.44 Allowed 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -156.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 179.82 -150.72 9.44 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 117.967 1.947 . . . . 0.0 117.967 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.9 m -115.89 133.79 55.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.516 HG11 HG23 ' A' ' 15' ' ' THR . 46.9 t -60.06 118.31 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.003 0 O-C-N 121.384 -0.822 . . . . 0.0 109.102 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -84.24 -31.44 25.01 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.599 -1.938 . . . . 0.0 111.874 165.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -147.04 143.88 28.7 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 122.726 1.251 . . . . 0.0 111.807 167.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.516 HG23 HG11 ' A' ' 12' ' ' VAL . 24.3 p -104.16 105.68 15.93 Favored 'General case' 0 N--CA 1.516 2.862 0 N-CA-C 100.793 -3.781 . . . . 0.0 100.793 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.371 0.3 OUTLIER -75.26 173.39 7.06 Favored Pre-proline 0 CA--C 1.591 2.526 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -167.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -47.58 -35.26 22.14 Favored 'Trans proline' 0 CA--C 1.567 2.128 0 N-CA-C 122.103 3.847 . . . . 0.0 122.103 -174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -85.3 -96.34 0.07 Allowed 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 m -157.68 73.38 0.7 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 95.9 mtp -125.38 167.27 15.19 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.385 1.074 . . . . 0.0 112.529 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.534 ' CE1' HD11 ' A' ' 46' ' ' ILE . 55.3 m-85 -130.04 114.06 15.32 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 118.883 -2.386 . . . . 0.0 108.363 -164.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.2 ttm105 -85.34 97.95 10.26 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.5 t -106.75 143.03 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -162.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -88.13 106.73 18.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 171.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.285 3.8 mt -72.31 176.37 5.34 Favored 'General case' 0 CA--C 1.58 2.107 0 CA-C-O 123.995 1.855 . . . . 0.0 113.208 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.77 -25.12 62.75 Favored 'General case' 0 CA--C 1.585 2.304 0 CA-C-N 114.088 -1.415 . . . . 0.0 114.101 166.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -72.02 -5.83 37.84 Favored 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.72 -4.47 79.0 Favored Glycine 0 CA--C 1.557 2.706 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -88.33 147.71 24.64 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.77 1.228 . . . . 0.0 112.903 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.44 106.84 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.95 151.32 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.1 m -92.53 124.83 36.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.525 -1.359 . . . . 0.0 109.005 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.53 159.59 41.34 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -113.25 -164.28 0.91 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 169.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -108.34 -177.94 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.384 0 O-C-N 120.254 -1.529 . . . . 0.0 108.369 166.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 84.8 p -76.79 20.08 0.26 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.98 -55.18 0.79 Allowed Glycine 0 N--CA 1.499 2.871 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -57.11 -52.54 64.9 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.259 0.7 OUTLIER -70.11 -19.48 63.24 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 117.611 2.449 . . . . 0.0 117.611 177.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -39.43 -35.59 0.29 Allowed 'General case' 0 CA--C 1.578 2.056 0 N-CA-C 117.338 2.347 . . . . 0.0 117.338 170.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.8 38.62 1.21 Allowed 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 171.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -152.93 -74.82 0.13 Allowed 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.44 99.75 11.87 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 164.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mt -76.39 -64.59 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 O-C-N 121.666 -0.646 . . . . 0.0 111.773 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -128.47 167.42 17.08 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 119.94 3.311 . . . . 0.0 119.94 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.534 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.268 1.5 pt -142.65 170.83 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 109.57 -3.468 . . . . 0.0 110.666 176.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.3 tp -111.22 163.27 14.1 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.147 0.975 . . . . 0.0 111.406 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.1 m -69.97 88.41 0.57 Allowed 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 123.451 1.596 . . . . 0.0 111.206 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.499 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 129.49 22.17 1.22 Allowed Glycine 0 N--CA 1.493 2.473 0 CA-C-N 113.184 -1.825 . . . . 0.0 117.304 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -93.42 160.33 14.86 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 122.891 1.329 . . . . 0.0 113.478 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -88.35 84.54 6.83 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 125.438 2.542 . . . . 0.0 112.765 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -71.13 166.63 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-N 110.156 -3.202 . . . . 0.0 115.218 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.321 14.3 m -125.95 75.71 1.53 Allowed 'General case' 0 N--CA 1.508 2.445 0 CA-C-O 123.798 1.761 . . . . 0.0 113.54 171.283 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.643 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -75.04 101.3 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.315 1.446 . . . . 0.0 109.528 -172.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -80.65 146.01 31.36 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.277 1.037 . . . . 0.0 109.911 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 8' ' ' MET . 3.1 mm? -98.39 -173.46 2.57 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 124.623 2.154 . . . . 0.0 116.405 -171.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 p -131.32 153.84 81.76 Favored Pre-proline 0 CA--C 1.578 2.045 0 CA-C-N 111.027 -2.806 . . . . 0.0 111.421 165.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.2 -42.85 61.93 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 123.734 2.956 . . . . 0.0 118.352 165.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -87.27 -54.4 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -96.86 74.25 2.65 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -171.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.8 mp -66.11 -20.99 66.33 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.3 m -73.36 1.55 9.38 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -135.36 169.89 16.78 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 123.333 1.54 . . . . 0.0 111.963 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.55 -164.83 31.69 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 115.87 1.108 . . . . 0.0 115.87 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.24 110.83 1.21 Allowed 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 119.234 3.049 . . . . 0.0 119.234 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.513 ' CD1' ' H ' ' A' ' 66' ' ' ILE 0.264 0.7 OUTLIER -25.1 89.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 163.924 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 CA--C 1.568 1.647 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.459 173.523 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 . . . . . 0 CA--C 1.572 1.821 0 CA-C-O 121.567 0.698 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.5 140.11 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.58 1.152 . . . . 0.0 110.444 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.375 11.4 pt-20 -92.21 123.48 35.58 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 124.644 2.164 . . . . 0.0 109.81 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.259 25.2 ttt -172.62 86.93 0.07 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 110.143 -3.208 . . . . 0.0 105.228 -147.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.657 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -116.24 -147.07 0.41 Allowed 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -156.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.88 -144.59 9.02 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 121.23 3.252 . . . . 0.0 121.23 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.2 m -102.74 129.54 49.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.235 -0.568 . . . . 0.0 109.611 -176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.484 HG11 HG23 ' A' ' 15' ' ' THR . 56.0 t -61.64 123.46 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.773 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 173.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.296 63.3 mt -101.68 -17.53 16.26 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 119.816 -1.803 . . . . 0.0 112.99 167.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 6.1 tp10 -148.18 143.35 27.0 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.512 1.149 . . . . 0.0 110.598 161.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.484 HG23 HG11 ' A' ' 12' ' ' VAL . 22.8 p -106.18 106.09 16.43 Favored 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 100.545 -3.872 . . . . 0.0 100.545 171.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.364 0.3 OUTLIER -75.23 173.58 6.74 Favored Pre-proline 0 CA--C 1.592 2.56 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -167.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -48.65 -34.48 27.19 Favored 'Trans proline' 0 CA--C 1.567 2.148 0 N-CA-C 121.729 3.704 . . . . 0.0 121.729 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -84.69 -95.46 0.07 Allowed 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -158.97 73.53 0.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 58.8 mtt -126.92 167.3 16.04 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.703 0.801 . . . . 0.0 112.264 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.601 ' CE2' HG23 ' A' ' 35' ' ' ILE . 57.7 m-85 -128.82 114.59 16.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 118.544 -2.598 . . . . 0.0 108.205 -163.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -87.28 91.35 8.69 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.5 t -99.3 142.02 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -162.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -82.98 124.37 30.33 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 165.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.269 3.0 mt -74.47 -173.89 1.88 Allowed 'General case' 0 CA--C 1.579 2.066 0 CA-C-O 123.76 1.743 . . . . 0.0 112.016 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -26.03 63.65 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 171.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -90.77 8.72 33.23 Favored 'General case' 0 CA--C 1.582 2.209 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 169.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.55 6.55 89.26 Favored Glycine 0 CA--C 1.552 2.393 0 N-CA-C 119.61 2.604 . . . . 0.0 119.61 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -89.48 142.69 27.44 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 119.908 1.854 . . . . 0.0 112.001 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 t -84.57 124.35 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 122.087 0.946 . . . . 0.0 110.805 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.41 145.69 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.745 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 m -91.24 122.1 33.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.533 -1.354 . . . . 0.0 108.547 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.91 153.68 44.56 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -114.51 148.34 38.05 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.511 1.148 . . . . 0.0 109.129 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.601 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.1 pt -66.94 179.24 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.598 2.798 0 O-C-N 121.025 -1.047 . . . . 0.0 112.521 166.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.7 p -102.82 157.3 17.06 Favored 'General case' 0 CA--C 1.558 1.287 0 O-C-N 119.513 -1.992 . . . . 0.0 115.048 -176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.31 -3.98 27.73 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 119.297 2.479 . . . . 0.0 119.297 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.282 21.9 pttm -95.31 -54.26 3.47 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.691 1.738 . . . . 0.0 115.691 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -31.47 66.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 118.197 2.665 . . . . 0.0 118.197 175.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -35.58 -42.25 0.23 Allowed 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 120.344 3.461 . . . . 0.0 120.344 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.83 34.79 0.72 Allowed 'General case' 0 CA--C 1.581 2.149 0 CA-C-N 111.306 -2.679 . . . . 0.0 116.567 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -155.53 -74.9 0.11 Allowed 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 102.226 -3.25 . . . . 0.0 102.226 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.4 97.44 8.95 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.485 1.514 . . . . 0.0 107.943 165.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mt -74.26 -63.44 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.255 -0.903 . . . . 0.0 111.768 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -129.24 170.45 13.57 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.548 HD11 ' CE1' ' A' ' 21' ' ' PHE . 2.8 pt -146.73 171.56 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 109.507 -3.497 . . . . 0.0 111.363 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.5 tp -116.39 167.03 11.4 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.179 0.99 . . . . 0.0 110.973 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.1 m -70.74 86.17 0.67 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 123.539 1.638 . . . . 0.0 111.905 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.453 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 133.83 19.43 0.92 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 117.726 1.85 . . . . 0.0 117.726 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -94.79 165.71 12.34 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.985 1.314 . . . . 0.0 113.312 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -88.29 121.87 31.18 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 124.178 1.942 . . . . 0.0 111.945 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.69 163.98 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.881 0 CA-C-N 111.183 -2.735 . . . . 0.0 113.109 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 9' ' ' GLN 0.361 22.7 m -121.85 75.3 1.2 Allowed 'General case' 0 N--CA 1.514 2.743 0 CA-C-O 124.543 2.116 . . . . 0.0 114.754 172.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.657 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -75.84 100.56 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 126.82 2.048 . . . . 0.0 110.56 -174.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -83.25 144.34 29.81 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 120.842 -1.161 . . . . 0.0 109.081 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.4 -175.01 4.61 Favored 'General case' 0 CA--C 1.564 1.495 0 O-C-N 120.863 -1.148 . . . . 0.0 112.042 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -94.28 159.95 32.95 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -52.14 -41.45 65.0 Favored 'Trans proline' 0 CA--C 1.57 2.297 0 C-N-CA 123.443 2.762 . . . . 0.0 118.868 164.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -91.18 -54.55 3.89 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -93.64 78.9 4.28 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 122.507 1.146 . . . . 0.0 113.234 -171.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.16 -8.82 57.46 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 119.711 3.226 . . . . 0.0 119.711 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -75.96 -0.82 22.87 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -129.86 179.99 5.54 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.89 1.677 . . . . 0.0 113.053 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.18 -177.58 46.2 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 117.522 1.769 . . . . 0.0 117.522 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.34 111.27 1.64 Allowed 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.801 ' H ' HD12 ' A' ' 66' ' ' ILE 0.351 1.3 mp -38.57 89.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 119.152 -2.217 . . . . 0.0 116.547 164.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.56 1.365 0 CA-C-N 114.246 -1.343 . . . . 0.0 114.273 -176.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.981 0.42 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.97 155.49 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.705 -1.247 . . . . 0.0 110.246 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.331 12.4 pt-20 -113.78 119.32 36.93 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 124.128 1.918 . . . . 0.0 111.565 170.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.276 25.8 ttt -164.43 68.98 0.17 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 110.807 -2.906 . . . . 0.0 112.48 -152.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.665 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.597 0.3 OUTLIER -133.69 -167.86 2.01 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 177.075 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.45 -112.39 0.89 Allowed Glycine 0 N--CA 1.483 1.798 0 N-CA-C 122.226 3.65 . . . . 0.0 122.226 -167.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.2 m -103.97 136.32 43.84 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.682 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 45.9 t -71.49 100.01 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.615 3.451 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -64.5 -44.58 90.47 Favored 'General case' 0 N--CA 1.521 3.084 2 CA-C-N 127.163 4.529 . . . . 0.0 112.81 174.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -129.76 150.35 51.1 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 122.921 1.343 . . . . 0.0 110.464 171.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 p -104.34 97.9 7.77 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 101.391 -3.559 . . . . 0.0 101.391 171.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.281 5.2 mt -78.76 155.98 77.85 Favored Pre-proline 0 CA--C 1.595 2.68 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.259 -163.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.347 6.1 Cg_endo -14.15 -62.62 0.01 OUTLIER 'Trans proline' 0 CA--C 1.567 2.145 2 N-CA-C 125.343 5.093 . . . . 0.0 125.343 -169.676 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -75.81 -85.87 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.152 1.342 . . . . 0.0 109.108 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.6 m -155.94 75.11 0.89 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 81.3 mtp -120.24 179.37 4.31 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.756 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.476 ' HB3' HG22 ' A' ' 23' ' ' VAL . 58.3 m-85 -145.29 106.52 4.19 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 -165.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.3 ttt85 -84.2 93.94 8.29 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 170.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.6 t -98.57 136.0 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -162.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -96.03 108.42 20.82 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 26' ' ' GLU 0.345 0.3 OUTLIER -48.8 178.39 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 N-CA-C 121.473 3.879 . . . . 0.0 121.473 -177.15 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.554 ' H ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -75.43 -23.13 56.93 Favored 'General case' 0 CA--C 1.579 2.074 0 CA-C-N 112.462 -2.154 . . . . 0.0 113.704 166.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.264 0.1 OUTLIER -93.45 4.89 53.23 Favored 'General case' 0 CA--C 1.595 2.707 0 C-N-CA 124.703 1.201 . . . . 0.0 112.481 168.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.79 15.36 79.47 Favored Glycine 0 CA--C 1.547 2.056 0 N-CA-C 119.634 2.613 . . . . 0.0 119.634 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -101.08 136.12 41.44 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.007 1.904 . . . . 0.0 111.62 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.67 128.12 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 119.926 -1.734 . . . . 0.0 112.398 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -122.47 169.76 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.281 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -112.04 121.88 46.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.909 -1.12 . . . . 0.0 109.793 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.81 158.74 43.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 118.377 2.732 . . . . 0.0 118.377 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -106.74 166.21 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.806 1.289 . . . . 0.0 109.499 167.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.427 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.1 pt -78.55 -176.37 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.58 0 O-C-N 119.854 -1.779 . . . . 0.0 111.414 168.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.8 p -102.42 97.05 7.34 Favored 'General case' 0 CA--C 1.552 1.04 0 O-C-N 120.173 -1.58 . . . . 0.0 107.347 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -39.41 -30.43 0.16 Allowed Glycine 0 N--CA 1.499 2.868 0 N-CA-C 122.914 3.926 . . . . 0.0 122.914 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -66.13 -50.45 63.97 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -52.78 5.18 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 124.759 1.224 . . . . 0.0 113.596 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . 0.314 37.7 mmt180 -70.37 -47.84 59.1 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -171.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -94.13 46.21 1.16 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 123.855 1.788 . . . . 0.0 114.891 169.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -103.69 -53.38 2.79 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 167.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.264 39.4 p90 -72.33 -138.82 0.01 OUTLIER 'General case' 0 CA--C 1.592 2.594 0 CA-C-O 122.149 0.976 . . . . 0.0 108.96 154.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -118.62 -82.03 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 O-C-N 119.986 -1.696 . . . . 0.0 111.509 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -141.87 166.71 23.97 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 123.895 1.807 . . . . 0.0 114.802 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.284 2.4 pp -105.58 151.01 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.32 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.3 tp -86.64 162.49 17.92 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -165.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -65.43 99.33 0.41 Allowed 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 123.893 1.806 . . . . 0.0 112.069 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.682 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 113.66 -4.34 24.57 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 120.428 2.931 . . . . 0.0 120.428 -175.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -60.55 155.45 18.58 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -83.17 87.97 6.91 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 126.08 2.848 . . . . 0.0 113.235 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.19 146.06 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 108.987 -3.733 . . . . 0.0 110.314 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.3 m -137.02 115.91 12.28 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 100.421 -3.918 . . . . 0.0 100.421 171.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.665 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.26 92.3 t -121.46 127.05 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 112.779 -2.01 . . . . 0.0 107.429 -158.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -80.46 125.64 30.2 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.449 0.642 . . . . 0.0 111.955 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.263 0.3 OUTLIER -111.85 -110.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.209 -171.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.15 166.32 15.4 Favored Pre-proline 0 CA--C 1.582 2.183 0 C-N-CA 123.793 0.837 . . . . 0.0 112.924 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -60.09 -46.33 19.49 Favored 'Trans proline' 0 CA--C 1.568 2.22 0 C-N-CA 123.412 2.741 . . . . 0.0 117.759 166.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -100.5 -55.55 2.57 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -93.62 70.19 4.17 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.1 mp -68.63 2.24 2.61 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -69.31 -11.17 60.58 Favored 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -142.96 159.14 42.81 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 125.824 1.65 . . . . 0.0 113.223 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.47 -158.97 19.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 117.016 1.566 . . . . 0.0 117.016 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.26 124.29 7.43 Favored 'General case' 0 CA--C 1.59 2.498 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.486 ' CD1' ' H ' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -41.29 99.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 174.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 CA--C 1.579 2.095 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 170.708 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 CA--C 1.577 2.004 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.84 156.97 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.457 -1.402 . . . . 0.0 111.878 -171.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.35 9.8 pt-20 -106.29 120.78 42.76 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 124.537 2.113 . . . . 0.0 110.684 165.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 21.0 ttt -169.61 78.74 0.11 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 110.601 -3.0 . . . . 0.0 109.08 -155.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.669 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.612 0.0 OUTLIER -139.24 -168.42 2.44 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 173.274 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.64 -108.51 1.0 Allowed Glycine 0 N--CA 1.478 1.497 0 N-CA-C 121.198 3.239 . . . . 0.0 121.198 -165.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 98.9 m -121.88 135.31 54.88 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.497 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 73.7 t -61.49 117.57 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.612 3.327 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.7 mt -81.14 -45.23 16.72 Favored 'General case' 0 N--CA 1.511 2.577 0 CA-C-N 123.091 2.678 . . . . 0.0 110.809 167.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 6.1 tp10 -129.53 143.03 50.66 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 122.752 1.263 . . . . 0.0 111.535 170.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.458 HG23 HG11 ' A' ' 12' ' ' VAL . 20.4 p -103.01 107.56 18.4 Favored 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 101.03 -3.693 . . . . 0.0 101.03 171.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.391 0.2 OUTLIER -75.45 -175.35 0.46 Allowed Pre-proline 0 CA--C 1.594 2.646 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -167.086 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -52.35 -51.1 11.9 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 124.091 3.194 . . . . 0.0 119.493 -173.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.39 -86.75 0.05 OUTLIER 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -163.02 75.1 0.39 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 172.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 69.1 mtm -123.28 175.9 6.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.464 -0.772 . . . . 0.0 111.551 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.705 ' CE2' HG23 ' A' ' 35' ' ' ILE . 60.0 m-85 -140.68 113.67 8.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 118.908 -2.37 . . . . 0.0 107.29 -163.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -86.59 96.34 10.06 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 169.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -100.2 136.54 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -162.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -94.07 113.14 25.05 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 171.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.256 0.5 OUTLIER -56.5 178.77 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 -175.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.77 -25.63 66.57 Favored 'General case' 0 CA--C 1.573 1.844 0 CA-C-N 113.564 -1.653 . . . . 0.0 114.976 167.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -93.26 8.01 42.05 Favored 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 168.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.89 8.78 85.37 Favored Glycine 0 CA--C 1.556 2.639 0 N-CA-C 120.333 2.893 . . . . 0.0 120.333 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -93.67 138.97 31.35 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 119.275 1.537 . . . . 0.0 112.789 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.9 t -85.56 130.34 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.209 -1.557 . . . . 0.0 112.805 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.3 m -126.72 167.42 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 114.359 -1.291 . . . . 0.0 113.571 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 m -109.29 123.26 48.98 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.966 -1.084 . . . . 0.0 110.152 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.26 151.95 39.17 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 119.171 3.026 . . . . 0.0 119.171 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.33 170.16 8.62 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.036 -1.04 . . . . 0.0 109.594 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.705 HG23 ' CE2' ' A' ' 21' ' ' PHE . 6.4 pt -76.76 -177.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.552 0 O-C-N 119.531 -1.981 . . . . 0.0 110.97 164.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.2 p -100.73 144.52 29.6 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 119.646 -1.909 . . . . 0.0 110.761 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.93 -23.2 6.89 Favored Glycine 0 N--CA 1.508 3.463 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -63.78 -55.78 20.52 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.246 1.818 . . . . 0.0 114.768 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.6 ptp -73.77 -36.14 65.05 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 116.148 -1.882 . . . . 0.0 115.791 172.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HG2' HD11 ' A' ' 35' ' ' ILE . 51.4 mtt85 -37.33 -41.03 0.39 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.549 2.425 . . . . 0.0 117.549 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -93.19 -1.44 56.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -94.34 -68.68 0.79 Allowed 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.61 130.8 55.29 Favored 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 125.501 1.52 . . . . 0.0 107.717 170.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.6 mt -73.54 -65.37 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.044 0 O-C-N 120.004 -1.685 . . . . 0.0 111.166 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -105.33 164.52 11.79 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 120.954 3.687 . . . . 0.0 120.954 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.275 0.5 OUTLIER -133.97 168.6 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-N 109.545 -3.479 . . . . 0.0 109.457 173.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.59 163.81 12.17 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.445 1.117 . . . . 0.0 113.206 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 m -72.67 89.64 1.34 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 123.351 1.548 . . . . 0.0 110.955 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.497 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 121.64 24.17 2.41 Favored Glycine 0 N--CA 1.489 2.213 0 CA-C-N 113.382 -1.736 . . . . 0.0 116.749 -174.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -92.28 156.64 17.14 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-O 122.634 1.207 . . . . 0.0 112.224 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -86.69 91.67 8.68 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 125.76 2.695 . . . . 0.0 113.685 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -93.17 151.3 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.038 0 CA-C-N 109.59 -3.459 . . . . 0.0 111.503 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -143.55 112.18 6.47 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 100.34 -3.948 . . . . 0.0 100.34 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.669 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.278 94.1 t -120.54 125.5 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 112.108 -2.314 . . . . 0.0 107.066 -156.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -78.0 120.61 23.1 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.671 0.748 . . . . 0.0 111.102 -174.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.278 0.2 OUTLIER -105.2 -122.87 0.22 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.858 -175.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.4 169.05 11.22 Favored Pre-proline 0 CA--C 1.584 2.257 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.98 -49.31 0.69 Allowed 'Trans proline' 0 CA--C 1.551 1.346 0 C-N-CA 124.766 3.644 . . . . 0.0 118.517 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -96.24 -34.14 11.74 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.048 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -103.56 81.33 1.9 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.971 -173.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.13 -19.47 34.14 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 118.815 2.894 . . . . 0.0 118.815 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.0 m -65.69 -6.37 11.23 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 160.19 41.05 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 125.746 1.618 . . . . 0.0 113.654 -177.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.81 -159.32 17.84 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -157.07 117.96 3.63 Favored 'General case' 0 CA--C 1.586 2.332 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -38.79 97.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 174.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 CA--C 1.568 1.672 0 C-N-CA 124.388 1.075 . . . . 0.0 112.455 171.209 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 . . . . . 0 CA--C 1.572 1.79 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.14 139.75 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.561 1.144 . . . . 0.0 109.663 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.308 6.6 pt-20 -97.56 116.51 29.92 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 124.89 2.281 . . . . 0.0 109.115 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 21.7 ttt -168.22 76.32 0.13 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 109.392 -3.549 . . . . 0.0 110.208 -148.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.662 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.613 0.0 OUTLIER -140.1 -166.92 2.2 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 174.691 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.16 -112.02 1.1 Allowed Glycine 0 N--CA 1.479 1.546 0 N-CA-C 120.633 3.013 . . . . 0.0 120.633 -165.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.8 m -118.26 137.53 52.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.473 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 58.8 t -64.57 105.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.608 3.176 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 mp -77.0 -45.0 28.83 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 117.966 -2.959 . . . . 0.0 113.175 170.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -122.56 148.84 44.73 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.354 1.074 . . . . 0.0 111.029 167.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 p -103.3 98.35 8.28 Favored 'General case' 0 N--CA 1.516 2.86 0 N-CA-C 101.667 -3.457 . . . . 0.0 101.667 170.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.27 5.3 mt -79.38 151.7 75.23 Favored Pre-proline 0 CA--C 1.591 2.535 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.482 -163.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.415 3.8 Cg_exo 8.61 -80.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.268 2 C-N-CA 126.686 4.924 . . . . 0.0 124.283 -170.696 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -76.04 -75.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 120.435 1.47 . . . . 0.0 110.869 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -158.34 75.96 0.75 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.258 61.9 mtt -118.37 -174.11 2.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 0.0 111.011 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.712 ' CE2' HG23 ' A' ' 35' ' ' ILE . 61.8 m-85 -148.3 108.83 4.16 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 118.919 -2.363 . . . . 0.0 105.152 -165.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -86.57 92.76 8.99 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 103.725 -2.695 . . . . 0.0 103.725 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -99.37 135.53 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -163.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.94 113.93 26.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 170.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.29 0.5 OUTLIER -58.46 -179.92 0.07 Allowed 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -176.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.79 -24.29 64.39 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-N 113.46 -1.7 . . . . 0.0 115.01 168.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -90.21 5.09 48.53 Favored 'General case' 0 CA--C 1.585 2.308 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.37 5.24 82.69 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 120.165 2.826 . . . . 0.0 120.165 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -94.93 142.46 27.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.616 1.708 . . . . 0.0 113.346 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.86 129.76 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-O 122.153 0.977 . . . . 0.0 112.384 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 m -139.83 152.6 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-O 122.208 1.004 . . . . 0.0 113.185 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -89.87 128.52 36.2 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.156 -1.59 . . . . 0.0 111.594 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.59 150.48 36.45 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -103.32 155.43 18.47 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.081 0.943 . . . . 0.0 110.595 170.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.712 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.1 pt -66.15 175.32 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.601 2.942 0 CA-C-O 122.913 1.339 . . . . 0.0 112.053 165.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.2 p -103.38 140.43 37.46 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 119.826 -1.796 . . . . 0.0 109.655 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.13 -16.27 6.17 Favored Glycine 0 N--CA 1.505 3.273 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -72.1 -49.64 34.62 Favored 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 126.656 1.982 . . . . 0.0 114.74 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.7 ptp -73.04 -24.16 60.68 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -38.74 -33.25 0.1 Allowed 'General case' 0 CA--C 1.587 2.381 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -91.85 -4.78 54.4 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -89.16 -72.97 0.52 Allowed 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 168.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -101.35 135.13 43.35 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 124.41 1.084 . . . . 0.0 108.759 166.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mt -71.5 -53.38 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.76 -1.212 . . . . 0.0 110.803 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -135.6 175.26 9.75 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-O 124.516 2.103 . . . . 0.0 112.792 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.403 HD11 ' CE1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -137.11 156.15 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 113.138 -1.846 . . . . 0.0 108.758 177.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.8 mp -95.77 166.51 11.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -73.69 87.14 1.68 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 123.48 1.609 . . . . 0.0 111.18 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 124.6 18.86 2.63 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-N 113.308 -1.769 . . . . 0.0 117.233 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -91.26 167.0 12.63 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 122.781 1.276 . . . . 0.0 111.234 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -90.08 129.67 36.35 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 124.951 2.31 . . . . 0.0 114.306 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.5 m -134.14 152.53 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.827 0 CA-C-N 110.511 -3.041 . . . . 0.0 110.693 -173.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.9 m -142.99 111.6 6.32 Favored 'General case' 0 N--CA 1.501 2.103 1 N-CA-C 100.19 -4.004 . . . . 0.0 100.19 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.662 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.276 71.7 t -125.35 123.85 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 112.261 -2.245 . . . . 0.0 107.182 -156.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -79.32 141.58 36.86 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.45 -175.81 4.93 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 122.125 0.964 . . . . 0.0 110.864 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -90.41 158.48 43.22 Favored Pre-proline 0 CA--C 1.573 1.835 0 O-C-N 120.611 -1.306 . . . . 0.0 112.999 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -54.86 -42.65 66.79 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 123.068 2.512 . . . . 0.0 118.422 164.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -90.39 -45.73 8.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -102.74 81.44 2.01 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 122.35 1.072 . . . . 0.0 113.031 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.67 43.06 0.81 Allowed 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 64.2 m -95.32 -28.6 14.89 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -132.29 -178.23 4.82 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-O 122.749 1.261 . . . . 0.0 114.049 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.49 177.25 40.2 Favored Glycine 0 CA--C 1.554 2.514 0 N-CA-C 117.145 1.618 . . . . 0.0 117.145 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.3 113.21 3.15 Favored 'General case' 0 CA--C 1.596 2.732 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 168.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.48 ' CD1' ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -45.5 104.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 CA-C-N 122.495 2.407 . . . . 0.0 113.968 173.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.564 1.511 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.941 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 CA--C 1.577 1.991 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 mt -92.3 143.95 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.773 -1.204 . . . . 0.0 110.84 -171.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.293 8.8 pt-20 -99.22 122.57 42.59 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 124.664 2.173 . . . . 0.0 109.512 170.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.293 6.5 ttt -152.95 -4.49 0.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 109.898 -3.319 . . . . 0.0 119.283 -151.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.848 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.537 0.5 OUTLIER -75.8 -164.03 0.32 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 121.657 3.947 . . . . 0.0 121.657 -166.607 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.42 -112.54 1.08 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 122.514 3.766 . . . . 0.0 122.514 -163.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.8 m -108.78 135.97 49.12 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.712 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 78.3 t -71.81 107.38 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.981 0 CA-C-N 120.379 1.445 . . . . 0.0 107.327 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.13 -42.56 72.45 Favored 'General case' 0 N--CA 1.516 2.843 0 CA-C-N 124.814 3.461 . . . . 0.0 112.056 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -132.6 147.83 52.35 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.151 0.977 . . . . 0.0 110.988 170.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.409 HG23 HG11 ' A' ' 12' ' ' VAL . 11.0 p -102.66 102.99 13.23 Favored 'General case' 0 N--CA 1.514 2.728 0 N-CA-C 101.94 -3.356 . . . . 0.0 101.94 170.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.347 5.4 mt -80.82 -179.03 1.3 Allowed Pre-proline 0 CA--C 1.598 2.797 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -164.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.273 21.1 Cg_endo -47.51 -45.55 22.79 Favored 'Trans proline' 0 CA--C 1.568 2.185 1 N-CA-C 123.786 4.495 . . . . 0.0 123.786 -167.963 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.58 -89.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.38 1.445 . . . . 0.0 108.31 172.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.4 m -153.03 76.22 1.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 171.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.4 mtt -120.61 176.25 5.6 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.521 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CE2' HG23 ' A' ' 35' ' ' ILE . 55.6 m-85 -146.05 108.71 4.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -164.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 tpt85 -83.51 94.63 8.08 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.9 t -100.72 139.09 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -162.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -92.36 115.24 27.92 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.27 0.6 OUTLIER -64.7 178.92 0.7 Allowed 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -177.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -67.66 -27.37 66.8 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 168.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -91.79 8.86 35.19 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 171.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.06 16.62 78.46 Favored Glycine 0 CA--C 1.555 2.549 0 N-CA-C 119.929 2.731 . . . . 0.0 119.929 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -98.58 131.46 44.78 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.188 1.494 . . . . 0.0 111.823 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -83.89 127.61 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 123.17 1.462 . . . . 0.0 111.435 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.73 HG21 HE21 ' A' ' 9' ' ' GLN . 18.7 m -123.38 159.77 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.882 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 m -106.73 123.24 47.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.54 -1.35 . . . . 0.0 109.432 172.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.57 157.85 44.28 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 118.881 2.919 . . . . 0.0 118.881 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -104.47 167.58 9.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 163.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.58 HG23 ' CE2' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -77.12 177.19 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.526 0 O-C-N 119.98 -1.7 . . . . 0.0 110.295 162.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.3 p -77.97 87.83 4.14 Favored 'General case' 0 CA--C 1.573 1.829 0 O-C-N 119.062 -2.274 . . . . 0.0 108.591 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -17.93 -47.61 0.01 OUTLIER Glycine 0 N--CA 1.505 3.26 1 N-CA-C 124.297 4.479 . . . . 0.0 124.297 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -45.36 -46.16 12.93 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 118.776 2.88 . . . . 0.0 118.776 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.27 0.0 OUTLIER -69.46 -23.87 63.71 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 177.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.454 ' HG3' HD11 ' A' ' 35' ' ' ILE . 98.7 mtt180 -37.97 -41.18 0.53 Allowed 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 122.9 2.591 . . . . 0.0 117.159 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -96.76 3.93 52.06 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 119.804 3.261 . . . . 0.0 119.804 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -110.37 -63.12 1.42 Allowed 'General case' 0 CA--C 1.571 1.764 0 C-N-CA 125.605 1.562 . . . . 0.0 107.062 172.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.88 104.08 10.22 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 169.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -67.91 112.64 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-O 124.426 2.06 . . . . 0.0 107.906 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -41.84 161.34 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.851 1 N-CA-C 123.557 4.651 . . . . 0.0 123.557 -167.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.46 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.255 1.1 pt -89.61 160.82 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.78 0 CA-C-N 109.26 -3.609 . . . . 0.0 115.409 -175.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 tp -115.14 175.54 5.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.378 -170.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -67.7 91.84 0.32 Allowed 'General case' 0 CA--C 1.575 1.917 0 CA-C-O 124.389 2.042 . . . . 0.0 114.296 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.712 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 124.04 -2.15 9.13 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -65.32 156.89 30.67 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -81.91 90.75 6.47 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 125.699 2.666 . . . . 0.0 113.962 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 m -93.07 154.67 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 CA-C-N 109.435 -3.529 . . . . 0.0 110.766 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.3 m -147.9 103.25 3.48 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 100.609 -3.848 . . . . 0.0 100.609 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.848 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 23.7 t -109.06 131.63 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 111.076 -2.784 . . . . 0.0 107.305 -162.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -83.77 130.16 34.94 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.908 -1.12 . . . . 0.0 111.991 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.275 0.5 OUTLIER -108.28 -155.81 0.56 Allowed 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 122.047 0.927 . . . . 0.0 110.962 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.4 p -138.12 161.39 59.77 Favored Pre-proline 0 CA--C 1.572 1.789 0 O-C-N 121.021 -1.049 . . . . 0.0 112.064 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.99 -42.16 59.99 Favored 'Trans proline' 0 CA--C 1.573 2.441 0 C-N-CA 123.315 2.677 . . . . 0.0 118.459 163.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -87.49 -50.42 6.55 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -102.37 80.68 1.97 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.314 1.054 . . . . 0.0 112.337 -172.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -28.51 64.89 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.9 t -76.75 13.62 0.98 Allowed 'General case' 0 CA--C 1.587 2.374 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -139.14 172.75 12.38 Favored 'General case' 0 CA--C 1.57 1.732 0 O-C-N 119.643 -1.911 . . . . 0.0 114.353 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.57 -165.84 38.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.52 122.67 5.46 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.768 ' H ' HD12 ' A' ' 66' ' ' ILE . 2.2 mp -46.62 104.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.933 0 CA-C-N 121.734 2.061 . . . . 0.0 114.475 170.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 CA--C 1.564 1.519 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.164 -179.9 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 . . . . . 0 CA--C 1.572 1.801 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -95.37 141.33 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.098 0.959 . . . . 0.0 110.222 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.303 9.1 pt-20 -96.4 122.09 38.91 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 125.068 2.366 . . . . 0.0 108.62 169.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 22.0 ttt -172.61 89.06 0.09 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 109.471 -3.513 . . . . 0.0 105.035 -149.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.711 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -117.19 -151.15 0.47 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -157.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 177.56 -137.65 3.52 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 117.348 1.699 . . . . 0.0 117.348 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.8 m -124.71 133.72 53.09 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 59.7 t -59.22 116.53 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.602 2.959 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.561 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.1 mt -83.9 -42.07 16.73 Favored 'General case' 0 N--CA 1.509 2.504 0 CA-C-N 122.299 2.318 . . . . 0.0 110.941 166.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 6.1 tt0 -133.97 143.97 48.49 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.829 1.299 . . . . 0.0 111.576 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.4 p -97.8 105.1 17.19 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 170.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.324 5.2 mt -78.86 179.77 1.65 Allowed Pre-proline 0 CA--C 1.596 2.718 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -164.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.266 27.8 Cg_endo -47.89 -45.91 23.24 Favored 'Trans proline' 0 CA--C 1.568 2.191 1 N-CA-C 122.552 4.02 . . . . 0.0 122.552 -169.591 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -82.84 -92.33 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.1 1.318 . . . . 0.0 107.735 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -151.61 73.28 1.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 171.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.7 mtp -119.78 176.52 5.36 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.641 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.48 ' HB3' HG22 ' A' ' 23' ' ' VAL . 56.9 m-85 -140.68 112.04 7.32 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -166.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -83.28 94.26 7.88 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 169.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.1 t -100.96 136.91 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -163.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -88.48 113.06 23.68 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.268 4.3 mt -73.39 -179.54 3.48 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 124.1 1.905 . . . . 0.0 112.554 -172.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.37 -22.18 61.18 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -90.11 6.37 42.77 Favored 'General case' 0 CA--C 1.585 2.292 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.95 15.79 76.52 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 119.828 2.691 . . . . 0.0 119.828 -176.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -102.91 139.9 37.88 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 119.248 1.524 . . . . 0.0 111.837 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -87.42 113.39 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.762 -1.211 . . . . 0.0 109.93 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.7 m -109.93 153.93 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -96.23 118.42 32.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.813 -1.179 . . . . 0.0 109.588 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.11 158.59 44.11 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.72 2.118 . . . . 0.0 116.72 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -105.68 -176.51 3.1 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.492 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -90.45 175.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.367 0 O-C-N 119.899 -1.751 . . . . 0.0 109.215 161.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.6 p -75.12 20.07 0.14 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 120.612 3.56 . . . . 0.0 120.612 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.79 -45.79 1.1 Allowed Glycine 0 N--CA 1.499 2.844 0 N-CA-C 118.644 2.218 . . . . 0.0 118.644 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -63.62 -54.07 41.68 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -22.8 64.79 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.9 mtp-105 -39.81 -35.81 0.38 Allowed 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -90.63 4.78 50.42 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 118.965 2.95 . . . . 0.0 118.965 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -97.15 -74.07 0.58 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 167.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -110.87 138.47 47.23 Favored 'General case' 0 CA--C 1.579 2.061 0 C-N-CA 125.334 1.453 . . . . 0.0 107.217 166.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.4 mt -73.66 -68.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 119.976 -1.702 . . . . 0.0 111.275 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -113.54 168.14 10.01 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 119.755 3.243 . . . . 0.0 119.755 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.357 1.8 pp -119.12 169.66 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 110.017 -3.265 . . . . 0.0 108.873 171.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.6 tp -100.98 163.2 12.4 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -168.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 m -69.73 92.94 0.69 Allowed 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 123.783 1.754 . . . . 0.0 111.49 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.511 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 117.01 22.92 4.07 Favored Glycine 0 N--CA 1.488 2.148 0 CA-C-N 112.678 -2.055 . . . . 0.0 117.439 -175.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -93.11 156.68 16.71 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.881 1.324 . . . . 0.0 113.33 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -88.66 83.32 6.74 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 125.231 2.444 . . . . 0.0 112.967 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.512 ' HB ' HD12 ' A' ' 66' ' ' ILE . 6.9 m -73.64 165.24 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 CA-C-N 110.436 -3.075 . . . . 0.0 114.972 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.801 ' H ' HG23 ' A' ' 66' ' ' ILE 0.274 5.1 m -120.52 77.23 1.25 Allowed 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 124.079 1.895 . . . . 0.0 112.434 173.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.711 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -75.47 94.05 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 O-C-N 120.219 -1.551 . . . . 0.0 110.328 -171.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -81.97 136.41 35.28 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.059 -1.026 . . . . 0.0 109.049 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.251 2.4 pt? -136.62 -165.01 1.66 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.844 -1.16 . . . . 0.0 112.351 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 p -110.29 159.5 31.82 Favored Pre-proline 0 CA--C 1.573 1.856 0 O-C-N 120.731 -1.231 . . . . 0.0 113.342 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.18 -38.91 81.76 Favored 'Trans proline' 0 CA--C 1.569 2.258 0 C-N-CA 123.39 2.727 . . . . 0.0 119.094 163.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -87.06 -52.23 5.55 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -96.86 78.87 2.88 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 122.323 1.058 . . . . 0.0 113.286 -172.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.36 -11.2 60.19 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 120.316 3.45 . . . . 0.0 120.316 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.0 m -73.69 -2.96 25.41 Favored 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 173.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.58 178.85 6.18 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.451 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . -178.31 -172.4 42.67 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 116.942 1.537 . . . . 0.0 116.942 175.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.3 105.9 1.0 Allowed 'General case' 0 CA--C 1.583 2.234 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.819 HD13 ' H ' ' A' ' 66' ' ' ILE 0.26 0.0 OUTLIER -28.08 87.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.063 0 N-CA-C 119.276 3.065 . . . . 0.0 119.276 167.261 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 CA--C 1.569 1.701 0 C-N-CA 124.483 1.113 . . . . 0.0 112.88 177.557 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 CA--C 1.577 2.0 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mt -109.35 141.55 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.885 -1.134 . . . . 0.0 110.356 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.339 12.7 pt-20 -100.78 118.7 37.38 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 124.014 1.864 . . . . 0.0 110.664 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.285 21.2 ttt -159.26 38.5 0.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.603 -2.544 . . . . 0.0 117.312 -148.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.783 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.531 0.0 OUTLIER -123.11 -175.91 3.29 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 120.01 3.337 . . . . 0.0 120.01 -173.201 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.9 -110.97 1.09 Allowed Glycine 0 N--CA 1.481 1.7 1 N-CA-C 123.653 4.221 . . . . 0.0 123.653 -163.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.1 m -102.89 131.01 50.11 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.476 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 83.8 t -63.46 107.19 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.601 2.913 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.318 98.4 mt -86.33 -36.02 19.51 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 118.813 -2.429 . . . . 0.0 111.98 173.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -128.21 147.05 50.56 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 123.149 1.452 . . . . 0.0 110.563 164.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.3 p -108.89 105.08 14.48 Favored 'General case' 0 N--CA 1.511 2.615 1 N-CA-C 99.889 -4.115 . . . . 0.0 99.889 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.356 0.4 OUTLIER -74.06 -178.78 0.82 Allowed Pre-proline 0 CA--C 1.592 2.584 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -165.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -55.24 -40.91 83.21 Favored 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 123.886 3.057 . . . . 0.0 120.036 -174.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -83.13 -92.95 0.07 Allowed 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.4 m -157.58 73.87 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.7 mtt -124.14 166.63 15.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.964 0.887 . . . . 0.0 112.658 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 46' ' ' ILE . 57.5 m-85 -127.84 110.88 13.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -165.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -84.22 92.02 7.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 171.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.495 HG21 HG21 ' A' ' 54' ' ' VAL . 1.4 t -99.72 134.03 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -164.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -83.26 115.11 21.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.567 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.264 0.1 OUTLIER -69.54 177.05 3.1 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 178.881 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.6 -14.24 40.66 Favored 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 167.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.567 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 23.7 t30 -92.12 -3.82 55.15 Favored 'General case' 0 CA--C 1.586 2.362 0 O-C-N 121.352 -0.843 . . . . 0.0 112.845 167.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.46 -5.38 81.28 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 119.182 2.433 . . . . 0.0 119.182 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -86.93 142.17 28.19 Favored 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 124.071 0.948 . . . . 0.0 110.388 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.8 131.4 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 CA-C-O 122.476 1.131 . . . . 0.0 112.831 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 m -130.97 150.25 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.5 m -92.62 124.88 36.96 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.263 -1.523 . . . . 0.0 110.801 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.77 170.16 16.4 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -120.23 136.04 54.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.736 -1.227 . . . . 0.0 112.518 174.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.559 HD13 ' HG3' ' A' ' 40' ' ' ARG 0.349 0.0 OUTLIER -79.56 146.92 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.068 0 O-C-N 120.541 -1.349 . . . . 0.0 109.304 176.211 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.97 92.25 1.63 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 119.434 -2.041 . . . . 0.0 113.88 -170.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -42.69 -30.34 0.91 Allowed Glycine 0 N--CA 1.491 2.327 1 N-CA-C 123.944 4.338 . . . . 0.0 123.944 -173.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -54.32 -49.46 69.64 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.94 -45.2 11.03 Favored 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 125.903 1.681 . . . . 0.0 114.717 170.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.559 ' HG3' HD13 ' A' ' 35' ' ' ILE 0.28 3.9 mmp_? -82.42 -40.58 21.03 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.203 1.801 . . . . 0.0 115.185 -166.035 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -92.91 40.03 1.05 Allowed 'General case' 0 CA--C 1.586 2.358 0 CA-C-O 122.52 1.152 . . . . 0.0 113.284 164.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -96.55 -43.93 7.38 Favored 'General case' 0 CA--C 1.576 1.945 0 C-N-CA 124.949 1.299 . . . . 0.0 108.45 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.278 35.2 p90 -68.54 -113.34 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 126.04 1.736 . . . . 0.0 109.81 162.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.45 -91.26 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.71 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -147.85 172.41 14.19 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 124.035 1.874 . . . . 0.0 109.957 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.508 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.252 1.1 pp -89.79 152.67 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.984 170.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -86.93 160.32 18.73 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 -166.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 m -73.57 83.81 1.54 Allowed 'General case' 0 CA--C 1.571 1.751 0 CA-C-O 123.854 1.787 . . . . 0.0 111.001 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.476 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 129.47 22.2 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 CA-C-N 112.982 -1.917 . . . . 0.0 116.813 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -91.61 160.14 15.54 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 123.331 1.538 . . . . 0.0 112.332 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -87.71 94.35 9.71 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 125.719 2.676 . . . . 0.0 113.518 -175.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.41 HG23 HG11 ' A' ' 23' ' ' VAL . 21.7 m -99.8 145.78 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-N 109.757 -3.383 . . . . 0.0 110.122 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.7 m -137.07 112.02 8.93 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.783 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.251 24.2 t -116.32 130.64 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.531 -159.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -88.4 136.46 32.97 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.006 0.907 . . . . 0.0 112.397 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.25 -169.98 2.24 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.64 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 58' ' ' PRO . 0.5 OUTLIER -153.83 166.0 16.66 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 120.321 -1.487 . . . . 0.0 111.395 175.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -35.1 -48.87 0.77 Allowed 'Trans proline' 0 CA--C 1.561 1.828 1 N-CA-C 122.778 4.107 . . . . 0.0 122.778 173.348 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.5 -29.76 52.67 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.825 1.298 . . . . 0.0 113.992 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -96.65 69.91 2.54 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 114.106 -1.406 . . . . 0.0 113.474 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.5 mt -87.09 -41.3 13.92 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -76.88 5.56 7.67 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -143.09 173.77 11.27 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 120.991 1.723 . . . . 0.0 114.953 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.95 -165.53 34.0 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -155.86 122.64 5.28 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.539 -1.565 . . . . 0.0 113.554 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.725 HD12 ' H ' ' A' ' 66' ' ' ILE . 1.8 mp -45.81 113.15 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 172.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.572 1.796 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.21 173.267 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 CA--C 1.573 1.839 0 CA-C-O 121.338 0.59 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -97.48 143.96 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.287 1.035 . . . . 0.0 111.29 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.325 11.1 pt-20 -92.86 120.45 33.22 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 125.525 2.583 . . . . 0.0 108.305 168.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.282 16.1 ttt -167.16 81.29 0.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 108.873 -3.785 . . . . 0.0 105.308 -150.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.557 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -97.33 -152.55 0.39 Allowed 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -158.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -164.38 -173.42 33.01 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 120.411 2.924 . . . . 0.0 120.411 -172.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.8 m -98.49 127.96 44.64 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 57.4 t -60.55 117.09 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.912 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 175.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.285 68.2 mt -101.34 -16.88 16.77 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 119.786 -1.822 . . . . 0.0 113.467 170.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -146.8 141.52 26.77 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.956 1.36 . . . . 0.0 109.621 160.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.3 p -94.56 100.62 12.56 Favored 'General case' 0 N--CA 1.516 2.825 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 169.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.282 6.0 mt -79.78 154.26 75.7 Favored Pre-proline 0 CA--C 1.594 2.644 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.873 -166.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.399 2.3 Cg_endo 2.11 -78.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.57 2.324 2 C-N-CA 126.777 4.985 . . . . 0.0 124.997 -171.618 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.29 -77.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 120.64 1.564 . . . . 0.0 110.877 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -156.38 76.03 0.88 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtt -119.69 -177.3 3.36 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.517 0.727 . . . . 0.0 111.708 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.493 ' CE1' HD11 ' A' ' 46' ' ' ILE . 57.1 m-85 -146.74 108.32 4.31 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 119.669 -1.894 . . . . 0.0 106.735 -166.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -86.9 94.52 9.61 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.3 t -102.86 135.73 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -163.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.55 111.75 21.55 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.532 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.286 0.1 OUTLIER -78.6 171.46 15.09 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 124.116 1.912 . . . . 0.0 115.782 -176.704 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.34 -13.96 44.81 Favored 'General case' 0 CA--C 1.578 2.056 0 CA-C-N 112.454 -2.157 . . . . 0.0 114.652 167.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.532 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 46.0 t30 -83.64 -11.21 57.56 Favored 'General case' 0 CA--C 1.587 2.371 0 CA-C-N 119.334 0.97 . . . . 0.0 113.337 164.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.84 -22.18 40.76 Favored Glycine 0 CA--C 1.549 2.216 0 N-CA-C 118.351 2.1 . . . . 0.0 118.351 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -79.71 143.38 34.61 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.122 0.969 . . . . 0.0 112.168 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.7 t -83.75 121.33 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 122.447 1.118 . . . . 0.0 109.507 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.54 144.36 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.801 -175.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.7 m -86.79 126.33 34.54 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.489 -1.382 . . . . 0.0 110.574 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.93 159.37 42.29 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -119.5 164.86 15.17 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 168.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -78.47 171.8 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.594 2.65 0 O-C-N 120.562 -1.336 . . . . 0.0 110.906 168.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.1 p -76.19 14.11 0.79 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 120.353 3.464 . . . . 0.0 120.353 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.83 -47.86 0.78 Allowed Glycine 0 N--CA 1.5 2.953 0 N-CA-C 117.819 1.888 . . . . 0.0 117.819 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -63.21 -51.13 67.54 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 126.54 1.936 . . . . 0.0 115.289 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ptm -70.16 -17.94 63.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 118.607 2.817 . . . . 0.0 118.607 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -39.14 -34.05 0.16 Allowed 'General case' 0 CA--C 1.583 2.244 0 CA-C-N 121.772 2.078 . . . . 0.0 116.443 167.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm -93.56 40.52 1.07 Allowed 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 173.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -157.56 -68.81 0.1 Allowed 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -93.38 101.18 13.4 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 165.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.27 20.9 mt -72.66 -77.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.768 -1.207 . . . . 0.0 111.444 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -136.61 171.09 15.0 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-O 125.988 2.804 . . . . 0.0 114.013 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.493 HD11 ' CE1' ' A' ' 21' ' ' PHE . 1.8 pt -147.08 167.18 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 109.959 -3.291 . . . . 0.0 109.581 -172.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.279 1.3 pt? -122.73 -174.71 2.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 111.262 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.255 94.2 m -75.25 87.12 2.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 123.376 1.56 . . . . 0.0 113.399 -175.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.43 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 133.77 22.7 0.74 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.62 170.33 9.28 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 125.389 1.475 . . . . 0.0 114.77 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -81.6 118.55 22.87 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 125.342 2.496 . . . . 0.0 112.402 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.08 149.1 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 109.761 -3.381 . . . . 0.0 111.265 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.557 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.311 89.3 m -94.42 162.39 13.84 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 162.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.455 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -158.07 87.03 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 O-C-N 118.452 -2.655 . . . . 0.0 105.104 -179.234 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -76.86 140.62 40.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.09 -1.006 . . . . 0.0 110.059 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.96 -167.53 2.8 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 121.7 0.762 . . . . 0.0 112.582 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -99.52 160.46 27.39 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -56.8 -42.53 63.74 Favored 'Trans proline' 0 CA--C 1.57 2.312 0 N-CA-C 118.756 2.56 . . . . 0.0 118.756 164.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -92.24 -45.02 8.44 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -174.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -102.0 81.9 2.17 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.068 0.937 . . . . 0.0 112.685 -173.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.05 41.04 0.73 Allowed 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.7 m -101.47 -20.98 14.89 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -137.52 178.77 6.85 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 124.761 1.225 . . . . 0.0 113.593 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.0 -171.08 43.11 Favored Glycine 0 CA--C 1.551 2.314 0 O-C-N 121.468 -0.77 . . . . 0.0 114.687 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.96 121.53 2.81 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.584 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -40.0 92.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 119.346 -2.096 . . . . 0.0 116.216 166.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.272 0.2 OUTLIER . . . . . 0 CA--C 1.568 1.652 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.931 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 . . . . . 0 CA--C 1.576 1.953 0 CA-C-O 120.732 0.301 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.02 140.31 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.492 -1.38 . . . . 0.0 110.249 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.382 11.3 pt-20 -99.23 120.48 39.61 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 124.466 2.079 . . . . 0.0 110.778 169.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 20.2 ttt -170.69 76.94 0.07 Allowed 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 110.565 -3.016 . . . . 0.0 110.764 -149.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.587 ' HB2' ' HB ' ' A' ' 54' ' ' VAL 0.608 0.0 OUTLIER -143.13 -166.13 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 119.231 3.049 . . . . 0.0 119.231 175.548 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 -111.16 1.19 Allowed Glycine 0 CA--C 1.542 1.764 0 N-CA-C 121.871 3.508 . . . . 0.0 121.871 -164.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -122.35 139.43 53.84 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.502 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 60.6 t -67.25 101.21 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.605 3.058 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.96 -44.2 61.41 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 117.947 -2.971 . . . . 0.0 113.39 171.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.25 148.89 47.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.305 1.05 . . . . 0.0 110.857 167.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 p -102.16 101.62 11.96 Favored 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 168.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.274 5.5 mt -79.86 150.55 72.43 Favored Pre-proline 0 CA--C 1.59 2.484 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.031 -164.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.413 3.0 Cg_exo 8.62 -77.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.351 2 C-N-CA 126.624 4.883 . . . . 0.0 124.378 -170.126 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -79.31 -81.67 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.017 1.281 . . . . 0.0 110.461 174.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.4 m -149.23 74.79 1.26 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.274 61.3 mtt -118.79 -175.83 2.98 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.221 -0.925 . . . . 0.0 111.521 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.601 ' HE2' HG22 ' A' ' 35' ' ' ILE . 58.1 m-85 -147.35 107.87 4.11 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 -166.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -86.35 96.21 9.92 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.7 t -103.81 133.04 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -162.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.38 110.19 21.49 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.301 0.5 OUTLIER -56.25 179.22 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 -175.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.44 -25.47 66.76 Favored 'General case' 0 CA--C 1.58 2.11 0 CA-C-N 113.55 -1.659 . . . . 0.0 114.375 165.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.25 1.5 m-20 -78.87 -12.46 60.03 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 169.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.41 5.98 74.75 Favored Glycine 0 CA--C 1.562 2.984 0 N-CA-C 117.432 1.733 . . . . 0.0 117.432 -169.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -90.94 132.36 36.0 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.391 1.596 . . . . 0.0 112.701 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.14 125.38 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.73 -1.231 . . . . 0.0 111.698 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.42 154.5 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 122.287 1.041 . . . . 0.0 113.126 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 m -88.36 127.19 35.49 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.178 -1.576 . . . . 0.0 111.095 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.2 168.88 18.69 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -138.87 141.21 38.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.675 0.79 . . . . 0.0 111.802 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.601 HG22 ' HE2' ' A' ' 21' ' ' PHE 0.3 0.0 OUTLIER -73.13 137.84 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 O-C-N 120.202 -1.561 . . . . 0.0 110.372 173.259 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.33 128.34 35.2 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 120.786 -1.196 . . . . 0.0 112.566 -171.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.39 -27.67 4.22 Favored Glycine 0 N--CA 1.508 3.491 0 N-CA-C 119.276 2.471 . . . . 0.0 119.276 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -58.22 -51.36 70.09 Favored 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 125.898 1.679 . . . . 0.0 114.243 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.4 ptm -78.53 -32.68 48.11 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -39.35 -38.0 0.5 Allowed 'General case' 0 CA--C 1.578 2.042 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -93.42 29.99 1.83 Allowed 'General case' 0 CA--C 1.583 2.223 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -144.01 -66.34 0.35 Allowed 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -75.86 96.84 3.79 Favored 'General case' 0 CA--C 1.571 1.764 0 C-N-CA 125.652 1.581 . . . . 0.0 109.571 167.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.62 111.44 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-O 124.026 1.869 . . . . 0.0 106.552 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -40.51 168.97 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.095 1 N-CA-C 124.101 4.852 . . . . 0.0 124.101 -166.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -106.67 165.24 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 109.32 -3.582 . . . . 0.0 116.749 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.1 tp -121.44 179.14 4.53 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 122.319 1.057 . . . . 0.0 112.204 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -69.47 97.07 0.96 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 123.415 1.578 . . . . 0.0 113.28 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.502 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 115.74 20.82 5.23 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 117.884 1.914 . . . . 0.0 117.884 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -91.78 160.72 15.19 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 123.119 1.437 . . . . 0.0 111.899 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -88.05 116.78 26.48 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 124.932 2.301 . . . . 0.0 112.561 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.52 152.22 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.92 0 CA-C-N 110.437 -3.074 . . . . 0.0 111.822 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.5 m -142.86 113.92 7.69 Favored 'General case' 0 N--CA 1.502 2.13 1 N-CA-C 100.052 -4.055 . . . . 0.0 100.052 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 9' ' ' GLN . 74.5 t -128.41 124.89 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 112.459 -2.155 . . . . 0.0 107.1 -155.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -78.58 135.33 37.25 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -133.88 -178.02 4.83 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.051 1.34 . . . . 0.0 108.518 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -94.72 164.12 20.57 Favored Pre-proline 0 CA--C 1.575 1.933 0 O-C-N 119.964 -1.71 . . . . 0.0 114.209 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -61.16 -38.2 68.73 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 C-N-CA 123.982 3.122 . . . . 0.0 116.709 166.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -89.91 -54.63 3.96 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.056 -1.883 . . . . 0.0 115.589 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -102.86 80.37 1.88 Allowed 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 122.423 1.106 . . . . 0.0 113.033 -171.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.5 mp -78.66 1.62 22.22 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 120.363 3.468 . . . . 0.0 120.363 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.3 t -70.37 -9.49 56.4 Favored 'General case' 0 CA--C 1.579 2.06 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -130.98 -177.12 4.24 Favored 'General case' 0 CA--C 1.576 1.95 0 CA-C-N 120.182 1.356 . . . . 0.0 113.069 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.5 174.55 40.54 Favored Glycine 0 CA--C 1.555 2.579 0 N-CA-C 117.919 1.928 . . . . 0.0 117.919 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -154.28 111.82 3.45 Favored 'General case' 0 CA--C 1.597 2.763 0 O-C-N 120.639 -1.507 . . . . 0.0 112.845 169.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.586 HD11 ' CG ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -47.52 103.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 O-C-N 118.554 -2.591 . . . . 0.0 115.204 172.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 CA--C 1.568 1.65 0 N-CA-C 120.01 3.337 . . . . 0.0 120.01 -175.539 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 . . . . . 0 CA--C 1.573 1.863 0 CA-C-O 121.349 0.595 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mt -87.04 141.63 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.436 -1.415 . . . . 0.0 111.521 -170.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.333 12.9 pt-20 -97.45 122.98 41.13 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 123.676 1.703 . . . . 0.0 110.092 169.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.29 13.1 ttt -155.49 10.02 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 -150.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.783 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.532 0.2 OUTLIER -98.55 -161.64 0.89 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 120.79 3.626 . . . . 0.0 120.79 -166.679 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.42 -106.06 0.52 Allowed Glycine 0 N--CA 1.487 2.067 1 N-CA-C 123.86 4.304 . . . . 0.0 123.86 -163.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m -106.52 131.32 53.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.561 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 65.6 t -66.54 105.43 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.608 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 172.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.308 82.6 mt -85.91 -29.18 23.83 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.555 -1.966 . . . . 0.0 112.254 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.4 tp10 -139.14 149.32 44.34 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.194 -0.941 . . . . 0.0 110.64 164.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' MET . 4.2 p -96.01 116.67 29.3 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 101.536 -3.505 . . . . 0.0 101.536 167.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' HB3' ' CD ' ' A' ' 17' ' ' PRO 0.394 6.5 mt -76.83 -108.22 0.0 OUTLIER Pre-proline 0 CA--C 1.598 2.818 0 CA-C-O 113.683 -3.056 . . . . 0.0 112.311 -158.295 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.47 ' CD ' ' HB3' ' A' ' 16' ' ' LEU . 92.9 Cg_endo -82.3 -69.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.574 2.494 1 CA-C-N 130.138 4.657 . . . . 0.0 115.038 177.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -83.45 -71.96 0.48 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 120.369 1.44 . . . . 0.0 111.945 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -151.24 71.56 1.01 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.374 74.4 mtp -114.23 -166.27 1.09 Allowed 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.073 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.556 ' HB3' HG22 ' A' ' 23' ' ' VAL . 52.6 m-85 -156.66 109.46 2.57 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 124.864 3.483 . . . . 0.0 109.859 -163.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -88.85 96.97 10.91 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.58 HG21 HG21 ' A' ' 54' ' ' VAL . 1.8 t -104.77 136.35 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -163.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -92.09 112.58 24.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 170.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.542 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.251 0.1 OUTLIER -69.13 176.32 3.3 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 179.425 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -15.11 53.5 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 167.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.542 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 39.8 t30 -89.98 -6.46 55.62 Favored 'General case' 0 CA--C 1.585 2.292 0 CA-C-N 118.895 0.771 . . . . 0.0 112.628 168.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.71 -13.7 61.95 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 118.598 2.199 . . . . 0.0 118.598 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -78.25 135.3 37.54 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.278 1.031 . . . . 0.0 110.945 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.3 t -85.69 129.57 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 CA-C-O 123.017 1.389 . . . . 0.0 111.629 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.24 156.3 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 114.113 -1.403 . . . . 0.0 112.804 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -98.29 124.57 42.98 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.581 -1.325 . . . . 0.0 110.152 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.02 161.16 39.48 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 118.316 2.709 . . . . 0.0 118.316 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.57 -179.87 4.04 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 164.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.73 169.66 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.557 0 O-C-N 119.588 -1.945 . . . . 0.0 107.82 157.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.3 p -73.24 17.05 0.14 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 117.671 -3.143 . . . . 0.0 119.362 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.15 -51.2 0.76 Allowed Glycine 0 N--CA 1.499 2.886 0 N-CA-C 118.01 1.964 . . . . 0.0 118.01 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.53 -46.26 89.19 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 126.39 1.876 . . . . 0.0 115.451 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.402 ' SD ' ' O ' ' A' ' 67' ' ' VAL . 1.0 OUTLIER -73.41 -17.02 61.31 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 175.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -38.67 -38.45 0.41 Allowed 'General case' 0 CA--C 1.582 2.178 0 CA-C-N 122.838 2.563 . . . . 0.0 116.895 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -94.17 33.96 1.31 Allowed 'General case' 0 CA--C 1.585 2.314 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -148.12 -64.52 0.25 Allowed 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -78.66 93.47 4.89 Favored 'General case' 0 CA--C 1.571 1.766 0 C-N-CA 125.346 1.458 . . . . 0.0 108.623 166.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.5 mt -69.54 107.02 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.535 0 CA-C-O 124.554 2.121 . . . . 0.0 105.939 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.16 174.97 0.01 OUTLIER 'General case' 0 CA--C 1.577 1.986 1 N-CA-C 121.891 4.034 . . . . 0.0 121.891 -161.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 pt -119.36 167.73 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 111.082 -2.781 . . . . 0.0 115.194 -164.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.2 tp -125.93 -177.58 3.99 Favored 'General case' 0 CA--C 1.573 1.847 0 CA-C-O 122.038 0.923 . . . . 0.0 112.662 -171.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 m -68.34 95.55 0.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.475 1.607 . . . . 0.0 113.712 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.561 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 119.08 19.39 4.35 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 118.281 2.073 . . . . 0.0 118.281 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.33 163.31 13.65 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 122.953 1.359 . . . . 0.0 112.919 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -86.54 117.55 25.39 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 124.772 2.225 . . . . 0.0 112.949 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -121.85 157.6 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.692 0 CA-C-N 110.654 -2.975 . . . . 0.0 111.484 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.4 m -150.4 106.83 3.49 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 100.506 -3.887 . . . . 0.0 100.506 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.783 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 27.3 t -112.21 130.73 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 111.413 -2.63 . . . . 0.0 107.945 -161.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -83.67 136.98 34.0 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 121.163 -0.961 . . . . 0.0 111.876 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.285 2.2 pt? -123.97 -168.59 1.81 Allowed 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 121.252 0.549 . . . . 0.0 110.705 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.0 p -118.48 160.57 39.33 Favored Pre-proline 0 CA--C 1.572 1.807 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.73 -41.15 63.46 Favored 'Trans proline' 0 CA--C 1.569 2.235 0 C-N-CA 123.626 2.884 . . . . 0.0 118.773 164.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -88.85 -54.45 4.13 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -99.66 79.49 2.26 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 122.421 1.105 . . . . 0.0 112.716 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mp -70.19 -22.49 62.94 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -72.31 4.4 3.74 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -124.22 -174.55 3.03 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.462 1.483 . . . . 0.0 114.538 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.02 168.05 39.7 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 120.068 2.787 . . . . 0.0 120.068 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -153.39 110.2 3.42 Favored 'General case' 0 CA--C 1.594 2.669 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 167.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.716 ' H ' HD12 ' A' ' 66' ' ' ILE . 3.2 mp -44.05 104.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 O-C-N 117.437 -3.289 . . . . 0.0 115.86 168.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.402 ' O ' ' SD ' ' A' ' 39' ' ' MET . 14.2 m . . . . . 0 CA--C 1.578 2.033 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.927 171.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 CA--C 1.577 1.994 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.55 151.84 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.372 1.069 . . . . 0.0 109.631 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.279 8.1 pt-20 -108.51 124.74 50.92 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 123.831 1.777 . . . . 0.0 109.833 168.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.3 10.2 ttt -153.17 3.66 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 -151.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.753 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.533 0.0 OUTLIER -86.04 -166.31 1.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 121.287 3.81 . . . . 0.0 121.287 -166.905 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.19 -112.4 0.99 Allowed Glycine 0 N--CA 1.48 1.613 0 N-CA-C 121.45 3.34 . . . . 0.0 121.45 -164.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -102.29 130.23 48.93 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.441 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 99.6 t -63.9 111.51 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.881 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 171.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.324 58.6 mt -92.85 -34.04 13.99 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 122.585 2.448 . . . . 0.0 112.21 172.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.03 148.38 50.54 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-O 122.776 1.274 . . . . 0.0 109.922 163.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.9 p -105.52 106.23 16.63 Favored 'General case' 0 N--CA 1.513 2.675 0 N-CA-C 100.75 -3.796 . . . . 0.0 100.75 171.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.507 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.441 4.4 mt -82.8 -138.4 0.0 OUTLIER Pre-proline 0 CA--C 1.604 3.056 0 CA-C-O 115.033 -2.413 . . . . 0.0 113.779 -160.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 62.8 Cg_endo -73.66 -73.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 1 CA-C-N 129.599 4.464 . . . . 0.0 117.766 -172.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -63.66 -67.35 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.979 -1.076 . . . . 0.0 111.965 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -169.7 79.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.5 mtt -119.93 177.37 5.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.607 0.763 . . . . 0.0 112.589 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HB3' HG22 ' A' ' 23' ' ' VAL . 57.2 m-85 -145.6 109.68 4.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -165.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -85.3 94.92 9.05 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 168.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -100.23 133.16 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -164.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -93.31 113.19 25.31 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 26' ' ' GLU 0.358 0.2 OUTLIER -53.93 -179.13 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 120.662 3.579 . . . . 0.0 120.662 -176.238 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.557 ' H ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -70.34 -28.72 65.37 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 112.212 -2.267 . . . . 0.0 114.347 167.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -90.91 4.54 51.61 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 168.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.18 8.22 78.79 Favored Glycine 0 CA--C 1.549 2.199 0 N-CA-C 119.432 2.533 . . . . 0.0 119.432 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -91.54 140.29 29.88 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.197 2.498 . . . . 0.0 113.081 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.61 123.85 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 O-C-N 120.799 -1.188 . . . . 0.0 112.029 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 m -131.33 152.14 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.0 m -91.46 130.25 37.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.548 -1.345 . . . . 0.0 110.712 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.14 155.49 43.33 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -104.32 177.49 4.83 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 123.349 1.547 . . . . 0.0 108.573 165.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.527 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -87.42 161.17 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.52 0 O-C-N 120.313 -1.492 . . . . 0.0 108.771 166.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 90.8 p -78.18 24.87 0.24 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 119.864 3.283 . . . . 0.0 119.864 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.52 -45.7 1.03 Allowed Glycine 0 N--CA 1.501 3.032 0 N-CA-C 116.645 1.418 . . . . 0.0 116.645 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -58.9 -48.56 81.0 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 127.061 2.144 . . . . 0.0 116.568 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.513 ' SD ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.85 -21.88 61.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 118.487 2.773 . . . . 0.0 118.487 177.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -41.97 -34.02 0.64 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 171.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -84.55 -11.17 56.57 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 118.795 2.887 . . . . 0.0 118.795 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -89.75 -72.63 0.55 Allowed 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -101.96 132.03 48.02 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.55 1.14 . . . . 0.0 109.38 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.7 mt -70.64 -51.06 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 O-C-N 120.285 -1.509 . . . . 0.0 110.235 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -130.52 174.63 9.71 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 124.634 2.159 . . . . 0.0 113.053 171.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.418 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.286 0.7 OUTLIER -135.05 161.11 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-N 112.685 -2.052 . . . . 0.0 108.773 175.363 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.48 159.74 18.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.717 -1.24 . . . . 0.0 113.923 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.1 m -75.08 79.12 2.24 Favored 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 123.884 1.802 . . . . 0.0 110.59 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 136.6 22.3 0.55 Allowed Glycine 0 N--CA 1.491 2.349 0 CA-C-N 113.182 -1.827 . . . . 0.0 116.802 -176.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -92.16 159.49 15.63 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 122.869 1.319 . . . . 0.0 112.81 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -90.57 85.5 6.13 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 125.598 2.618 . . . . 0.0 114.032 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.97 158.09 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.021 0 CA-C-N 109.818 -3.356 . . . . 0.0 111.771 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -146.89 112.7 5.71 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 101.387 -3.561 . . . . 0.0 101.387 174.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.753 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 40.3 t -117.77 131.19 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 111.988 -2.369 . . . . 0.0 107.354 -160.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -83.91 128.59 34.65 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.027 0.917 . . . . 0.0 111.593 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.76 -129.96 0.23 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -146.43 167.38 14.04 Favored Pre-proline 0 CA--C 1.569 1.709 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.16 -43.23 19.57 Favored 'Trans proline' 0 CA--C 1.576 2.624 0 C-N-CA 123.09 2.527 . . . . 0.0 115.518 164.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -80.4 -48.24 13.2 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 111.864 -2.426 . . . . 0.0 116.449 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -115.22 88.66 2.92 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 122.507 1.146 . . . . 0.0 112.425 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.32 12.61 5.15 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 118.909 2.929 . . . . 0.0 118.909 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.2 p -75.47 -30.5 59.94 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -140.27 167.82 21.24 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 124.305 1.042 . . . . 0.0 113.103 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.44 -166.61 32.03 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 117.272 1.669 . . . . 0.0 117.272 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -154.94 122.51 5.69 Favored 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.75 ' H ' HD12 ' A' ' 66' ' ' ILE . 1.5 mp -45.11 106.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 CA-C-N 121.753 2.07 . . . . 0.0 114.657 170.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.572 1.806 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.517 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 N--CA 1.501 2.097 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -95.39 148.81 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.112 -0.992 . . . . 0.0 111.001 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.314 6.6 pt-20 -98.09 120.26 38.18 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 125.573 2.606 . . . . 0.0 108.31 166.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 18.5 ttt -168.91 87.1 0.17 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 108.795 -3.82 . . . . 0.0 105.053 -150.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.702 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -110.35 -148.99 0.44 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 111.078 -2.783 . . . . 0.0 115.652 -156.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 179.79 -141.89 4.91 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 116.94 1.536 . . . . 0.0 116.94 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.2 m -122.17 134.34 54.73 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.481 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 42.4 t -59.07 114.74 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.871 0 O-C-N 121.689 -0.632 . . . . 0.0 110.187 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.1 mt -82.24 -32.8 29.53 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 119.641 -1.912 . . . . 0.0 111.956 166.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -146.56 141.74 27.29 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.024 1.392 . . . . 0.0 111.025 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.1 p -92.88 110.18 21.63 Favored 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 102.464 -3.161 . . . . 0.0 102.464 169.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.434 3.8 mt -81.83 -133.35 0.0 OUTLIER Pre-proline 0 CA--C 1.602 2.958 0 CA-C-O 114.609 -2.615 . . . . 0.0 114.191 -160.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 69.9 Cg_endo -73.43 -69.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.379 2.163 1 CA-C-N 129.994 4.605 . . . . 0.0 117.086 -174.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -73.01 -76.06 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.126 -0.984 . . . . 0.0 110.318 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -157.73 77.06 0.82 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.2 mtt -121.23 179.13 4.51 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.83 0.852 . . . . 0.0 112.242 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.529 ' CE1' HD11 ' A' ' 46' ' ' ILE . 55.8 m-85 -145.21 109.74 4.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.66 -1.9 . . . . 0.0 106.812 -166.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -84.57 101.92 12.48 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 167.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.4 t -109.77 141.11 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -163.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -93.36 108.04 19.77 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 171.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.57 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.261 0.1 OUTLIER -77.11 169.27 18.63 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 124.058 1.885 . . . . 0.0 115.047 -176.234 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.271 20.8 pt-20 -68.03 -8.9 41.54 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 112.555 -2.111 . . . . 0.0 114.703 169.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.57 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 15.3 t30 -91.14 -6.45 53.56 Favored 'General case' 0 CA--C 1.588 2.432 0 CA-C-N 119.124 0.874 . . . . 0.0 112.647 164.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.47 -20.9 45.78 Favored Glycine 0 CA--C 1.549 2.182 0 N-CA-C 118.961 2.345 . . . . 0.0 118.961 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -78.09 137.76 38.39 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.735 0.814 . . . . 0.0 111.486 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.45 112.99 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 122.879 1.323 . . . . 0.0 109.304 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 m -102.64 148.91 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 113.932 -1.486 . . . . 0.0 113.661 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.5 m -93.22 120.93 34.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.007 -1.058 . . . . 0.0 108.28 171.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.36 161.41 36.37 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -113.04 -160.6 0.72 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.436 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -115.1 173.79 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.07 0 O-C-N 120.584 -1.323 . . . . 0.0 108.524 166.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.1 p -78.54 100.69 7.03 Favored 'General case' 0 CA--C 1.561 1.382 0 O-C-N 119.254 -2.154 . . . . 0.0 108.39 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -31.69 -30.8 0.01 OUTLIER Glycine 0 N--CA 1.506 3.329 1 N-CA-C 123.852 4.301 . . . . 0.0 123.852 -175.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -62.46 -46.67 87.45 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 174.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 ptm -73.25 -17.82 61.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -39.75 -30.51 0.08 Allowed 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 118.348 2.721 . . . . 0.0 118.348 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -90.55 -5.93 55.34 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -103.9 -66.91 0.92 Allowed 'General case' 0 CA--C 1.578 2.026 0 C-N-CA 126.155 1.782 . . . . 0.0 106.617 169.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -81.6 98.24 8.25 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 125.509 1.524 . . . . 0.0 107.838 168.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.9 mt -73.3 -71.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.411 -0.805 . . . . 0.0 110.908 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -140.03 171.69 13.82 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 125.853 2.74 . . . . 0.0 115.491 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 21' ' ' PHE . 1.3 pt -142.86 167.86 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 110.56 -3.018 . . . . 0.0 108.483 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.54 177.35 4.71 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.838 1.304 . . . . 0.0 112.822 -173.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.8 m -76.0 83.65 2.88 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 123.36 1.552 . . . . 0.0 110.998 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.481 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 134.04 23.31 0.69 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 117.524 1.77 . . . . 0.0 117.524 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.76 160.53 14.72 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 122.858 1.313 . . . . 0.0 113.877 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -87.99 82.46 7.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 125.754 2.693 . . . . 0.0 113.368 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -71.93 163.83 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-N 110.088 -3.233 . . . . 0.0 115.504 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.669 HG23 ' HG3' ' A' ' 9' ' ' GLN 0.355 19.5 m -125.63 78.94 1.78 Allowed 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 124.261 1.981 . . . . 0.0 113.417 170.309 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.702 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.2 OUTLIER -75.99 101.3 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 125.813 1.645 . . . . 0.0 109.806 -173.409 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -82.75 140.97 32.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.709 -0.619 . . . . 0.0 109.354 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.21 -116.64 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 110.584 -171.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.42 166.32 17.15 Favored Pre-proline 0 CA--C 1.575 1.907 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -176.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -61.38 -47.36 12.07 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 C-N-CA 123.088 2.526 . . . . 0.0 117.425 166.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -97.46 -43.63 7.18 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -175.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -95.49 77.3 3.35 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.17 49.47 1.66 Allowed 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 94.5 p -106.92 -27.86 10.43 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 125.668 1.587 . . . . 0.0 114.744 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -126.24 -173.49 2.87 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 124.06 0.944 . . . . 0.0 112.736 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.424 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . 174.59 179.73 45.38 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.73 108.27 1.17 Allowed 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 118.895 2.924 . . . . 0.0 118.895 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.512 ' CD1' ' H ' ' A' ' 66' ' ' ILE . 0.9 OUTLIER -26.71 91.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.118 0 N-CA-C 118.889 2.922 . . . . 0.0 118.889 162.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 CA--C 1.58 2.117 0 N-CA-C 117.271 2.322 . . . . 0.0 117.271 176.408 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 . . . . . 0 CA--C 1.572 1.812 0 CA-C-O 120.891 0.377 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.14 141.97 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.107 -0.996 . . . . 0.0 111.411 -174.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.328 12.5 pt-20 -99.14 124.35 44.1 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.636 1.684 . . . . 0.0 110.224 168.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.284 11.4 ttt -154.71 -8.06 0.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 120.539 3.533 . . . . 0.0 120.539 -151.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.611 ' HB2' ' HB ' ' A' ' 54' ' ' VAL 0.574 0.0 OUTLIER -78.9 -165.35 0.72 Allowed 'General case' 0 N--CA 1.491 1.583 1 N-CA-C 122.053 4.094 . . . . 0.0 122.053 -165.11 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.39 -112.61 1.53 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 122.42 3.728 . . . . 0.0 122.42 -166.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.3 m -110.78 141.11 44.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.532 -0.981 . . . . 0.0 108.363 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.543 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 90.4 t -69.51 101.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.602 2.948 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 174.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 24' ' ' GLU . 2.8 mm? -77.12 -38.38 52.25 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 117.923 -2.985 . . . . 0.0 112.828 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -128.93 145.71 51.15 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.761 1.267 . . . . 0.0 110.762 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 p -95.77 106.0 18.07 Favored 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 101.775 -3.417 . . . . 0.0 101.775 167.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.288 5.7 mt -78.47 166.47 42.64 Favored Pre-proline 0 CA--C 1.593 2.626 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.482 -167.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.385 6.0 Cg_endo -20.54 -57.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.57 2.302 2 N-CA-C 125.459 5.138 . . . . 0.0 125.459 -164.798 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -82.71 -78.34 0.21 Allowed 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 120.651 1.569 . . . . 0.0 109.782 172.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -158.13 72.81 0.64 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.255 67.3 mtm -115.98 -169.61 1.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.681 0.792 . . . . 0.0 110.588 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.531 ' HE2' HG23 ' A' ' 35' ' ' ILE . 62.0 m-85 -148.49 108.15 3.99 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 119.114 -2.241 . . . . 0.0 106.952 -166.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -84.48 97.59 9.62 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -103.78 133.7 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -164.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' H ' HD23 ' A' ' 13' ' ' LEU . 32.2 tt0 -95.96 111.49 23.47 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 172.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 26' ' ' GLU 0.365 0.2 OUTLIER -52.26 -178.54 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 120.608 3.558 . . . . 0.0 120.608 -176.11 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.62 ' H ' HD23 ' A' ' 25' ' ' LEU . 11.0 pt-20 -69.62 -31.45 69.57 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 112.729 -2.032 . . . . 0.0 113.949 167.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -88.68 6.74 37.05 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.19 13.41 79.06 Favored Glycine 0 CA--C 1.549 2.165 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -95.1 130.01 41.96 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 120.821 2.31 . . . . 0.0 112.561 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.0 t -82.76 124.9 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.438 -1.414 . . . . 0.0 112.333 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.16 149.76 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 114.705 -1.134 . . . . 0.0 113.499 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 m -87.45 127.08 35.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.487 -1.383 . . . . 0.0 110.396 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.4 139.98 28.75 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.71 155.73 17.47 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 168.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.531 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -64.31 170.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.536 0 O-C-N 120.456 -1.402 . . . . 0.0 112.166 168.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -75.68 92.9 3.01 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 119.226 -2.171 . . . . 0.0 107.902 169.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.81 -38.23 0.01 OUTLIER Glycine 0 N--CA 1.505 3.266 1 N-CA-C 123.314 4.086 . . . . 0.0 123.314 -174.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -54.32 -45.54 72.65 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -73.18 -21.87 60.59 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 173.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -37.06 -39.68 0.25 Allowed 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 123.718 2.963 . . . . 0.0 117.524 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -91.07 47.41 1.4 Allowed 'General case' 0 CA--C 1.582 2.183 0 CA-C-O 124.231 1.967 . . . . 0.0 114.402 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -168.12 -60.36 0.02 OUTLIER 'General case' 0 CA--C 1.581 2.17 0 C-N-CA 128.151 2.581 . . . . 0.0 105.193 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -83.43 68.45 9.73 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 127.144 2.178 . . . . 0.0 114.017 175.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 mt -88.33 71.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.389 84.8 mmt-85 -100.98 -76.02 0.57 Allowed 'General case' 0 N--CA 1.489 1.488 1 N-CA-C 124.465 4.987 . . . . 0.0 124.465 -164.003 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pt -99.77 162.47 3.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 112.116 -2.311 . . . . 0.0 116.678 -157.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -129.45 -174.55 3.32 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.528 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.8 m -70.52 84.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.768 1.27 . . . . 0.0 112.585 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.543 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 132.68 19.22 1.06 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 118.218 2.047 . . . . 0.0 118.218 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.03 157.73 16.62 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-O 123.014 1.388 . . . . 0.0 111.803 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -90.61 94.11 9.56 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 125.217 2.437 . . . . 0.0 113.429 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -97.01 142.46 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.827 0 CA-C-N 109.733 -3.394 . . . . 0.0 111.836 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 m -126.48 119.15 26.47 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 100.62 -3.844 . . . . 0.0 100.62 171.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.611 ' HB ' ' HB2' ' A' ' 9' ' ' GLN 0.252 93.6 t -127.86 125.42 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 112.9 -1.955 . . . . 0.0 106.345 -157.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -79.09 137.97 37.74 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -172.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.275 2.3 pt? -129.03 -171.19 2.42 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 121.625 0.726 . . . . 0.0 111.14 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 p -106.13 164.87 14.05 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -43.04 -51.66 5.38 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 N-CA-C 122.212 3.889 . . . . 0.0 122.212 161.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -110.75 -41.4 4.29 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.61 69.14 6.69 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.859 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.42 -9.09 58.33 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.3 t -69.71 -6.57 32.64 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -124.05 -176.62 3.53 Favored 'General case' 0 CA--C 1.575 1.928 0 CA-C-O 123.211 1.482 . . . . 0.0 113.259 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.89 174.47 43.46 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -153.7 106.74 2.92 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 171.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.525 HD11 ' CD2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -41.3 110.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 117.973 2.582 . . . . 0.0 117.973 173.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.572 1.82 0 C-N-CA 124.708 1.203 . . . . 0.0 110.444 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 m120 . . . . . 0 CA--C 1.582 2.203 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mt -97.21 144.82 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.112 -1.617 . . . . 0.0 111.095 -170.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.279 7.2 pt-20 -99.84 119.56 38.38 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 124.219 1.961 . . . . 0.0 109.219 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.295 10.8 ttt -154.26 -4.77 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 110.399 -3.091 . . . . 0.0 119.322 -152.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.758 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.603 0.2 OUTLIER -75.89 -157.85 0.08 Allowed 'General case' 0 CA--C 1.566 1.584 1 N-CA-C 125.778 5.473 . . . . 0.0 125.778 -162.18 . . . . . . . . 5 4 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.43 -150.75 10.2 Favored Glycine 0 CA--C 1.535 1.292 1 N-CA-C 126.29 5.276 . . . . 0.0 126.29 -157.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -101.79 136.53 41.47 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.541 HG22 ' HD1' ' A' ' 21' ' ' PHE . 63.1 t -64.56 111.66 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.588 0 O-C-N 121.074 -1.017 . . . . 0.0 109.332 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.9 -36.56 64.77 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-N 122.738 2.517 . . . . 0.0 111.943 168.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -146.07 147.3 31.46 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 122.32 1.057 . . . . 0.0 111.789 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.93 116.23 28.66 Favored 'General case' 0 N--CA 1.511 2.593 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 169.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.604 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.454 1.2 mm? -79.79 -127.71 0.0 OUTLIER Pre-proline 0 CA--C 1.597 2.779 0 CA-C-O 114.369 -2.729 . . . . 0.0 114.81 -164.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 90.9 Cg_endo -67.55 -67.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.566 2.113 1 CA-C-N 130.159 4.664 . . . . 0.0 116.966 -176.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -81.24 -72.94 0.4 Allowed 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.387 -0.82 . . . . 0.0 110.603 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m -157.43 74.31 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.26 89.4 mtp -113.98 -169.57 1.54 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 117.326 -1.321 . . . . 0.0 111.901 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.583 ' HB3' HG22 ' A' ' 23' ' ' VAL . 57.9 m-85 -154.92 112.01 3.33 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 123.366 2.803 . . . . 0.0 111.337 -166.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -93.89 97.61 10.5 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 167.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 21' ' ' PHE . 2.5 t -101.52 141.2 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -163.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -98.35 107.86 20.42 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.0 171.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.264 0.6 OUTLIER -50.47 176.56 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 118.718 2.859 . . . . 0.0 118.718 -177.089 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -22.68 66.31 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 168.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -95.47 6.11 49.84 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.47 -1.58 85.96 Favored Glycine 0 CA--C 1.554 2.52 0 N-CA-C 119.955 2.742 . . . . 0.0 119.955 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -82.63 140.44 33.18 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.834 1.817 . . . . 0.0 113.04 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.3 130.18 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 CA-C-O 122.846 1.307 . . . . 0.0 111.374 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.654 HG21 HE21 ' A' ' 9' ' ' GLN . 13.8 m -131.27 153.03 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.376 -1.284 . . . . 0.0 113.168 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.8 m -98.16 126.1 43.48 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.439 -1.413 . . . . 0.0 110.256 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.42 163.39 34.77 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.6 176.14 5.14 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.825 -1.534 . . . . 0.0 107.63 164.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.497 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -85.14 171.0 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.59 2.49 0 O-C-N 119.731 -1.856 . . . . 0.0 108.84 161.581 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 p -74.91 27.48 0.09 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 118.26 -2.775 . . . . 0.0 117.988 177.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.06 -49.78 0.18 Allowed Glycine 0 N--CA 1.502 3.048 0 N-CA-C 119.937 2.735 . . . . 0.0 119.937 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -65.62 -52.34 52.73 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.044 2.138 . . . . 0.0 115.499 -177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -18.1 65.1 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -38.43 -39.21 0.43 Allowed 'General case' 0 CA--C 1.575 1.922 0 CA-C-N 122.419 2.372 . . . . 0.0 116.492 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -92.28 32.4 1.19 Allowed 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -149.73 -54.98 0.17 Allowed 'General case' 0 CA--C 1.577 1.991 0 C-N-CA 127.25 2.22 . . . . 0.0 107.141 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -76.46 63.47 2.02 Favored 'General case' 0 CA--C 1.58 2.107 0 C-N-CA 125.605 1.562 . . . . 0.0 112.947 171.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mt -84.98 72.18 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 CA-C-O 124.752 2.215 . . . . 0.0 108.788 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -112.19 -43.19 3.58 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 120.811 3.634 . . . . 0.0 120.811 -169.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.403 0.0 OUTLIER -120.23 160.82 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 1 N-CA-C 122.992 4.442 . . . . 0.0 122.992 -138.901 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.9 tp -159.15 178.67 9.76 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 110.203 -3.18 . . . . 0.0 112.387 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.1 m -68.55 116.02 8.61 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.615 1.198 . . . . 0.0 111.709 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.401 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 95.27 14.37 48.42 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 119.371 2.508 . . . . 0.0 119.371 -175.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.46 172.97 8.04 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 124.96 1.304 . . . . 0.0 111.757 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -97.59 136.62 37.72 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 124.516 2.103 . . . . 0.0 115.87 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.06 153.95 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.954 0 CA-C-N 111.51 -2.587 . . . . 0.0 110.901 -171.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.8 m -143.71 102.89 3.99 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 101.978 -3.341 . . . . 0.0 101.978 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.758 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 19.7 t -105.87 132.14 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 111.107 -2.77 . . . . 0.0 108.056 -164.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -82.86 127.54 33.59 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.665 -1.272 . . . . 0.0 111.771 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.321 2.2 pt? -102.0 -165.53 1.2 Allowed 'General case' 0 CA--C 1.566 1.574 0 CA-C-O 121.26 0.552 . . . . 0.0 111.385 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 p -131.74 161.49 62.08 Favored Pre-proline 0 CA--C 1.572 1.813 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -51.54 -43.74 48.37 Favored 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 123.999 3.133 . . . . 0.0 118.843 164.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -95.57 -57.2 2.45 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -95.16 74.08 3.4 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.343 1.068 . . . . 0.0 113.342 -172.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.51 -20.0 65.94 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 118.377 2.732 . . . . 0.0 118.377 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 t -74.98 4.53 6.44 Favored 'General case' 0 CA--C 1.583 2.241 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 171.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 170.71 15.6 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 121.093 1.769 . . . . 0.0 115.516 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.53 -169.19 42.13 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.98 124.9 7.89 Favored 'General case' 0 CA--C 1.59 2.49 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 173.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.776 ' H ' HD12 ' A' ' 66' ' ' ILE . 2.8 mp -43.71 104.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 171.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.1 m . . . . . 0 CA--C 1.579 2.069 0 CA-C-N 113.891 -1.504 . . . . 0.0 114.054 174.479 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.561 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -123.72 -87.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.882 0.764 . . . . 0.0 109.385 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -87.18 56.38 3.96 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.34 155.28 27.29 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 123.397 1.57 . . . . 0.0 114.079 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -76.91 128.91 35.41 Favored 'General case' 0 CA--C 1.571 1.772 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.82 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -96.66 141.13 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 124.187 0.995 . . . . 0.0 110.104 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.378 14.7 pt-20 -92.29 126.21 37.27 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 124.858 2.266 . . . . 0.0 109.536 165.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.283 20.4 ttt -168.46 82.96 0.16 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 109.968 -3.287 . . . . 0.0 104.765 -152.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -98.47 -153.03 0.42 Allowed 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 -159.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -167.36 -174.37 36.39 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 120.487 2.955 . . . . 0.0 120.487 -170.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.7 m -100.54 124.97 46.81 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.503 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 67.3 t -60.66 117.54 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.763 0 CA-C-N 121.096 1.771 . . . . 0.0 107.294 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.302 73.3 mt -100.95 -26.43 13.74 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.169 -1.582 . . . . 0.0 112.773 171.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -136.42 145.86 45.74 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 123.09 1.424 . . . . 0.0 109.487 162.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 20' ' ' MET . 5.8 p -96.61 110.27 22.72 Favored 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 100.827 -3.768 . . . . 0.0 100.827 168.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.429 2.5 mt -79.65 -124.89 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.91 0 CA-C-O 113.986 -2.911 . . . . 0.0 115.655 -159.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 95.6 Cg_endo -73.36 -70.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.185 1 CA-C-N 130.561 4.807 . . . . 0.0 116.243 -176.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -78.67 -70.31 0.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.251 -0.906 . . . . 0.0 110.731 175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 m -159.33 75.89 0.67 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.415 ' O ' ' HA ' ' A' ' 15' ' ' THR . 67.9 mtt -118.58 -175.42 2.88 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.512 0.725 . . . . 0.0 111.426 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CE1' HD11 ' A' ' 46' ' ' ILE . 60.5 m-85 -144.29 109.88 5.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 119.454 -2.029 . . . . 0.0 106.398 -166.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -85.32 93.86 8.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 170.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.2 t -100.94 135.21 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -163.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -85.91 116.18 23.99 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.298 4.7 mt -70.52 174.95 5.2 Favored 'General case' 0 CA--C 1.577 1.99 0 CA-C-O 124.112 1.91 . . . . 0.0 112.569 -172.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -24.17 63.21 Favored 'General case' 0 CA--C 1.586 2.355 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.908 165.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.6 -8.25 56.3 Favored 'General case' 0 CA--C 1.586 2.365 0 C-N-CA 126.186 1.794 . . . . 0.0 115.398 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.72 9.31 75.08 Favored Glycine 0 CA--C 1.554 2.521 0 N-CA-C 119.496 2.558 . . . . 0.0 119.496 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -114.36 147.45 39.14 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 118.665 1.232 . . . . 0.0 112.452 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.4 t -82.27 126.88 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.861 -1.149 . . . . 0.0 111.216 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.3 147.68 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.598 1.19 . . . . 0.0 112.791 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.9 m -89.59 123.64 33.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.72 -1.238 . . . . 0.0 109.08 172.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.31 155.17 47.9 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 159.71 19.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 172.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.481 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -73.0 176.33 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.631 0 O-C-N 119.973 -1.704 . . . . 0.0 110.758 166.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 92.5 p -79.9 25.24 0.37 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 121.086 3.735 . . . . 0.0 121.086 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.85 -52.44 1.63 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.295 64.4 pttt -59.83 -58.17 9.73 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 118.061 2.615 . . . . 0.0 118.061 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -21.5 62.97 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -38.44 -39.02 0.42 Allowed 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . 0.258 14.4 mptt -98.02 -4.55 35.87 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 121.639 3.94 . . . . 0.0 121.639 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -93.46 53.25 1.86 Allowed 'General case' 0 CA--C 1.587 2.404 0 N-CA-C 102.316 -3.216 . . . . 0.0 102.316 153.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.416 1.8 t80 -45.74 98.11 0.01 OUTLIER 'General case' 0 C--N 1.379 1.86 0 N-CA-C 118.679 2.844 . . . . 0.0 118.679 -152.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mt -82.07 74.53 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 109.175 -3.648 . . . . 0.0 107.562 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 137.96 58.03 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 -170.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.559 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.274 1.4 pt -141.78 154.96 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 CA-C-N 111.466 -2.606 . . . . 0.0 111.87 -176.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 tp -131.39 -174.44 3.4 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.128 0.966 . . . . 0.0 111.033 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -72.87 84.88 1.24 Allowed 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 123.317 1.532 . . . . 0.0 113.074 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.503 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 130.34 25.23 0.88 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 117.631 1.812 . . . . 0.0 117.631 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.55 165.62 12.44 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 123.2 1.476 . . . . 0.0 114.131 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -84.73 82.65 8.33 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 125.583 2.611 . . . . 0.0 113.674 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 m -79.03 152.82 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 CA-C-N 110.595 -3.002 . . . . 0.0 113.284 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.489 ' HA ' ' HB3' ' A' ' 9' ' ' GLN . 63.8 m -94.76 161.15 14.29 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 160.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.459 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -157.35 86.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 O-C-N 118.128 -2.858 . . . . 0.0 105.658 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -78.19 138.6 38.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.102 -0.999 . . . . 0.0 109.743 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -136.0 -179.32 5.59 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.665 1.221 . . . . 0.0 111.699 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 p -100.36 161.06 25.28 Favored Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -53.9 -43.48 57.7 Favored 'Trans proline' 0 CA--C 1.572 2.388 0 C-N-CA 123.231 2.621 . . . . 0.0 118.22 163.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -82.87 -49.39 9.71 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.72 83.25 2.23 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 122.25 1.024 . . . . 0.0 112.049 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -17.1 61.17 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.2 p -68.97 -7.97 40.26 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -122.73 -177.74 3.73 Favored 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 119.963 1.256 . . . . 0.0 114.056 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . -177.33 177.0 48.29 Favored Glycine 0 CA--C 1.548 2.127 0 N-CA-C 117.686 1.834 . . . . 0.0 117.686 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -162.69 115.86 1.67 Allowed 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 172.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.618 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -38.99 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 118.929 -2.357 . . . . 0.0 116.912 165.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.279 2.1 m -77.19 -87.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.538 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -116.96 145.91 43.34 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -60.64 99.86 0.09 Allowed 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.0 m -110.82 -29.76 7.83 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -175.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 . . . . . 0 CA--C 1.56 1.331 0 CA-C-O 124.799 2.238 . . . . 0.0 112.472 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.56 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -79.25 84.31 5.21 Favored 'General case' 0 CA--C 1.574 1.883 0 O-C-N 120.919 -1.113 . . . . 0.0 113.309 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.46 47.97 2.21 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -133.32 113.48 12.65 Favored 'General case' 0 CA--C 1.568 1.656 0 C-N-CA 124.357 1.063 . . . . 0.0 112.914 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -83.98 107.75 16.54 Favored 'General case' 0 CA--C 1.575 1.925 0 O-C-N 120.985 -1.072 . . . . 0.0 108.818 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -89.16 138.44 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.427 -1.421 . . . . 0.0 111.741 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.332 10.5 pt-20 -93.74 123.29 36.99 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 125.257 2.456 . . . . 0.0 109.219 168.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.26 20.5 ttt -170.34 85.08 0.11 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 109.173 -3.649 . . . . 0.0 104.626 -151.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -105.16 -149.24 0.41 Allowed 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -162.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 179.29 -142.44 5.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.8 m -122.86 135.26 54.46 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.513 HG11 HG23 ' A' ' 15' ' ' THR . 54.0 t -58.99 124.6 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.607 3.168 0 O-C-N 121.364 -0.835 . . . . 0.0 109.528 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.5 mt -90.66 -27.6 18.92 Favored 'General case' 0 N--CA 1.514 2.737 0 O-C-N 119.314 -2.116 . . . . 0.0 112.031 163.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.4 tp10 -148.47 143.51 26.77 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 120.83 -1.169 . . . . 0.0 111.736 166.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.513 HG23 HG11 ' A' ' 12' ' ' VAL . 33.1 p -103.94 103.76 13.64 Favored 'General case' 0 N--CA 1.518 2.958 0 N-CA-C 102.087 -3.301 . . . . 0.0 102.087 173.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.393 0.2 OUTLIER -77.08 178.6 1.97 Allowed Pre-proline 0 CA--C 1.593 2.626 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -168.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -54.41 -36.15 86.81 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 N-CA-C 121.25 3.519 . . . . 0.0 121.25 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -79.74 -100.78 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.4 m -152.97 72.77 0.97 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 76.0 mtp -126.04 162.7 24.68 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 46' ' ' ILE . 56.7 m-85 -132.77 114.48 14.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.141 -1.6 . . . . 0.0 107.087 -163.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.2 ttm105 -85.67 89.41 7.73 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.3 t -96.3 137.29 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -162.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.7 111.82 22.4 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.302 4.9 mt -72.3 174.24 7.56 Favored 'General case' 0 CA--C 1.577 2.002 0 CA-C-O 124.135 1.921 . . . . 0.0 112.779 -173.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.96 -22.59 61.43 Favored 'General case' 0 CA--C 1.585 2.298 0 CA-C-N 113.804 -1.544 . . . . 0.0 114.128 166.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -74.58 -9.09 58.23 Favored 'General case' 0 CA--C 1.587 2.366 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.68 23.79 55.09 Favored Glycine 0 CA--C 1.555 2.54 0 N-CA-C 118.632 2.213 . . . . 0.0 118.632 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -125.94 145.71 50.16 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.309 1.044 . . . . 0.0 111.224 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.0 t -86.04 117.5 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.728 -1.232 . . . . 0.0 110.123 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.7 148.9 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.1 m -92.54 125.5 37.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.405 -1.434 . . . . 0.0 110.062 173.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.32 159.84 40.79 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 177.11 4.75 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 165.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.514 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.2 pt -88.99 -178.27 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.36 0 O-C-N 119.211 -2.181 . . . . 0.0 110.632 165.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.4 p -82.49 122.32 27.9 Favored 'General case' 0 CA--C 1.56 1.33 0 O-C-N 119.714 -1.866 . . . . 0.0 109.205 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.49 -20.34 0.59 Allowed Glycine 0 N--CA 1.503 3.161 0 N-CA-C 122.312 3.685 . . . . 0.0 122.312 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -71.24 -55.75 7.46 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 125.641 1.577 . . . . 0.0 114.405 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 ptm -69.39 -20.54 63.81 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -37.93 -35.66 0.16 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -94.47 33.58 1.4 Allowed 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -150.93 -69.93 0.18 Allowed 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.64 101.04 10.55 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 163.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.83 -73.55 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.439 -0.788 . . . . 0.0 109.381 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -132.1 -179.27 5.31 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-O 124.512 2.101 . . . . 0.0 114.316 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.258 1.1 pt -143.39 175.67 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 C-N-CA 126.932 2.093 . . . . 0.0 110.858 -173.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.4 158.5 16.3 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.256 1.027 . . . . 0.0 111.115 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 m -71.58 86.84 0.9 Allowed 'General case' 0 CA--C 1.572 1.807 0 CA-C-O 123.577 1.655 . . . . 0.0 110.423 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 130.36 24.2 0.95 Allowed Glycine 0 N--CA 1.492 2.423 0 CA-C-N 113.02 -1.9 . . . . 0.0 117.049 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -94.57 162.3 13.86 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-O 122.976 1.37 . . . . 0.0 114.166 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -85.59 81.35 8.7 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 125.575 2.607 . . . . 0.0 113.796 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -77.79 158.15 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 110.324 -3.126 . . . . 0.0 113.839 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.299 35.3 m -95.44 162.78 13.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 160.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -158.44 89.55 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 118.473 -2.642 . . . . 0.0 104.897 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.55 134.87 36.5 Favored 'General case' 0 CA--C 1.563 1.47 0 O-C-N 121.17 -0.956 . . . . 0.0 110.014 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 mp -101.06 -171.76 2.05 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 125.972 2.796 . . . . 0.0 111.878 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 p -122.5 162.04 40.32 Favored Pre-proline 0 CA--C 1.577 1.987 0 CA-C-N 109.657 -3.429 . . . . 0.0 112.657 173.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -52.85 -41.27 71.6 Favored 'Trans proline' 0 CA--C 1.569 2.249 0 C-N-CA 123.656 2.904 . . . . 0.0 119.166 164.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -95.21 -52.81 4.03 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -91.39 77.03 5.87 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 122.528 1.156 . . . . 0.0 112.779 -172.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.5 mt -70.89 -22.86 62.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 117.643 2.46 . . . . 0.0 117.643 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.5 t -75.89 6.95 4.41 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -139.8 166.48 24.5 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 120.564 1.529 . . . . 0.0 113.475 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.14 -164.08 29.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 115.633 1.013 . . . . 0.0 115.633 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.95 122.31 2.57 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.607 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -35.64 91.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 166.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.268 2.8 m -77.94 -71.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.412 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.288 47.4 t80 61.69 -84.25 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 173.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -153.52 148.79 26.99 Favored 'General case' 0 CA--C 1.57 1.726 0 C-N-CA 124.262 1.025 . . . . 0.0 110.885 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 99.6 p -64.23 -48.25 76.54 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 124.935 2.302 . . . . 0.0 108.82 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.553 0 CA-C-O 121.656 0.741 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -83.21 79.15 9.48 Favored 'General case' 0 CA--C 1.572 1.81 0 O-C-N 120.953 -1.092 . . . . 0.0 112.84 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -104.33 66.11 0.8 Allowed 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 122.321 1.057 . . . . 0.0 112.172 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.19 125.1 24.47 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -64.58 124.3 21.51 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.08 142.24 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.615 1.166 . . . . 0.0 109.661 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.409 16.3 pt-20 -95.03 122.27 37.51 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 125.036 2.351 . . . . 0.0 109.82 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.275 18.6 ttt -168.34 81.2 0.16 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 109.777 -3.374 . . . . 0.0 105.683 -149.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -96.04 -149.86 0.32 Allowed 'General case' 0 CA--C 1.563 1.456 0 N-CA-C 118.713 2.857 . . . . 0.0 118.713 -157.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -166.88 -178.34 39.27 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 121.951 3.54 . . . . 0.0 121.951 -168.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.6 m -99.73 124.88 45.43 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 15' ' ' THR . 61.4 t -60.2 122.14 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.989 0 CA-C-N 120.487 1.494 . . . . 0.0 107.253 175.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.299 62.6 mt -99.51 -22.06 15.65 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 119.823 -1.798 . . . . 0.0 112.844 168.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.9 tp10 -145.01 143.84 30.7 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 122.372 1.082 . . . . 0.0 110.833 161.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.485 HG23 HG11 ' A' ' 12' ' ' VAL . 24.7 p -106.17 106.58 17.16 Favored 'General case' 0 N--CA 1.515 2.798 0 N-CA-C 101.395 -3.557 . . . . 0.0 101.395 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.374 0.3 OUTLIER -76.48 174.37 5.81 Favored Pre-proline 0 CA--C 1.591 2.544 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -167.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -47.11 -42.22 26.42 Favored 'Trans proline' 0 CA--C 1.565 2.064 0 N-CA-C 121.493 3.613 . . . . 0.0 121.493 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -80.49 -93.21 0.05 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.9 m -159.5 75.38 0.64 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 69.6 mtm -126.78 167.87 15.19 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.795 0.838 . . . . 0.0 112.512 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.545 ' CE1' HD11 ' A' ' 46' ' ' ILE . 59.8 m-85 -132.22 114.89 15.0 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 118.703 -2.498 . . . . 0.0 108.815 -163.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -87.05 95.89 10.1 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 170.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.4 t -105.13 139.97 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -162.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.87 111.57 18.88 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 167.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.257 0.1 OUTLIER -79.84 166.21 21.93 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 121.879 2.127 . . . . 0.0 113.082 -179.971 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.308 18.1 pt-20 -67.41 -6.35 18.78 Favored 'General case' 0 CA--C 1.579 2.065 0 CA-C-N 112.677 -2.056 . . . . 0.0 114.959 169.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.573 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 45.8 t-20 -86.41 -15.47 40.23 Favored 'General case' 0 CA--C 1.588 2.408 0 O-C-N 121.129 -0.982 . . . . 0.0 112.721 162.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.51 -25.73 24.89 Favored Glycine 0 CA--C 1.549 2.178 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -75.17 140.2 43.18 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 124.292 1.037 . . . . 0.0 112.334 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.4 t -81.53 112.69 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 122.688 1.232 . . . . 0.0 108.947 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.91 147.63 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 114.129 -1.396 . . . . 0.0 113.465 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 m -87.3 127.19 35.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.805 -1.184 . . . . 0.0 108.54 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.16 152.3 49.78 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.1 151.29 42.2 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 170.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.465 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.7 OUTLIER -69.57 162.68 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.437 0 O-C-N 120.738 -1.226 . . . . 0.0 111.287 173.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.7 p -76.52 98.4 4.63 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 119.246 -2.159 . . . . 0.0 109.937 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -16.52 -50.19 0.01 OUTLIER Glycine 0 N--CA 1.505 3.234 1 N-CA-C 123.761 4.264 . . . . 0.0 123.761 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -47.69 -49.51 27.57 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 119.065 2.987 . . . . 0.0 119.065 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ptm -70.89 -18.08 62.69 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -39.6 -35.54 0.32 Allowed 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 169.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -92.79 34.06 1.11 Allowed 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -150.23 -71.63 0.18 Allowed 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 102.958 -2.978 . . . . 0.0 102.958 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -81.09 93.49 6.43 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.802 1.241 . . . . 0.0 107.771 164.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mt -74.01 -70.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.217 -0.927 . . . . 0.0 111.491 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -134.78 171.94 13.67 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 125.284 2.469 . . . . 0.0 115.009 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.265 1.0 OUTLIER -148.73 170.36 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 CA-C-N 110.85 -2.886 . . . . 0.0 109.777 -175.899 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.6 tp -109.43 163.41 13.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.891 -1.13 . . . . 0.0 112.986 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.8 m -71.48 85.15 0.84 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 123.813 1.768 . . . . 0.0 111.095 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 131.77 23.15 0.89 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 112.8 -2.0 . . . . 0.0 117.053 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -94.5 160.89 14.44 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 123.043 1.401 . . . . 0.0 113.145 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -88.78 83.63 6.69 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 124.999 2.333 . . . . 0.0 112.475 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -71.76 163.35 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 CA-C-N 110.802 -2.908 . . . . 0.0 114.34 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.306 75.3 m -95.13 160.2 14.67 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 159.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -158.44 84.55 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 O-C-N 118.37 -2.706 . . . . 0.0 105.769 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -76.77 134.8 39.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.019 -1.051 . . . . 0.0 109.838 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -137.61 -172.14 3.16 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.821 0.82 . . . . 0.0 111.299 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -104.79 155.74 37.04 Favored Pre-proline 0 CA--C 1.573 1.833 0 O-C-N 120.993 -1.067 . . . . 0.0 113.259 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -54.34 -42.03 71.2 Favored 'Trans proline' 0 CA--C 1.572 2.392 0 C-N-CA 123.738 2.959 . . . . 0.0 118.387 164.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -79.42 -47.38 15.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -108.22 89.24 2.93 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 122.195 0.998 . . . . 0.0 110.308 -174.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.82 -14.9 57.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 118.996 2.962 . . . . 0.0 118.996 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.9 t -73.46 -1.28 17.74 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -129.56 -177.5 4.29 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 120.276 1.398 . . . . 0.0 113.277 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.0 -173.86 45.22 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -161.63 113.65 1.77 Allowed 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 119.595 3.183 . . . . 0.0 119.595 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.581 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -36.45 94.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 118.762 -2.461 . . . . 0.0 117.556 166.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.33 -64.48 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.737 0 CA-C-N 114.062 -1.426 . . . . 0.0 112.847 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.251 32.6 m-85 63.9 -54.84 0.23 Allowed 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -177.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mmt-85 -75.45 60.59 1.18 Allowed 'General case' 0 CA--C 1.582 2.207 0 C-N-CA 124.746 1.218 . . . . 0.0 113.196 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.9 p -168.96 -34.45 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 124.037 1.875 . . . . 0.0 115.846 -178.197 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 1.698 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -81.81 80.62 8.07 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 120.804 1.638 . . . . 0.0 111.396 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -125.0 53.68 1.48 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.35 108.96 18.68 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 120.459 -1.401 . . . . 0.0 111.979 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -86.29 119.34 26.46 Favored 'General case' 0 CA--C 1.568 1.667 0 O-C-N 121.748 -0.595 . . . . 0.0 111.322 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -91.33 142.05 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.847 -1.158 . . . . 0.0 111.227 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.337 13.2 pt-20 -100.28 123.17 44.18 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 123.705 1.717 . . . . 0.0 110.177 169.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.261 13.9 ttt -155.15 -12.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 119.315 3.08 . . . . 0.0 119.315 -151.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.725 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.503 0.0 OUTLIER -69.68 -173.02 0.55 Allowed 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 121.765 3.987 . . . . 0.0 121.765 -169.915 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.56 -108.64 1.78 Allowed Glycine 0 N--CA 1.48 1.567 0 N-CA-C 122.442 3.737 . . . . 0.0 122.442 -164.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.7 m -121.43 136.92 54.91 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.506 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 79.1 t -62.76 117.05 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.91 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.7 mt -79.34 -37.36 37.71 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 122.107 2.231 . . . . 0.0 111.236 165.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.5 tp10 -143.31 144.96 32.31 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 122.062 0.934 . . . . 0.0 112.346 169.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.526 HG22 ' HE1' ' A' ' 21' ' ' PHE . 32.2 p -104.2 109.3 21.06 Favored 'General case' 0 N--CA 1.513 2.725 0 N-CA-C 101.763 -3.421 . . . . 0.0 101.763 171.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.376 0.5 OUTLIER -77.32 -177.51 0.81 Allowed Pre-proline 0 CA--C 1.592 2.559 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -167.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -54.38 -36.59 87.8 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 N-CA-C 120.893 3.382 . . . . 0.0 120.893 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -85.72 -93.83 0.08 Allowed 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -156.23 74.89 0.86 Allowed 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.9 mtt -130.23 162.25 29.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.976 -1.077 . . . . 0.0 112.76 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.691 ' CE2' HG23 ' A' ' 35' ' ' ILE . 62.3 m-85 -128.75 113.3 15.16 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 118.723 -2.485 . . . . 0.0 106.979 -162.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -85.76 96.11 9.62 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 167.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 21' ' ' PHE . 2.1 t -99.95 140.13 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -164.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.06 114.92 26.67 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.49 HD21 HE21 ' A' ' 9' ' ' GLN 0.256 0.5 OUTLIER -58.4 178.07 0.11 Allowed 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -177.751 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.49 -24.57 66.42 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 167.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -92.63 6.96 45.44 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 170.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.9 -1.74 87.86 Favored Glycine 0 CA--C 1.554 2.519 0 N-CA-C 119.911 2.725 . . . . 0.0 119.911 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -83.9 143.19 30.04 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.641 1.72 . . . . 0.0 113.262 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.5 t -89.05 130.84 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.663 0 CA-C-O 122.578 1.18 . . . . 0.0 111.52 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.86 153.92 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.54 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.0 m -99.51 122.0 41.97 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.495 -1.378 . . . . 0.0 109.853 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.39 149.36 32.6 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 119.733 3.235 . . . . 0.0 119.733 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -99.95 158.26 15.94 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.509 -1.37 . . . . 0.0 111.206 170.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.691 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -71.17 178.21 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.752 0 O-C-N 120.444 -1.41 . . . . 0.0 111.981 164.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.2 p -80.08 15.72 1.42 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 120.07 3.359 . . . . 0.0 120.07 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.67 -25.66 0.06 OUTLIER Glycine 0 N--CA 1.506 3.33 0 N-CA-C 121.842 3.497 . . . . 0.0 121.842 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -79.99 -45.95 17.51 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -46.25 89.42 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 118.537 2.792 . . . . 0.0 118.537 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HB3' HD11 ' A' ' 35' ' ' ILE . 7.6 ptm85 -36.28 -45.99 0.5 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.806 3.262 . . . . 0.0 119.806 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -92.0 0.6 57.47 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-N 110.048 -3.251 . . . . 0.0 118.929 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -96.57 -71.58 0.67 Allowed 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 167.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.27 125.81 37.09 Favored 'General case' 0 CA--C 1.57 1.744 0 C-N-CA 124.154 0.982 . . . . 0.0 109.122 170.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.57 108.99 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.722 0 CA-C-O 124.429 2.061 . . . . 0.0 107.747 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -44.66 174.62 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.878 1 N-CA-C 124.267 4.914 . . . . 0.0 124.267 -165.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' A' ' 21' ' ' PHE . 1.1 pt -75.57 159.79 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 109.845 -3.343 . . . . 0.0 116.604 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -122.44 174.77 6.82 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.184 0.993 . . . . 0.0 112.285 -171.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -68.47 100.61 1.11 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 123.494 1.616 . . . . 0.0 112.576 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.506 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 113.36 20.47 6.22 Favored Glycine 0 N--CA 1.489 2.224 0 CA-C-N 112.837 -1.983 . . . . 0.0 117.883 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.55 158.58 15.92 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-O 122.917 1.341 . . . . 0.0 112.764 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -87.75 94.54 9.78 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 125.764 2.697 . . . . 0.0 113.106 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.419 ' CG1' HD13 ' A' ' 46' ' ' ILE . 19.7 m -94.56 148.12 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 CA-C-N 109.594 -3.457 . . . . 0.0 110.986 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.2 m -140.94 107.19 5.23 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 100.33 -3.952 . . . . 0.0 100.33 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.725 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.252 51.0 t -117.17 128.45 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 111.177 -2.738 . . . . 0.0 106.042 -159.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -80.65 134.32 35.86 Favored 'General case' 0 CA--C 1.558 1.266 0 O-C-N 121.345 -0.847 . . . . 0.0 112.182 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.56 -176.38 3.37 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.488 1.137 . . . . 0.0 110.707 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 p -108.56 164.12 15.44 Favored Pre-proline 0 CA--C 1.571 1.772 0 O-C-N 120.987 -1.071 . . . . 0.0 113.883 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -51.09 -40.77 59.26 Favored 'Trans proline' 0 CA--C 1.572 2.393 0 N-CA-C 118.976 2.645 . . . . 0.0 118.976 163.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -94.98 -53.39 3.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -89.63 79.87 6.73 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.576 1.179 . . . . 0.0 111.924 -172.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.65 -21.23 57.88 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.2 t -77.64 11.75 1.95 Allowed 'General case' 0 CA--C 1.58 2.127 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 173.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 mtmm -137.56 177.38 7.91 Favored 'General case' 0 CA--C 1.57 1.742 0 CA-C-N 120.249 1.386 . . . . 0.0 114.612 -175.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.2 -176.25 45.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.22 114.85 3.69 Favored 'General case' 0 CA--C 1.592 2.58 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 168.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.64 ' H ' HD12 ' A' ' 66' ' ' ILE . 1.3 mp -45.13 108.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 O-C-N 119.076 -2.265 . . . . 0.0 114.893 171.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -90.6 -40.81 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.87 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.799 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.6 t80 67.85 148.7 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 171.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.33 52.77 2.11 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.0 t -160.15 -84.7 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 . . . . . 0 CA--C 1.566 1.583 0 CA-C-O 125.018 2.342 . . . . 0.0 107.9 171.487 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.532 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -69.76 -27.33 64.84 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.37 56.11 3.43 Favored 'General case' 0 CA--C 1.579 2.082 0 CA-C-N 120.256 1.389 . . . . 0.0 114.323 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -104.26 114.95 29.53 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -85.46 105.89 16.41 Favored 'General case' 0 CA--C 1.579 2.066 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mt -88.99 138.73 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.294 -1.504 . . . . 0.0 112.298 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.328 8.6 pt-20 -88.56 121.63 31.15 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 125.052 2.358 . . . . 0.0 109.235 170.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.407 ' HB3' HD23 ' A' ' 56' ' ' LEU . 18.0 ttt -172.01 84.79 0.07 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 109.289 -3.596 . . . . 0.0 104.852 -148.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.643 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -110.92 -149.03 0.44 Allowed 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -156.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 179.82 -150.72 9.44 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 117.967 1.947 . . . . 0.0 117.967 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.9 m -115.89 133.79 55.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.516 HG11 HG23 ' A' ' 15' ' ' THR . 46.9 t -60.06 118.31 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.003 0 O-C-N 121.384 -0.822 . . . . 0.0 109.102 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -84.24 -31.44 25.01 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.599 -1.938 . . . . 0.0 111.874 165.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -147.04 143.88 28.7 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 122.726 1.251 . . . . 0.0 111.807 167.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.516 HG23 HG11 ' A' ' 12' ' ' VAL . 24.3 p -104.16 105.68 15.93 Favored 'General case' 0 N--CA 1.516 2.862 0 N-CA-C 100.793 -3.781 . . . . 0.0 100.793 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.371 0.3 OUTLIER -75.26 173.39 7.06 Favored Pre-proline 0 CA--C 1.591 2.526 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -167.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -47.58 -35.26 22.14 Favored 'Trans proline' 0 CA--C 1.567 2.128 0 N-CA-C 122.103 3.847 . . . . 0.0 122.103 -174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -85.3 -96.34 0.07 Allowed 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 m -157.68 73.38 0.7 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 95.9 mtp -125.38 167.27 15.19 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.385 1.074 . . . . 0.0 112.529 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.534 ' CE1' HD11 ' A' ' 46' ' ' ILE . 55.3 m-85 -130.04 114.06 15.32 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 118.883 -2.386 . . . . 0.0 108.363 -164.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.2 ttm105 -85.34 97.95 10.26 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.5 t -106.75 143.03 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -162.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -88.13 106.73 18.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 171.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.285 3.8 mt -72.31 176.37 5.34 Favored 'General case' 0 CA--C 1.58 2.107 0 CA-C-O 123.995 1.855 . . . . 0.0 113.208 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.77 -25.12 62.75 Favored 'General case' 0 CA--C 1.585 2.304 0 CA-C-N 114.088 -1.415 . . . . 0.0 114.101 166.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -72.02 -5.83 37.84 Favored 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.72 -4.47 79.0 Favored Glycine 0 CA--C 1.557 2.706 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -88.33 147.71 24.64 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.77 1.228 . . . . 0.0 112.903 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.44 106.84 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.95 151.32 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.1 m -92.53 124.83 36.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.525 -1.359 . . . . 0.0 109.005 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.53 159.59 41.34 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -113.25 -164.28 0.91 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 169.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -108.34 -177.94 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.384 0 O-C-N 120.254 -1.529 . . . . 0.0 108.369 166.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 84.8 p -76.79 20.08 0.26 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.98 -55.18 0.79 Allowed Glycine 0 N--CA 1.499 2.871 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -57.11 -52.54 64.9 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.259 0.7 OUTLIER -70.11 -19.48 63.24 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 117.611 2.449 . . . . 0.0 117.611 177.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -39.43 -35.59 0.29 Allowed 'General case' 0 CA--C 1.578 2.056 0 N-CA-C 117.338 2.347 . . . . 0.0 117.338 170.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.8 38.62 1.21 Allowed 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 171.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -152.93 -74.82 0.13 Allowed 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.44 99.75 11.87 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 164.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mt -76.39 -64.59 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 O-C-N 121.666 -0.646 . . . . 0.0 111.773 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -128.47 167.42 17.08 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 119.94 3.311 . . . . 0.0 119.94 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.534 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.268 1.5 pt -142.65 170.83 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 109.57 -3.468 . . . . 0.0 110.666 176.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.3 tp -111.22 163.27 14.1 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.147 0.975 . . . . 0.0 111.406 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.1 m -69.97 88.41 0.57 Allowed 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 123.451 1.596 . . . . 0.0 111.206 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.499 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 129.49 22.17 1.22 Allowed Glycine 0 N--CA 1.493 2.473 0 CA-C-N 113.184 -1.825 . . . . 0.0 117.304 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -93.42 160.33 14.86 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 122.891 1.329 . . . . 0.0 113.478 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -88.35 84.54 6.83 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 125.438 2.542 . . . . 0.0 112.765 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -71.13 166.63 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-N 110.156 -3.202 . . . . 0.0 115.218 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.321 14.3 m -125.95 75.71 1.53 Allowed 'General case' 0 N--CA 1.508 2.445 0 CA-C-O 123.798 1.761 . . . . 0.0 113.54 171.283 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.643 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -75.04 101.3 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.315 1.446 . . . . 0.0 109.528 -172.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -80.65 146.01 31.36 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.277 1.037 . . . . 0.0 109.911 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 8' ' ' MET . 3.1 mm? -98.39 -173.46 2.57 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 124.623 2.154 . . . . 0.0 116.405 -171.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 p -131.32 153.84 81.76 Favored Pre-proline 0 CA--C 1.578 2.045 0 CA-C-N 111.027 -2.806 . . . . 0.0 111.421 165.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.2 -42.85 61.93 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 123.734 2.956 . . . . 0.0 118.352 165.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -87.27 -54.4 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -96.86 74.25 2.65 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -171.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.8 mp -66.11 -20.99 66.33 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.3 m -73.36 1.55 9.38 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -135.36 169.89 16.78 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 123.333 1.54 . . . . 0.0 111.963 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.55 -164.83 31.69 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 115.87 1.108 . . . . 0.0 115.87 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.24 110.83 1.21 Allowed 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 119.234 3.049 . . . . 0.0 119.234 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.513 ' CD1' ' H ' ' A' ' 66' ' ' ILE 0.264 0.7 OUTLIER -25.1 89.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 163.924 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -82.0 -56.9 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.459 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.1 t80 58.34 91.95 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -80.61 64.56 5.44 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 t -156.83 -76.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.094 0.958 . . . . 0.0 110.211 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 124.894 2.283 . . . . 0.0 108.866 178.821 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.536 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.0 90.36 6.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.981 -1.075 . . . . 0.0 112.03 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.3 57.95 4.73 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 122.399 1.095 . . . . 0.0 113.763 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -148.25 153.72 39.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 123.302 1.525 . . . . 0.0 111.18 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -77.46 129.47 35.78 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.143 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.5 140.11 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.58 1.152 . . . . 0.0 110.444 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.375 11.4 pt-20 -92.21 123.48 35.58 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 124.644 2.164 . . . . 0.0 109.81 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.259 25.2 ttt -172.62 86.93 0.07 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 110.143 -3.208 . . . . 0.0 105.228 -147.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.657 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -116.24 -147.07 0.41 Allowed 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -156.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.88 -144.59 9.02 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 121.23 3.252 . . . . 0.0 121.23 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.2 m -102.74 129.54 49.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.235 -0.568 . . . . 0.0 109.611 -176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.484 HG11 HG23 ' A' ' 15' ' ' THR . 56.0 t -61.64 123.46 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.773 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 173.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.296 63.3 mt -101.68 -17.53 16.26 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 119.816 -1.803 . . . . 0.0 112.99 167.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 6.1 tp10 -148.18 143.35 27.0 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.512 1.149 . . . . 0.0 110.598 161.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.484 HG23 HG11 ' A' ' 12' ' ' VAL . 22.8 p -106.18 106.09 16.43 Favored 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 100.545 -3.872 . . . . 0.0 100.545 171.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.364 0.3 OUTLIER -75.23 173.58 6.74 Favored Pre-proline 0 CA--C 1.592 2.56 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -167.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -48.65 -34.48 27.19 Favored 'Trans proline' 0 CA--C 1.567 2.148 0 N-CA-C 121.729 3.704 . . . . 0.0 121.729 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -84.69 -95.46 0.07 Allowed 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -158.97 73.53 0.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 58.8 mtt -126.92 167.3 16.04 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.703 0.801 . . . . 0.0 112.264 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.601 ' CE2' HG23 ' A' ' 35' ' ' ILE . 57.7 m-85 -128.82 114.59 16.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 118.544 -2.598 . . . . 0.0 108.205 -163.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -87.28 91.35 8.69 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.5 t -99.3 142.02 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -162.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -82.98 124.37 30.33 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 165.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.269 3.0 mt -74.47 -173.89 1.88 Allowed 'General case' 0 CA--C 1.579 2.066 0 CA-C-O 123.76 1.743 . . . . 0.0 112.016 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -26.03 63.65 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 171.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -90.77 8.72 33.23 Favored 'General case' 0 CA--C 1.582 2.209 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 169.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.55 6.55 89.26 Favored Glycine 0 CA--C 1.552 2.393 0 N-CA-C 119.61 2.604 . . . . 0.0 119.61 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -89.48 142.69 27.44 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 119.908 1.854 . . . . 0.0 112.001 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 t -84.57 124.35 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 122.087 0.946 . . . . 0.0 110.805 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.41 145.69 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.745 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 m -91.24 122.1 33.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.533 -1.354 . . . . 0.0 108.547 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.91 153.68 44.56 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -114.51 148.34 38.05 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.511 1.148 . . . . 0.0 109.129 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.601 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.1 pt -66.94 179.24 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.598 2.798 0 O-C-N 121.025 -1.047 . . . . 0.0 112.521 166.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.7 p -102.82 157.3 17.06 Favored 'General case' 0 CA--C 1.558 1.287 0 O-C-N 119.513 -1.992 . . . . 0.0 115.048 -176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.31 -3.98 27.73 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 119.297 2.479 . . . . 0.0 119.297 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.282 21.9 pttm -95.31 -54.26 3.47 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.691 1.738 . . . . 0.0 115.691 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -31.47 66.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 118.197 2.665 . . . . 0.0 118.197 175.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -35.58 -42.25 0.23 Allowed 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 120.344 3.461 . . . . 0.0 120.344 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.83 34.79 0.72 Allowed 'General case' 0 CA--C 1.581 2.149 0 CA-C-N 111.306 -2.679 . . . . 0.0 116.567 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -155.53 -74.9 0.11 Allowed 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 102.226 -3.25 . . . . 0.0 102.226 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.4 97.44 8.95 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.485 1.514 . . . . 0.0 107.943 165.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mt -74.26 -63.44 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.255 -0.903 . . . . 0.0 111.768 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -129.24 170.45 13.57 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.548 HD11 ' CE1' ' A' ' 21' ' ' PHE . 2.8 pt -146.73 171.56 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 109.507 -3.497 . . . . 0.0 111.363 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.5 tp -116.39 167.03 11.4 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.179 0.99 . . . . 0.0 110.973 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.1 m -70.74 86.17 0.67 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 123.539 1.638 . . . . 0.0 111.905 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.453 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 133.83 19.43 0.92 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 117.726 1.85 . . . . 0.0 117.726 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -94.79 165.71 12.34 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.985 1.314 . . . . 0.0 113.312 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -88.29 121.87 31.18 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 124.178 1.942 . . . . 0.0 111.945 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.69 163.98 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.881 0 CA-C-N 111.183 -2.735 . . . . 0.0 113.109 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 9' ' ' GLN 0.361 22.7 m -121.85 75.3 1.2 Allowed 'General case' 0 N--CA 1.514 2.743 0 CA-C-O 124.543 2.116 . . . . 0.0 114.754 172.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.657 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -75.84 100.56 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 126.82 2.048 . . . . 0.0 110.56 -174.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -83.25 144.34 29.81 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 120.842 -1.161 . . . . 0.0 109.081 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.4 -175.01 4.61 Favored 'General case' 0 CA--C 1.564 1.495 0 O-C-N 120.863 -1.148 . . . . 0.0 112.042 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -94.28 159.95 32.95 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -52.14 -41.45 65.0 Favored 'Trans proline' 0 CA--C 1.57 2.297 0 C-N-CA 123.443 2.762 . . . . 0.0 118.868 164.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -91.18 -54.55 3.89 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -93.64 78.9 4.28 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 122.507 1.146 . . . . 0.0 113.234 -171.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.16 -8.82 57.46 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 119.711 3.226 . . . . 0.0 119.711 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -75.96 -0.82 22.87 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -129.86 179.99 5.54 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.89 1.677 . . . . 0.0 113.053 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.18 -177.58 46.2 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 117.522 1.769 . . . . 0.0 117.522 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.34 111.27 1.64 Allowed 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.801 ' H ' HD12 ' A' ' 66' ' ' ILE 0.351 1.3 mp -38.57 89.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 119.152 -2.217 . . . . 0.0 116.547 164.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -75.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 CA-C-N 114.246 -1.343 . . . . 0.0 114.273 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -145.8 77.68 1.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.903 1.683 . . . . 0.0 114.568 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.3 ttm-85 -95.97 66.58 2.6 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.9 t -146.33 -98.74 0.09 Allowed 'General case' 0 CA--C 1.569 1.692 0 O-C-N 120.863 -1.148 . . . . 0.0 112.426 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 125.02 2.343 . . . . 0.0 112.32 -177.059 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.547 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.277 59.5 mtpt 68.46 -76.3 0.06 Allowed 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.89 78.33 6.06 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.339 1.066 . . . . 0.0 110.714 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.71 160.05 26.41 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.871 1.32 . . . . 0.0 114.225 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -94.64 136.41 34.98 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.563 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.97 155.49 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.705 -1.247 . . . . 0.0 110.246 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.331 12.4 pt-20 -113.78 119.32 36.93 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 124.128 1.918 . . . . 0.0 111.565 170.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.276 25.8 ttt -164.43 68.98 0.17 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 110.807 -2.906 . . . . 0.0 112.48 -152.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.665 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.597 0.3 OUTLIER -133.69 -167.86 2.01 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 177.075 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.45 -112.39 0.89 Allowed Glycine 0 N--CA 1.483 1.798 0 N-CA-C 122.226 3.65 . . . . 0.0 122.226 -167.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.2 m -103.97 136.32 43.84 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.682 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 45.9 t -71.49 100.01 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.615 3.451 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -64.5 -44.58 90.47 Favored 'General case' 0 N--CA 1.521 3.084 2 CA-C-N 127.163 4.529 . . . . 0.0 112.81 174.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -129.76 150.35 51.1 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 122.921 1.343 . . . . 0.0 110.464 171.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 p -104.34 97.9 7.77 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 101.391 -3.559 . . . . 0.0 101.391 171.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.281 5.2 mt -78.76 155.98 77.85 Favored Pre-proline 0 CA--C 1.595 2.68 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.259 -163.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.347 6.1 Cg_endo -14.15 -62.62 0.01 OUTLIER 'Trans proline' 0 CA--C 1.567 2.145 2 N-CA-C 125.343 5.093 . . . . 0.0 125.343 -169.676 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -75.81 -85.87 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.152 1.342 . . . . 0.0 109.108 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.6 m -155.94 75.11 0.89 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 81.3 mtp -120.24 179.37 4.31 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.756 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.476 ' HB3' HG22 ' A' ' 23' ' ' VAL . 58.3 m-85 -145.29 106.52 4.19 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 -165.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.3 ttt85 -84.2 93.94 8.29 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 170.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.6 t -98.57 136.0 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -162.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -96.03 108.42 20.82 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 26' ' ' GLU 0.345 0.3 OUTLIER -48.8 178.39 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 N-CA-C 121.473 3.879 . . . . 0.0 121.473 -177.15 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.554 ' H ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -75.43 -23.13 56.93 Favored 'General case' 0 CA--C 1.579 2.074 0 CA-C-N 112.462 -2.154 . . . . 0.0 113.704 166.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.264 0.1 OUTLIER -93.45 4.89 53.23 Favored 'General case' 0 CA--C 1.595 2.707 0 C-N-CA 124.703 1.201 . . . . 0.0 112.481 168.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.79 15.36 79.47 Favored Glycine 0 CA--C 1.547 2.056 0 N-CA-C 119.634 2.613 . . . . 0.0 119.634 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -101.08 136.12 41.44 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.007 1.904 . . . . 0.0 111.62 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.67 128.12 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 119.926 -1.734 . . . . 0.0 112.398 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -122.47 169.76 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.281 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -112.04 121.88 46.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.909 -1.12 . . . . 0.0 109.793 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.81 158.74 43.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 118.377 2.732 . . . . 0.0 118.377 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -106.74 166.21 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.806 1.289 . . . . 0.0 109.499 167.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.427 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.1 pt -78.55 -176.37 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.58 0 O-C-N 119.854 -1.779 . . . . 0.0 111.414 168.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.8 p -102.42 97.05 7.34 Favored 'General case' 0 CA--C 1.552 1.04 0 O-C-N 120.173 -1.58 . . . . 0.0 107.347 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -39.41 -30.43 0.16 Allowed Glycine 0 N--CA 1.499 2.868 0 N-CA-C 122.914 3.926 . . . . 0.0 122.914 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -66.13 -50.45 63.97 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -52.78 5.18 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 124.759 1.224 . . . . 0.0 113.596 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . 0.314 37.7 mmt180 -70.37 -47.84 59.1 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -171.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -94.13 46.21 1.16 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 123.855 1.788 . . . . 0.0 114.891 169.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -103.69 -53.38 2.79 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 167.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.264 39.4 p90 -72.33 -138.82 0.01 OUTLIER 'General case' 0 CA--C 1.592 2.594 0 CA-C-O 122.149 0.976 . . . . 0.0 108.96 154.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -118.62 -82.03 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 O-C-N 119.986 -1.696 . . . . 0.0 111.509 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -141.87 166.71 23.97 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 123.895 1.807 . . . . 0.0 114.802 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.284 2.4 pp -105.58 151.01 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.32 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.3 tp -86.64 162.49 17.92 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -165.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -65.43 99.33 0.41 Allowed 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 123.893 1.806 . . . . 0.0 112.069 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.682 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 113.66 -4.34 24.57 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 120.428 2.931 . . . . 0.0 120.428 -175.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -60.55 155.45 18.58 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -83.17 87.97 6.91 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 126.08 2.848 . . . . 0.0 113.235 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.19 146.06 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 108.987 -3.733 . . . . 0.0 110.314 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.3 m -137.02 115.91 12.28 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 100.421 -3.918 . . . . 0.0 100.421 171.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.665 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.26 92.3 t -121.46 127.05 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 112.779 -2.01 . . . . 0.0 107.429 -158.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -80.46 125.64 30.2 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.449 0.642 . . . . 0.0 111.955 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.263 0.3 OUTLIER -111.85 -110.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.209 -171.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.15 166.32 15.4 Favored Pre-proline 0 CA--C 1.582 2.183 0 C-N-CA 123.793 0.837 . . . . 0.0 112.924 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -60.09 -46.33 19.49 Favored 'Trans proline' 0 CA--C 1.568 2.22 0 C-N-CA 123.412 2.741 . . . . 0.0 117.759 166.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -100.5 -55.55 2.57 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -93.62 70.19 4.17 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.1 mp -68.63 2.24 2.61 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -69.31 -11.17 60.58 Favored 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -142.96 159.14 42.81 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 125.824 1.65 . . . . 0.0 113.223 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.47 -158.97 19.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 117.016 1.566 . . . . 0.0 117.016 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.26 124.29 7.43 Favored 'General case' 0 CA--C 1.59 2.498 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.486 ' CD1' ' H ' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -41.29 99.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 174.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -96.37 -30.87 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.095 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -124.47 146.2 49.08 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -89.47 111.09 21.88 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.926 0.89 . . . . 0.0 110.025 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 m -97.3 -0.16 47.01 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 . . . . . 0 CA--C 1.563 1.443 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 179.486 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 1.465 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -126.99 79.79 1.9 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.983 1.265 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.281 24.9 tt0 -130.46 -130.1 0.2 Allowed 'General case' 0 CA--C 1.57 1.726 0 CA-C-O 122.526 1.155 . . . . 0.0 108.887 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -109.06 149.68 28.93 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.17 1.388 . . . . 0.0 111.128 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -64.86 119.25 10.32 Favored 'General case' 0 CA--C 1.577 2.004 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.459 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.84 156.97 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.457 -1.402 . . . . 0.0 111.878 -171.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.35 9.8 pt-20 -106.29 120.78 42.76 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 124.537 2.113 . . . . 0.0 110.684 165.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 21.0 ttt -169.61 78.74 0.11 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 110.601 -3.0 . . . . 0.0 109.08 -155.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.669 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.612 0.0 OUTLIER -139.24 -168.42 2.44 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 173.274 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.64 -108.51 1.0 Allowed Glycine 0 N--CA 1.478 1.497 0 N-CA-C 121.198 3.239 . . . . 0.0 121.198 -165.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 98.9 m -121.88 135.31 54.88 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.497 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 73.7 t -61.49 117.57 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.612 3.327 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.7 mt -81.14 -45.23 16.72 Favored 'General case' 0 N--CA 1.511 2.577 0 CA-C-N 123.091 2.678 . . . . 0.0 110.809 167.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 6.1 tp10 -129.53 143.03 50.66 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 122.752 1.263 . . . . 0.0 111.535 170.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.458 HG23 HG11 ' A' ' 12' ' ' VAL . 20.4 p -103.01 107.56 18.4 Favored 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 101.03 -3.693 . . . . 0.0 101.03 171.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.391 0.2 OUTLIER -75.45 -175.35 0.46 Allowed Pre-proline 0 CA--C 1.594 2.646 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -167.086 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -52.35 -51.1 11.9 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 124.091 3.194 . . . . 0.0 119.493 -173.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.39 -86.75 0.05 OUTLIER 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -163.02 75.1 0.39 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 172.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 69.1 mtm -123.28 175.9 6.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.464 -0.772 . . . . 0.0 111.551 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.705 ' CE2' HG23 ' A' ' 35' ' ' ILE . 60.0 m-85 -140.68 113.67 8.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 118.908 -2.37 . . . . 0.0 107.29 -163.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -86.59 96.34 10.06 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 169.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -100.2 136.54 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -162.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -94.07 113.14 25.05 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 171.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.256 0.5 OUTLIER -56.5 178.77 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 -175.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.77 -25.63 66.57 Favored 'General case' 0 CA--C 1.573 1.844 0 CA-C-N 113.564 -1.653 . . . . 0.0 114.976 167.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -93.26 8.01 42.05 Favored 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 168.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.89 8.78 85.37 Favored Glycine 0 CA--C 1.556 2.639 0 N-CA-C 120.333 2.893 . . . . 0.0 120.333 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -93.67 138.97 31.35 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 119.275 1.537 . . . . 0.0 112.789 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.9 t -85.56 130.34 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.209 -1.557 . . . . 0.0 112.805 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.3 m -126.72 167.42 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 114.359 -1.291 . . . . 0.0 113.571 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 m -109.29 123.26 48.98 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.966 -1.084 . . . . 0.0 110.152 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.26 151.95 39.17 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 119.171 3.026 . . . . 0.0 119.171 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.33 170.16 8.62 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.036 -1.04 . . . . 0.0 109.594 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.705 HG23 ' CE2' ' A' ' 21' ' ' PHE . 6.4 pt -76.76 -177.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.552 0 O-C-N 119.531 -1.981 . . . . 0.0 110.97 164.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.2 p -100.73 144.52 29.6 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 119.646 -1.909 . . . . 0.0 110.761 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.93 -23.2 6.89 Favored Glycine 0 N--CA 1.508 3.463 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -63.78 -55.78 20.52 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.246 1.818 . . . . 0.0 114.768 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.6 ptp -73.77 -36.14 65.05 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 116.148 -1.882 . . . . 0.0 115.791 172.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HG2' HD11 ' A' ' 35' ' ' ILE . 51.4 mtt85 -37.33 -41.03 0.39 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.549 2.425 . . . . 0.0 117.549 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -93.19 -1.44 56.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -94.34 -68.68 0.79 Allowed 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.61 130.8 55.29 Favored 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 125.501 1.52 . . . . 0.0 107.717 170.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.6 mt -73.54 -65.37 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.044 0 O-C-N 120.004 -1.685 . . . . 0.0 111.166 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -105.33 164.52 11.79 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 120.954 3.687 . . . . 0.0 120.954 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.275 0.5 OUTLIER -133.97 168.6 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-N 109.545 -3.479 . . . . 0.0 109.457 173.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.59 163.81 12.17 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.445 1.117 . . . . 0.0 113.206 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 m -72.67 89.64 1.34 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 123.351 1.548 . . . . 0.0 110.955 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.497 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 121.64 24.17 2.41 Favored Glycine 0 N--CA 1.489 2.213 0 CA-C-N 113.382 -1.736 . . . . 0.0 116.749 -174.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -92.28 156.64 17.14 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-O 122.634 1.207 . . . . 0.0 112.224 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -86.69 91.67 8.68 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 125.76 2.695 . . . . 0.0 113.685 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -93.17 151.3 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.038 0 CA-C-N 109.59 -3.459 . . . . 0.0 111.503 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -143.55 112.18 6.47 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 100.34 -3.948 . . . . 0.0 100.34 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.669 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.278 94.1 t -120.54 125.5 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 112.108 -2.314 . . . . 0.0 107.066 -156.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -78.0 120.61 23.1 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.671 0.748 . . . . 0.0 111.102 -174.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.278 0.2 OUTLIER -105.2 -122.87 0.22 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.858 -175.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.4 169.05 11.22 Favored Pre-proline 0 CA--C 1.584 2.257 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.98 -49.31 0.69 Allowed 'Trans proline' 0 CA--C 1.551 1.346 0 C-N-CA 124.766 3.644 . . . . 0.0 118.517 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -96.24 -34.14 11.74 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.048 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -103.56 81.33 1.9 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.971 -173.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.13 -19.47 34.14 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 118.815 2.894 . . . . 0.0 118.815 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.0 m -65.69 -6.37 11.23 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 160.19 41.05 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 125.746 1.618 . . . . 0.0 113.654 -177.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.81 -159.32 17.84 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -157.07 117.96 3.63 Favored 'General case' 0 CA--C 1.586 2.332 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -38.79 97.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 174.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -95.99 -48.07 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 C-N-CA 124.388 1.075 . . . . 0.0 112.455 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.281 15.8 t80 71.95 -72.03 0.12 Allowed 'General case' 0 CA--C 1.572 1.816 0 C-N-CA 125.527 1.531 . . . . 0.0 112.782 -175.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -108.44 55.94 0.63 Allowed 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.9 p -80.67 -35.26 34.01 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? . . . . . 0 CA--C 1.558 1.283 0 CA-C-O 124.679 2.18 . . . . 0.0 110.758 -179.84 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.539 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -63.26 -55.29 26.04 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.46 73.24 4.45 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 121.475 -0.766 . . . . 0.0 110.042 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -71.61 151.63 43.59 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-O 123.679 1.704 . . . . 0.0 114.152 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -77.56 126.98 31.75 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 113.604 -1.635 . . . . 0.0 113.44 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.14 139.75 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.561 1.144 . . . . 0.0 109.663 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.308 6.6 pt-20 -97.56 116.51 29.92 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 124.89 2.281 . . . . 0.0 109.115 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 21.7 ttt -168.22 76.32 0.13 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 109.392 -3.549 . . . . 0.0 110.208 -148.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.662 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.613 0.0 OUTLIER -140.1 -166.92 2.2 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 174.691 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.16 -112.02 1.1 Allowed Glycine 0 N--CA 1.479 1.546 0 N-CA-C 120.633 3.013 . . . . 0.0 120.633 -165.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.8 m -118.26 137.53 52.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.473 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 58.8 t -64.57 105.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.608 3.176 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 mp -77.0 -45.0 28.83 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 117.966 -2.959 . . . . 0.0 113.175 170.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -122.56 148.84 44.73 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.354 1.074 . . . . 0.0 111.029 167.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 p -103.3 98.35 8.28 Favored 'General case' 0 N--CA 1.516 2.86 0 N-CA-C 101.667 -3.457 . . . . 0.0 101.667 170.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.27 5.3 mt -79.38 151.7 75.23 Favored Pre-proline 0 CA--C 1.591 2.535 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.482 -163.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.415 3.8 Cg_exo 8.61 -80.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.268 2 C-N-CA 126.686 4.924 . . . . 0.0 124.283 -170.696 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -76.04 -75.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 120.435 1.47 . . . . 0.0 110.869 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -158.34 75.96 0.75 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.258 61.9 mtt -118.37 -174.11 2.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 0.0 111.011 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.712 ' CE2' HG23 ' A' ' 35' ' ' ILE . 61.8 m-85 -148.3 108.83 4.16 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 118.919 -2.363 . . . . 0.0 105.152 -165.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -86.57 92.76 8.99 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 103.725 -2.695 . . . . 0.0 103.725 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -99.37 135.53 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -163.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.94 113.93 26.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 170.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.29 0.5 OUTLIER -58.46 -179.92 0.07 Allowed 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -176.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.79 -24.29 64.39 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-N 113.46 -1.7 . . . . 0.0 115.01 168.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -90.21 5.09 48.53 Favored 'General case' 0 CA--C 1.585 2.308 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.37 5.24 82.69 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 120.165 2.826 . . . . 0.0 120.165 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -94.93 142.46 27.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.616 1.708 . . . . 0.0 113.346 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.86 129.76 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-O 122.153 0.977 . . . . 0.0 112.384 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 m -139.83 152.6 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-O 122.208 1.004 . . . . 0.0 113.185 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -89.87 128.52 36.2 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.156 -1.59 . . . . 0.0 111.594 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.59 150.48 36.45 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -103.32 155.43 18.47 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.081 0.943 . . . . 0.0 110.595 170.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.712 HG23 ' CE2' ' A' ' 21' ' ' PHE . 1.1 pt -66.15 175.32 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.601 2.942 0 CA-C-O 122.913 1.339 . . . . 0.0 112.053 165.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.2 p -103.38 140.43 37.46 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 119.826 -1.796 . . . . 0.0 109.655 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.13 -16.27 6.17 Favored Glycine 0 N--CA 1.505 3.273 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -72.1 -49.64 34.62 Favored 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 126.656 1.982 . . . . 0.0 114.74 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.7 ptp -73.04 -24.16 60.68 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -38.74 -33.25 0.1 Allowed 'General case' 0 CA--C 1.587 2.381 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -91.85 -4.78 54.4 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -89.16 -72.97 0.52 Allowed 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 168.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -101.35 135.13 43.35 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 124.41 1.084 . . . . 0.0 108.759 166.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mt -71.5 -53.38 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.76 -1.212 . . . . 0.0 110.803 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -135.6 175.26 9.75 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-O 124.516 2.103 . . . . 0.0 112.792 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.403 HD11 ' CE1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -137.11 156.15 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 113.138 -1.846 . . . . 0.0 108.758 177.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.8 mp -95.77 166.51 11.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -73.69 87.14 1.68 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 123.48 1.609 . . . . 0.0 111.18 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.473 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 124.6 18.86 2.63 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-N 113.308 -1.769 . . . . 0.0 117.233 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -91.26 167.0 12.63 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 122.781 1.276 . . . . 0.0 111.234 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -90.08 129.67 36.35 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 124.951 2.31 . . . . 0.0 114.306 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.5 m -134.14 152.53 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.827 0 CA-C-N 110.511 -3.041 . . . . 0.0 110.693 -173.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.9 m -142.99 111.6 6.32 Favored 'General case' 0 N--CA 1.501 2.103 1 N-CA-C 100.19 -4.004 . . . . 0.0 100.19 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.662 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.276 71.7 t -125.35 123.85 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 112.261 -2.245 . . . . 0.0 107.182 -156.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -79.32 141.58 36.86 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.45 -175.81 4.93 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 122.125 0.964 . . . . 0.0 110.864 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -90.41 158.48 43.22 Favored Pre-proline 0 CA--C 1.573 1.835 0 O-C-N 120.611 -1.306 . . . . 0.0 112.999 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -54.86 -42.65 66.79 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 123.068 2.512 . . . . 0.0 118.422 164.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -90.39 -45.73 8.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -102.74 81.44 2.01 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 122.35 1.072 . . . . 0.0 113.031 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.67 43.06 0.81 Allowed 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 64.2 m -95.32 -28.6 14.89 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -132.29 -178.23 4.82 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-O 122.749 1.261 . . . . 0.0 114.049 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.49 177.25 40.2 Favored Glycine 0 CA--C 1.554 2.514 0 N-CA-C 117.145 1.618 . . . . 0.0 117.145 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.3 113.21 3.15 Favored 'General case' 0 CA--C 1.596 2.732 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 168.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.48 ' CD1' ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -45.5 104.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 CA-C-N 122.495 2.407 . . . . 0.0 113.968 173.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m -94.67 145.25 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -109.46 28.61 8.36 Favored 'General case' 0 CA--C 1.586 2.36 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -147.44 164.21 34.07 Favored 'General case' 0 CA--C 1.574 1.894 0 C-N-CA 125.488 1.515 . . . . 0.0 110.502 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.5 p -94.39 71.59 3.77 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.058 -1.651 . . . . 0.0 112.569 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 123.326 1.536 . . . . 0.0 113.616 -177.796 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.583 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.287 60.8 mttp 74.78 -55.36 0.65 Allowed 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.08 33.76 0.29 Allowed 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.256 4.8 p-10 -109.0 -151.13 0.47 Allowed 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 125.795 1.638 . . . . 0.0 111.802 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -76.0 97.2 3.95 Favored 'General case' 0 CA--C 1.577 1.991 0 O-C-N 120.484 -1.385 . . . . 0.0 108.472 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 mt -92.3 143.95 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.773 -1.204 . . . . 0.0 110.84 -171.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.293 8.8 pt-20 -99.22 122.57 42.59 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 124.664 2.173 . . . . 0.0 109.512 170.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.293 6.5 ttt -152.95 -4.49 0.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 109.898 -3.319 . . . . 0.0 119.283 -151.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.848 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.537 0.5 OUTLIER -75.8 -164.03 0.32 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 121.657 3.947 . . . . 0.0 121.657 -166.607 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.42 -112.54 1.08 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 122.514 3.766 . . . . 0.0 122.514 -163.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.8 m -108.78 135.97 49.12 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.712 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 78.3 t -71.81 107.38 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.981 0 CA-C-N 120.379 1.445 . . . . 0.0 107.327 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.13 -42.56 72.45 Favored 'General case' 0 N--CA 1.516 2.843 0 CA-C-N 124.814 3.461 . . . . 0.0 112.056 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -132.6 147.83 52.35 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.151 0.977 . . . . 0.0 110.988 170.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.409 HG23 HG11 ' A' ' 12' ' ' VAL . 11.0 p -102.66 102.99 13.23 Favored 'General case' 0 N--CA 1.514 2.728 0 N-CA-C 101.94 -3.356 . . . . 0.0 101.94 170.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.347 5.4 mt -80.82 -179.03 1.3 Allowed Pre-proline 0 CA--C 1.598 2.797 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -164.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.273 21.1 Cg_endo -47.51 -45.55 22.79 Favored 'Trans proline' 0 CA--C 1.568 2.185 1 N-CA-C 123.786 4.495 . . . . 0.0 123.786 -167.963 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.58 -89.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.38 1.445 . . . . 0.0 108.31 172.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.4 m -153.03 76.22 1.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 171.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.4 mtt -120.61 176.25 5.6 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.521 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CE2' HG23 ' A' ' 35' ' ' ILE . 55.6 m-85 -146.05 108.71 4.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -164.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 tpt85 -83.51 94.63 8.08 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.9 t -100.72 139.09 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -162.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -92.36 115.24 27.92 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.27 0.6 OUTLIER -64.7 178.92 0.7 Allowed 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -177.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -67.66 -27.37 66.8 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 168.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -91.79 8.86 35.19 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 171.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.06 16.62 78.46 Favored Glycine 0 CA--C 1.555 2.549 0 N-CA-C 119.929 2.731 . . . . 0.0 119.929 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -98.58 131.46 44.78 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.188 1.494 . . . . 0.0 111.823 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -83.89 127.61 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 123.17 1.462 . . . . 0.0 111.435 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.73 HG21 HE21 ' A' ' 9' ' ' GLN . 18.7 m -123.38 159.77 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.882 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 m -106.73 123.24 47.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.54 -1.35 . . . . 0.0 109.432 172.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.57 157.85 44.28 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 118.881 2.919 . . . . 0.0 118.881 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -104.47 167.58 9.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 163.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.58 HG23 ' CE2' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -77.12 177.19 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.526 0 O-C-N 119.98 -1.7 . . . . 0.0 110.295 162.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.3 p -77.97 87.83 4.14 Favored 'General case' 0 CA--C 1.573 1.829 0 O-C-N 119.062 -2.274 . . . . 0.0 108.591 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -17.93 -47.61 0.01 OUTLIER Glycine 0 N--CA 1.505 3.26 1 N-CA-C 124.297 4.479 . . . . 0.0 124.297 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -45.36 -46.16 12.93 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 118.776 2.88 . . . . 0.0 118.776 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.27 0.0 OUTLIER -69.46 -23.87 63.71 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 177.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.454 ' HG3' HD11 ' A' ' 35' ' ' ILE . 98.7 mtt180 -37.97 -41.18 0.53 Allowed 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 122.9 2.591 . . . . 0.0 117.159 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -96.76 3.93 52.06 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 119.804 3.261 . . . . 0.0 119.804 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -110.37 -63.12 1.42 Allowed 'General case' 0 CA--C 1.571 1.764 0 C-N-CA 125.605 1.562 . . . . 0.0 107.062 172.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.88 104.08 10.22 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 169.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -67.91 112.64 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-O 124.426 2.06 . . . . 0.0 107.906 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -41.84 161.34 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.851 1 N-CA-C 123.557 4.651 . . . . 0.0 123.557 -167.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.46 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.255 1.1 pt -89.61 160.82 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.78 0 CA-C-N 109.26 -3.609 . . . . 0.0 115.409 -175.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 tp -115.14 175.54 5.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.378 -170.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -67.7 91.84 0.32 Allowed 'General case' 0 CA--C 1.575 1.917 0 CA-C-O 124.389 2.042 . . . . 0.0 114.296 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.712 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 124.04 -2.15 9.13 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -65.32 156.89 30.67 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -81.91 90.75 6.47 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 125.699 2.666 . . . . 0.0 113.962 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 m -93.07 154.67 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 CA-C-N 109.435 -3.529 . . . . 0.0 110.766 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.3 m -147.9 103.25 3.48 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 100.609 -3.848 . . . . 0.0 100.609 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.848 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 23.7 t -109.06 131.63 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 111.076 -2.784 . . . . 0.0 107.305 -162.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -83.77 130.16 34.94 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.908 -1.12 . . . . 0.0 111.991 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.275 0.5 OUTLIER -108.28 -155.81 0.56 Allowed 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 122.047 0.927 . . . . 0.0 110.962 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.4 p -138.12 161.39 59.77 Favored Pre-proline 0 CA--C 1.572 1.789 0 O-C-N 121.021 -1.049 . . . . 0.0 112.064 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.99 -42.16 59.99 Favored 'Trans proline' 0 CA--C 1.573 2.441 0 C-N-CA 123.315 2.677 . . . . 0.0 118.459 163.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -87.49 -50.42 6.55 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -102.37 80.68 1.97 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.314 1.054 . . . . 0.0 112.337 -172.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -28.51 64.89 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.9 t -76.75 13.62 0.98 Allowed 'General case' 0 CA--C 1.587 2.374 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -139.14 172.75 12.38 Favored 'General case' 0 CA--C 1.57 1.732 0 O-C-N 119.643 -1.911 . . . . 0.0 114.353 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.57 -165.84 38.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.52 122.67 5.46 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.768 ' H ' HD12 ' A' ' 66' ' ' ILE . 2.2 mp -46.62 104.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.933 0 CA-C-N 121.734 2.061 . . . . 0.0 114.475 170.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 m -96.43 142.28 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.164 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -88.1 70.16 9.3 Favored 'General case' 0 CA--C 1.578 2.049 0 O-C-N 121.045 -1.035 . . . . 0.0 110.67 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.637 ' HE ' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -160.02 173.58 15.64 Favored 'General case' 0 CA--C 1.575 1.942 0 C-N-CA 124.358 1.063 . . . . 0.0 111.779 -176.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.637 ' H ' ' HE ' ' A' ' 69' ' ' ARG . 83.2 p -123.3 76.13 1.37 Allowed 'General case' 0 CA--C 1.571 1.771 0 O-C-N 120.782 -1.198 . . . . 0.0 113.257 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 125.062 2.363 . . . . 0.0 110.897 178.686 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.572 0 CA-C-O 121.874 0.845 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -84.42 91.31 7.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.999 -1.063 . . . . 0.0 111.926 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -89.69 62.03 5.67 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-O 122.727 1.251 . . . . 0.0 113.741 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.77 143.74 43.9 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -67.93 122.98 19.34 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -95.37 141.33 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.098 0.959 . . . . 0.0 110.222 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.303 9.1 pt-20 -96.4 122.09 38.91 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 125.068 2.366 . . . . 0.0 108.62 169.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 22.0 ttt -172.61 89.06 0.09 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 109.471 -3.513 . . . . 0.0 105.035 -149.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.711 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -117.19 -151.15 0.47 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -157.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 177.56 -137.65 3.52 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 117.348 1.699 . . . . 0.0 117.348 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.8 m -124.71 133.72 53.09 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.511 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 59.7 t -59.22 116.53 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.602 2.959 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.561 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.1 mt -83.9 -42.07 16.73 Favored 'General case' 0 N--CA 1.509 2.504 0 CA-C-N 122.299 2.318 . . . . 0.0 110.941 166.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 6.1 tt0 -133.97 143.97 48.49 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.829 1.299 . . . . 0.0 111.576 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.4 p -97.8 105.1 17.19 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 170.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.324 5.2 mt -78.86 179.77 1.65 Allowed Pre-proline 0 CA--C 1.596 2.718 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -164.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.266 27.8 Cg_endo -47.89 -45.91 23.24 Favored 'Trans proline' 0 CA--C 1.568 2.191 1 N-CA-C 122.552 4.02 . . . . 0.0 122.552 -169.591 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -82.84 -92.33 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.1 1.318 . . . . 0.0 107.735 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -151.61 73.28 1.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 171.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.7 mtp -119.78 176.52 5.36 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.641 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.48 ' HB3' HG22 ' A' ' 23' ' ' VAL . 56.9 m-85 -140.68 112.04 7.32 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -166.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -83.28 94.26 7.88 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 169.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.1 t -100.96 136.91 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -163.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -88.48 113.06 23.68 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.268 4.3 mt -73.39 -179.54 3.48 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 124.1 1.905 . . . . 0.0 112.554 -172.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.37 -22.18 61.18 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -90.11 6.37 42.77 Favored 'General case' 0 CA--C 1.585 2.292 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.95 15.79 76.52 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 119.828 2.691 . . . . 0.0 119.828 -176.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -102.91 139.9 37.88 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 119.248 1.524 . . . . 0.0 111.837 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -87.42 113.39 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.762 -1.211 . . . . 0.0 109.93 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.7 m -109.93 153.93 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -96.23 118.42 32.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.813 -1.179 . . . . 0.0 109.588 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.11 158.59 44.11 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.72 2.118 . . . . 0.0 116.72 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -105.68 -176.51 3.1 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.492 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -90.45 175.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.367 0 O-C-N 119.899 -1.751 . . . . 0.0 109.215 161.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.6 p -75.12 20.07 0.14 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 120.612 3.56 . . . . 0.0 120.612 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.79 -45.79 1.1 Allowed Glycine 0 N--CA 1.499 2.844 0 N-CA-C 118.644 2.218 . . . . 0.0 118.644 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -63.62 -54.07 41.68 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -22.8 64.79 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.9 mtp-105 -39.81 -35.81 0.38 Allowed 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -90.63 4.78 50.42 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 118.965 2.95 . . . . 0.0 118.965 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -97.15 -74.07 0.58 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 167.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -110.87 138.47 47.23 Favored 'General case' 0 CA--C 1.579 2.061 0 C-N-CA 125.334 1.453 . . . . 0.0 107.217 166.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.4 mt -73.66 -68.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 119.976 -1.702 . . . . 0.0 111.275 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -113.54 168.14 10.01 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 119.755 3.243 . . . . 0.0 119.755 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.357 1.8 pp -119.12 169.66 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 110.017 -3.265 . . . . 0.0 108.873 171.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.6 tp -100.98 163.2 12.4 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -168.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 m -69.73 92.94 0.69 Allowed 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 123.783 1.754 . . . . 0.0 111.49 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.511 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 117.01 22.92 4.07 Favored Glycine 0 N--CA 1.488 2.148 0 CA-C-N 112.678 -2.055 . . . . 0.0 117.439 -175.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -93.11 156.68 16.71 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.881 1.324 . . . . 0.0 113.33 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -88.66 83.32 6.74 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 125.231 2.444 . . . . 0.0 112.967 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.512 ' HB ' HD12 ' A' ' 66' ' ' ILE . 6.9 m -73.64 165.24 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 CA-C-N 110.436 -3.075 . . . . 0.0 114.972 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.801 ' H ' HG23 ' A' ' 66' ' ' ILE 0.274 5.1 m -120.52 77.23 1.25 Allowed 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 124.079 1.895 . . . . 0.0 112.434 173.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.711 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -75.47 94.05 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 O-C-N 120.219 -1.551 . . . . 0.0 110.328 -171.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -81.97 136.41 35.28 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.059 -1.026 . . . . 0.0 109.049 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.251 2.4 pt? -136.62 -165.01 1.66 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.844 -1.16 . . . . 0.0 112.351 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 p -110.29 159.5 31.82 Favored Pre-proline 0 CA--C 1.573 1.856 0 O-C-N 120.731 -1.231 . . . . 0.0 113.342 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.18 -38.91 81.76 Favored 'Trans proline' 0 CA--C 1.569 2.258 0 C-N-CA 123.39 2.727 . . . . 0.0 119.094 163.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -87.06 -52.23 5.55 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -96.86 78.87 2.88 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 122.323 1.058 . . . . 0.0 113.286 -172.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.36 -11.2 60.19 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 120.316 3.45 . . . . 0.0 120.316 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.0 m -73.69 -2.96 25.41 Favored 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 173.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.58 178.85 6.18 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.451 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . -178.31 -172.4 42.67 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 116.942 1.537 . . . . 0.0 116.942 175.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.3 105.9 1.0 Allowed 'General case' 0 CA--C 1.583 2.234 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.819 HD13 ' H ' ' A' ' 66' ' ' ILE 0.26 0.0 OUTLIER -28.08 87.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.063 0 N-CA-C 119.276 3.065 . . . . 0.0 119.276 167.261 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -88.67 140.5 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 C-N-CA 124.483 1.113 . . . . 0.0 112.88 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -80.53 96.3 6.75 Favored 'General case' 0 CA--C 1.569 1.7 0 O-C-N 120.806 -1.184 . . . . 0.0 111.399 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.33 141.35 39.75 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.482 0.658 . . . . 0.0 112.415 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.2 p -84.28 66.75 9.51 Favored 'General case' 0 CA--C 1.571 1.788 0 O-C-N 120.828 -1.17 . . . . 0.0 113.284 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 . . . . . 0 CA--C 1.56 1.365 0 CA-C-O 125.109 2.385 . . . . 0.0 114.279 -179.057 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.567 1.622 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -81.91 -29.57 32.29 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.44 59.26 2.86 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -91.38 20.84 4.9 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 118.997 2.962 . . . . 0.0 118.997 -175.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.85 128.36 35.37 Favored 'General case' 0 CA--C 1.577 2.0 0 C-N-CA 123.976 0.91 . . . . 0.0 113.235 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mt -109.35 141.55 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.885 -1.134 . . . . 0.0 110.356 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.339 12.7 pt-20 -100.78 118.7 37.38 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 124.014 1.864 . . . . 0.0 110.664 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.285 21.2 ttt -159.26 38.5 0.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.603 -2.544 . . . . 0.0 117.312 -148.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.783 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.531 0.0 OUTLIER -123.11 -175.91 3.29 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 120.01 3.337 . . . . 0.0 120.01 -173.201 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.9 -110.97 1.09 Allowed Glycine 0 N--CA 1.481 1.7 1 N-CA-C 123.653 4.221 . . . . 0.0 123.653 -163.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.1 m -102.89 131.01 50.11 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.476 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 83.8 t -63.46 107.19 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.601 2.913 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.318 98.4 mt -86.33 -36.02 19.51 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 118.813 -2.429 . . . . 0.0 111.98 173.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -128.21 147.05 50.56 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 123.149 1.452 . . . . 0.0 110.563 164.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.3 p -108.89 105.08 14.48 Favored 'General case' 0 N--CA 1.511 2.615 1 N-CA-C 99.889 -4.115 . . . . 0.0 99.889 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.356 0.4 OUTLIER -74.06 -178.78 0.82 Allowed Pre-proline 0 CA--C 1.592 2.584 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -165.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -55.24 -40.91 83.21 Favored 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 123.886 3.057 . . . . 0.0 120.036 -174.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -83.13 -92.95 0.07 Allowed 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.4 m -157.58 73.87 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.7 mtt -124.14 166.63 15.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.964 0.887 . . . . 0.0 112.658 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 46' ' ' ILE . 57.5 m-85 -127.84 110.88 13.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -165.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -84.22 92.02 7.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 171.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.495 HG21 HG21 ' A' ' 54' ' ' VAL . 1.4 t -99.72 134.03 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -164.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -83.26 115.11 21.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.567 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.264 0.1 OUTLIER -69.54 177.05 3.1 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 178.881 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.6 -14.24 40.66 Favored 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 167.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.567 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 23.7 t30 -92.12 -3.82 55.15 Favored 'General case' 0 CA--C 1.586 2.362 0 O-C-N 121.352 -0.843 . . . . 0.0 112.845 167.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.46 -5.38 81.28 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 119.182 2.433 . . . . 0.0 119.182 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -86.93 142.17 28.19 Favored 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 124.071 0.948 . . . . 0.0 110.388 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.8 131.4 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 CA-C-O 122.476 1.131 . . . . 0.0 112.831 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 m -130.97 150.25 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.5 m -92.62 124.88 36.96 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.263 -1.523 . . . . 0.0 110.801 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.77 170.16 16.4 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -120.23 136.04 54.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.736 -1.227 . . . . 0.0 112.518 174.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.559 HD13 ' HG3' ' A' ' 40' ' ' ARG 0.349 0.0 OUTLIER -79.56 146.92 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.068 0 O-C-N 120.541 -1.349 . . . . 0.0 109.304 176.211 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.97 92.25 1.63 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 119.434 -2.041 . . . . 0.0 113.88 -170.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -42.69 -30.34 0.91 Allowed Glycine 0 N--CA 1.491 2.327 1 N-CA-C 123.944 4.338 . . . . 0.0 123.944 -173.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -54.32 -49.46 69.64 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.94 -45.2 11.03 Favored 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 125.903 1.681 . . . . 0.0 114.717 170.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.559 ' HG3' HD13 ' A' ' 35' ' ' ILE 0.28 3.9 mmp_? -82.42 -40.58 21.03 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.203 1.801 . . . . 0.0 115.185 -166.035 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -92.91 40.03 1.05 Allowed 'General case' 0 CA--C 1.586 2.358 0 CA-C-O 122.52 1.152 . . . . 0.0 113.284 164.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -96.55 -43.93 7.38 Favored 'General case' 0 CA--C 1.576 1.945 0 C-N-CA 124.949 1.299 . . . . 0.0 108.45 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . 0.278 35.2 p90 -68.54 -113.34 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 126.04 1.736 . . . . 0.0 109.81 162.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.45 -91.26 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.71 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -147.85 172.41 14.19 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 124.035 1.874 . . . . 0.0 109.957 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.508 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.252 1.1 pp -89.79 152.67 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.984 170.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -86.93 160.32 18.73 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 -166.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 m -73.57 83.81 1.54 Allowed 'General case' 0 CA--C 1.571 1.751 0 CA-C-O 123.854 1.787 . . . . 0.0 111.001 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.476 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 129.47 22.2 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 CA-C-N 112.982 -1.917 . . . . 0.0 116.813 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -91.61 160.14 15.54 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 123.331 1.538 . . . . 0.0 112.332 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -87.71 94.35 9.71 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 125.719 2.676 . . . . 0.0 113.518 -175.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.41 HG23 HG11 ' A' ' 23' ' ' VAL . 21.7 m -99.8 145.78 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-N 109.757 -3.383 . . . . 0.0 110.122 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.7 m -137.07 112.02 8.93 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.783 ' H ' ' HB2' ' A' ' 9' ' ' GLN 0.251 24.2 t -116.32 130.64 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.531 -159.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -88.4 136.46 32.97 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.006 0.907 . . . . 0.0 112.397 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.25 -169.98 2.24 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.64 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 58' ' ' PRO . 0.5 OUTLIER -153.83 166.0 16.66 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 120.321 -1.487 . . . . 0.0 111.395 175.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -35.1 -48.87 0.77 Allowed 'Trans proline' 0 CA--C 1.561 1.828 1 N-CA-C 122.778 4.107 . . . . 0.0 122.778 173.348 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.5 -29.76 52.67 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.825 1.298 . . . . 0.0 113.992 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -96.65 69.91 2.54 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 114.106 -1.406 . . . . 0.0 113.474 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.5 mt -87.09 -41.3 13.92 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -76.88 5.56 7.67 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -143.09 173.77 11.27 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 120.991 1.723 . . . . 0.0 114.953 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.95 -165.53 34.0 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -155.86 122.64 5.28 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.539 -1.565 . . . . 0.0 113.554 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.725 HD12 ' H ' ' A' ' 66' ' ' ILE . 1.8 mp -45.81 113.15 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 172.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -94.06 -70.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.21 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -165.73 132.11 2.66 Favored 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.68 1.192 . . . . 0.0 110.183 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.0 ttt85 -87.19 71.5 10.07 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.456 -1.402 . . . . 0.0 112.111 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.4 m -163.26 74.75 0.36 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.436 1.094 . . . . 0.0 109.257 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 123.839 1.78 . . . . 0.0 112.169 -178.423 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.564 1.494 0 CA-C-O 121.628 0.728 . . . . 0.0 112.574 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -152.42 -74.94 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.453 -0.779 . . . . 0.0 110.375 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.32 8.3 tp10 -115.31 -117.06 0.32 Allowed 'General case' 0 CA--C 1.565 1.528 0 CA-C-O 122.766 1.27 . . . . 0.0 109.915 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -100.65 134.38 43.7 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 125.63 1.572 . . . . 0.0 114.881 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -72.65 116.1 12.72 Favored 'General case' 0 CA--C 1.573 1.839 0 O-C-N 121.071 -1.018 . . . . 0.0 111.53 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mt -97.48 143.96 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.287 1.035 . . . . 0.0 111.29 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.325 11.1 pt-20 -92.86 120.45 33.22 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 125.525 2.583 . . . . 0.0 108.305 168.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.282 16.1 ttt -167.16 81.29 0.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 108.873 -3.785 . . . . 0.0 105.308 -150.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.557 ' HB3' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -97.33 -152.55 0.39 Allowed 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -158.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . -164.38 -173.42 33.01 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 120.411 2.924 . . . . 0.0 120.411 -172.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.8 m -98.49 127.96 44.64 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 57.4 t -60.55 117.09 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.912 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 175.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.285 68.2 mt -101.34 -16.88 16.77 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 119.786 -1.822 . . . . 0.0 113.467 170.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -146.8 141.52 26.77 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.956 1.36 . . . . 0.0 109.621 160.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.3 p -94.56 100.62 12.56 Favored 'General case' 0 N--CA 1.516 2.825 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 169.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.282 6.0 mt -79.78 154.26 75.7 Favored Pre-proline 0 CA--C 1.594 2.644 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.873 -166.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.399 2.3 Cg_endo 2.11 -78.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.57 2.324 2 C-N-CA 126.777 4.985 . . . . 0.0 124.997 -171.618 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.29 -77.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 120.64 1.564 . . . . 0.0 110.877 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -156.38 76.03 0.88 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtt -119.69 -177.3 3.36 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.517 0.727 . . . . 0.0 111.708 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.493 ' CE1' HD11 ' A' ' 46' ' ' ILE . 57.1 m-85 -146.74 108.32 4.31 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 119.669 -1.894 . . . . 0.0 106.735 -166.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -86.9 94.52 9.61 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.3 t -102.86 135.73 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -163.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.55 111.75 21.55 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.532 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.286 0.1 OUTLIER -78.6 171.46 15.09 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 124.116 1.912 . . . . 0.0 115.782 -176.704 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.34 -13.96 44.81 Favored 'General case' 0 CA--C 1.578 2.056 0 CA-C-N 112.454 -2.157 . . . . 0.0 114.652 167.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.532 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 46.0 t30 -83.64 -11.21 57.56 Favored 'General case' 0 CA--C 1.587 2.371 0 CA-C-N 119.334 0.97 . . . . 0.0 113.337 164.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.84 -22.18 40.76 Favored Glycine 0 CA--C 1.549 2.216 0 N-CA-C 118.351 2.1 . . . . 0.0 118.351 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -79.71 143.38 34.61 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.122 0.969 . . . . 0.0 112.168 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.7 t -83.75 121.33 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 122.447 1.118 . . . . 0.0 109.507 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.54 144.36 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.801 -175.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.7 m -86.79 126.33 34.54 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.489 -1.382 . . . . 0.0 110.574 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.93 159.37 42.29 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -119.5 164.86 15.17 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 168.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -78.47 171.8 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.594 2.65 0 O-C-N 120.562 -1.336 . . . . 0.0 110.906 168.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.1 p -76.19 14.11 0.79 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 120.353 3.464 . . . . 0.0 120.353 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.83 -47.86 0.78 Allowed Glycine 0 N--CA 1.5 2.953 0 N-CA-C 117.819 1.888 . . . . 0.0 117.819 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -63.21 -51.13 67.54 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 126.54 1.936 . . . . 0.0 115.289 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ptm -70.16 -17.94 63.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 118.607 2.817 . . . . 0.0 118.607 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -39.14 -34.05 0.16 Allowed 'General case' 0 CA--C 1.583 2.244 0 CA-C-N 121.772 2.078 . . . . 0.0 116.443 167.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm -93.56 40.52 1.07 Allowed 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 173.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -157.56 -68.81 0.1 Allowed 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -93.38 101.18 13.4 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 165.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.27 20.9 mt -72.66 -77.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.768 -1.207 . . . . 0.0 111.444 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -136.61 171.09 15.0 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-O 125.988 2.804 . . . . 0.0 114.013 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.493 HD11 ' CE1' ' A' ' 21' ' ' PHE . 1.8 pt -147.08 167.18 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 109.959 -3.291 . . . . 0.0 109.581 -172.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.279 1.3 pt? -122.73 -174.71 2.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 111.262 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.255 94.2 m -75.25 87.12 2.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 123.376 1.56 . . . . 0.0 113.399 -175.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 133.77 22.7 0.74 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.62 170.33 9.28 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 125.389 1.475 . . . . 0.0 114.77 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -81.6 118.55 22.87 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 125.342 2.496 . . . . 0.0 112.402 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.08 149.1 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 109.761 -3.381 . . . . 0.0 111.265 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.557 ' HA ' ' HB3' ' A' ' 9' ' ' GLN 0.311 89.3 m -94.42 162.39 13.84 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 162.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.455 ' N ' ' HB3' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -158.07 87.03 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 O-C-N 118.452 -2.655 . . . . 0.0 105.104 -179.234 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -76.86 140.62 40.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.09 -1.006 . . . . 0.0 110.059 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.96 -167.53 2.8 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 121.7 0.762 . . . . 0.0 112.582 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -99.52 160.46 27.39 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -56.8 -42.53 63.74 Favored 'Trans proline' 0 CA--C 1.57 2.312 0 N-CA-C 118.756 2.56 . . . . 0.0 118.756 164.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -92.24 -45.02 8.44 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -174.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -102.0 81.9 2.17 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.068 0.937 . . . . 0.0 112.685 -173.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.05 41.04 0.73 Allowed 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.7 m -101.47 -20.98 14.89 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -137.52 178.77 6.85 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 124.761 1.225 . . . . 0.0 113.593 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.0 -171.08 43.11 Favored Glycine 0 CA--C 1.551 2.314 0 O-C-N 121.468 -0.77 . . . . 0.0 114.687 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.96 121.53 2.81 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.584 ' H ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -40.0 92.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 119.346 -2.096 . . . . 0.0 116.216 166.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.272 0.2 OUTLIER -70.92 -67.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.652 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.931 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -140.41 84.43 1.95 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.404 1.456 . . . . 0.0 112.513 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -108.49 86.42 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.2 m -152.75 -80.47 0.1 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.597 -1.314 . . . . 0.0 112.012 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 . . . . . 0 CA--C 1.555 1.155 0 CA-C-O 124.842 2.258 . . . . 0.0 111.428 -176.307 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.328 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.292 56.2 mtpt 69.47 -74.7 0.08 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.297 0.3 OUTLIER -112.14 -113.67 0.33 Allowed 'General case' 0 CA--C 1.564 1.49 0 CA-C-O 122.522 1.153 . . . . 0.0 109.463 179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -100.5 113.87 27.01 Favored 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 125.206 1.402 . . . . 0.0 114.395 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -157.14 139.99 15.17 Favored 'General case' 0 CA--C 1.576 1.953 0 C-N-CA 124.079 0.952 . . . . 0.0 110.489 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.02 140.31 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.492 -1.38 . . . . 0.0 110.249 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.382 11.3 pt-20 -99.23 120.48 39.61 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 124.466 2.079 . . . . 0.0 110.778 169.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 20.2 ttt -170.69 76.94 0.07 Allowed 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 110.565 -3.016 . . . . 0.0 110.764 -149.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.587 ' HB2' ' HB ' ' A' ' 54' ' ' VAL 0.608 0.0 OUTLIER -143.13 -166.13 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 119.231 3.049 . . . . 0.0 119.231 175.548 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 -111.16 1.19 Allowed Glycine 0 CA--C 1.542 1.764 0 N-CA-C 121.871 3.508 . . . . 0.0 121.871 -164.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -122.35 139.43 53.84 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.502 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 60.6 t -67.25 101.21 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.605 3.058 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.96 -44.2 61.41 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 117.947 -2.971 . . . . 0.0 113.39 171.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.25 148.89 47.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.305 1.05 . . . . 0.0 110.857 167.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 p -102.16 101.62 11.96 Favored 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 168.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.274 5.5 mt -79.86 150.55 72.43 Favored Pre-proline 0 CA--C 1.59 2.484 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.031 -164.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.413 3.0 Cg_exo 8.62 -77.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.351 2 C-N-CA 126.624 4.883 . . . . 0.0 124.378 -170.126 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -79.31 -81.67 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.017 1.281 . . . . 0.0 110.461 174.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.4 m -149.23 74.79 1.26 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.274 61.3 mtt -118.79 -175.83 2.98 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.221 -0.925 . . . . 0.0 111.521 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.601 ' HE2' HG22 ' A' ' 35' ' ' ILE . 58.1 m-85 -147.35 107.87 4.11 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 -166.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -86.35 96.21 9.92 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.7 t -103.81 133.04 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -162.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.38 110.19 21.49 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.301 0.5 OUTLIER -56.25 179.22 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 -175.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.44 -25.47 66.76 Favored 'General case' 0 CA--C 1.58 2.11 0 CA-C-N 113.55 -1.659 . . . . 0.0 114.375 165.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.25 1.5 m-20 -78.87 -12.46 60.03 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 169.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.41 5.98 74.75 Favored Glycine 0 CA--C 1.562 2.984 0 N-CA-C 117.432 1.733 . . . . 0.0 117.432 -169.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -90.94 132.36 36.0 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.391 1.596 . . . . 0.0 112.701 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.14 125.38 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.73 -1.231 . . . . 0.0 111.698 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.42 154.5 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 122.287 1.041 . . . . 0.0 113.126 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 m -88.36 127.19 35.49 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.178 -1.576 . . . . 0.0 111.095 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.2 168.88 18.69 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -138.87 141.21 38.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.675 0.79 . . . . 0.0 111.802 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.601 HG22 ' HE2' ' A' ' 21' ' ' PHE 0.3 0.0 OUTLIER -73.13 137.84 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 O-C-N 120.202 -1.561 . . . . 0.0 110.372 173.259 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.33 128.34 35.2 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 120.786 -1.196 . . . . 0.0 112.566 -171.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.39 -27.67 4.22 Favored Glycine 0 N--CA 1.508 3.491 0 N-CA-C 119.276 2.471 . . . . 0.0 119.276 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -58.22 -51.36 70.09 Favored 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 125.898 1.679 . . . . 0.0 114.243 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.4 ptm -78.53 -32.68 48.11 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -39.35 -38.0 0.5 Allowed 'General case' 0 CA--C 1.578 2.042 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -93.42 29.99 1.83 Allowed 'General case' 0 CA--C 1.583 2.223 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -144.01 -66.34 0.35 Allowed 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -75.86 96.84 3.79 Favored 'General case' 0 CA--C 1.571 1.764 0 C-N-CA 125.652 1.581 . . . . 0.0 109.571 167.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.62 111.44 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-O 124.026 1.869 . . . . 0.0 106.552 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -40.51 168.97 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.095 1 N-CA-C 124.101 4.852 . . . . 0.0 124.101 -166.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -106.67 165.24 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 109.32 -3.582 . . . . 0.0 116.749 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.1 tp -121.44 179.14 4.53 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 122.319 1.057 . . . . 0.0 112.204 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -69.47 97.07 0.96 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 123.415 1.578 . . . . 0.0 113.28 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.502 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 115.74 20.82 5.23 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 117.884 1.914 . . . . 0.0 117.884 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -91.78 160.72 15.19 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 123.119 1.437 . . . . 0.0 111.899 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -88.05 116.78 26.48 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 124.932 2.301 . . . . 0.0 112.561 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.52 152.22 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.92 0 CA-C-N 110.437 -3.074 . . . . 0.0 111.822 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.5 m -142.86 113.92 7.69 Favored 'General case' 0 N--CA 1.502 2.13 1 N-CA-C 100.052 -4.055 . . . . 0.0 100.052 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 9' ' ' GLN . 74.5 t -128.41 124.89 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 112.459 -2.155 . . . . 0.0 107.1 -155.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -78.58 135.33 37.25 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -133.88 -178.02 4.83 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.051 1.34 . . . . 0.0 108.518 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -94.72 164.12 20.57 Favored Pre-proline 0 CA--C 1.575 1.933 0 O-C-N 119.964 -1.71 . . . . 0.0 114.209 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -61.16 -38.2 68.73 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 C-N-CA 123.982 3.122 . . . . 0.0 116.709 166.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -89.91 -54.63 3.96 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.056 -1.883 . . . . 0.0 115.589 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -102.86 80.37 1.88 Allowed 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 122.423 1.106 . . . . 0.0 113.033 -171.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.5 mp -78.66 1.62 22.22 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 120.363 3.468 . . . . 0.0 120.363 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.3 t -70.37 -9.49 56.4 Favored 'General case' 0 CA--C 1.579 2.06 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -130.98 -177.12 4.24 Favored 'General case' 0 CA--C 1.576 1.95 0 CA-C-N 120.182 1.356 . . . . 0.0 113.069 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.5 174.55 40.54 Favored Glycine 0 CA--C 1.555 2.579 0 N-CA-C 117.919 1.928 . . . . 0.0 117.919 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -154.28 111.82 3.45 Favored 'General case' 0 CA--C 1.597 2.763 0 O-C-N 120.639 -1.507 . . . . 0.0 112.845 169.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.586 HD11 ' CG ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -47.52 103.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 O-C-N 118.554 -2.591 . . . . 0.0 115.204 172.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 m -96.45 -15.48 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 N-CA-C 120.01 3.337 . . . . 0.0 120.01 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -14.24 -68.65 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 121.071 3.73 . . . . 0.0 121.071 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -101.28 45.51 0.97 Allowed 'General case' 0 CA--C 1.579 2.09 0 CA-C-N 119.475 1.034 . . . . 0.0 113.538 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.3 p -148.8 -95.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.411 -1.43 . . . . 0.0 112.523 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 . . . . . 0 CA--C 1.56 1.36 0 CA-C-O 124.945 2.307 . . . . 0.0 111.214 -175.635 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.52 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -72.06 -39.13 69.25 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -79.47 31.0 0.23 Allowed 'General case' 0 CA--C 1.582 2.19 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -148.78 -160.6 1.2 Allowed 'General case' 0 CA--C 1.575 1.92 0 O-C-N 120.642 -1.286 . . . . 0.0 108.951 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -77.46 101.41 6.41 Favored 'General case' 0 CA--C 1.573 1.863 0 O-C-N 120.132 -1.605 . . . . 0.0 109.411 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mt -87.04 141.63 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.436 -1.415 . . . . 0.0 111.521 -170.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.333 12.9 pt-20 -97.45 122.98 41.13 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 123.676 1.703 . . . . 0.0 110.092 169.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.29 13.1 ttt -155.49 10.02 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 -150.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.783 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.532 0.2 OUTLIER -98.55 -161.64 0.89 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 120.79 3.626 . . . . 0.0 120.79 -166.679 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.42 -106.06 0.52 Allowed Glycine 0 N--CA 1.487 2.067 1 N-CA-C 123.86 4.304 . . . . 0.0 123.86 -163.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m -106.52 131.32 53.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.561 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 65.6 t -66.54 105.43 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.608 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 172.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.308 82.6 mt -85.91 -29.18 23.83 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.555 -1.966 . . . . 0.0 112.254 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.4 tp10 -139.14 149.32 44.34 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.194 -0.941 . . . . 0.0 110.64 164.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' MET . 4.2 p -96.01 116.67 29.3 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 101.536 -3.505 . . . . 0.0 101.536 167.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' HB3' ' CD ' ' A' ' 17' ' ' PRO 0.394 6.5 mt -76.83 -108.22 0.0 OUTLIER Pre-proline 0 CA--C 1.598 2.818 0 CA-C-O 113.683 -3.056 . . . . 0.0 112.311 -158.295 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.47 ' CD ' ' HB3' ' A' ' 16' ' ' LEU . 92.9 Cg_endo -82.3 -69.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.574 2.494 1 CA-C-N 130.138 4.657 . . . . 0.0 115.038 177.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -83.45 -71.96 0.48 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 120.369 1.44 . . . . 0.0 111.945 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -151.24 71.56 1.01 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 15' ' ' THR 0.374 74.4 mtp -114.23 -166.27 1.09 Allowed 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.073 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.556 ' HB3' HG22 ' A' ' 23' ' ' VAL . 52.6 m-85 -156.66 109.46 2.57 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 124.864 3.483 . . . . 0.0 109.859 -163.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -88.85 96.97 10.91 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.58 HG21 HG21 ' A' ' 54' ' ' VAL . 1.8 t -104.77 136.35 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -163.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -92.09 112.58 24.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 170.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.542 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.251 0.1 OUTLIER -69.13 176.32 3.3 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 179.425 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -15.11 53.5 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 167.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.542 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 39.8 t30 -89.98 -6.46 55.62 Favored 'General case' 0 CA--C 1.585 2.292 0 CA-C-N 118.895 0.771 . . . . 0.0 112.628 168.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.71 -13.7 61.95 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 118.598 2.199 . . . . 0.0 118.598 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -78.25 135.3 37.54 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.278 1.031 . . . . 0.0 110.945 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.3 t -85.69 129.57 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 CA-C-O 123.017 1.389 . . . . 0.0 111.629 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.24 156.3 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 114.113 -1.403 . . . . 0.0 112.804 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -98.29 124.57 42.98 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.581 -1.325 . . . . 0.0 110.152 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.02 161.16 39.48 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 118.316 2.709 . . . . 0.0 118.316 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.57 -179.87 4.04 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 164.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.73 169.66 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.557 0 O-C-N 119.588 -1.945 . . . . 0.0 107.82 157.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.3 p -73.24 17.05 0.14 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 117.671 -3.143 . . . . 0.0 119.362 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.15 -51.2 0.76 Allowed Glycine 0 N--CA 1.499 2.886 0 N-CA-C 118.01 1.964 . . . . 0.0 118.01 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.53 -46.26 89.19 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 126.39 1.876 . . . . 0.0 115.451 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.402 ' SD ' ' O ' ' A' ' 67' ' ' VAL . 1.0 OUTLIER -73.41 -17.02 61.31 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 175.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -38.67 -38.45 0.41 Allowed 'General case' 0 CA--C 1.582 2.178 0 CA-C-N 122.838 2.563 . . . . 0.0 116.895 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -94.17 33.96 1.31 Allowed 'General case' 0 CA--C 1.585 2.314 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -148.12 -64.52 0.25 Allowed 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -78.66 93.47 4.89 Favored 'General case' 0 CA--C 1.571 1.766 0 C-N-CA 125.346 1.458 . . . . 0.0 108.623 166.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.5 mt -69.54 107.02 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.535 0 CA-C-O 124.554 2.121 . . . . 0.0 105.939 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.16 174.97 0.01 OUTLIER 'General case' 0 CA--C 1.577 1.986 1 N-CA-C 121.891 4.034 . . . . 0.0 121.891 -161.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 pt -119.36 167.73 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 111.082 -2.781 . . . . 0.0 115.194 -164.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.2 tp -125.93 -177.58 3.99 Favored 'General case' 0 CA--C 1.573 1.847 0 CA-C-O 122.038 0.923 . . . . 0.0 112.662 -171.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 m -68.34 95.55 0.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.475 1.607 . . . . 0.0 113.712 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.561 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 119.08 19.39 4.35 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 118.281 2.073 . . . . 0.0 118.281 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.33 163.31 13.65 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 122.953 1.359 . . . . 0.0 112.919 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -86.54 117.55 25.39 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 124.772 2.225 . . . . 0.0 112.949 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -121.85 157.6 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.692 0 CA-C-N 110.654 -2.975 . . . . 0.0 111.484 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.4 m -150.4 106.83 3.49 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 100.506 -3.887 . . . . 0.0 100.506 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.783 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 27.3 t -112.21 130.73 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 111.413 -2.63 . . . . 0.0 107.945 -161.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -83.67 136.98 34.0 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 121.163 -0.961 . . . . 0.0 111.876 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.285 2.2 pt? -123.97 -168.59 1.81 Allowed 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 121.252 0.549 . . . . 0.0 110.705 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.0 p -118.48 160.57 39.33 Favored Pre-proline 0 CA--C 1.572 1.807 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.73 -41.15 63.46 Favored 'Trans proline' 0 CA--C 1.569 2.235 0 C-N-CA 123.626 2.884 . . . . 0.0 118.773 164.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -88.85 -54.45 4.13 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -99.66 79.49 2.26 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 122.421 1.105 . . . . 0.0 112.716 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mp -70.19 -22.49 62.94 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -72.31 4.4 3.74 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -124.22 -174.55 3.03 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.462 1.483 . . . . 0.0 114.538 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.02 168.05 39.7 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 120.068 2.787 . . . . 0.0 120.068 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -153.39 110.2 3.42 Favored 'General case' 0 CA--C 1.594 2.669 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 167.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.716 ' H ' HD12 ' A' ' 66' ' ' ILE . 3.2 mp -44.05 104.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 O-C-N 117.437 -3.289 . . . . 0.0 115.86 168.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' O ' ' SD ' ' A' ' 39' ' ' MET . 14.2 m -95.83 -43.05 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.033 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.927 171.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.285 1.2 t80 55.05 -88.15 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 172.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -134.47 27.98 3.69 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.1 t -152.71 -77.82 0.12 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.644 -1.285 . . . . 0.0 112.693 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 124.308 2.004 . . . . 0.0 110.382 -174.033 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.559 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -72.89 -79.52 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.163 -0.96 . . . . 0.0 113.002 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pm0 -79.94 45.51 0.72 Allowed 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -119.06 47.79 1.6 Allowed 'General case' 0 CA--C 1.58 2.116 0 CA-C-O 123.971 1.843 . . . . 0.0 111.667 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -49.3 125.53 11.15 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -170.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.55 151.84 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.372 1.069 . . . . 0.0 109.631 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.279 8.1 pt-20 -108.51 124.74 50.92 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 123.831 1.777 . . . . 0.0 109.833 168.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.3 10.2 ttt -153.17 3.66 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 -151.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.753 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.533 0.0 OUTLIER -86.04 -166.31 1.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 121.287 3.81 . . . . 0.0 121.287 -166.905 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.19 -112.4 0.99 Allowed Glycine 0 N--CA 1.48 1.613 0 N-CA-C 121.45 3.34 . . . . 0.0 121.45 -164.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -102.29 130.23 48.93 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.441 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 99.6 t -63.9 111.51 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.881 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 171.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.324 58.6 mt -92.85 -34.04 13.99 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 122.585 2.448 . . . . 0.0 112.21 172.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.03 148.38 50.54 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-O 122.776 1.274 . . . . 0.0 109.922 163.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.9 p -105.52 106.23 16.63 Favored 'General case' 0 N--CA 1.513 2.675 0 N-CA-C 100.75 -3.796 . . . . 0.0 100.75 171.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.507 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.441 4.4 mt -82.8 -138.4 0.0 OUTLIER Pre-proline 0 CA--C 1.604 3.056 0 CA-C-O 115.033 -2.413 . . . . 0.0 113.779 -160.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 62.8 Cg_endo -73.66 -73.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 1 CA-C-N 129.599 4.464 . . . . 0.0 117.766 -172.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -63.66 -67.35 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.979 -1.076 . . . . 0.0 111.965 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -169.7 79.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.5 mtt -119.93 177.37 5.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.607 0.763 . . . . 0.0 112.589 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HB3' HG22 ' A' ' 23' ' ' VAL . 57.2 m-85 -145.6 109.68 4.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -165.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -85.3 94.92 9.05 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 168.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -100.23 133.16 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -164.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -93.31 113.19 25.31 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 26' ' ' GLU 0.358 0.2 OUTLIER -53.93 -179.13 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 120.662 3.579 . . . . 0.0 120.662 -176.238 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.557 ' H ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -70.34 -28.72 65.37 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 112.212 -2.267 . . . . 0.0 114.347 167.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -90.91 4.54 51.61 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 168.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.18 8.22 78.79 Favored Glycine 0 CA--C 1.549 2.199 0 N-CA-C 119.432 2.533 . . . . 0.0 119.432 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -91.54 140.29 29.88 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.197 2.498 . . . . 0.0 113.081 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.61 123.85 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 O-C-N 120.799 -1.188 . . . . 0.0 112.029 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 m -131.33 152.14 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.0 m -91.46 130.25 37.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.548 -1.345 . . . . 0.0 110.712 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.14 155.49 43.33 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -104.32 177.49 4.83 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 123.349 1.547 . . . . 0.0 108.573 165.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.527 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -87.42 161.17 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.52 0 O-C-N 120.313 -1.492 . . . . 0.0 108.771 166.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 90.8 p -78.18 24.87 0.24 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 119.864 3.283 . . . . 0.0 119.864 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.52 -45.7 1.03 Allowed Glycine 0 N--CA 1.501 3.032 0 N-CA-C 116.645 1.418 . . . . 0.0 116.645 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -58.9 -48.56 81.0 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 127.061 2.144 . . . . 0.0 116.568 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.513 ' SD ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.85 -21.88 61.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 118.487 2.773 . . . . 0.0 118.487 177.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -41.97 -34.02 0.64 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 171.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -84.55 -11.17 56.57 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 118.795 2.887 . . . . 0.0 118.795 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -89.75 -72.63 0.55 Allowed 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -101.96 132.03 48.02 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.55 1.14 . . . . 0.0 109.38 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.7 mt -70.64 -51.06 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 O-C-N 120.285 -1.509 . . . . 0.0 110.235 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -130.52 174.63 9.71 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 124.634 2.159 . . . . 0.0 113.053 171.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.418 HD11 ' CE1' ' A' ' 21' ' ' PHE 0.286 0.7 OUTLIER -135.05 161.11 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-N 112.685 -2.052 . . . . 0.0 108.773 175.363 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.48 159.74 18.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.717 -1.24 . . . . 0.0 113.923 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.1 m -75.08 79.12 2.24 Favored 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 123.884 1.802 . . . . 0.0 110.59 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 136.6 22.3 0.55 Allowed Glycine 0 N--CA 1.491 2.349 0 CA-C-N 113.182 -1.827 . . . . 0.0 116.802 -176.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -92.16 159.49 15.63 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 122.869 1.319 . . . . 0.0 112.81 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -90.57 85.5 6.13 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 125.598 2.618 . . . . 0.0 114.032 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.97 158.09 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.021 0 CA-C-N 109.818 -3.356 . . . . 0.0 111.771 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -146.89 112.7 5.71 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 101.387 -3.561 . . . . 0.0 101.387 174.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.753 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 40.3 t -117.77 131.19 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 111.988 -2.369 . . . . 0.0 107.354 -160.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -83.91 128.59 34.65 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.027 0.917 . . . . 0.0 111.593 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.76 -129.96 0.23 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 p -146.43 167.38 14.04 Favored Pre-proline 0 CA--C 1.569 1.709 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.16 -43.23 19.57 Favored 'Trans proline' 0 CA--C 1.576 2.624 0 C-N-CA 123.09 2.527 . . . . 0.0 115.518 164.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -80.4 -48.24 13.2 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 111.864 -2.426 . . . . 0.0 116.449 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -115.22 88.66 2.92 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 122.507 1.146 . . . . 0.0 112.425 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.32 12.61 5.15 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 118.909 2.929 . . . . 0.0 118.909 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.2 p -75.47 -30.5 59.94 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -140.27 167.82 21.24 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 124.305 1.042 . . . . 0.0 113.103 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.44 -166.61 32.03 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 117.272 1.669 . . . . 0.0 117.272 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -154.94 122.51 5.69 Favored 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.75 ' H ' HD12 ' A' ' 66' ' ' ILE . 1.5 mp -45.11 106.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 CA-C-N 121.753 2.07 . . . . 0.0 114.657 170.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.37 170.05 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.517 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -71.82 80.83 0.88 Allowed 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -94.03 119.06 32.38 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.243 1.017 . . . . 0.0 109.93 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.0 m -81.77 -59.85 2.45 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.619 -0.676 . . . . 0.0 112.744 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 . . . . . 0 CA--C 1.564 1.509 0 CA-C-O 123.686 1.708 . . . . 0.0 113.732 175.629 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 1.529 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.295 61.4 mtpt 71.33 -73.81 0.09 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -86.29 70.91 10.56 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 122.565 1.174 . . . . 0.0 111.594 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -95.67 -161.22 0.85 Allowed 'General case' 0 CA--C 1.575 1.94 0 C-N-CA 124.029 0.931 . . . . 0.0 111.862 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -61.14 114.77 3.31 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 119.454 -2.029 . . . . 0.0 112.162 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -95.39 148.81 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.112 -0.992 . . . . 0.0 111.001 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.314 6.6 pt-20 -98.09 120.26 38.18 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 125.573 2.606 . . . . 0.0 108.31 166.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 18.5 ttt -168.91 87.1 0.17 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 108.795 -3.82 . . . . 0.0 105.053 -150.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.702 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -110.35 -148.99 0.44 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 111.078 -2.783 . . . . 0.0 115.652 -156.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' A' ' 9' ' ' GLN . . . 179.79 -141.89 4.91 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 116.94 1.536 . . . . 0.0 116.94 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.2 m -122.17 134.34 54.73 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.481 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 42.4 t -59.07 114.74 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.871 0 O-C-N 121.689 -0.632 . . . . 0.0 110.187 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.1 mt -82.24 -32.8 29.53 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 119.641 -1.912 . . . . 0.0 111.956 166.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -146.56 141.74 27.29 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.024 1.392 . . . . 0.0 111.025 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.1 p -92.88 110.18 21.63 Favored 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 102.464 -3.161 . . . . 0.0 102.464 169.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.434 3.8 mt -81.83 -133.35 0.0 OUTLIER Pre-proline 0 CA--C 1.602 2.958 0 CA-C-O 114.609 -2.615 . . . . 0.0 114.191 -160.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 69.9 Cg_endo -73.43 -69.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.379 2.163 1 CA-C-N 129.994 4.605 . . . . 0.0 117.086 -174.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -73.01 -76.06 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.126 -0.984 . . . . 0.0 110.318 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -157.73 77.06 0.82 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.2 mtt -121.23 179.13 4.51 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.83 0.852 . . . . 0.0 112.242 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.529 ' CE1' HD11 ' A' ' 46' ' ' ILE . 55.8 m-85 -145.21 109.74 4.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.66 -1.9 . . . . 0.0 106.812 -166.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -84.57 101.92 12.48 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 167.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.4 t -109.77 141.11 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -163.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -93.36 108.04 19.77 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 171.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.57 ' HG ' ' H ' ' A' ' 27' ' ' ASN 0.261 0.1 OUTLIER -77.11 169.27 18.63 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 124.058 1.885 . . . . 0.0 115.047 -176.234 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.271 20.8 pt-20 -68.03 -8.9 41.54 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 112.555 -2.111 . . . . 0.0 114.703 169.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.57 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 15.3 t30 -91.14 -6.45 53.56 Favored 'General case' 0 CA--C 1.588 2.432 0 CA-C-N 119.124 0.874 . . . . 0.0 112.647 164.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.47 -20.9 45.78 Favored Glycine 0 CA--C 1.549 2.182 0 N-CA-C 118.961 2.345 . . . . 0.0 118.961 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -78.09 137.76 38.39 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.735 0.814 . . . . 0.0 111.486 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.45 112.99 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 122.879 1.323 . . . . 0.0 109.304 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 m -102.64 148.91 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 113.932 -1.486 . . . . 0.0 113.661 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.5 m -93.22 120.93 34.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.007 -1.058 . . . . 0.0 108.28 171.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.36 161.41 36.37 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -113.04 -160.6 0.72 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.436 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -115.1 173.79 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.07 0 O-C-N 120.584 -1.323 . . . . 0.0 108.524 166.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.1 p -78.54 100.69 7.03 Favored 'General case' 0 CA--C 1.561 1.382 0 O-C-N 119.254 -2.154 . . . . 0.0 108.39 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -31.69 -30.8 0.01 OUTLIER Glycine 0 N--CA 1.506 3.329 1 N-CA-C 123.852 4.301 . . . . 0.0 123.852 -175.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -62.46 -46.67 87.45 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 174.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 ptm -73.25 -17.82 61.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -39.75 -30.51 0.08 Allowed 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 118.348 2.721 . . . . 0.0 118.348 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -90.55 -5.93 55.34 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.486 HD22 ' HE ' ' A' ' 69' ' ' ARG . 53.0 t-20 -103.9 -66.91 0.92 Allowed 'General case' 0 CA--C 1.578 2.026 0 C-N-CA 126.155 1.782 . . . . 0.0 106.617 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -81.6 98.24 8.25 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 125.509 1.524 . . . . 0.0 107.838 168.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.9 mt -73.3 -71.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.411 -0.805 . . . . 0.0 110.908 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -140.03 171.69 13.82 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 125.853 2.74 . . . . 0.0 115.491 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 21' ' ' PHE . 1.3 pt -142.86 167.86 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 110.56 -3.018 . . . . 0.0 108.483 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.54 177.35 4.71 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.838 1.304 . . . . 0.0 112.822 -173.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.8 m -76.0 83.65 2.88 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 123.36 1.552 . . . . 0.0 110.998 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 134.04 23.31 0.69 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 117.524 1.77 . . . . 0.0 117.524 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.76 160.53 14.72 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 122.858 1.313 . . . . 0.0 113.877 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -87.99 82.46 7.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 125.754 2.693 . . . . 0.0 113.368 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -71.93 163.83 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-N 110.088 -3.233 . . . . 0.0 115.504 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.669 HG23 ' HG3' ' A' ' 9' ' ' GLN 0.355 19.5 m -125.63 78.94 1.78 Allowed 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 124.261 1.981 . . . . 0.0 113.417 170.309 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.702 ' H ' ' HB3' ' A' ' 9' ' ' GLN . 0.2 OUTLIER -75.99 101.3 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 125.813 1.645 . . . . 0.0 109.806 -173.409 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -82.75 140.97 32.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.709 -0.619 . . . . 0.0 109.354 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.21 -116.64 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 110.584 -171.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.42 166.32 17.15 Favored Pre-proline 0 CA--C 1.575 1.907 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -176.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -61.38 -47.36 12.07 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 C-N-CA 123.088 2.526 . . . . 0.0 117.425 166.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -97.46 -43.63 7.18 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -175.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -95.49 77.3 3.35 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.17 49.47 1.66 Allowed 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 94.5 p -106.92 -27.86 10.43 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 125.668 1.587 . . . . 0.0 114.744 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -126.24 -173.49 2.87 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 124.06 0.944 . . . . 0.0 112.736 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.424 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . 174.59 179.73 45.38 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.73 108.27 1.17 Allowed 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 118.895 2.924 . . . . 0.0 118.895 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.512 ' CD1' ' H ' ' A' ' 66' ' ' ILE . 0.9 OUTLIER -26.71 91.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.118 0 N-CA-C 118.889 2.922 . . . . 0.0 118.889 162.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 m -92.14 -18.77 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 N-CA-C 117.271 2.322 . . . . 0.0 117.271 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -79.74 120.55 24.18 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -176.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.486 ' HE ' HD22 ' A' ' 42' ' ' ASN . 39.0 mtt85 -76.42 96.61 4.07 Favored 'General case' 0 CA--C 1.569 1.711 0 O-C-N 121.664 -0.648 . . . . 0.0 111.926 174.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.4 m -75.65 -28.33 58.72 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? . . . . . 0 CA--C 1.561 1.395 0 CA-C-O 125.238 2.447 . . . . 0.0 111.324 178.003 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.565 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.317 21.7 ptmt 47.8 54.47 9.88 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -88.21 69.87 9.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.221 -1.549 . . . . 0.0 110.933 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -107.91 164.94 11.83 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-O 122.708 1.242 . . . . 0.0 112.817 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -79.79 116.17 19.81 Favored 'General case' 0 CA--C 1.572 1.812 0 O-C-N 121.042 -1.036 . . . . 0.0 110.746 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.14 141.97 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.107 -0.996 . . . . 0.0 111.411 -174.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.328 12.5 pt-20 -99.14 124.35 44.1 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.636 1.684 . . . . 0.0 110.224 168.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.284 11.4 ttt -154.71 -8.06 0.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 120.539 3.533 . . . . 0.0 120.539 -151.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.611 ' HB2' ' HB ' ' A' ' 54' ' ' VAL 0.574 0.0 OUTLIER -78.9 -165.35 0.72 Allowed 'General case' 0 N--CA 1.491 1.583 1 N-CA-C 122.053 4.094 . . . . 0.0 122.053 -165.11 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.39 -112.61 1.53 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 122.42 3.728 . . . . 0.0 122.42 -166.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.3 m -110.78 141.11 44.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.532 -0.981 . . . . 0.0 108.363 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.543 ' HB ' ' H ' ' A' ' 49' ' ' GLY . 90.4 t -69.51 101.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.602 2.948 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 174.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 24' ' ' GLU . 2.8 mm? -77.12 -38.38 52.25 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 117.923 -2.985 . . . . 0.0 112.828 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -128.93 145.71 51.15 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.761 1.267 . . . . 0.0 110.762 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 p -95.77 106.0 18.07 Favored 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 101.775 -3.417 . . . . 0.0 101.775 167.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.288 5.7 mt -78.47 166.47 42.64 Favored Pre-proline 0 CA--C 1.593 2.626 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.482 -167.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . 0.385 6.0 Cg_endo -20.54 -57.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.57 2.302 2 N-CA-C 125.459 5.138 . . . . 0.0 125.459 -164.798 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -82.71 -78.34 0.21 Allowed 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 120.651 1.569 . . . . 0.0 109.782 172.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -158.13 72.81 0.64 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.255 67.3 mtm -115.98 -169.61 1.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.681 0.792 . . . . 0.0 110.588 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.531 ' HE2' HG23 ' A' ' 35' ' ' ILE . 62.0 m-85 -148.49 108.15 3.99 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 119.114 -2.241 . . . . 0.0 106.952 -166.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -84.48 97.59 9.62 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' A' ' 21' ' ' PHE . 1.8 t -103.78 133.7 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -164.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' H ' HD23 ' A' ' 13' ' ' LEU . 32.2 tt0 -95.96 111.49 23.47 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 172.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 26' ' ' GLU 0.365 0.2 OUTLIER -52.26 -178.54 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 120.608 3.558 . . . . 0.0 120.608 -176.11 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.62 ' H ' HD23 ' A' ' 25' ' ' LEU . 11.0 pt-20 -69.62 -31.45 69.57 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 112.729 -2.032 . . . . 0.0 113.949 167.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -88.68 6.74 37.05 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.19 13.41 79.06 Favored Glycine 0 CA--C 1.549 2.165 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -95.1 130.01 41.96 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 120.821 2.31 . . . . 0.0 112.561 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.0 t -82.76 124.9 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.438 -1.414 . . . . 0.0 112.333 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.16 149.76 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 114.705 -1.134 . . . . 0.0 113.499 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 m -87.45 127.08 35.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.487 -1.383 . . . . 0.0 110.396 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.4 139.98 28.75 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.71 155.73 17.47 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 168.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.531 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -64.31 170.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.591 2.536 0 O-C-N 120.456 -1.402 . . . . 0.0 112.166 168.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -75.68 92.9 3.01 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 119.226 -2.171 . . . . 0.0 107.902 169.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.81 -38.23 0.01 OUTLIER Glycine 0 N--CA 1.505 3.266 1 N-CA-C 123.314 4.086 . . . . 0.0 123.314 -174.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -54.32 -45.54 72.65 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -73.18 -21.87 60.59 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 173.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -37.06 -39.68 0.25 Allowed 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 123.718 2.963 . . . . 0.0 117.524 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -91.07 47.41 1.4 Allowed 'General case' 0 CA--C 1.582 2.183 0 CA-C-O 124.231 1.967 . . . . 0.0 114.402 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -168.12 -60.36 0.02 OUTLIER 'General case' 0 CA--C 1.581 2.17 0 C-N-CA 128.151 2.581 . . . . 0.0 105.193 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -83.43 68.45 9.73 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 127.144 2.178 . . . . 0.0 114.017 175.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 mt -88.33 71.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.389 84.8 mmt-85 -100.98 -76.02 0.57 Allowed 'General case' 0 N--CA 1.489 1.488 1 N-CA-C 124.465 4.987 . . . . 0.0 124.465 -164.003 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pt -99.77 162.47 3.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 112.116 -2.311 . . . . 0.0 116.678 -157.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -129.45 -174.55 3.32 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.528 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.8 m -70.52 84.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.768 1.27 . . . . 0.0 112.585 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.543 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 132.68 19.22 1.06 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 118.218 2.047 . . . . 0.0 118.218 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.03 157.73 16.62 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-O 123.014 1.388 . . . . 0.0 111.803 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -90.61 94.11 9.56 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 125.217 2.437 . . . . 0.0 113.429 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -97.01 142.46 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.827 0 CA-C-N 109.733 -3.394 . . . . 0.0 111.836 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 m -126.48 119.15 26.47 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 100.62 -3.844 . . . . 0.0 100.62 171.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.611 ' HB ' ' HB2' ' A' ' 9' ' ' GLN 0.252 93.6 t -127.86 125.42 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 112.9 -1.955 . . . . 0.0 106.345 -157.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -79.09 137.97 37.74 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -172.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.275 2.3 pt? -129.03 -171.19 2.42 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 121.625 0.726 . . . . 0.0 111.14 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 p -106.13 164.87 14.05 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -43.04 -51.66 5.38 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 N-CA-C 122.212 3.889 . . . . 0.0 122.212 161.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -110.75 -41.4 4.29 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.61 69.14 6.69 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.859 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.42 -9.09 58.33 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.3 t -69.71 -6.57 32.64 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -124.05 -176.62 3.53 Favored 'General case' 0 CA--C 1.575 1.928 0 CA-C-O 123.211 1.482 . . . . 0.0 113.259 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.89 174.47 43.46 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -153.7 106.74 2.92 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 171.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.525 HD11 ' CD2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -41.3 110.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 117.973 2.582 . . . . 0.0 117.973 173.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.32 -55.83 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 C-N-CA 124.708 1.203 . . . . 0.0 110.444 172.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.254 0.6 OUTLIER 72.7 -50.62 0.7 Allowed 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 118.481 2.771 . . . . 0.0 118.481 174.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 66.54 3.31 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 121.139 1.791 . . . . 0.0 113.943 177.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 m -176.37 -65.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 127.082 2.153 . . . . 0.0 107.17 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 . . . . . 0 CA--C 1.565 1.534 0 CA-C-O 124.919 2.295 . . . . 0.0 107.492 174.83 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.571 1.775 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.283 66.0 mttm 68.06 -75.19 0.07 Allowed 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.23 59.96 5.95 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -127.93 172.65 10.7 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 122.779 1.276 . . . . 0.0 111.259 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -83.42 77.63 9.78 Favored 'General case' 0 CA--C 1.582 2.203 0 O-C-N 120.157 -1.59 . . . . 0.0 108.66 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mt -97.21 144.82 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.112 -1.617 . . . . 0.0 111.095 -170.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.279 7.2 pt-20 -99.84 119.56 38.38 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 124.219 1.961 . . . . 0.0 109.219 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.295 10.8 ttt -154.26 -4.77 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 110.399 -3.091 . . . . 0.0 119.322 -152.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.758 ' HB2' ' H ' ' A' ' 54' ' ' VAL 0.603 0.2 OUTLIER -75.89 -157.85 0.08 Allowed 'General case' 0 CA--C 1.566 1.584 1 N-CA-C 125.778 5.473 . . . . 0.0 125.778 -162.18 . . . . . . . . 5 4 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.43 -150.75 10.2 Favored Glycine 0 CA--C 1.535 1.292 1 N-CA-C 126.29 5.276 . . . . 0.0 126.29 -157.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -101.79 136.53 41.47 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.541 HG22 ' HD1' ' A' ' 21' ' ' PHE . 63.1 t -64.56 111.66 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.588 0 O-C-N 121.074 -1.017 . . . . 0.0 109.332 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.9 -36.56 64.77 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-N 122.738 2.517 . . . . 0.0 111.943 168.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -146.07 147.3 31.46 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 122.32 1.057 . . . . 0.0 111.789 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.93 116.23 28.66 Favored 'General case' 0 N--CA 1.511 2.593 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 169.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.604 ' HB3' ' HD2' ' A' ' 17' ' ' PRO 0.454 1.2 mm? -79.79 -127.71 0.0 OUTLIER Pre-proline 0 CA--C 1.597 2.779 0 CA-C-O 114.369 -2.729 . . . . 0.0 114.81 -164.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 90.9 Cg_endo -67.55 -67.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.566 2.113 1 CA-C-N 130.159 4.664 . . . . 0.0 116.966 -176.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -81.24 -72.94 0.4 Allowed 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.387 -0.82 . . . . 0.0 110.603 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m -157.43 74.31 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.26 89.4 mtp -113.98 -169.57 1.54 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 117.326 -1.321 . . . . 0.0 111.901 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.583 ' HB3' HG22 ' A' ' 23' ' ' VAL . 57.9 m-85 -154.92 112.01 3.33 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 123.366 2.803 . . . . 0.0 111.337 -166.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -93.89 97.61 10.5 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 167.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 21' ' ' PHE . 2.5 t -101.52 141.2 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -163.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -98.35 107.86 20.42 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.0 171.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.264 0.6 OUTLIER -50.47 176.56 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 118.718 2.859 . . . . 0.0 118.718 -177.089 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -22.68 66.31 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 168.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -95.47 6.11 49.84 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.47 -1.58 85.96 Favored Glycine 0 CA--C 1.554 2.52 0 N-CA-C 119.955 2.742 . . . . 0.0 119.955 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -82.63 140.44 33.18 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.834 1.817 . . . . 0.0 113.04 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.3 130.18 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 CA-C-O 122.846 1.307 . . . . 0.0 111.374 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.654 HG21 HE21 ' A' ' 9' ' ' GLN . 13.8 m -131.27 153.03 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.376 -1.284 . . . . 0.0 113.168 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.8 m -98.16 126.1 43.48 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.439 -1.413 . . . . 0.0 110.256 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.42 163.39 34.77 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.6 176.14 5.14 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.825 -1.534 . . . . 0.0 107.63 164.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.497 HG23 ' HE2' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -85.14 171.0 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.59 2.49 0 O-C-N 119.731 -1.856 . . . . 0.0 108.84 161.581 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 p -74.91 27.48 0.09 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 118.26 -2.775 . . . . 0.0 117.988 177.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.06 -49.78 0.18 Allowed Glycine 0 N--CA 1.502 3.048 0 N-CA-C 119.937 2.735 . . . . 0.0 119.937 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -65.62 -52.34 52.73 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.044 2.138 . . . . 0.0 115.499 -177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -18.1 65.1 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -38.43 -39.21 0.43 Allowed 'General case' 0 CA--C 1.575 1.922 0 CA-C-N 122.419 2.372 . . . . 0.0 116.492 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -92.28 32.4 1.19 Allowed 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -149.73 -54.98 0.17 Allowed 'General case' 0 CA--C 1.577 1.991 0 C-N-CA 127.25 2.22 . . . . 0.0 107.141 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -76.46 63.47 2.02 Favored 'General case' 0 CA--C 1.58 2.107 0 C-N-CA 125.605 1.562 . . . . 0.0 112.947 171.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mt -84.98 72.18 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 CA-C-O 124.752 2.215 . . . . 0.0 108.788 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -112.19 -43.19 3.58 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 120.811 3.634 . . . . 0.0 120.811 -169.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.403 0.0 OUTLIER -120.23 160.82 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 1 N-CA-C 122.992 4.442 . . . . 0.0 122.992 -138.901 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.9 tp -159.15 178.67 9.76 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 110.203 -3.18 . . . . 0.0 112.387 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.1 m -68.55 116.02 8.61 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.615 1.198 . . . . 0.0 111.709 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.401 ' H ' ' HB ' ' A' ' 12' ' ' VAL . . . 95.27 14.37 48.42 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 119.371 2.508 . . . . 0.0 119.371 -175.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.46 172.97 8.04 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 124.96 1.304 . . . . 0.0 111.757 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -97.59 136.62 37.72 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 124.516 2.103 . . . . 0.0 115.87 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.06 153.95 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.954 0 CA-C-N 111.51 -2.587 . . . . 0.0 110.901 -171.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.8 m -143.71 102.89 3.99 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 101.978 -3.341 . . . . 0.0 101.978 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.758 ' H ' ' HB2' ' A' ' 9' ' ' GLN . 19.7 t -105.87 132.14 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 111.107 -2.77 . . . . 0.0 108.056 -164.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -82.86 127.54 33.59 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.665 -1.272 . . . . 0.0 111.771 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.321 2.2 pt? -102.0 -165.53 1.2 Allowed 'General case' 0 CA--C 1.566 1.574 0 CA-C-O 121.26 0.552 . . . . 0.0 111.385 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 p -131.74 161.49 62.08 Favored Pre-proline 0 CA--C 1.572 1.813 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -51.54 -43.74 48.37 Favored 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 123.999 3.133 . . . . 0.0 118.843 164.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -95.57 -57.2 2.45 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -95.16 74.08 3.4 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.343 1.068 . . . . 0.0 113.342 -172.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.51 -20.0 65.94 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 118.377 2.732 . . . . 0.0 118.377 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 t -74.98 4.53 6.44 Favored 'General case' 0 CA--C 1.583 2.241 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 171.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 170.71 15.6 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 121.093 1.769 . . . . 0.0 115.516 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.53 -169.19 42.13 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.98 124.9 7.89 Favored 'General case' 0 CA--C 1.59 2.49 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 173.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.776 ' H ' HD12 ' A' ' 66' ' ' ILE . 2.8 mp -43.71 104.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 171.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.1 m -102.23 -63.34 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.069 0 CA-C-N 113.891 -1.504 . . . . 0.0 114.054 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.442 0.0 OUTLIER 10.05 -102.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.049 1 N-CA-C 121.991 4.071 . . . . 0.0 121.991 -172.87 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -147.51 127.32 13.49 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 120.883 1.674 . . . . 0.0 111.635 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.7 p -104.61 81.86 1.83 Allowed 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 122.353 1.073 . . . . 0.0 109.271 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.526 ' HD3' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.225 0 CA-C-O 125.053 2.358 . . . . 0.0 112.332 -178.03 . . . . . . . . 2 2 . 1 stop_ save_